Rank	NCT Number	Title	Status	Study Results	Conditions	Interventions	Phases	Study Type	Locations	URL
1	NCT04372602	Duvelisib to Combat COVID-19	Not yet recruiting	No Results Available	COVID-19	Drug: Duvelisib|Procedure: Peripheral blood draw	Phase 2	Interventional	"Washington University School of Medicine, Saint Louis, Missouri, United States"	https://ClinicalTrials.gov/show/NCT04372602
2	NCT04425538	A Phase 2 Trial of Infliximab in Coronavirus Disease 2019 (COVID-19).	Recruiting	No Results Available	COVID-19	Drug: Infliximab	Phase 2	Interventional	"Tufts Medical Center, Boston, Massachusetts, United States"	https://ClinicalTrials.gov/show/NCT04425538
3	NCT04454307	Safety and Efficacy of Tramadol in COVID-19 Egyptian Patients	Not yet recruiting	No Results Available	COVID-19	Drug: Tramadol|Other: Standard care delivered in the isolation hospitals.	Phase 1|Phase 2	Interventional		https://ClinicalTrials.gov/show/NCT04454307
4	NCT04452435	Safety and Efficacy of C21 in Subjects With COVID-19	Recruiting	No Results Available	COVID-19	Drug: C21|Drug: Placebo	Phase 2	Interventional	"Department of Medicine, Civil Hospital and B J Medical College, Ahmadabad, Gujarat, India|Department of Medicine, Noble Hospitals Pvt. Ltd, Pune, Maharashtra, India|Respiratory Medicine, University College Hospital, London, United Kingdom"	https://ClinicalTrials.gov/show/NCT04452435
5	NCT04333550	Application of Desferal to Treat COVID-19	Recruiting	No Results Available	COVID-19	Drug: Deferoxamine	Phase 1|Phase 2	Interventional	"Regenerative Medicine Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran, Kermanshah, Iran, Islamic Republic of"	https://ClinicalTrials.gov/show/NCT04333550
6	NCT04432987	Dornase Alpha for the Treatment of COVID-19	Recruiting	No Results Available	COVID-19	Drug: Pulmozyme	Phase 2	Interventional	"Acıbadem Altunizade Hospital, Istanbul, Turkey"	https://ClinicalTrials.gov/show/NCT04432987
7	NCT04336904	Clinical Study To Evaluate The Performance And Safety Of Favipiravir in COVID-19	"Active, not recruiting"	No Results Available	COVID-19	Drug: Favipiravir|Other: Placebo	Phase 3	Interventional	"Asst Fatebenefratelli Sacco, Milano, Italy"	https://ClinicalTrials.gov/show/NCT04336904
8	NCT04445272	Clinical Trial to Evaluate the Effectiveness and Safety of Tocilizumab for Treating Patients With COVID-19 Pneumonia	Recruiting	No Results Available	COVID-19	Drug: Tocilizumab	Phase 2	Interventional	"Hospital Universitario de Cabueñes, Gijón, Asturias, Spain|Hospital Universitario Central Asturias, Oviedo, Asturias, Spain|Hospital Universitari de Bellvitge, L'Hospitalet De Llobregat, Barcelona, Spain|Hospital Sant Joan de Déu de Manresa, Manresa, Barcelona, Spain|Hospital de Mataró, Mataró, Barcelona, Spain|Hospital Universitario de Galdakao, Galdakao, Bizkaia, Spain|Hospital Universitario Marqués Valdecilla, Santander, Cantabria, Spain|Hospital Público General del Tomelloso, Tomelloso, Ciudad Real, Spain|Hospital Jerez de la Frontera, Jerez De La Frontera, Cádiz, Spain|Hospital Universitari Son Espases, Palma De Mallorca, Islas Baleares, Spain|Hospital Universitario Fundación Alcorcón, Alcorcón, Madrid, Spain|Hospital Universitario de Fuenlabrada, Fuenlabrada, Madrid, Spain|Hospital Universitario de Getafe, Getafe, Madrid, Spain|Hospital Universitario de Getafe, Getafe, Madrid, Spain|Hospital Rey Juan Carlos, Móstoles, Madrid, Spain|Hospital Universitario Rey Juan Carlos, Móstoles, Madrid, Spain|Hospital Universitario Infanta Sofía, San Sebastián De Los Reyes, Madrid, Spain|Complejo Hospitalario de Navarra, Pamplona, Navarra, Spain|Hospital Nuestra Señora del Prado, Talavera De La Reina, Toledo, Spain|Complejo Hospitalario Universitario de Albacete, Albacete, Spain|Hospital Infanta Cristina, Badajoz, Spain|Hospital Clínic i Provincial Barcelona, Barcelona, Spain|Hospital de la Santa Creu i Sant Pau, Barcelona, Spain|Hospital Universitario de Burgos, Burgos, Spain|Hospital General Universitario de Ciudad Real, Ciudad Real, Spain|Hospital San Pedro Alcántara, Cáceres, Spain|Hospital Universitario Dr. Josep Trueta, Gerona, Spain|Hospital Universitario Clínico San Cecilio, Granada, Spain|Hospital Universitario Virgen de las Nieves, Granada, Spain|Hospital General Universitario Gregorio Marañón, Madrid, Spain|Hospital Universitario 12 de Octubre, Madrid, Spain|Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain|Hospital Universitario HM Sanchinarro, Madrid, Spain|Hospital Universitario Infanta Leonor, Madrid, Spain|Hospital Universitario Ramón y Cajal, Madrid, Spain|Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, Spain|Hospital Regional Universitario de Málaga, Málaga, Spain|Complexo Hospitalario Universitario de Ourense, Orense, Spain|Hospital Universitario Salamanca, Salamanca, Spain|Hospital Universitario Virgen de la Macarena, Sevilla, Spain|Hospital Universitario Virgen del Rocío, Sevilla, Spain|Hospital Virgen de la Salud, Toledo, Spain|Hospital Clinico Universitario de Valencia, Valencia, Spain|Hospital Universitari i Poliectenic La Fe, Valencia, Spain|Hospital Universitario Dr. Peset, Valencia, Spain|Hospital Clínico Universitario Lozano Blesa, Zaragoza, Spain|Hospital Universitario Miguel Servet, Zaragoza, Spain"	https://ClinicalTrials.gov/show/NCT04445272
9	NCT04354831	A Study Evaluating the Efficacy and Safety of High-Titer Anti-SARS-CoV-2 Plasma in Hospitalized Patients With COVID-19 Infection	Recruiting	No Results Available	COVID-19	Biological: anti-SARS-CoV-2 convalescent plasma	Phase 2	Interventional	"Froedtert Hospital, Milwaukee, Wisconsin, United States"	https://ClinicalTrials.gov/show/NCT04354831
10	NCT04345445	Study to Evaluate the Efficacy and Safety of Tocilizumab Versus Corticosteroids in Hospitalised COVID-19 Patients With High Risk of Progression	Not yet recruiting	No Results Available	COVID-19	Drug: Tocilizumab|Drug: Methylprednisolone	Phase 3	Interventional	"University Malaya Medical Centre, Kuala Lumpur, Malaysia"	https://ClinicalTrials.gov/show/NCT04345445
11	NCT04359095	Effectiveness and Safety of Medical Treatment for SARS-CoV-2 (COVID-19) in Colombia	Not yet recruiting	No Results Available	COVID-19	Drug: Hydroxychloroquine|Drug: Lopinavir / Ritonavir Pill|Drug: Azithromycin|Other: Standard treatment	Phase 2|Phase 3	Interventional	"Hospital Universitario de Neiva, Neiva, Huila, Colombia|Clínica Reina Sofía, Bogotá, Colombia|Fundacion Cardio Infantil, Bogotá, Colombia|Hospital Universitario San Ignacio, Bogotá, Colombia|Clinica Universitaria Colombia, Bogotá, Colombia|Hospital Universitario Nacional de Colombia, Bogotá, Colombia"	https://ClinicalTrials.gov/show/NCT04359095
12	NCT04361422	Isotretinoin in Treatment of COVID-19	Not yet recruiting	No Results Available	COVID-19	Drug: Isotretinoin Only Product in Oral Dose Form	Phase 3	Interventional		https://ClinicalTrials.gov/show/NCT04361422
13	NCT04388683	Inhaled Nitric Oxide for Preventing Progression in COVID-19	Recruiting	No Results Available	COVID-19	Drug: Nitric Oxide	Phase 2	Interventional	"Tufts Medical Center, Boston, Massachusetts, United States"	https://ClinicalTrials.gov/show/NCT04388683
14	NCT04421534	Utility of Lactoferrin as an Adjunct Therapeutic Agent for COVID-19	Not yet recruiting	No Results Available	COVID-19	Drug: Lactoferrin	Phase 2|Phase 3	Interventional		https://ClinicalTrials.gov/show/NCT04421534
15	NCT04428801	Autologous Adipose-derived Stem Cells (AdMSCs) for COVID-19	Not yet recruiting	No Results Available	COVID-19	Biological: autologous adipose-derived stem cells	Phase 2	Interventional		https://ClinicalTrials.gov/show/NCT04428801
16	NCT04343183	Hyperbaric Oxygen Therapy (HBOT) as a Treatment for COVID-19 (COVID-19) Infection	Not yet recruiting	No Results Available	COVID-19	Device: Hyperbaric Oxygen Therapy	Not Applicable	Interventional	"Ochsner Medical Center, New Orleans, Louisiana, United States"	https://ClinicalTrials.gov/show/NCT04343183
17	NCT04347915	The Phase 2 Study to Evaluate the Safety and Efficacy of Clevudine in Patients With Moderate COVID-19	Recruiting	No Results Available	COVID-19	Drug: Clevudine|Drug: Placebo	Phase 2	Interventional	"Korea University Guro Hospital, Seoul, Korea, Republic of"	https://ClinicalTrials.gov/show/NCT04347915
18	NCT04401423	TXA COVID-19 Clinical Trial	Not yet recruiting	No Results Available	COVID-19	Drug: TXA127|Drug: Placebo	Phase 2	Interventional		https://ClinicalTrials.gov/show/NCT04401423
19	NCT04333407	Preventing Cardiac Complication of COVID-19 Disease With Early Acute Coronary Syndrome Therapy: A Randomised Controlled Trial.	Recruiting	No Results Available	COVID-19	Drug: Aspirin 75mg|Drug: Clopidogrel 75mg|Drug: Rivaroxaban 2.5 MG|Drug: Atorvastatin 40mg|Drug: Omeprazole 20mg	Not Applicable	Interventional	"Charing Cross Hospital, London, United Kingdom"	https://ClinicalTrials.gov/show/NCT04333407
20	NCT04406389	Anticoagulation in Critically Ill Patients With COVID-19 (The IMPACT Trial)	Not yet recruiting	No Results Available	COVID-19	Drug: Enoxaparin sodium|Drug: Unfractionated heparin|Drug: Fondapariniux|Drug: Argatroban	Phase 4	Interventional	"Weill Cornell Medicine, New York, New York, United States"	https://ClinicalTrials.gov/show/NCT04406389
21	NCT04291053	The Efficacy and Safety of Huai er in the Adjuvant Treatment of COVID-19	Not yet recruiting	No Results Available	COVID-19	Drug: Huaier Granule	Phase 2|Phase 3	Interventional		https://ClinicalTrials.gov/show/NCT04291053
22	NCT04412486	COVID-19 Convalescent Plasma (CCP) Transfusion	Recruiting	No Results Available	COVID-19	Biological: COVID Convalescent Plasma	Early Phase 1	Interventional	"University of Mississippi Medical Center, Jackson, Mississippi, United States"	https://ClinicalTrials.gov/show/NCT04412486
23	NCT04336462	Hydrogen-Oxygen Generator With Nebulizer in the Improvement of Symptoms in Patients Infected With COVID-19	Recruiting	No Results Available	COVID-19	Device: oxyhydrogen|Device: Oxygen	Not Applicable	Interventional	"First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China"	https://ClinicalTrials.gov/show/NCT04336462
24	NCT04393038	ABX464 in Treating Inflammation and Preventing Acute Respiratory Failure in Patients With COVID-19	Recruiting	No Results Available	COVID-19	Drug: ABX464|Drug: Placebo	Phase 2|Phase 3	Interventional	"Centre Hospitalier Universitaire de Nice, Nice, France"	https://ClinicalTrials.gov/show/NCT04393038
25	NCT04342689	The Role of Resistant Starch in COVID-19 Infection	Recruiting	No Results Available	COVID-19	Drug: Dietary Supplement containing resistant starch|Dietary Supplement: Placebo Starch	Phase 3	Interventional	"Yale University, New Haven, Connecticut, United States|University of Michigan, Ann Arbor, Michigan, United States"	https://ClinicalTrials.gov/show/NCT04342689
26	NCT04369820	C5a Receptor Expression - COVID-19 (C5-COV)	Recruiting	No Results Available	COVID-19	Other: draw blood	Not Applicable	Interventional	"Assistance Publique Hôpitaux de Marseille, Marseille, France"	https://ClinicalTrials.gov/show/NCT04369820
27	NCT04363346	Study of FT516 for the Treatment of COVID-19 in Hospitalized Patients With Hypoxia	Recruiting	No Results Available	COVID-19	Drug: FT516	Phase 1	Interventional	"University of Minnesota, Minneapolis, Minnesota, United States"	https://ClinicalTrials.gov/show/NCT04363346
28	NCT04392141	Colchicine Plus Phenolic Monoterpenes to Treat COVID-19	Recruiting	No Results Available	COVID-19	Drug: Standard Treatment|Drug: Oral administration of Colchicine plus Herbal Phenolic Monoterpene Fractions	Phase 1|Phase 2	Interventional	"Medical Biology Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran, Kermanshah, Iran, Islamic Republic of"	https://ClinicalTrials.gov/show/NCT04392141
29	NCT04449718	Vitamin D Supplementation in Patients With COVID-19	Recruiting	No Results Available	COVID-19	Dietary Supplement: Vitamin D|Dietary Supplement: Placebo	Not Applicable	Interventional	"Clinical Hospital of the School of Medicine, University of Sao Paulo, Sao Paulo, Brazil"	https://ClinicalTrials.gov/show/NCT04449718
30	NCT04324489	DAS181 for Severe COVID-19: Compassionate Use	Completed	No Results Available	COVID-19	Drug: DAS181	Not Applicable	Interventional	"Renmin Hospital of Wuhan University, Wuhan, Hubei, China"	https://ClinicalTrials.gov/show/NCT04324489
31	NCT04370262	Multi-site Adaptive Trials for COVID-19	Recruiting	No Results Available	COVID-19	Drug: SOC + Intravenous Famotidine|Drug: SOC + Placebo	Phase 3	Interventional	"Southside Hospital, Bay Shore, New York, United States|North Shore University Hospital, Manhasset, New York, United States|Northern Westchester Hospital, Mount Kisco, New York, United States|Lenox Hill Hospital, New York, New York, United States|Long Island Jewish Medical Center, Queens, New York, United States"	https://ClinicalTrials.gov/show/NCT04370262
32	NCT04333420	"Open-label, Randomized Study of IFX-1 in Patients With Severe COVID-19 Pneumonia"	Recruiting	No Results Available	COVID-19 Pneumonia	Drug: Best supportive Care (BSC) + IFX-1|Drug: Best supportive care only	Phase 2|Phase 3	Interventional	"University Amsterdam, Amsterdam, Netherlands|University Amsterdam, Amsterdam, Netherlands|University Maastricht, Maastricht, Netherlands"	https://ClinicalTrials.gov/show/NCT04333420
33	NCT04323228	Anti-inflammatory/Antioxidant Oral Nutrition Supplementation in COVID-19	Not yet recruiting	No Results Available	COVID-19	"Dietary Supplement: oral nutrition supplement (ONS) enriched in eicosapentaenoic acid, gamma-linolenic acid and antioxidants|Dietary Supplement: isocaloric/isonutrigenous ONS"	Phase 4	Interventional		https://ClinicalTrials.gov/show/NCT04323228
34	NCT04376788	Exchange Transfusion Versus Plasma From Convalescent Patients With Methylene Blue in Patients With COVID-19	Not yet recruiting	No Results Available	COVID-19	Biological: exchange blood transfusion from normal donor|Biological: plasma from convalescent patients with COVID-19|Drug: Methylene Blue 5 MG/ML	Phase 2	Interventional	"Ain Shams University, Cairo, Egypt"	https://ClinicalTrials.gov/show/NCT04376788
35	NCT04335123	Study of Open Label Losartan in COVID-19	Recruiting	No Results Available	COVID-19	Drug: Losartan	Phase 1	Interventional	"University of Kansas Medical Center, Kansas City, Kansas, United States"	https://ClinicalTrials.gov/show/NCT04335123
36	NCT04366882	Minimal Invasive Autopsies to Investigate Changes in Deceased COVID-19 Patients	Recruiting	No Results Available	COVID-19	Procedure: CT-scan with minimal invasive autopsy	Not Applicable	Interventional	"Jessa Hospital, Hasselt, Belgium"	https://ClinicalTrials.gov/show/NCT04366882
37	NCT04360356	Ivermectin and Nitazoxanide Combination Therapy for COVID-19	Not yet recruiting	No Results Available	COVID-19	Combination Product: Ivermectin plus Nitazoxanide|Other: Standard Care	Phase 2|Phase 3	Interventional		https://ClinicalTrials.gov/show/NCT04360356
38	NCT04434248	An Adaptive Study of Favipiravir Compared to Standard of Care in Hospitalized Patients With COVID-19	"Active, not recruiting"	No Results Available	COVID-19	Drug: Favipiravir|Drug: Standard of Care	Phase 2|Phase 3	Interventional	"Republican Clinical Hospital, Makhachkala, Russian Federation|""K+31"" Clinic, Moscow, Russian Federation|""Khaven"" Llc, Moscow, Russian Federation|Central Clinical Hospital with Polyclinic, Moscow, Russian Federation|Central Research Institute of Epidemiology, Moscow, Russian Federation|City Clinical Hospital n.a. O.M. Filatov, Moscow, Russian Federation|City Clinical Hospital named after S.S. Yudin, Moscow, Russian Federation|City Clinical Hospital No. 24, Moscow, Russian Federation|City Clinical Hospital No. 51, Moscow, Russian Federation|First Moscow State Medical University n.a. I.M. Sechenov, Moscow, Russian Federation|Moscow State University n.a. M. V. Lomonosov, Moscow, Russian Federation|National Medical and Surgical Center named after N.I. Pirogov, Moscow, Russian Federation|City Hospital № 33 of the Leninsky region of Nizhny Novgorod, Nizhny Novgorod, Russian Federation|Infectious clinical hospital No.2 of Nizhny Novgorod, Nizhny Novgorod, Russian Federation|Ryazan State Medical University named after I.P. Pavlov, Ryazan, Russian Federation|Military Medical Academy named after S.M. Kirova, Saint Petersburg, Russian Federation|Saratov State Medical University named after V.I. Razumovsky, Saratov, Russian Federation|Clinical hospital No.1, Smolensk, Russian Federation|Regional Clinic Hospital, Tver, Russian Federation|Bashkir State Medical University, Ufa, Russian Federation|Yakutsk City Clinical Hospital, Yakutsk, Russian Federation|Yaroslavl Regional Clinical Hospital for War Veterans, Yaroslavl, Russian Federation"	https://ClinicalTrials.gov/show/NCT04434248
39	NCT04350593	Dapagliflozin in Respiratory Failure in Patients With COVID-19	Recruiting	No Results Available	COVID-19	Drug: Dapagliflozin 10 MG|Drug: Placebo	Phase 3	Interventional	"NorthShore University HealthSystem, Evanston, Illinois, United States|University of Mississippi Medical Center, Jackson, Mississippi, United States|Saint Luke's Mid America Heart Institute, Kansas City, Missouri, United States|Washington University School of Medicine, Saint Louis, Missouri, United States|Jacobi Medical Center, Bronx, New York, United States|St. Francis Hospital, Roslyn, New York, United States|Sentara Healthcare, Norfolk, Virginia, United States"	https://ClinicalTrials.gov/show/NCT04350593
40	NCT04456413	Convalescent Plasma as Treatment for Subjects With Early COVID-19 Infection	Not yet recruiting	No Results Available	COVID-19	Biological: Convalescent Plasma|Other: Best Supportive Care	Phase 2	Interventional	"Hackensack University Medical Center, Hackensack, New Jersey, United States"	https://ClinicalTrials.gov/show/NCT04456413
41	NCT04372979	Efficacy of Convalescent Plasma Therapy in the Early Care of COVID-19 Patients.	Not yet recruiting	No Results Available	COVID-19	Drug: Transfusion of SARS-CoV-2 Convalescent Plasma.|Drug: Transfusion of standard Plasma.	Phase 3	Interventional	"HIA Percy, Clamart, France|HIA Laveran, Marseille, France|HIA Bégin, Saint-Mandé, France|HIA Sainte Anne, Toulon, France"	https://ClinicalTrials.gov/show/NCT04372979
42	NCT04343755	Convalescent Plasma as Treatment for Hospitalized Subjects With COVID-19 Infection	Recruiting	No Results Available	COVID-19	Biological: Convalescent Plasma	Phase 2	Interventional	"Hackensack University Medical Center, Hackensack, New Jersey, United States"	https://ClinicalTrials.gov/show/NCT04343755
43	NCT04425629	"Safety, Tolerability, and Efficacy of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies for the Treatment of Ambulatory Adult Patients With COVID-19"	Recruiting	No Results Available	COVID-19	Drug: REGN10933+REGN10987 combination therapy|Drug: Placebo	Phase 1|Phase 2	Interventional	"Regeneron Study Site, Aurora, Colorado, United States|Regeneron Study Site, Washington, District of Columbia, United States|Regeneron Study Site, Miami, Florida, United States|Regeneron Study Site, Bronx, New York, United States|Regeneron Study Site, Philadelphia, Pennsylvania, United States|Regeneron Study Site, Dallas, Texas, United States|Regeneron Study Site, San Antonio, Texas, United States|Regeneron Study Site, Tyler, Texas, United States"	https://ClinicalTrials.gov/show/NCT04425629
44	NCT04321421	Hyperimmune Plasma for Critical Patients With COVID-19	Completed	No Results Available	COVID-19	Other: hyperimmune plasma	Not Applicable	Interventional	"Catherine Klersy, Pavia, PV, Italy|Ospedale Asst Carlo Poma Mantova, Mantova, Italy"	https://ClinicalTrials.gov/show/NCT04321421
45	NCT04432298	"Study of the Efficacy and Safety of Intravenous Pamrevlumab, in Hospitalized Patients With Acute COVID-19 Disease"	Recruiting	No Results Available	COVID-19	Drug: Pamrevlumab|Drug: Placebo	Phase 2	Interventional	"Research Center, Greensboro, North Carolina, United States"	https://ClinicalTrials.gov/show/NCT04432298
46	NCT04405102	COVID-19 Ozanimod Intervention Study	Not yet recruiting	No Results Available	COVID-19	Drug: Ozanimod|Other: Standard of care	Phase 2	Interventional		https://ClinicalTrials.gov/show/NCT04405102
47	NCT04329611	ALBERTA HOPE COVID-19 for the Prevention of Severe COVID19 Disease	Suspended	No Results Available	COVID-19	Drug: Hydroxychloroquine	Phase 3	Interventional	"University of Calgary/Foothills Medical Centre, Calgary, Alberta, Canada|University of Alberta, Edmonton, Alberta, Canada"	https://ClinicalTrials.gov/show/NCT04329611
48	NCT04415086	Treatment of Patients With COVID-19 With Convalescent Plasma	Recruiting	No Results Available	COVID-19	Biological: convalescent plasma	Phase 2	Interventional	"University of Sao Paulo - General Hospital, São Paulo, SP, Brazil"	https://ClinicalTrials.gov/show/NCT04415086
49	NCT04325633	Efficacy of Addition of Naproxen in the Treatment of Critically Ill Patients Hospitalized for COVID-19 Infection	Not yet recruiting	No Results Available	COVID-19	Drug: 1: Naproxen|Drug: 2: Standard of care	Phase 3	Interventional		https://ClinicalTrials.gov/show/NCT04325633
50	NCT04323332	Traditional Chinese Medicine for Severe COVID-19	Not yet recruiting	No Results Available	COVID-19	Drug: Traditional Chinese Medicine Prescription	Phase 3	Interventional	"Hao Li, Beijing, Beijing, China"	https://ClinicalTrials.gov/show/NCT04323332
51	NCT04382066	Proof of Concept Study to Evaluate the Safety Profile of Plitidepsin in Patients With COVID-19	Recruiting	No Results Available	COVID-19	Drug: Plitidepsin 1.5 mg/day|Drug: Plitidepsin 2.0 mg/day|Drug: Plitidepsin 2.5 mg/day	Phase 1	Interventional	"Hospital Universitario Hm Montepríncipe, Boadilla Del Monte, Madrid, Spain|Hospital Germans Trias i Pujol, Badalona, Spain|Hospital de la Santa Creu i Sant Pau, Barcelona, Spain|Hospital Ciudad Real, Ciudad Real, Spain|Hospital Universitario de Getafe, Getafe, Spain|Hospital Universitario de Guadalajara, Guadalajara, Spain|Hospital La Princesa, Madrid, Spain|Hospital Gregorio Marañón, Madrid, Spain|Hospital Ramón Y Cajal, Madrid, Spain|Hospital Clínico San Carlos, Madrid, Spain|Hosptial Quironsalud Madrid, Madrid, Spain"	https://ClinicalTrials.gov/show/NCT04382066
52	NCT04352348	Cohort of Patients Infected With SARS-CoV2 (COVID-19) or Suspected of Being	Recruiting	No Results Available	COVID-19	Other: blood samples	Not Applicable	Interventional	"GH Pitié-Salpêtrière / Service d'Accueil des Urgences, Paris, Ile-de-France, France"	https://ClinicalTrials.gov/show/NCT04352348
53	NCT04390178	Convalescent Plasma as Treatment for Acute Coronavirus Disease (COVID-19)	"Active, not recruiting"	No Results Available	COVID-19	Biological: SARS-CoV-2 convalescent plasma	Phase 1|Phase 2	Interventional	"Danderyd Hospital, Danderyd, Sweden"	https://ClinicalTrials.gov/show/NCT04390178
54	NCT04339660	Clinical Research of Human Mesenchymal Stem Cells in the Treatment of COVID-19 Pneumonia	Recruiting	No Results Available	COVID-19	Biological: UC-MSCs|Other: Placebo	Phase 1|Phase 2	Interventional	"Puren Hospital Affiliated to Wuhan University of Science and Technology, Wuhan, Hubei, China"	https://ClinicalTrials.gov/show/NCT04339660
55	NCT04382092	Co-infection Management in COVID-19 Critically Ill	Completed	No Results Available	COVID-19	Diagnostic Test: FilmArray Pneumonia	Not Applicable	Interventional	"Cliniques Universitaires Saint-Luc, Brussels, Belgium"	https://ClinicalTrials.gov/show/NCT04382092
56	NCT04412252	Safety and Efficacy of Tofacitinib in Hospitalized Participants With COVID-19 Pneumonia Who Are Receiving Standard of Care Therapy	Not yet recruiting	No Results Available	COVID-19	Drug: Tofacitinib|Other: Placebo	Phase 2	Interventional	"University Hospitals Cleveland Medical Center, Cleveland, Ohio, United States"	https://ClinicalTrials.gov/show/NCT04412252
57	NCT04287686	Recombinant Human Angiotensin-converting Enzyme 2 (rhACE2) as a Treatment for Patients With COVID-19	Withdrawn	No Results Available	COVID-19	Drug: Recombinant human angiotensin-converting enzyme 2 (rhACE2)	Not Applicable	Interventional	"GCP Office of The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China"	https://ClinicalTrials.gov/show/NCT04287686
58	NCT04344015	COVID-19 Plasma Collection	Recruiting	No Results Available	COVID-19	Other: Plasma Donation	Not Applicable	Interventional	"Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, United States"	https://ClinicalTrials.gov/show/NCT04344015
59	NCT04375202	Colchicine in COVID-19: a Pilot Study	Recruiting	No Results Available	COVID-19	Drug: Colchicine 1 MG Oral Tablet	Phase 2	Interventional	"Associazione Italiana Pneumologi Ospedalieri, Milan, Italy|Società Italiana di Reumatologia, Milan, Italy"	https://ClinicalTrials.gov/show/NCT04375202
60	NCT04385108	Predictive Immune Biomarkers for COVID-19 Pathogenesis	Not yet recruiting	No Results Available	COVID-19	Biological: Blood collection on admission and longitudinally|Biological: Blood collection on their first consultation and 10 to 14 days later	Not Applicable	Interventional	"Purpan University Hospital, Toulouse, France"	https://ClinicalTrials.gov/show/NCT04385108
61	NCT04361916	Home Care for Patients With COVID-19: Active Monitoring in Two Italian Health Units (Casale Monferrato and Torino)	Recruiting	No Results Available	COVID-19	Other: home care monitoring	Not Applicable	Interventional	"Asl Alessandria, Casale Monferrato, Alessandria, Italy"	https://ClinicalTrials.gov/show/NCT04361916
62	NCT04354389	DAS181 for STOP COVID-19	Not yet recruiting	No Results Available	COVID-19	Drug: DAS181|Drug: Placebo	Phase 2|Phase 3	Interventional	"Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico, Milano, Italy|A.O.U Policlinico Di Modena, Modena, Italy"	https://ClinicalTrials.gov/show/NCT04354389
63	NCT04433013	A Randomized Controlled Trial Assessing the Efficacy of Lianhua Qingwen as an Adjuvant Treatment in Patients With Mild Symptoms of COVID-19	Not yet recruiting	No Results Available	COVID-19	Drug: Lianhua Qingwen|Drug: Placebo	Phase 3	Interventional		https://ClinicalTrials.gov/show/NCT04433013
64	NCT04324996	A Phase I/II Study of Universal Off-the-shelf NKG2D-ACE2 CAR-NK Cells for Therapy of COVID-19	Recruiting	No Results Available	COVID-19	"Biological: NK cells,IL15-NK cells,NKG2D CAR-NK cells,ACE2 CAR-NK cells,NKG2D-ACE2 CAR-NK cells"	Phase 1|Phase 2	Interventional	"Chongqing Public Health Medical Center, Chongqing, China"	https://ClinicalTrials.gov/show/NCT04324996
65	NCT04385043	Hyperimmune Plasma in Patients With COVID-19 Severe Infection	Recruiting	No Results Available	COVID-19	Other: plasma hyperimmune|Drug: standard therapy	Phase 2|Phase 3	Interventional	"Azienda Ospedaliera Policlinico Mater Domini, Catanzaro, Italy|Azienda Ospedaliera Pugliese Ciaccio Catanzaro, Catanzaro, Italy|Azienda Ospedaliera Annunziata, Cosenza, Italy|Azienda Sanitaria Provinciale, Crotone, Italy|Azienda Ospedaliera Bianchi Melacrino Morelli, Reggio Calabria, Italy|Azienda Sanitaria Provinciale, Vibo Valentia, Italy"	https://ClinicalTrials.gov/show/NCT04385043
66	NCT04426695	"Safety, Tolerability, and Efficacy of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies for Hospitalized Adult Patients With COVID-19"	Recruiting	No Results Available	COVID-19	Drug: REGN10933+REGN10987 combination therapy|Drug: Placebo	Phase 1|Phase 2	Interventional	"Regeneron Study Site, Aurora, Colorado, United States|Regeneron Study Site, Atlanta, Georgia, United States|Regeneron Study Site, Saint Louis, Missouri, United States|Regeneron Study Site, Teaneck, New Jersey, United States|Regeneron Study Site, Bronx, New York, United States|Regeneron Study Site, Bronx, New York, United States|Regeneron Study Site, Philadelphia, Pennsylvania, United States|Regeneron Study Site, Dallas, Texas, United States|Regeneron Study Site, Tyler, Texas, United States"	https://ClinicalTrials.gov/show/NCT04426695
67	NCT04443270	Chloroquine Phosphate Prophylactic Use in Health Personnel Exposed to COVID-19 Patients	Not yet recruiting	No Results Available	COVID-19	Drug: Chloroquine phosphate	Phase 1	Interventional	"Centro Médico Nacional ""20 de Noviembre"", Mexico City, Benito Juárez, Mexico"	https://ClinicalTrials.gov/show/NCT04443270
68	NCT04384497	Convalescent Plasma for Treatment of COVID-19: An Exploratory Dose Identifying Study	Recruiting	No Results Available	COVID-19	Biological: SARS-CoV-2 convalescent plasma	Phase 1|Phase 2	Interventional	"Danderyd Hospital, Danderyd, Stockholm, Sweden|Karolinska University Hospital, Stockholm, Sweden"	https://ClinicalTrials.gov/show/NCT04384497
69	NCT04317092	Tocilizumab in COVID-19 Pneumonia (TOCIVID-19)	Recruiting	No Results Available	COVID-19 Pneumonia	Drug: Tocilizumab Injection	Phase 2	Interventional	"Azienda Ospedaliera ""SS. Antonio e Biagio e C. Arrigo"" (Dipartimento Internistico SSD Reumatologia), Alessandria, Italy|Ospedale di Busto Arsizio ASST Valle Olona (U.O.C. Malattie Infettive), Busto Arsizio, Italy|A.O.U. Policlinico V. Emanuele (U.O. di Malattie infettive, U.O. di Anestesia e Rianimazione, U.O. di Medicina d'Urgenza), Catania, Italy|AOE Cannizzaro di Catania (U.O. di Malattie Infettive, U.O. di Anestesia e Rianimazione, U.O., Catania, Italy|Ospedale Annunziata Azienda Ospedaliera di Cosenza (U.O.C. Malattie Infettive), Cosenza, Italy|ASST OVEST MILANESE presidi Legnano - Magenta, Magenta, Italy|Azienda Ospedaliero-Universitaria di Modena, Modena, Italy|A.O.U. di Modena (Dipartimento Chirurgie Generali e Specialità Chirurgiche - Struttura Complessa di Anestesia e Rianimazione I), Modena, Italy|A.O.U. di Modena (Dipartimento Chirurgie Generali e Specialità Chirurgiche - Struttura Complessa di Anestesia e Rianimazione II), Modena, Italy|A.O.U. di Modena (Dipartimento Medicine Specialistiche - Struttura Complessa Malattie Infettive), Modena, Italy|Dipartimento Medicine Specialistiche - Struttura Complessa Malattie dell'Apparato Respiratorio, Modena, Italy|A.O.R.N. Ospedale dei Colli Monaldi-Cotugno-CTO (U.O.C. Oncologia), Naples, Italy|National Cancer Institute, Naples, Italy|A.O.R.N. Ospedale dei Colli Monaldi-Cotugno-CTO (U.O.C. Anestesia Rianimazione e terapia intensiva), Naples, Italy|A.O.R.N. Ospedale dei Colli Monaldi-Cotugno-CTO (U.O.C. Malattie Infettive ad indirizzo respiratorio), Naples, Italy|A.O. Ospedali Riuniti Marche Nord - Presidio Ospedaliero San Salvatore di Pesaro (UOC Pronto Soccorso e Medicina d'Urgenza), Pesaro, Italy|Denominazione: UOC di Medicina e Chirurgia d'Accettazione e d'Urgenza dell'Ospedale Santa Maria delle Grazie di Pozzuoli, Pozzuoli, Italy|Ospedale Santa Maria delle Croci, AUSL della Romagna (U.O. Anestesia e Rianimazione), Ravenna, Italy|Grande Ospedale Metropolitano, Reggio Calabria, Reggio Calabria, Italy|Ospedale Infermi, AUSL della Romagna (U.O. Malattie Infettive), Rimini, Italy|Policlinico Gemelli (U.O.C. Dipartimento Scienze di Laboratorio e Infettivologiche), Rome, Italy|ASST Sette Laghi (Dipartimento di Medicina Interna), Varese, Italy|ASST Sette Laghi (Dipartimento Emergenze ed Urgenze), Varese, Italy|ASST Sette Laghi (U.O.C. Anestesia e Rianimazione Neurochirurgica e Generale), Varese, Italy|ASST Sette Laghi (U.O.C. Malattie Infettive e Tropicali), Varese, Italy|A.O.U. Integrata di Verona (Dip. Malattie Infettive), Verona, Italy|Ospedale Magalini (U.O. Malattie Infettive), Villafranca Di Verona, Italy"	https://ClinicalTrials.gov/show/NCT04317092
70	NCT04364022	Efficacy of Pragmatic Same-day COVID-19 Ring Prophylaxis for Adult Individuals Exposed to SARS-CoV-2 in Switzerland	Recruiting	No Results Available	Prevention of COVID-19	Drug: Hydroxychloroquine Sulfate 200 MG [Plaquenil]|Drug: Lopinavir/ritonavir	Phase 3	Interventional	"Universitätsspital Basel and SwissTPH, Basel, Switzerland|Hôpitaux Universitaires de Genève, Geneva, Switzerland"	https://ClinicalTrials.gov/show/NCT04364022
71	NCT04432324	Study to Evaluate the Safety and Efficacy of High Dose IVIG in Hospitalized Participants With Coronavirus Disease (COVID-19)	Not yet recruiting	No Results Available	COVID-19	Biological: Intravenous Immune Globulin|Drug: Standard Medical Treatment	Phase 2	Interventional	"Hospital Germans Trias i Pujol, Badalona, Spain|Hospital Universitari Vall d'Hebron, Barcelona, Spain|Hospital Universitari de Bellvitge, Barcelona, Spain|Hospital de la Santa Creu i Sant Pau, Barcelona, Spain|Hospital General Universitario Gregorio Marañón, Madrid, Spain|Hospital Clinico San Carlos, Madrid, Spain"	https://ClinicalTrials.gov/show/NCT04432324
72	NCT04348071	Safety and Efficacy of Ruxolitinib for COVID-19	Not yet recruiting	No Results Available	COVID-19	Drug: Ruxolitinib	Phase 2|Phase 3	Interventional		https://ClinicalTrials.gov/show/NCT04348071
73	NCT04340232	Safety and Efficacy of Baricitinib for COVID-19	Not yet recruiting	No Results Available	COVID-19	Drug: Baricitinib	Phase 2|Phase 3	Interventional	"University of Colorado, Denver, Aurora, Colorado, United States"	https://ClinicalTrials.gov/show/NCT04340232
74	NCT04359615	Favipiravir in Hospitalized COVID-19 Patients	Not yet recruiting	No Results Available	COVID-19	Drug: Favipiravir|Drug: Hydroxychloroquine	Phase 4	Interventional	"Shahid Modarres Hospital, Shahid Beheshti University of Medical Sciences and Health Services, Tehran, Iran, Islamic Republic of"	https://ClinicalTrials.gov/show/NCT04359615
75	NCT04321993	Treatment of Moderate to Severe Coronavirus Disease (COVID-19) in Hospitalized Patients	Recruiting	No Results Available	COVID-19	Drug: Lopinavir/ritonavir|Drug: Hydroxychloroquine sulfate|Drug: Baricitinib (janus kinase inhibitor)	Phase 2	Interventional	"Nova Scotia Health Authority, Halifax, Nova Scotia, Canada"	https://ClinicalTrials.gov/show/NCT04321993
76	NCT04359316	Azithromycin in Hospitalized COVID-19 Patients	Not yet recruiting	No Results Available	COVID-19	Drug: Hydroxychloroquine|Drug: Azithromycin	Phase 4	Interventional	"Shahid Modarres Hospital, Shahid Beheshti University of Medical Sciences and Health Services, Tehran, Iran, Islamic Republic of"	https://ClinicalTrials.gov/show/NCT04359316
77	NCT04428008	Thymosin Alpha 1 to Prevent COVID-19 Infection in Elderly Renal Dialysis Patients	Not yet recruiting	No Results Available	COVID-19	Drug: Thymalfasin	Phase 2	Interventional		https://ClinicalTrials.gov/show/NCT04428008
78	NCT04364828	NGS Diagnostic in COVID-19 Hosts - Genetic Cause Relating to the Course of Disease Progression	Not yet recruiting	No Results Available	COVID-19	Genetic: Whole Genome Analysis|Genetic: T-cell receptor (TCR) repertoire|Genetic: SARS-CoV-2 viral composition	Not Applicable	Interventional		https://ClinicalTrials.gov/show/NCT04364828
79	NCT04343768	"An Investigation Into Beneficial Effects of Interferon Beta 1a, Compared to Interferon Beta 1b And The Base Therapeutic Regiment in Moderate to Severe COVID-19: A Randomized Clinical Trial"	Completed	No Results Available	COVID-19	Drug: Hydroxychloroquine|Drug: Lopinavir / Ritonavir|Drug: Interferon Beta-1A|Drug: Interferon Beta-1B	Phase 2	Interventional	"Loghman Hakim Hospital, Shahid Beheshti University of Medical Sciences and Health Services, Tehran, Iran, Islamic Republic of"	https://ClinicalTrials.gov/show/NCT04343768
80	NCT04364815	The University of the Philippines Hydroxychloroquine PEP Against COVID-19 Trial	Not yet recruiting	No Results Available	COVID-19	Drug: Hydroxychloroquine plus standard preventive measures|Drug: Placebo plus standard preventive measures	Phase 3	Interventional		https://ClinicalTrials.gov/show/NCT04364815
81	NCT04358835	Keto-diet for Intubated Critical Care COVID-19	Not yet recruiting	No Results Available	COVID-19	Dietary Supplement: Ketogenic diet|Other: standard of care	Not Applicable	Interventional		https://ClinicalTrials.gov/show/NCT04358835
82	NCT04329832	Hydroxychloroquine vs. Azithromycin for Hospitalized Patients With Suspected or Confirmed COVID-19	Recruiting	No Results Available	COVID-19	Drug: Hydroxychloroquine|Drug: Azithromycin	Phase 2	Interventional	"Intermountain Medical Center, Murray, Utah, United States|University of Utah, Salt Lake City, Utah, United States"	https://ClinicalTrials.gov/show/NCT04329832
83	NCT04388410	Safety and Efficacy of Convalescent Plasma Transfusion for Patients With COVID-19	Not yet recruiting	No Results Available	COVID-19	Biological: convalescent plasma	Phase 2|Phase 3	Interventional		https://ClinicalTrials.gov/show/NCT04388410
84	NCT04401579	Adaptive COVID-19 Treatment Trial 2 (ACTT-II)	Recruiting	No Results Available	COVID-19	Other: Placebo|Drug: Remdesivir|Drug: Baricitinib	Phase 3	Interventional	"University of Alabama at Birmingham School of Medicine - Infectious Disease, Birmingham, Alabama, United States|University of California San Diego Health - Jacobs Medical Center, La Jolla, California, United States|University of California Los Angeles Medical Center - Westwood Clinic, Los Angeles, California, United States|University of California Irvine Medical Center - Infectious Disease, Orange, California, United States|VA Palo Alto Health Care System - Infectious Diseases, Palo Alto, California, United States|Stanford University - Stanford Hospital and Clinics - Pediatrics - Infectious Diseases, Palo Alto, California, United States|University of California Davis Medical Center - Internal Medicine - Infectious Disease, Sacramento, California, United States|Naval Medical Center San Diego - Infectious Disease Clinic, San Diego, California, United States|University of California San Francisco - Zuckerberg San Francisco General Hospital - Division of Human Immunodeficiency Virus, Infectious Disease, and Global Medicine, San Francisco, California, United States|Cedars Sinai Medical Center, West Hollywood, California, United States|Rocky Mountain Regional Veteran Affairs Medical Center - Department of Infectious Diseases, Aurora, Colorado, United States|Denver Health Division of Hospital Medicine - Main Campus, Denver, Colorado, United States|Georgetown University Medical Center - Division of Infectious Diseases, Washington, District of Columbia, United States|University of Florida Health - Shands Hospital - Division of Infectious Diseases and Global Medicine, Gainesville, Florida, United States|University of Miami Miller School of Medicine - Infectious Diseases, Miami, Florida, United States|Emory Vaccine Center - The Hope Clinic, Decatur, Georgia, United States|Atlanta VA Medical Center - Infectious Diseases Clinic, Decatur, Georgia, United States|Northwestern Hospital - Infectious Disease, Chicago, Illinois, United States|University of Illinois at Chicago College of Medicine - Division of Infectious Diseases, Chicago, Illinois, United States|Indiana University School of Medicine - Infectious Diseases, Indianapolis, Indiana, United States|Ochsner Medical Center - Kenner - Department of Infectious Diseases, Kenner, Louisiana, United States|Southeast Louisiana Veterans Health Care System (SLVHCS) - Section of Infectious Diseases, New Orleans, Louisiana, United States|University of Maryland School of Medicine - Center for Vaccine Development - Baltimore, Baltimore, Maryland, United States|Johns Hopkins Hospital - Medicine - Infectious Diseases, Baltimore, Maryland, United States|Walter Reed National Military Medical Center, Bethesda, Maryland, United States|National Institutes of Health - Clinical Center, National Institute of Allergy and Infectious Diseases Laboratory Of Immunoregulation, Clinical Research Section, Bethesda, Maryland, United States|Massachusetts General Hospital - Infectious Diseases, Boston, Massachusetts, United States|University of Massachusetts Medical School - Infectious Diseases and Immunology, Worcester, Massachusetts, United States|University of Minnesota Medical Center, Fairview - Infectious Diseases and International Medicine, Minneapolis, Minnesota, United States|Saint Louis University - Center for Vaccine Development, Saint Louis, Missouri, United States|University of Nebraska Medical Center - Infectious Diseases, Omaha, Nebraska, United States|University of New Mexico Clinical and Translational Science Center, Albuquerque, New Mexico, United States|Montefiore Medical Center - Infectious Diseases, Bronx, New York, United States|New York University School of Medicine - Langone Medical Center - Microbiology - Parasitology, New York, New York, United States|University of Rochester Medical Center - Vaccine Research Unit, Rochester, New York, United States|Duke Human Vaccine Institute - Duke Vaccine and Trials Unit, Durham, North Carolina, United States|Penn State Health Milton S. Hershey Medical Center - Division of Infectious Diseases, Hershey, Pennsylvania, United States|University of Pennsylvania Perelman School of Medicine - Penn Institute for Immunology, Philadelphia, Pennsylvania, United States|Vanderbilt University Medical Center - Infectious Diseases, Nashville, Tennessee, United States|University of Texas Southwestern Medical Center - Internal Medicine - Infectious Diseases, Dallas, Texas, United States|Brooke Army Medical Center, Fort Sam Houston, Texas, United States|University of Texas Medical Branch - Division of Infectious Disease, Galveston, Texas, United States|Baylor College of Medicine - Molecular Virology and Microbiology, Houston, Texas, United States|University of Texas Health Science Center at San Antonio - Infectious Diseases, San Antonio, Texas, United States|University of Virginia - Acute Care Surgery, Charlottesville, Virginia, United States|Naval Medical Center Portsmouth - Infectious Disease Division, Portsmouth, Virginia, United States|EvergreenHealth Infectious Disease Service, Kirkland, Washington, United States|Providence Sacred Heart Medical Center, Spokane, Washington, United States|Madigan Army Medical Center - Infectious Disease Clinic, Tacoma, Washington, United States|National Center for Global Health and Medicine Hospital - Disease Control and Prevention Center, Tokyo, Japan|Seoul National University Bundang Hospital - Division of Infectious Diseases, Bundang-gu Seongnam-si, Korea, Republic of|Seoul National University Hospital, Seoul, Korea, Republic of|Instituto Nacional de Ciencias Medicas y Nutrición Salvador Zubirán - Departamento de Infectologia, Mexico City, Mexico|Instituto Nacional de Enfermedades Respiratorias (INER) - Ismael Cosío Villegas, Mexico City, Mexico|National University Health System - Division of Infectious Diseases, Singapore, Singapore|National Centre for Infectious Diseases (NCID), Singapore, Singapore|Changi General Hospital - Clinical Trials and Research Unit (CTRU), Singapore, Singapore|Ng Teng Fong General Hospital - Infectious Disease Service, Singapore, Singapore"	https://ClinicalTrials.gov/show/NCT04401579
85	NCT04280705	Adaptive COVID-19 Treatment Trial (ACTT)	Recruiting	No Results Available	COVID-19	Other: Placebo|Drug: Remdesivir	Phase 3	Interventional	"University of Alabama at Birmingham School of Medicine - Infectious Disease, Birmingham, Alabama, United States|University of California San Diego Health - Jacobs Medical Center, La Jolla, California, United States|University of California Los Angeles Medical Center - Westwood Clinic, Los Angeles, California, United States|University of California Irvine Medical Center - Infectious Disease, Orange, California, United States|VA Palo Alto Health Care System - Infectious Diseases, Palo Alto, California, United States|Stanford University - Stanford Hospital and Clinics - Pediatrics - Infectious Diseases, Palo Alto, California, United States|University of California Davis Medical Center - Internal Medicine - Infectious Disease, Sacramento, California, United States|Naval Medical Center San Diego - Infectious Disease Clinic, San Diego, California, United States|University of California San Francisco - Zuckerberg San Francisco General Hospital - Division of Human Immunodeficiency Virus, Infectious Disease, and Global Medicine, San Francisco, California, United States|Cedars Sinai Medical Center, West Hollywood, California, United States|Denver Health Division of Hospital Medicine - Main Campus, Denver, Colorado, United States|Emory Vaccine Center - The Hope Clinic, Decatur, Georgia, United States|Northwestern Hospital - Infectious Disease, Chicago, Illinois, United States|University of Illinois at Chicago College of Medicine - Division of Infectious Diseases, Chicago, Illinois, United States|Southeast Louisiana Veterans Health Care System (SLVHCS) - Section of Infectious Diseases, New Orleans, Louisiana, United States|University of Maryland School of Medicine - Center for Vaccine Development - Baltimore, Annapolis, Maryland, United States|Johns Hopkins Hospital - Medicine - Infectious Diseases, Baltimore, Maryland, United States|Walter Reed National Military Medical Center, Bethesda, Maryland, United States|National Institutes of Health - Clinical Center, National Institute of Allergy and Infectious Diseases Laboratory Of Immunoregulation, Clinical Research Section, Bethesda, Maryland, United States|Massachusetts General Hospital - Infectious Diseases, Boston, Massachusetts, United States|University of Massachusetts Medical School - Infectious Diseases and Immunology, Worcester, Massachusetts, United States|University of Minnesota Medical Center, Fairview - Infectious Diseases and International Medicine, Minneapolis, Minnesota, United States|Saint Louis University - Center for Vaccine Development, Saint Louis, Missouri, United States|University of Nebraska Medical Center - Infectious Diseases, Omaha, Nebraska, United States|Montefiore Medical Center - Infectious Diseases, Bronx, New York, United States|New York University School of Medicine - Langone Medical Center - Microbiology - Parasitology, New York, New York, United States|University of Rochester Medical Center - Vaccine Research Unit, Rochester, New York, United States|Duke Human Vaccine Institute - Duke Vaccine and Trials Unit, Durham, North Carolina, United States|Penn State Health Milton S. Hershey Medical Center - Division of Infectious Diseases, Hershey, Pennsylvania, United States|Hospital of the University of Pennsylvania - Infectious Diseases, Philadelphia, Pennsylvania, United States|Vanderbilt University Medical Center - Infectious Diseases, Nashville, Tennessee, United States|Brooke Army Medical Center, Fort Sam Houston, Texas, United States|University of Texas Medical Branch - Division of Infectious Disease, Galveston, Texas, United States|Baylor College of Medicine - Molecular Virology and Microbiology, Houston, Texas, United States|University of Texas Health Science Center at San Antonio - Infectious Diseases, San Antonio, Texas, United States|University of Virginia - Acute Care Surgery, Charlottesville, Virginia, United States|Naval Medical Center Portsmouth - Infectious Disease Division, Portsmouth, Virginia, United States|EvergreenHealth Infectious Disease Service, Kirkland, Washington, United States|The University of Washington - Virology Research Clinic, Seattle, Washington, United States|Providence Sacred Heart Medical Center, Spokane, Washington, United States|Madigan Army Medical Center - Infectious Disease Clinic, Tacoma, Washington, United States|University of Copenhagen - Centre of Excellence for Health, Immunity and Infections (CHIP) - Department of Infectious Diseases, Copenhagen, Denmark|Universitatsklinikum Bonn, Medizinische Klinik I - Bereich Infektiologie/HIV der Medizinischen Klinik, Bonn, Nordrhein-Westfalen, Germany|Universitatsklinikum Koeln Klinik I fur Innere Medizin Klinisches Studienzentrum fur Infektiologie I, Cologne, Germany|Universitätsklinikum Frankfurt -Medizinische Klinik II - Infektiologie, Frankfurt, Germany|AHEPA University Hospital - 1st Department of Internal Medicine, Thessaloniki, Central Macedonia, Greece|Medical School of Athens University - Evangelismos Hospital - Department of Critical Care and Pulmonary Services, Athens, Greece|National Center for Global Health and Medicine Hospital - Disease Control and Prevention Center, Tokyo, Japan|Seoul National University Bundang Hospital - Division of Infectious Diseases, Bundang-gu Seongnam-si, Gyeonggi-do, Korea, Republic of|Seoul National University Hospital, Seoul, Jongno-gu, Korea, Republic of|Instituto Nacional de Ciencias Medicas y Nutrición Salvador Zubirán - Departamento de Infectologia, Mexico City, Mexico|Instituto Nacional de Enfermedades Respiratorias (INER) - Ismael Cosío Villegas, Mexico City, Mexico|National Centre for Infectious Diseases (NCID), Singapore, Singapore|Hospital Clinic Barcelona, Servicio de Salud Internacional, Barcelona, Cataluña, Spain|Hospital Germans Trias i Pujol - Servei Malalties Infeccioses, Barcelona, Cataluña, Spain|Royal Sussex County Hospital - Department of Intensive Care Medicine, East Sussex, Brighton, United Kingdom|Saint Thomas' Hospital - Directorate of Infection, London, London, City Of, United Kingdom|Royal Victoria Infirmary - Department of Infectious Diseases, Level 6, Ward 19, Newcastle Upon Tyne, United Kingdom|St. James's University Hospital - Infectious Diseases, Leeds, West Yorkshire, United Kingdom|John Radcliffe Hospital, Headington, Oxford, United Kingdom"	https://ClinicalTrials.gov/show/NCT04280705
86	NCT04252118	Mesenchymal Stem Cell Treatment for Pneumonia Patients Infected With COVID-19	Recruiting	No Results Available	COVID-19	Biological: MSCs	Phase 1	Interventional	"Beijing 302 Military Hospital of China, Beijing, China"	https://ClinicalTrials.gov/show/NCT04252118
87	NCT04410354	Study of Merimepodib in Combination With Remdesivir in Adult Patients With Advanced COVID-19	Recruiting	No Results Available	COVID-19	Drug: Merimepodib|Drug: Matching Placebo|Drug: Remdesivir	Phase 2	Interventional	"Mayo Clinic in Arizona, Phoenix, Arizona, United States|Mayo Clinic in Florida, Jacksonville, Florida, United States|Mayo Clinic, Rochester, Minnesota, United States|Atlantic Health System / Morristown Medical Center, Morristown, New Jersey, United States|Atlantic Health System / Overlook Medical Center, Summit, New Jersey, United States|St. David's South Austin Medical Center, Austin, Texas, United States"	https://ClinicalTrials.gov/show/NCT04410354
88	NCT04397328	COVID-19 PEP- High-risk Individuals in Long-term and Specialized Care - Canada	Not yet recruiting	No Results Available	COVID-19	Drug: Hydroxychloroquine|Drug: Placebo	Phase 3	Interventional		https://ClinicalTrials.gov/show/NCT04397328
89	NCT04449588	Efficacy and Safety Study of BDB-001 in Severe COVID-19 With ALI/ARDS	Recruiting	No Results Available	COVID-19 Pneumonia	Drug: BDB-001 Injection|Other: Conventional treatment	Phase 2|Phase 3	Interventional	"Southwest Hospital Chongqing, Chongqing, Chongqing, China|RSUP Persahabatan(Persahabatan General Hospital), East Jakarta, Jakarta, Indonesia|RSUD Pasar Minggu(Pasar Minggu General Hospital), South Jakarta, Jakarta, Indonesia|RSUD Cengkareng(Cengkareng General Hospital), West Jakrata, Jakrata, Indonesia"	https://ClinicalTrials.gov/show/NCT04449588
90	NCT04380688	Acalabrutinib Study With Best Supportive Care Versus Best Supportive Care in Subjects Hospitalized With COVID-19.	Not yet recruiting	No Results Available	COVID-19	Drug: Acalabrutinib	Phase 2	Interventional	"Research Site, Washington, District of Columbia, United States|Research Site, Louisville, Kentucky, United States|Research Site, Baltimore, Maryland, United States|Research Site, Bethesda, Maryland, United States|Research Site, Bethesda, Maryland, United States|Research Site, Hackensack, New Jersey, United States|Research Site, Buffalo, New York, United States"	https://ClinicalTrials.gov/show/NCT04380688
91	NCT04346199	Acalabrutinib Study With Best Supportive Care Versus Best Supportive Care in Subjects Hospitalized With COVID-19.	Not yet recruiting	No Results Available	COVID-19	Drug: Acalabrutinib	Phase 2	Interventional	"Research Site, Bobigny, France|Research Site, Villejuif Cedex, France|Research Site, Bologna, Italy|Research Site, Firenze, Italy|Research Site, Milano, Italy|Research Site, Roma, Italy|Research Site, Roma, Italy|Research Site, Fuenlabrada, Spain|Research Site, Madrid, Spain|Research Site, Mérida, Spain|Research Site, Pozuelo de Alarcón, Spain"	https://ClinicalTrials.gov/show/NCT04346199
92	NCT04418505	Vielight RX Plus for the Treatment of COVID-19 Respiratory Symptoms	Not yet recruiting	No Results Available	COVID-19	Device: Vielight RX Plus	Not Applicable	Interventional	"Dr. Michael Zahavi, Oshawa, Ontario, Canada"	https://ClinicalTrials.gov/show/NCT04418505
93	NCT04361942	Treatment of Severe COVID-19 Pneumonia With Allogeneic Mesenchymal Stromal Cells (COVID_MSV)	Recruiting	No Results Available	COVID-19 Pneumonia	Biological: Mesenchymal Stromal Cells|Other: Placebo	Phase 2	Interventional	"Hospital Universitario Rio Hortega, Valladolid, Spain"	https://ClinicalTrials.gov/show/NCT04361942
94	NCT04365257	Prazosin to Prevent COVID-19 (PREVENT-COVID Trial)	Recruiting	No Results Available	COVID-19	Drug: Prazosin|Other: Standard of care	Phase 2	Interventional	"Johns Hopkins Hospital, Baltimore, Maryland, United States"	https://ClinicalTrials.gov/show/NCT04365257
95	NCT04350671	Interferon Beta 1a in Hospitalized COVID-19 Patients	Enrolling by invitation	No Results Available	COVID-19	Drug: Interferon Beta-1A|Drug: Lopinavir / Ritonavir|Drug: Single Dose of Hydroxychloroquine	Phase 4	Interventional	"Loghman Hakim Hospital, Shahid Beheshti University of Medical Sciences and Health Services, Tehran, Iran, Islamic Republic of"	https://ClinicalTrials.gov/show/NCT04350671
96	NCT04456153	Atovaquone for Treatment of COVID-19	Not yet recruiting	No Results Available	COVID-19	Drug: Experimental Group|Drug: Placebo Group	Phase 2	Interventional		https://ClinicalTrials.gov/show/NCT04456153
97	NCT04361318	Hydroxychloroquine and Nitazoxanide Combination Therapy for COVID-19	Not yet recruiting	No Results Available	COVID-19	Combination Product: Hydroxychloroquine plus Nitazoxanide|Other: Standard care	Phase 2|Phase 3	Interventional		https://ClinicalTrials.gov/show/NCT04361318
98	NCT04348656	CONvalescent Plasma for Hospitalized Adults With COVID-19 Respiratory Illness (CONCOR-1)	Recruiting	No Results Available	COVID-19	Biological: Convalescent plasma	Phase 3	Interventional	"Brooklyn Hospital, Brooklyn, New York, United States|Lower Manhattan Hospital, New York, New York, United States|Weill Cornell Medical Center, New York, New York, United States|Hamilton General Hospital, Hamilton, Ontario, Canada|Juravinski Hospital, Hamilton, Ontario, Canada|Grand River Hospital, Kitchener, Ontario, Canada|London Health Sciences Centre - University Hospital, London, Ontario, Canada|Trillium Health Partners, Mississauga, Ontario, Canada|Trillium Health Partners - Credit Valley, Mississauga, Ontario, Canada|Ottawa Hospital - General Campus, Ottawa, Ontario, Canada|Ottawa Hospital - Civic Campus, Ottawa, Ontario, Canada|Scarborough Health Network - Centenary Hospital, Scarborough, Ontario, Canada|Scarborough Health Network - General Hospital, Scarborough, Ontario, Canada|Scarborough Health Network - Birchmount Hospital, Scarborough, Ontario, Canada|Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada|Unity Health St. Michael's Hospital, Toronto, Ontario, Canada|Sinai Health System, Toronto, Ontario, Canada|Toronto General Hospital, Toronto, Ontario, Canada|Toronto Western Hospital, Toronto, Ontario, Canada|Windsor Regional Hospital - Metropolitan Campus, Windsor, Ontario, Canada|Windsor Regional Hospital - Ouellette Campus, Windsor, Ontario, Canada|Hôpital de la Cité-de-la-Santé, Laval, Quebec, Canada|Hotel Dieu Hospital of Lévis, Lévis, Quebec, Canada|Hôpital Maisonneuve-Rosemont, Montréal, Quebec, Canada|Centre hospitalier de l'Université de Montréal, Montréal, Quebec, Canada|Centre hospitalier universitaire Sainte-Justine, Montréal, Quebec, Canada|Jewish General Hospital, Montréal, Quebec, Canada|McGill University Health Centre, Montréal, Quebec, Canada|Hôpital du Sacré-Coeur de Montreal, Montréal, Quebec, Canada|Ciussse De L'Estrie CHUS, Sherbrooke, Quebec, Canada|Centre hospitalier affilié universitaire régional de Trois-Rivières, Trois-Rivières, Quebec, Canada"	https://ClinicalTrials.gov/show/NCT04348656
99	NCT04354714	Ruxolitinib to Combat COVID-19	Withdrawn	No Results Available	COVID-19	Drug: Ruxolitinib|Procedure: Peripheral blood draw	Phase 2	Interventional		https://ClinicalTrials.gov/show/NCT04354714
100	NCT04350684	Umifenovir in Hospitalized COVID-19 Patients	Enrolling by invitation	No Results Available	COVID-19	Drug: Umifenovir|Drug: Interferon-β 1a|Drug: Lopinavir / Ritonavir|Drug: Single Dose of Hydroxychloroquine|Drug: Standards of Care	Phase 4	Interventional	"Loghman Hakim Hospital, Shahid Beheshti University of Medical Sciences and Health Services, Tehran, Iran, Islamic Republic of"	https://ClinicalTrials.gov/show/NCT04350684
101	NCT04330586	A Trial of Ciclesonide in Adults With Mild COVID-19	Not yet recruiting	No Results Available	COVID-19	Drug: Ciclesonide Metered Dose Inhaler [Alvesco]|Drug: Hydroxychloroquine	Phase 2	Interventional		https://ClinicalTrials.gov/show/NCT04330586
102	NCT04359953	"Efficacy of Hydroxychloroquine, Telmisartan and Azithromycin on the Survival of Hospitalized Elderly Patients With COVID-19"	Not yet recruiting	No Results Available	COVID-19 Infection	Drug: Hydroxychloroquine|Drug: Azithromycin|Drug: Telmisartan	Phase 3	Interventional	"CHU de Strasbourg, Strasbourg, France"	https://ClinicalTrials.gov/show/NCT04359953
103	NCT04435184	Crizanlizumab for Treating COVID-19 Vasculopathy	Not yet recruiting	No Results Available	COVID-19	Drug: Crizanlizumab|Other: 0.9% saline	Phase 2	Interventional	"Johns Hopkins Hospital, Baltimore, Maryland, United States"	https://ClinicalTrials.gov/show/NCT04435184
104	NCT04416048	Effect of Anticoagulation Therapy on Clinical Outcomes in COVID-19	Not yet recruiting	No Results Available	COVID-19	Drug: Rivaroxaban|Other: Standard Of Care (SOC)	Phase 3	Interventional	"Kardiologie und Angiologie I Universitätsherzzentrum Freiburg, Freiburg, Baden-Württemberg, Germany|Clinic for Gastroenterology, Infectology and Poisoning Universitäsklinikum Heidelberg, Heidelberg, Baden-Württemberg, Germany|Cardiology and Pneumology Clinic Klinikum Garmisch-Partenkirchen, Garmisch-Partenkirchen, Bayern, Germany|Medical Clinic and Polyclinic I. L. Ludwigs-Maximilians-University Clinic, Munich, Munich, Bayern, Germany|Cardiology, Pneumology and Intensive Care Clinic, München Klinik Neuperlach, München, Bayern, Germany|Internal Medicine and Cardiology Klinik Henningsdorf. Oberhavel Kliniken, Hennigsdorf, Brandenburg, Germany|Clinic for Cardiology, Angiology und Nephrology Universitätsklinikum Frankfurt, Goethe-Universität, Frankfurt am Main, Hessen, Germany|Clinic and Polyclinic Internal Medicine Universitätsmedizin Greifswald, Greifswald, Mecklenburg-Vorpommern, Germany|Cardiology and Pneumology Clinic Universitätsmedizin Göttingen, Göttingen, Niedersachsen, Germany|Clinic for Cardiology and Intensive Care - Klinikum Bielefeld, Bielefeld, Nordrhein-Westfalen, Germany|Medical Clinic I. Marien Hospital, Universitätsklinikum der Ruhr Universität Bochum, Herne, Herne, Nordrhein-Westfalen, Germany|Pneumology, Allergology, Sleep-and Respiratory Medicine Clinic Helios Universitätsklinikum Wupperthal, Wuppertal, Nordrhein-Westfalen, Germany|Center for Cardiology, University Medicine Mainz, Mainz, Rheinland-Pfalz, Germany|Clinic for Vascular Medicine, Städtisches Krankenhaus Dresden, Dresden, Sachsen, Germany|Medical Clinic I. Universitätsklinikum Carl Gustav Carus, Dresden, Dresden, Sachsen, Germany|Cardiology, Pneumology and Intensive Care Clinic Helios Klinikum Pirna, Dresden, Pirna, Sachsen, Germany|Medical Clinic II, University Clinic Schleswig-Holstein - Campus Lübeck, Lübeck, Schleswig-Holstein, Germany|Department of Pneumology and Infectology Charité University Medicine Berlin, Campus Mitte, Berlin, Germany|Internal Medicine II, Cardiology, Sana Klinikum, Lichtenberg. Berlin, Berlin, Germany|Medical Clinic II. St. Joseph Hospital Berlin, Berlin, Germany|Department of Cardiology Charité University Medicine Berlin, Campus Benjamin Franklin, Berlin, Germany|Internal Medicine, Hospital Bethel Berlin in Lichterfelde, Berlin, Germany|Internal Medicine/Cardiology department Unfallkrankenhaus Berlin, Berlin, Germany|Department of Cardiology Charité University Medicine Berlin, Campus Virchow, Berlin, Germany|Internal Medicine, Cardiology and Intensive Care Clinic Vivantes Humboldt Klinikum, Berlin, Berlin, Germany|Intensive Care and Cardiology, Hospital Havelhöhe, Berlin, Germany|Internal Medicine Deparment Hospital Waldfriede, Berlin, Berlin, Germany"	https://ClinicalTrials.gov/show/NCT04416048
105	NCT04441385	Study to Evaluate the Efficacy and Safety of Maraviroc in SARS-CoV-2 Infection (COVID-19).	Not yet recruiting	No Results Available	COVID-19	Drug: Maraviroc 300 mg|Other: Standard care therapy	Phase 2	Interventional	"Hospital Clínic, Barcelona, Spain|Hospital Universitario Infanta Leonor, Madrid, Spain"	https://ClinicalTrials.gov/show/NCT04441385
106	NCT04328285	Chemoprophylaxis of SARS-CoV-2 Infection (COVID-19) in Exposed Healthcare Workers	"Active, not recruiting"	No Results Available	COVID-19	Drug: Hydroxychloroquine|Drug: Placebo of Hydroxychloroquine|Drug: Lopinavir and ritonavir|Drug: Placebo of LPV/r Tablets	Phase 3	Interventional	"CHU d'Angers, Angers, France|CHU de Bordeaux, Bordeaux, France|CHU de Clermont-Ferrand, Clermont-ferrand, France|CHU de Montpellier, Montpellier, France|CHU de Nancy, Nancy, France|CHU de Nantes, Nantes, France|AP-HP - Hôpital Bichat, Paris, France|CHU de Rennes, Rennes, France|CHU de Rouen, Rouen, France|CHU de Saint-Etienne, Saint-Étienne, France"	https://ClinicalTrials.gov/show/NCT04328285
107	NCT04390594	Efficacy and Safety Evaluation of Treatment Regimens in Adult COVID-19 Patients in Senegal	Not yet recruiting	No Results Available	COVID-19	Drug: Hydroxychloroquine|Drug: Hydroxychloroquine + Azithromycin	Phase 3	Interventional	"Infectious and Tropical Diseases Department, Fann Hospital, Dakar, Senegal|Diamniadio Children Hospital, Diamniadio, Senegal|Dalal Jamm Hospital, Guédiawaye, Senegal"	https://ClinicalTrials.gov/show/NCT04390594
108	NCT04389359	PROphylaxis for paTiEnts at Risk of COVID-19 infecTion	Not yet recruiting	No Results Available	COVID-19	Drug: Hydroxychloroquine Sulfate 200 MG	Phase 2|Phase 3	Interventional		https://ClinicalTrials.gov/show/NCT04389359
109	NCT04315298	Evaluation of the Efficacy and Safety of Sarilumab in Hospitalized Patients With COVID-19	Recruiting	No Results Available	COVID-19	Drug: Sarilumab|Drug: Placebo	Phase 2|Phase 3	Interventional	"Regeneron Study Site, Los Angeles, California, United States|Regeneron Study Site, Sacramento, California, United States|Regeneron Study Site, Santa Monica, California, United States|Regeneron Study Site, Aurora, Colorado, United States|Regeneron Study Site, Denver, Colorado, United States|Regeneron Study Site, New Haven, Connecticut, United States|Regeneron Study Site, Washington, District of Columbia, United States|Regeneron Study Site, Coral Gables, Florida, United States|Regeneron Study Site, Gainesville, Florida, United States|Regeneron Study Site, Orlando, Florida, United States|Regeneron Study Site, Tampa, Florida, United States|Regeneron Study Site, Atlanta, Georgia, United States|Regeneron Study Site, Decatur, Georgia, United States|Regeneron Study Site, Marietta, Georgia, United States|Regeneron Study Site, Chicago, Illinois, United States|Regeneron Study Site, Chicago, Illinois, United States|Regeneron Study Site, New Orleans, Louisiana, United States|Regeneron Study Site, Baltimore, Maryland, United States|Regeneron Study Site, Boston, Massachusetts, United States|Regeneron Study Site, Boston, Massachusetts, United States|Regeneron Study Site, Boston, Massachusetts, United States|Regeneron Study Site, Boston, Massachusetts, United States|Regeneron Study Site, Ann Arbor, Michigan, United States|Regeneron Study Site, Rochester, Minnesota, United States|Regeneron Study Site, Edison, New Jersey, United States|Regeneron Study Site, Hackensack, New Jersey, United States|Regeneron Study Site, Livingston, New Jersey, United States|Regeneron Study Site, Morristown, New Jersey, United States|Regeneron Study Site, Neptune, New Jersey, United States|Regeneron Study Site, Newark, New Jersey, United States|Regeneron Study Site, Teaneck, New Jersey, United States|Regeneron Study Site, Bronx, New York, United States|Regeneron Study Site 1, Bronx, New York, United States|Regeneron Study Site 2, Bronx, New York, United States|Regeneron Study Site, Bronx, New York, United States|Regeneron Study Site, Brooklyn, New York, United States|Regeneron Study Site, Buffalo, New York, United States|Regeneron Study Site, Elmhurst, New York, United States|Regeneron Study Site 1, Manhasset, New York, United States|Regeneron Study Site 2, Manhasset, New York, United States|Regeneron Study Site, New York, New York, United States|Regeneron Study Site, New York, New York, United States|Regeneron Study Site 1, New York, New York, United States|Regeneron Study Site 2, New York, New York, United States|Regeneron Study Site, New York, New York, United States|Regeneron Study Site, New York, New York, United States|Regeneron Study Site, New York, New York, United States|Regeneron Study Site, New York, New York, United States|Regeneron Study Site, New York, New York, United States|Regeneron Study Site, Stony Brook, New York, United States|Regeneron Study Site, Valhalla, New York, United States|Regeneron Study Site, Tulsa, Oklahoma, United States|Regeneron Study Site, Portland, Oregon, United States|Regeneron Study Site, Portland, Oregon, United States|Regeneron Study Site, Danville, Pennsylvania, United States|Regeneron Study Site, Philadelphia, Pennsylvania, United States|Regeneron Study Site, Scranton, Pennsylvania, United States|Regeneron Study Site, Wilkes-Barre, Pennsylvania, United States|Regeneron Study Site, Dallas, Texas, United States|Regeneron Study Site, Dallas, Texas, United States|Regeneron Study Site, Murray, Utah, United States|Regeneron Study Site, Falls Church, Virginia, United States|Regeneron Study Site, Richmond, Virginia, United States|Regeneron Study Site, Everett, Washington, United States|Regeneron Study Site, Renton, Washington, United States"	https://ClinicalTrials.gov/show/NCT04315298
110	NCT04366739	Repurposing of Chlorpromazine in Covid-19 Treatment	Not yet recruiting	No Results Available	COVID-19	Drug: CHLORPROMAZINE (CPZ)|Combination Product: Standard of Care (SOC)	Phase 3	Interventional	"Centre Hospitalier Sainte-Anne, Paris, France"	https://ClinicalTrials.gov/show/NCT04366739
111	NCT04355936	Telmisartan for Treatment of COVID-19 Patients	Recruiting	No Results Available	COVID-19 Drug Treatment	Drug: Telmisartan arm will receive 80 mg Telmisartan twice daily plus standard care.	Phase 2	Interventional	"Hospital de Clínicas 'José de San Martín', Facultad de Medicina, Universidad de Buenos Aires, Buenos Aires, Ciudad De Buenos Aires, Argentina"	https://ClinicalTrials.gov/show/NCT04355936
112	NCT04425252	Safety and Anti-coronavirus Response of Suppression of Host Nucleotide Synthesis in Patients With COVID-19	Recruiting	No Results Available	COVID-19	Drug: Brequinar|Other: Standard of Care	Phase 1|Phase 2	Interventional	"Hartford Hospital, Hartford, Connecticut, United States|University of South Florida/Tampa General, Tampa, Florida, United States|Temple University, Philadelphia, Pennsylvania, United States"	https://ClinicalTrials.gov/show/NCT04425252
113	NCT04352933	PROLIFIC ChemoprophylaxisTrial (COVID-19)	Recruiting	No Results Available	COVID-19	Drug: Hydroxychloroquine - Daily dosing|Drug: Hydroxychloroquine - Weekly Dosing|Other: Matched Placebo Hydroxychloroquine	Phase 3	Interventional	"Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom"	https://ClinicalTrials.gov/show/NCT04352933
114	NCT04385940	Vitamin D and COVID-19 Management	Not yet recruiting	No Results Available	COVID-19	"Dietary Supplement: Ddrops® products, 50,000 IU, Oral|Dietary Supplement: Vitamin D3"	Phase 3	Interventional		https://ClinicalTrials.gov/show/NCT04385940
115	NCT04394442	Hydroxychloroquine in COVID-19 Patients	Recruiting	No Results Available	COVID-19	Drug: Hydroxychloroquine	Phase 2	Interventional	"SNH, Mecca, Saudi Arabia"	https://ClinicalTrials.gov/show/NCT04394442
116	NCT04405310	Convalescent Plasma of Covid-19 to Treat SARS-COV-2 a Randomized Doble Blind 2 Center Trial	Recruiting	No Results Available	COVID-19	Biological: Convalescent Plasma of patients with COVID-19|Other: placebo (hartmann plus albumine)	Phase 2	Interventional	"Hospital Nava de Alta Especialidad, Mexico City, Mexico|Hospital General de Mexico Dr Eduardo Liceaga, Mexico City, Mexico"	https://ClinicalTrials.gov/show/NCT04405310
117	NCT04377620	Assessment of Efficacy and Safety of Ruxolitinib in Participants With COVID-19-Associated ARDS Who Require Mechanical Ventilation (RUXCOVID-DEVENT)	Recruiting	No Results Available	COVID-19	Drug: Placebo|Drug: Ruxolitinib	Phase 3	Interventional	"Georgetown University Hospital, Washington, District of Columbia, United States|Tampa General Hospital, Tampa, Florida, United States|Indiana University Simon Cancer Center, Indianapolis, Indiana, United States|Boston Medical Center, Boston, Massachusetts, United States|Lahey Clinic Inc., Burlington, Massachusetts, United States|UMass MMC - University Campus, Worcester, Massachusetts, United States|Duke University Medical Center, Durham, North Carolina, United States|Jefferson Hospital, Philadelphia, Pennsylvania, United States|West Penn Hospital, Pittsburgh, Pennsylvania, United States"	https://ClinicalTrials.gov/show/NCT04377620
118	NCT04337996	Dynamic Evaluation of COVID-19 Diagnostic Tests	Not yet recruiting	No Results Available	COVID-19	Diagnostic Test: COVID-19 diagnostic test	Not Applicable	Interventional		https://ClinicalTrials.gov/show/NCT04337996
119	NCT04381884	Ivermectin Effect on SARS-CoV-2 Replication in Patients With COVID-19	Recruiting	No Results Available	COVID-19 Drug Treatment	Drug: IVERMECTIN (IVER P®) arm will receive IVM 600 µg / kg once daily plus standard care. CONTROL arm will receive standard care.	Phase 2	Interventional	"Centro de Educación Médica e Investigaciones Clínicas ""Norberto Quirno"" CEMIC, Buenos Aires, Ciudad De Buenos Aires, Argentina"	https://ClinicalTrials.gov/show/NCT04381884
120	NCT04422509	Lanadelumab for Treatment of COVID-19 Disease	Not yet recruiting	No Results Available	COVID-19	Biological: lanadelumab|Other: regular care	Phase 1|Phase 2	Interventional	"Jereoen Bosch hospital, 's-Hertogenbosch, Netherlands|Amsterdam UMC, Amsterdam, Netherlands|Rijnstate hospital, Arnhem, Netherlands|Tergooi ziekenhuizen, Blaricum, Netherlands|Amphia hospital, Breda, Netherlands|Haga hospital, Den Haag, Netherlands|Radboudumc, Nijmegen, Netherlands|Elisabeth-Tweesteden ziekenhuis, Tilburg, Netherlands|UMC Utrecht, Utrecht, Netherlands|Isala klinieken, Zwolle, Netherlands"	https://ClinicalTrials.gov/show/NCT04422509
121	NCT04330638	Treatment of COVID-19 Patients With Anti-interleukin Drugs	Recruiting	No Results Available	COVID-19	Other: Usual Care|Drug: Anakinra|Drug: Siltuximab|Drug: Tocilizumab	Phase 3	Interventional	"AZ Sint-Jan Brugge, Brugge, Belgium|University Hospital Saint-Pierre, Brussels, Belgium|Erasmus University Hospital, Brussels, Belgium|University Hospital Saint-Luc, Brussels, Belgium|University Hospital Antwerp, Edegem, Belgium|Ziekenhuis Oost-Limurg, Genk, Belgium|AZ Sint-Lucas, Gent, Belgium|University Hospital Ghent, Gent, Belgium|Jessa ZH, Hasselt, Belgium|University Hospital Brussels, Jette, Belgium|CHU Tivoli, La Louvière, Belgium|CHR de la Citadelle, Liège, Belgium|University Hospital Liège, Liège, Belgium|Cliniques Saint-Pierre Ottignies, Ottignies-Louvain-la-Neuve, Belgium|AZ Delta, Roeselare, Belgium"	https://ClinicalTrials.gov/show/NCT04330638
122	NCT04359797	COVID-19 Patient Positioning Pragmatic Trial	Enrolling by invitation	No Results Available	COVID-19	Other: Prone|Other: Usual Care	Not Applicable	Interventional	"Vanderbilt University Medical Center, Nashville, Tennessee, United States"	https://ClinicalTrials.gov/show/NCT04359797
123	NCT04361214	Leflunomide in Mild COVID-19 Patients	Recruiting	No Results Available	COVID-19	Drug: Leflunomide	Phase 1	Interventional	"University of Chicago, Chicago, Illinois, United States"	https://ClinicalTrials.gov/show/NCT04361214
124	NCT04363372	A Study for Efficacy and Safety of Live Biotherapeutic MRx4DP0004 to Treat COVID-19	Recruiting	No Results Available	COVID-19	Drug: MRx-4DP0004|Drug: Placebo	Phase 2	Interventional	"University Hospitals Plymouth NHS Trust, Plymouth, United Kingdom"	https://ClinicalTrials.gov/show/NCT04363372
125	NCT04369742	Treating COVID-19 With Hydroxychloroquine (TEACH)	Suspended	No Results Available	COVID-19	Drug: Hydroxychloroquine (HCQ)|Other: Pacebo: Calcium citrate	Phase 2	Interventional	"State University of New York (SUNY) Downstate Medical Center, Brooklyn, New York, United States|NYU Langone Health, New York, New York, United States"	https://ClinicalTrials.gov/show/NCT04369742
126	NCT04343690	COPING With COVID-19( CWC-19)	Not yet recruiting	No Results Available	COVID-19	Behavioral: Crisis management coaching	Not Applicable	Interventional	"Duke University, Durham, North Carolina, United States"	https://ClinicalTrials.gov/show/NCT04343690
127	NCT04418518	A Trial of CONvalescent Plasma for Hospitalized Adults With Acute COVID-19 Respiratory Illness	Not yet recruiting	No Results Available	COVID-19	Biological: Convalescent plasma	Phase 3	Interventional	"Weill Cornell Medicine, New York, New York, United States"	https://ClinicalTrials.gov/show/NCT04418518
128	NCT04355767	Convalescent Plasma in Outpatients With COVID-19	Not yet recruiting	No Results Available	COVID-19	Biological: Convalescent Plasma|Biological: Saline	Phase 3	Interventional	"Stanford University, Stanford, California, United States|University of Michigan, Ann Arbor, Michigan, United States|University of Pittsburgh, Pittsburgh, Pennsylvania, United States|Medical University of South Carolina, Charleston, South Carolina, United States"	https://ClinicalTrials.gov/show/NCT04355767
129	NCT04408066	COVID-19: A POC Test Under Research & Evaluation	Recruiting	No Results Available	COVID-19	Diagnostic Test: Sample Collection/Performance Evaluation (A)|Diagnostic Test: Sample Collection/Performance Evaluation (B)	Not Applicable	Interventional	"Barts Health NHS Trust, London, United Kingdom|Homerton University Hospital NHS Foundation Trust, London, United Kingdom|University College London Hospitals NHS Foundation Trust, London, United Kingdom"	https://ClinicalTrials.gov/show/NCT04408066
130	NCT04452474	Study of the Efficacy and Safety of a Single Administration of Olokizumab vs. Placebo in Addition to Standard Treatment in Patients With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection (COVID-19).	Not yet recruiting	No Results Available	COVID-19	Drug: Olokizumab 64 mg|Drug: Placebo	Phase 2|Phase 3	Interventional	"George Washington University Medical Center, Washington, District of Columbia, United States|Center For Haptitis C/ Atlanta Medical Center, Atlanta, Georgia, United States|PMG Research of DuPage Medical Group, Downers Grove, Illinois, United States|Northwest Indiana Center for Clinical Research, Portage, Indiana, United States|Baystate Infectious Diseases Clinical Research, Springfield, Massachusetts, United States|PMG Research, Inc., Winston-Salem, North Carolina, United States"	https://ClinicalTrials.gov/show/NCT04452474
131	NCT04332081	Hyperbaric Oxygen for COVID-19 Patients	Terminated	No Results Available	COVID-19	Device: hyperbaric oxygen therapy (HBOT)	Not Applicable	Interventional	"NYU Winthrop Hospital, Mineola, New York, United States"	https://ClinicalTrials.gov/show/NCT04332081
132	NCT04377477	COVID-19 Pneumonitis Low Dose Lung Radiotherapy (COLOR-19)	Recruiting	No Results Available	COVID-19	Radiation: Single fraction whole lung radiotherapy	Not Applicable	Interventional	"Radiation Oncology Department, ASST SpedaliCivili, Brescia, Brescia, Italy"	https://ClinicalTrials.gov/show/NCT04377477
133	NCT04326920	Sargramostim in Patients With Acute Hypoxic Respiratory Failure Due to COVID-19 (SARPAC)	Recruiting	No Results Available	COVID-19	Drug: Sargramostim|Other: Control	Phase 4	Interventional	"AZ Sint Jan Brugge, Brugge, Belgium|University Hospital Ghent, Gent, Belgium|UZ Brussel, Jette, Belgium|AZ Delta Roeselare, Roeselare, Belgium"	https://ClinicalTrials.gov/show/NCT04326920
134	NCT04380519	Study of the Efficacy and Safety of a Single Administration of Olokizumab and RPH-104 With Standard Therapy in Patients With Severe Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection (COVID-19)	Recruiting	No Results Available	COVID-19	Biological: RPH-104 80 mg|Drug: Olokizumab 64 mg|Drug: Placebo	Phase 2|Phase 3	Interventional	"Federal State Budget Institution ""National Medical Surgery Center named after N.I. Pirogov"" of Ministry of Health of Russian Federation, Moscow, Russian Federation|State Budget Healthcare Institution ""City Clinical Hospital № 15 named after O.M. Filatov"" of Moscow City Healthcare Department, Moscow, Russian Federation|Federal State Budgetary Institution ""Federal Center for Cerebrovascular Pathology and Stroke"" of the Ministry of Health of the Russian Federation, Moscow, Russian Federation|Federal State Autonomous Education Insitution of High Education the First Moscow State Medical University named after I.M. Sechenov of Ministry of Healthcare of Russian Federation (Sechenov University), Moscow, Russian Federation|Federal State Budget Institution ""National Medicine Research Center on Cardiology"" By Ministry of Healthcare of Russian Federation, Moscow, Russian Federation|State Budget Institution of Healthcare ""City Clinical Hospital #52"", Moscow City Healthcare Department, Moscow, Russian Federation|Moscow State Budget Institution of Healthcare ""Scientific Research Institute of Emergency Medicine named after N.V. Sklifosovsky of Moscow Department of Healthcare"", Moscow, Russian Federation|State Budget Healthcare Institution ""City Clinical Hospital #40"", Moscow City Healthcare Department, ""Communarca"" Division, Moscow, Russian Federation|АО ""State Company ""Medsi"" based on Clinical Hospital №1"", Moscow, Russian Federation|Saint Petersburg State Budget Institution of Healthcare ""Clinical infectious diseases hospital named after S.P. Botkin"", Saint Petersburg, Russian Federation|Saint-Petersburg State Budget Institution of Healthcare ""City Hospital №40"", Saint Petersburg, Russian Federation"	https://ClinicalTrials.gov/show/NCT04380519
135	NCT04365699	Cardiovascular Effects of COVID-19	Recruiting	No Results Available	COVID-19	Drug: AT-001	Phase 2	Interventional	"NYU Langone Health, New York, New York, United States"	https://ClinicalTrials.gov/show/NCT04365699
136	NCT04304313	A Pilot Study of Sildenafil in COVID-19	Recruiting	No Results Available	COVID-19	Drug: Sildenafil citrate tablets	Phase 3	Interventional	"Department and Institute of Infectious Disease, Wuhan, Hubei, China"	https://ClinicalTrials.gov/show/NCT04304313
137	NCT04405908	SCB-2019 as COVID-19 Vaccine	Recruiting	No Results Available	COVID-19	Biological: SCB-2019|Biological: SCB-2019 with AS03 adjuvant|Biological: SCB-2019 with CpG 1018 adjuvant plus Alum adjuvant	Phase 1	Interventional	"Linear Clinical Research Ltd, Nedlands, Western Australia, Australia"	https://ClinicalTrials.gov/show/NCT04405908
138	NCT04344587	Awake Prone Position for Early Hypoxemia in COVID-19	Enrolling by invitation	No Results Available	COVID-19	Other: Self-prone position recommendation|Other: Usual care	Not Applicable	Interventional	"MedStar Georgetown University Hospital, Washington, District of Columbia, United States|Piedmont Atlanta, Atlanta, Georgia, United States|University of Kansas Medical Center, Kansas City, Kansas, United States|Boston Medical Center, Boston, Massachusetts, United States|University of Michigan, Ann Arbor, Michigan, United States|Creighton University, Omaha, Nebraska, United States"	https://ClinicalTrials.gov/show/NCT04344587
139	NCT04441996	Therapeutic Plasma Exchange for COVID-19-associated Hyperviscosity	Not yet recruiting	No Results Available	COVID-19	Biological: Therapeutic plasma exchange (TPE)|Other: Standard of care	Phase 4	Interventional	"Emory Saint Joseph's Hospital, Atlanta, Georgia, United States|Emory University Hospital Midtown, Atlanta, Georgia, United States|Emory University Hospital, Atlanta, Georgia, United States"	https://ClinicalTrials.gov/show/NCT04441996
140	NCT04353284	Camostat Mesylate in COVID-19 Outpatients	Recruiting	No Results Available	COVID-19	Drug: Camostat Mesilate|Other: Placebo	Phase 2	Interventional	"Yale University, New Haven, Connecticut, United States"	https://ClinicalTrials.gov/show/NCT04353284
141	NCT04382755	Zilucoplan® in Improving Oxygenation and Short- and Long-term Outcome of COVID-19 Patients With Acute Hypoxic Respiratory Failure	Not yet recruiting	No Results Available	COVID-19	Drug: Zilucoplan®|Drug: Placebo	Phase 2	Interventional	"OLVZ Aalst, Aalst, Belgium|AZ Sint Jan Brugge, Brugge, Belgium|Erasmus University Hospital, Brussels, Belgium|AZ Sint-Lucas, Gent, Belgium|University Hospital Ghent, Gent, Belgium|Jan Yperman Ziekenhuis Ieper, Ieper, Belgium|University Hospital Liège, Liège, Belgium|AZ Delta, Roeselare, Belgium|AZ Vesalius, Tongeren, Belgium"	https://ClinicalTrials.gov/show/NCT04382755
142	NCT04389710	Convalescent Plasma for the Treatment of COVID-19	Recruiting	No Results Available	COVID-19	Drug: Convalescent Plasma	Phase 2	Interventional	"Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, United States"	https://ClinicalTrials.gov/show/NCT04389710
143	NCT04337541	Reduction in COVID-19 Infection Using Surgical Facial Masks Outside the Healthcare System	Recruiting	No Results Available	COVID-19	Other: Surgical facial mask	Not Applicable	Interventional	"Rigshospitalet, Copenhagen, Denmark"	https://ClinicalTrials.gov/show/NCT04337541
144	NCT04380402	Atorvastatin as Adjunctive Therapy in COVID-19	Not yet recruiting	No Results Available	COVID-19	Drug: Atorvastatin	Phase 2	Interventional		https://ClinicalTrials.gov/show/NCT04380402
145	NCT04359277	A Randomized Trial of Anticoagulation Strategies in COVID-19	Recruiting	No Results Available	COVID-19	Drug: Enoxaparin Higher Dose|Drug: Lower-dose prophylactic anticoagulation	Phase 3	Interventional	"NYU Langone Health, New York, New York, United States"	https://ClinicalTrials.gov/show/NCT04359277
146	NCT04354805	Administration of Chlorpromazine as a Treatment for COVID-19	Not yet recruiting	No Results Available	COVID-19	Drug: Chlorpromazine	Phase 2|Phase 3	Interventional	"Cairo University, Cairo, Egypt"	https://ClinicalTrials.gov/show/NCT04354805
147	NCT04351763	Amiodarone or Verapamil in COVID-19 Hospitalized Patients With Symptoms	Recruiting	No Results Available	COVID-19	Drug: Amiodarone|Drug: Verapamil	Phase 2|Phase 3	Interventional	"Nicolaus Copernicus University, Bydgoszcz, Poland"	https://ClinicalTrials.gov/show/NCT04351763
148	NCT04400890	Randomized Proof-of-Concept Trial to Evaluate the Safety and Explore the Effectiveness of Resveratrol for COVID-19	Not yet recruiting	No Results Available	COVID-19	Drug: Resveratrol|Dietary Supplement: Vitamin D3	Phase 2	Interventional		https://ClinicalTrials.gov/show/NCT04400890
149	NCT04340544	Hydroxychloroquine for the Treatment of Mild COVID-19 Disease	Recruiting	No Results Available	COVID-19	Drug: Hydroxychloroquine|Drug: Placebo	Phase 3	Interventional	"Institute for Tropical Medicine, Tübingen, Germany"	https://ClinicalTrials.gov/show/NCT04340544
150	NCT04415151	Tofacitinib for Treatment of Moderate COVID-19	Not yet recruiting	No Results Available	COVID-19	Drug: Tofacitinib 10 mg|Drug: Placebo	Phase 2	Interventional		https://ClinicalTrials.gov/show/NCT04415151
151	NCT04384900	Accelerated Prone Position Ventilation of Patients With COVID-19	Recruiting	No Results Available	COVID-19	Procedure: Prone position ventilation	Not Applicable	Interventional	"Nordsjællands Hospital, Hillerød, Region Hovedstanden, Denmark"	https://ClinicalTrials.gov/show/NCT04384900
152	NCT04356690	Etoposide in Patients With COVID-19 Infection	Recruiting	No Results Available	COVID-19	Drug: Etoposide	Phase 2	Interventional	"Boston Medical Center, Boston, Massachusetts, United States"	https://ClinicalTrials.gov/show/NCT04356690
153	NCT04333355	Safety in Convalescent Plasma Transfusion to COVID-19	Recruiting	No Results Available	COVID-19	Biological: Convalescent Plasma	Phase 1	Interventional	"Hospital San José, Monterrey, Nuevo Leon, Mexico"	https://ClinicalTrials.gov/show/NCT04333355
154	NCT04375124	Treatment of Angiotensin Peptide (1-7) for COVID-19	Recruiting	No Results Available	COVID-19	Biological: Biological/Vaccine: Angiotensin peptide (1-7) derived plasma	Not Applicable	Interventional	"Kanuni Sultan Suleyman Training and Research Hospital, Istanbul, Turkey"	https://ClinicalTrials.gov/show/NCT04375124
155	NCT04412785	Cyclosporine in Patients With Moderate COVID-19	Recruiting	No Results Available	COVID-19	Drug: Cyclosporine	Phase 1	Interventional	"University of Pennsylvania, Philadelphia, Pennsylvania, United States"	https://ClinicalTrials.gov/show/NCT04412785
156	NCT04377789	Effect of Quercetin on Prophylaxis and Treatment of COVID-19	Recruiting	No Results Available	COVID-19	Dietary Supplement: Quercetin Prophylaxis|Dietary Supplement: Quercetin Treatment	Not Applicable	Interventional	"Kanuni Sultan Suleyman Training and Research Hospital, Istanbul, Turkey"	https://ClinicalTrials.gov/show/NCT04377789
157	NCT04443725	Efficacy and Safety of Anti HCV Drugs in the Treatment of COVID-19	Not yet recruiting	No Results Available	COVID-19	"Drug: Hydroxychloroquine , Sofosbuvir, daclatasvir|Drug: Standard of care treatment"	Phase 2|Phase 3	Interventional		https://ClinicalTrials.gov/show/NCT04443725
158	NCT04383002	High Dose Inhaled Nitric Oxide for COVID-19 (ICU Patients)	Not yet recruiting	No Results Available	COVID-19	Drug: Nitric Oxide	Phase 1	Interventional		https://ClinicalTrials.gov/show/NCT04383002
159	NCT04366115	Evaluating AVM0703 for Treatment of COVID-19	Not yet recruiting	No Results Available	COVID-19	Drug: AVM0703|Drug: Placebo|Drug: hydrocortisone	Phase 1|Phase 2	Interventional		https://ClinicalTrials.gov/show/NCT04366115
160	NCT04424797	Prone Positioning on Admission for Hospitalized COVID-19 Pneumonia Protocol	Recruiting	No Results Available	COVID-19	Other: Prone Positioning|Other: Supine Positioning	Not Applicable	Interventional	"UCHealth Poudre Valley Hospital, Fort Collins, Colorado, United States|UCHealth Greeley Hospital, Greeley, Colorado, United States|UCHealth Medical Center of the Rockies, Loveland, Colorado, United States"	https://ClinicalTrials.gov/show/NCT04424797
161	NCT04451889	Probe-based Confocal Laser Endomicroscopy in Critically Ill COVID-19 Patients	Recruiting	No Results Available	COVID-19	Device: miniprobe Alveoflex	Not Applicable	Interventional	"Federal Research Clinical Center FMBA Russia, Moscow, Russian Federation"	https://ClinicalTrials.gov/show/NCT04451889
162	NCT04366050	Ramipril for the Treatment of COVID-19	Not yet recruiting	No Results Available	COVID-19	Drug: Ramipril 2.5 MG Oral Capsule|Drug: Placebo oral capsule	Phase 2	Interventional		https://ClinicalTrials.gov/show/NCT04366050
163	NCT04391712	Cold Laser Therapy for COVID-19 Positive Patients With Pulmonary Disease	Recruiting	No Results Available	COVID-19	Device: MLS Laser|Other: Regular Inpatient Medical Care	Phase 2	Interventional	"Lowell General Hospital, Lowell, Massachusetts, United States"	https://ClinicalTrials.gov/show/NCT04391712
164	NCT04444271	Mesenchymal Stem Cell Infusion for COVID-19 Infection	Recruiting	No Results Available	COVID-19	Drug: Mesenchymal stem cells|Other: Placebo	Phase 2	Interventional	"NIBMT, Rawalpindi, Punjab, Pakistan"	https://ClinicalTrials.gov/show/NCT04444271
165	NCT04341675	Sirolimus Treatment in Hospitalized Patients With COVID-19 Pneumonia	Recruiting	No Results Available	COVID-19	Drug: Sirolimus|Drug: Placebo	Phase 2	Interventional	"Loyola University Medical Center, Chicago, Illinois, United States|University of Cincinnati, Cincinnati, Ohio, United States"	https://ClinicalTrials.gov/show/NCT04341675
166	NCT04394416	Trial of Imatinib for Hospitalized Adults With COVID-19	Recruiting	No Results Available	COVID-19	Drug: Imatinib|Drug: Placebo oral tablet	Phase 3	Interventional	"University of Maryland Medical Center, Baltimore, Maryland, United States"	https://ClinicalTrials.gov/show/NCT04394416
167	NCT04397757	COVID-19 Convalescent Plasma for the Treatment of Hospitalized Patients With Pneumonia Caused by SARS-CoV-2.	Recruiting	No Results Available	COVID-19	Biological: COVID-19 Convalescent Plasma	Phase 1	Interventional	"Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, United States"	https://ClinicalTrials.gov/show/NCT04397757
168	NCT04329923	The PATCH Trial (Prevention And Treatment of COVID-19 With Hydroxychloroquine)	Recruiting	No Results Available	COVID-19	Drug: Hydroxychloroquine Sulfate 400 mg twice a day|Drug: Hydroxychloroquine Sulfate 600 mg twice a day|Drug: Hydroxychloroquine Sulfate 600 mg once a day|Drug: Placebo oral tablet	Phase 2	Interventional	"University of Pennsylvania, Philadelphia, Pennsylvania, United States"	https://ClinicalTrials.gov/show/NCT04329923
169	NCT04361643	Low-dose Lenalidomide for Non-severe COVID-19 Treatment Trial	Not yet recruiting	No Results Available	COVID-19	"Drug: Lenalidomide as a 5 mg capsule PO daily, days 1, 3, and 5.|Drug: Placebo"	Phase 4	Interventional	"Hospital Universitario de Getafe, Getafe, Spain"	https://ClinicalTrials.gov/show/NCT04361643
170	NCT04455243	Inflammatory Regulation Effect of NAC on COVID-19 Treatment	Not yet recruiting	No Results Available	COVID-19	Drug: N-Acetyl cysteine|Drug: Placebo	Phase 3	Interventional		https://ClinicalTrials.gov/show/NCT04455243
171	NCT04429763	Safety and Efficacy of Mesenchymal Stem Cells in the Management of Severe COVID-19 Pneumonia	Not yet recruiting	No Results Available	COVID-19	Biological: Umbilical cord derived mesenchymal stem cells|Biological: Placebo	Phase 2	Interventional		https://ClinicalTrials.gov/show/NCT04429763
172	NCT04333628	Chloroquine for Mild Symptomatic and Asymptomatic COVID-19	Not yet recruiting	No Results Available	COVID-19	Drug: chloroquine|Other: standard care	Phase 2|Phase 3	Interventional		https://ClinicalTrials.gov/show/NCT04333628
173	NCT04365738	Pulmonary Rehabilitation in Post-Acute Period of COVID-19 Infection	Completed	No Results Available	COVID-19	Other: Rehabilitation	Not Applicable	Interventional	"Istanbul Bilgi University, Istanbul, Turkey"	https://ClinicalTrials.gov/show/NCT04365738
174	NCT04427865	Utility of Lactoferrin as a Preventive Agent for Healthcare Workers Exposed to COVID-19	Not yet recruiting	No Results Available	COVID-19	Drug: prophylactic lactoferrin daily	Phase 2|Phase 3	Interventional		https://ClinicalTrials.gov/show/NCT04427865
175	NCT04421027	A Study of Baricitinib (LY3009104) in Participants With COVID-19	Recruiting	No Results Available	COVID-19	Drug: Baricitinib|Drug: Placebo	Phase 3	Interventional	"Chandler Regional Medical Center, Chandler, Arizona, United States|Mercy Gilbert Medical Center, Gilbert, Arizona, United States|Valleywise Health, Phoenix, Arizona, United States|St Josephs Hospital and Medical Center, Phoenix, Arizona, United States|Sharp Healthcare, San Diego, California, United States|San Francisco VA Medical Center, San Francisco, California, United States|Morehouse School of Medicine, Atlanta, Georgia, United States|Community Hospital South, Indianapolis, Indiana, United States|White Oak Medical Center, Adventist Healthcare, Silver Spring, Maryland, United States|South Shore Hospital, Weymouth, Massachusetts, United States|Henry Ford Hospital, Detroit, Michigan, United States|SUNY Downstate, Brooklyn, New York, United States|Oregon Health and Science University, Portland, Oregon, United States|Temple University School of Medicine, Philadelphia, Pennsylvania, United States|Swedish Medical Center, Seattle, Washington, United States|Multicare Health System, Tacoma, Washington, United States|Hospital Z.G.A.D ""Evita Pueblo"", Berazategui, Buenos Aires, Argentina|Sanatorio de la Trinidad Mitre, Caba, Buenos Aires, Argentina|Fundacion Sanatorio Guemes, Caba, Buenos Aires, Argentina|Hospital Central de San Isidro ""Dr. Melchor Ángel Posse"", San Isidro, Buenos Aires, Argentina|Clinica Central S.A., Villa Regina, Rio Negro, Argentina|Hospital San Roque, Cordoba, Argentina|Hospital Felício Rocho, Belo Horizonte, Minas Gerais, Brazil|CEPETI Centro de Ensino e Pesquisa em Terapia Intensiva, Curitiba, Paraná, Brazil|CPCLIN, Natal, Rio Grande Do Norte, Brazil|Hospital de Clinicas de Porto Alegre, Porto Alegre, RS, Brazil|Pesquisare, Santo Andre, Sao Paulo, Brazil|Upeclin - Unidade de Pesquisa Clínica da Faculdade de Medicina de Botucatu - UNESP, Botucatu, São Paulo, Brazil|Hospital PUC-CAMPINAS, Campinas, São Paulo, Brazil|Real e Benemerita Associação Portuguesa de Beneficiencia, São Paulo, Brazil|Hospital Alemão Oswaldo Cruz, São Paulo, Brazil|Universidade Federal de São Paulo - Escola Paulista de Medicina, São Paulo, Brazil|Hospital Santa Paula, São Paulo, Brazil|Casa de Saude Santa Marcelina - Centro de Pesquisa Clinica, São Paulo, Brazil|Universitätsklinikum Erlangen, Erlangen, Bayern, Germany|Universitätsklinikum Schleswig-Holstein, Kiel, Schleswig-Holstein, Germany|Klinikum Chemnitz gGmbH, Chemnitz, Germany|Ospedale Clinicizzato SS Annunziata, Chieti Scalo, Chieti, Italy|INMI Lazzaro Spallanzani, Roma, Rome, Italy|ASST Fatebenefratelli - Ospedale Luigi Sacco, Milano, Italy|Ospedale Niguarda Ca Granda, Milano, Italy|Nuovo Ospedale di Prato S. Stefano, Prato, Italy|Medica Sur, Mexico, DF, Mexico|Instituto Nacional de Cardiologia Ignacio Chavez, Mexico, DF, Mexico|Instituto Nacional de Cancerologia, Mexico City, FD, Mexico|ITESM Campus Monterrey, Monterrey, Nuevo Leon, Mexico|Hospital Universitario ""Dr. Jose Eleuterio Gonzalez"", Monterrey, Nuevo León, Mexico|Infectious Clinical Hospital #2, Moscow, Russian Federation|City Clinical Hospital #15 named after O.M. Filatov, Moscow, Russian Federation|City Clinical Hospital #64, Moscow, Russian Federation|Saint-Petersburg City Pokrovskaya Hospital, Saint-Petersburg, Russian Federation|Hospital Txagorritxu, Vitoria, Alava, Spain|Hospital Universitario Infanta Leonor-INTERNAL MED, Madrid, Spain|Hospital Clinico San Carlos, Madrid, Spain|Hospital Clínico Universitario de Valencia, Valencia, Spain|Royal Cornwall Hospital, Truro, Cornwall, United Kingdom|St. George'S Healthcare Nhs Trust, London, United Kingdom"	https://ClinicalTrials.gov/show/NCT04421027
176	NCT04355143	Colchicine to Reduce Cardiac Injury in COVID-19 (COLHEART-19)	Recruiting	No Results Available	COVID-19	Drug: Colchicine Tablets|Other: Current care per UCLA treating physicians	Phase 2	Interventional	"UCLA Ronald Reagan Medical Center, Los Angeles, California, United States|UCLA Santa Monica Hospital, Santa Monica, California, United States"	https://ClinicalTrials.gov/show/NCT04355143
177	NCT04304053	Treatment of COVID-19 Cases and Chemoprophylaxis of Contacts as Prevention	Completed	No Results Available	COVID-19	Drug: Treatment and prophylaxis|Other: Standard Public Health measures	Phase 3	Interventional	"Departament de Salut, Barcelona, Spain"	https://ClinicalTrials.gov/show/NCT04304053
178	NCT04362085	Coagulopathy of COVID-19: A Pragmatic Randomized Controlled Trial of Therapeutic Anticoagulation Versus Standard Care	Recruiting	No Results Available	COVID-19	Drug: Therapeutic Anticoagulation	Phase 3	Interventional	"St. Michael's Hospital, Toronto, Ontario, Canada"	https://ClinicalTrials.gov/show/NCT04362085
179	NCT04372004	Comparison of the Efficacy of Rapid Tests to Identify COVID-19 Infection (CATCh COVID-19)	Not yet recruiting	No Results Available	COVID-19	Diagnostic Test: diagnostic tests for COVID-19 infection	Not Applicable	Interventional		https://ClinicalTrials.gov/show/NCT04372004
180	NCT04351620	High-dose Hydroxychloroquine for the Treatment of Ambulatory Patients With Mild COVID-19	Recruiting	No Results Available	COVID-19	Drug: Hydroxychloroquine	Phase 1	Interventional	"University of Chicago, Chicago, Illinois, United States"	https://ClinicalTrials.gov/show/NCT04351620
181	NCT04363216	Pharmacologic Ascorbic Acid as an Activator of Lymphocyte Signaling for COVID-19 Treatment	Not yet recruiting	No Results Available	COVID-19	Drug: Ascorbic Acid	Phase 2	Interventional		https://ClinicalTrials.gov/show/NCT04363216
182	NCT04412772	A RCT - Safety & Efficacy of Tocilizumab - Tx of Severe COVID-19: ARCHITECTS	Recruiting	No Results Available	COVID-19	Drug: Tocilizumab|Drug: Placebo	Phase 3	Interventional	"Queen's Medical Center, Honolulu, Hawaii, United States"	https://ClinicalTrials.gov/show/NCT04412772
183	NCT04446377	A Study of LAM-002A for the Prevention of Progression of COVID-19	Not yet recruiting	No Results Available	COVID-19 Disease	Drug: Apilimod Dimesylate Capsule|Other: Placebo	Phase 2	Interventional	"Yale University, New Haven, Connecticut, United States"	https://ClinicalTrials.gov/show/NCT04446377
184	NCT04438057	Evaluating the Efficacy of Convalescent Plasma in Symptomatic Outpatients Infected With COVID-19	Not yet recruiting	No Results Available	COVID-19	Biological: CCP	Phase 2	Interventional	"Metro Infectious Disease Consultants, Burr Ridge, Illinois, United States"	https://ClinicalTrials.gov/show/NCT04438057
185	NCT04334382	Hydroxychloroquine vs. Azithromycin for Outpatients in Utah With COVID-19	Recruiting	No Results Available	COVID-19	Drug: Hydroxychloroquine|Drug: Azithromycin	Phase 3	Interventional	"Intermountain Medical Center, Murray, Utah, United States|University of Utah, Salt Lake City, Utah, United States"	https://ClinicalTrials.gov/show/NCT04334382
186	NCT04398303	ACT-20 in Patients With Severe COVID-19 Pneumonia	Not yet recruiting	No Results Available	COVID-19 Pneumonia	Biological: ACT-20-MSC|Biological: ACT-20-CM|Biological: Placebo	Phase 1|Phase 2	Interventional		https://ClinicalTrials.gov/show/NCT04398303
187	NCT04367662	Study of the Vascular Compartment and Hypercoagulability During Coronavirus Infection COVID-19	Completed	No Results Available	COVID-19	Procedure: blood sampling	Not Applicable	Interventional	"Rouen University Hospital, Rouen, France"	https://ClinicalTrials.gov/show/NCT04367662
188	NCT04410159	Povidone-Iodine Vs Essential Oil Vs Tap Water Gargling For COVID-19 Patients	Recruiting	No Results Available	COVID-19	Drug: Povidone-Iodine|Drug: Essential oils|Other: Tap water	Phase 2	Interventional	"Universiti Kebangsaan Malaysia Medical Centre, Bandar Tun Razak, Wilayah Persekutuan Kuala Lumpur, Malaysia"	https://ClinicalTrials.gov/show/NCT04410159
189	NCT04393311	Ulinastatin for the Treatment of COVID-19 in Hospitalized Patients	Not yet recruiting	No Results Available	COVID-19	Drug: Ulinastatin|Drug: Placebo	Phase 1|Phase 2	Interventional	"Stanford University, Stanford, California, United States"	https://ClinicalTrials.gov/show/NCT04393311
190	NCT04357990	Kerecis Oral and Nasal Spray for Treating the Symptoms of COVID-19	Recruiting	No Results Available	COVID-19	Device: Kerecis Oral and Nasal Spray|Other: Placebo	Not Applicable	Interventional	"National Hospital of Iceland (Landspítali), Reykjavík, Iceland"	https://ClinicalTrials.gov/show/NCT04357990
191	NCT04442191	Convalescent Plasma as a Possible Treatment for COVID-19	Recruiting	No Results Available	COVID-19	Biological: Convalescent plasma|Biological: Placebo	Phase 2	Interventional	"University of Illinois at Chicago, Chicago, Illinois, United States"	https://ClinicalTrials.gov/show/NCT04442191
192	NCT04370223	Ozone Auto-hemotherapy for COVID-19 Pneumonia	Not yet recruiting	No Results Available	COVID-19 Pneumonia	Biological: Ozone auto-hemotherapy	Phase 3	Interventional	"Hospital Universitari Dr Josep Trueta, Girona, Spain|Clinica Nuestra Señora del Rosario, Ibiza, Spain|Hospital Quirón Rey Juan Carlos I, Madrid, Spain|Hospital Universitario 12 de Octubre, Madrid, Spain|Hospital Universitario Infanta Leonor, Madrid, Spain|Hospital Universitario Príncipe de Asturias de Alcalá de Henares, Madrid, Spain|Fundació Althaia de Manresa, Manresa, Spain|Hospital Vithas Valencia Consuelo, Valencia, Spain|Hospital Clínico Universitario de Valladolid, Valladolid, Spain|Clinica Claro, Vigo, Spain"	https://ClinicalTrials.gov/show/NCT04370223
193	NCT04392414	Hyperimmune Convalescent Plasma in Moderate and Severe COVID-19 Disease	Recruiting	No Results Available	COVID-19	Biological: COVID-19 convalescent hyperimmune plasma|Biological: Non-convalescent fresh frozen plasma (Standard plasma)	Phase 2	Interventional	"Federal Research Clinical Center of Federal Medical & Biological Agency, Moscow, Russian Federation"	https://ClinicalTrials.gov/show/NCT04392414
194	NCT04368013	"Host-pathogen Interactions, Immune Response, and Clinical Prognosis at COVID-19 - the CoVUm Trial"	Not yet recruiting	No Results Available	COVID-19	Procedure: Extended sampling and procedures	Not Applicable	Interventional	"Incectious Diseases Clinic, Umeå, Västerbotten, Sweden"	https://ClinicalTrials.gov/show/NCT04368013
195	NCT04391127	Hydroxychloroquine and Ivermectin for the Treatment of COVID-19 Infection	Recruiting	No Results Available	COVID-19	Drug: Hydroxychloroquine|Drug: Ivermectin|Drug: Placebo	Phase 3	Interventional	"Jose Manuel Arreola Guerra, Aguascalientes, Mexico"	https://ClinicalTrials.gov/show/NCT04391127
196	NCT04354597	Hydroxychloroquine and Azithromycin as Prophylaxis for Healthcare Workers Dealing With COVID19 Patients	Not yet recruiting	No Results Available	COVID-19	Drug: HCQ & AZ	Not Applicable	Interventional	"King Hussein Cancer Center, Amman, Jordan"	https://ClinicalTrials.gov/show/NCT04354597
197	NCT04335136	Recombinant Human Angiotensin-converting Enzyme 2 (rhACE2) as a Treatment for Patients With COVID-19	Recruiting	No Results Available	COVID-19	Drug: RhACE2 APN01|Drug: Physiological saline solution	Phase 2	Interventional	"Medizinische Universität Innsbruck, Innsbruck, Austria|Kaiser Franz Josef Spital, 4. Medizinische Abteilung mit Infektions- und Tropenmedizin, Wien, Austria|Medizinische Universität Wien, Wien, Austria|The National University Hospital, Rigshospitalet, Copenhagen, Denmark|Herlev Gentofte Hospital, Herlev, Denmark|Nordsjællands Hospital, Hillerød, Denmark|Hvidovre Hospital, Hvidovre, Denmark|Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany|Klinikum rechts der Isar, Technische Universität München, München, Germany"	https://ClinicalTrials.gov/show/NCT04335136
198	NCT04331366	Bidirectional Oxygenation Valve in the Management of Pulmonary Complications of COVID-19	Recruiting	No Results Available	COVID-19	Device: GO2 PEEP MOUTHPIECE	Not Applicable	Interventional	"Emory University Hospital, Atlanta, Georgia, United States|Emory St. Joseph's Hospital, Atlanta, Georgia, United States"	https://ClinicalTrials.gov/show/NCT04331366
199	NCT04362189	Efficacy and Safety Study of Allogeneic HB-adMSCs for the Treatment of COVID-19	Not yet recruiting	No Results Available	COVID-19	Drug: HB-adMSC|Drug: Placebo	Phase 2	Interventional	"River Oaks Hospital and Clinics, Houston, Texas, United States"	https://ClinicalTrials.gov/show/NCT04362189
200	NCT04330690	Treatments for COVID-19: Canadian Arm of the SOLIDARITY Trial	Recruiting	No Results Available	COVID-19	Drug: Lopinavir/ritonavir|Drug: Hydroxychloroquine|Drug: remdesivir	Phase 2	Interventional	"Peter Lougheed Centre, Calgary, Alberta, Canada|Foothills Medical Centre, Calgary, Alberta, Canada|Rockyview General Hospital, Calgary, Alberta, Canada|South Health Campus, Calgary, Alberta, Canada|Royal Alexandra Hospital, Edmonton, Alberta, Canada|University of Alberta Hopsital, Edmonton, Alberta, Canada|Vancouver General Hospital, Vancouver Coastal Health, Univeristy of British Columbia, Vancouver, British Columbia, Canada|St Paul's Hospital, Vancouver, British Columbia, Canada|Island Health - Royal Jubilee Hospital, Victoria, British Columbia, Canada|Island Health - Victoria General Hospital, Victoria, British Columbia, Canada|William Osler Health System - Brampton Civic Hospital, Brampton, Ontario, Canada|William Osler Health System - Etobicoke General Hospital, Etobicoke, Ontario, Canada|St. Joseph's Healthcare Hamilton, Hamilton, Ontario, Canada|Grand River Hospital, Kitchener, Ontario, Canada|St.Joseph's Health Care, London, Ontario, Canada|University Hospital, London, Ontario, Canada|Victoria Hospital, London, Ontario, Canada|Trillium Health Partners -Mississauga Site, Mississauga, Ontario, Canada|Trillium Health Partners-Credit Valley Hospital, Mississauga, Ontario, Canada|The Ottawa Hospital - General Campus, Ottawa, Ontario, Canada|Hôpital Montfort, Ottawa, Ontario, Canada|The Ottawa Hospital - Civic Campus, Ottawa, Ontario, Canada|Queensway Carleton Hospital, Ottawa, Ontario, Canada|Thunder Bay Regional Health Sciences Centre, Thunder Bay, Ontario, Canada|North York General Hospital, Toronto, Ontario, Canada|Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada|Toronto Western Hospital, Toronto, Ontario, Canada|Centre Hospitalier de l'Université de Montréal (CHUM), Montréal, Quebec, Canada|McGill University Health Centre-Glen Site Royal Victoria Hospital, Montréal, Quebec, Canada|CHU de Québec - Université Laval, Québec, Quebec, Canada|Institut Universitaire de Cardiologie et de Pneumologie de Québec- Université Laval, Québec, Quebec, Canada|Centre Intégré Universitaire de Santé et de Services Sociaux de l'Estrie - Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, Quebec, Canada"	https://ClinicalTrials.gov/show/NCT04330690
201	NCT04456452	Study of Ampion for the Treatment of Adult COVID-19 Patients Requiring Oxygen Supplementation	Not yet recruiting	No Results Available	COVID-19	Biological: Ampion|Other: Standard of Care	Phase 1	Interventional	"Research Site, Colorado Springs, Colorado, United States"	https://ClinicalTrials.gov/show/NCT04456452
202	NCT04370236	XPro1595 for the Treatment of Pulmonary Complications From COVID-19	Not yet recruiting	No Results Available	COVID-19	Drug: XPro1595|Drug: Placebo	Phase 2|Phase 3	Interventional		https://ClinicalTrials.gov/show/NCT04370236
203	NCT04359511	Efficacy and Safety of Corticosteroids in Oxygen-dependent Patients With COVID-19 Pneumonia	Not yet recruiting	No Results Available	COVID-19	Drug: Prednisone|Drug: Hydrocortisone	Phase 3	Interventional		https://ClinicalTrials.gov/show/NCT04359511
204	NCT04396106	Safety and Efficacy of AT-527 in Subjects With Moderate Coronavirus Disease (COVID-19)	Not yet recruiting	No Results Available	COVID-19	Drug: AT-527|Other: Placebo	Phase 2	Interventional	"Atea Study Site, Sacramento, California, United States|Atea Study Site, San Diego, California, United States|Atea Study Site, Chicago, Illinois, United States|Atea Study Site, Baltimore, Maryland, United States|Atea Study Site, Boston, Massachusetts, United States|Atea Study Site, Saint Louis, Missouri, United States|Atea Study Site, Cincinnati, Ohio, United States|Atea Study Site, Cleveland, Ohio, United States|Atea Study Site, Columbus, Ohio, United States|Atea Study Site, Charleston, South Carolina, United States"	https://ClinicalTrials.gov/show/NCT04396106
205	NCT04331795	"Tocilizumab to Prevent Clinical Decompensation in Hospitalized, Non-critically Ill Patients With COVID-19 Pneumonitis"	Completed	No Results Available	COVID-19	Drug: Tocilizumab	Phase 2	Interventional	"University of Chicago Medicine, Chicago, Illinois, United States"	https://ClinicalTrials.gov/show/NCT04331795
206	NCT04405843	Efficacy of Ivermectin in Adult Patients With Early Stages of COVID-19	Not yet recruiting	No Results Available	COVID-19	Drug: Ivermectin Oral Product|Drug: Placebo	Phase 2|Phase 3	Interventional		https://ClinicalTrials.gov/show/NCT04405843
207	NCT04333225	Hydroxychloroquine in the Prevention of COVID-19 Infection in Healthcare Workers	"Active, not recruiting"	No Results Available	COVID-19	Drug: Hydroxychloroquine	Phase 2	Interventional	"Baylor University Medical Center, Dallas, Texas, United States"	https://ClinicalTrials.gov/show/NCT04333225
208	NCT04351724	Austrian CoronaVirus Adaptive Clinical Trial (COVID-19)	Recruiting	No Results Available	COVID-19	Drug: Chloroquine or Hydroxychloroquine|Drug: Lopinavir/Ritonavir|Other: Best standard of care|Drug: Rivaroxaban|Drug: Thromboprophylaxis|Drug: Candesartan|Drug: non-RAS blocking antihypertensives|Drug: Clazakizumab|Drug: placebo for clazakizumab	Phase 2|Phase 3	Interventional	"Medical University of Innsbruck, Innsbruck, Tirol, Austria|Medical University of Vienna, Vienna, Austria|Wilhelminenspital, Vienna, Austria|SMZ Süd Kaiser Franz Josef Spital, Vienna, Austria|KH Hietzing, Vienna, Austria|SMZ Baumgartner Höhe Otto Wagner Spital, Vienna, Austria|SMZ Ost Donauspital, Vienna, Austria"	https://ClinicalTrials.gov/show/NCT04351724
209	NCT04429867	Hydroxychloroquine Use in Hospitalized Patients With COVID-19: Impact on Progression to Severe or Critical Disease	"Active, not recruiting"	No Results Available	COVID-19	Drug: Hydroxychloroquine|Drug: Placebo	Phase 4	Interventional	"Wellstar Kennestone Hospital, Marietta, Georgia, United States"	https://ClinicalTrials.gov/show/NCT04429867
210	NCT04344444	Treatment in Patients With Suspected or Confirmed COVID-19 With Early Moderate or Severe Disease	Recruiting	No Results Available	COVID-19	Drug: Hydroxychloroquine|Drug: Azithromycin	Phase 3	Interventional	"University Medical Center New Orleans, New Orleans, Louisiana, United States"	https://ClinicalTrials.gov/show/NCT04344444
211	NCT04425772	A Clinical Trial for Azvudine in the Treatment of Novel Coronavirus Pneumonia (COVID-19）	Not yet recruiting	No Results Available	COVID-19	Drug: FNC+Standard of Care|Drug: FNC dummy tablet+Standard of Care	Not Applicable	Interventional		https://ClinicalTrials.gov/show/NCT04425772
212	NCT04359264	Direct Income SupporT and Advice Negating Spread of Epidemic COVID-19: a Randomized Controlled Trial	"Active, not recruiting"	No Results Available	COVID-19	Other: Cash transfer	Not Applicable	Interventional	"Municipality of Assiginack Family Health Team, Assiginack, Ontario, Canada|St Michael's Hospital Academic Family Health Team, Toronto, Ontario, Canada"	https://ClinicalTrials.gov/show/NCT04359264
213	NCT04377659	Tocilizumab for Prevention of Respiratory Failure in Patients With Severe COVID-19 Infection	Recruiting	No Results Available	COVID-19	Drug: Tocilizumab	Phase 2	Interventional	"Memorial Sloan Kettering Cancer Center, New York, New York, United States"	https://ClinicalTrials.gov/show/NCT04377659
214	NCT04344080	Effect of CytoSorb Adsorber on Hemodynamic and Immunological Parameters in Critical Ill Patients With COVID-19	Recruiting	No Results Available	COVID-19	Device: CytoSorb-Therapy	Not Applicable	Interventional	"University Medical Center Hamburg-Eppendorf, Hamburg, Germany"	https://ClinicalTrials.gov/show/NCT04344080
215	NCT04374903	Hydroxychloroquine in Combination With Azithromycin or Sirolimus for Treating COVID-19 Patients	Not yet recruiting	No Results Available	COVID-19 Patients	Drug: HCQ & AZ vs HCQ+SIR	Not Applicable	Interventional	"King Hussein Cancer Center, Amman, Jordan"	https://ClinicalTrials.gov/show/NCT04374903
216	NCT04352465	Efficacy and Safety of MTX-loaded Nanoparticles to Treat Severe COVID-19 Patients	Not yet recruiting	No Results Available	COVID-19	Drug: Methotrexate	Phase 1|Phase 2	Interventional	"Prevent Senior Private Operadora de Saúde LTDA., São Paulo, Brazil"	https://ClinicalTrials.gov/show/NCT04352465
217	NCT04427501	A Study of LY3819253 (LY-CoV555) in Participants With Early Mild to Moderate COVID-19 Illness	Recruiting	No Results Available	COVID-19	Drug: LY3819253|Drug: Placebo	Phase 2	Interventional	"Long Beach Clinical Trials LLC, Long Beach, California, United States|Cedars Sinai Medical Center, Los Angeles, California, United States|Stanford University, Palo Alto, California, United States|Zion Medical Center, San Diego, California, United States|Kaiser Permanente - San Diego Medical Center, San Diego, California, United States|Georgetown University School of Medicine, Washington, District of Columbia, United States|Northwestern University, Chicago, Illinois, United States|John H. Stroger Hospital of Cook County, Chicago, Illinois, United States|University of Chicago Medical Center, Chicago, Illinois, United States|Franciscan Health Hammond, Hammond, Indiana, United States|Community Hospital South, Indianapolis, Indiana, United States|Franciscan St. Francis Health, Indianapolis, Indiana, United States|Massachusetts General Hospital, Boston, Massachusetts, United States|Massachusetts General Hospital, Chelsea, Massachusetts, United States|Henry Ford Hospital, Detroit, Michigan, United States|Mount Sinai Morningside, New York, New York, United States|Mount Sinai Medical Center, New York, New York, United States|University of North Carolina, Chapel Hill, North Carolina, United States|Cleveland Clinic, Cleveland, Ohio, United States|Ohio State Univ College Of Medicine, Columbus, Ohio, United States|Jefferson Hospital for Neuroscience, Philadelphia, Pennsylvania, United States|Temple University School of Medicine, Philadelphia, Pennsylvania, United States|Baylor Scott & White Cancer Center, Dallas, Texas, United States|CARE ID, Annandale, Virginia, United States"	https://ClinicalTrials.gov/show/NCT04427501
218	NCT04427566	Low Dose Whole Lung Radiation Therapy for Patients With COVID-19 and Respiratory Compromise	Recruiting	No Results Available	COVID-19	Radiation: Radiation therapy	Phase 2	Interventional	"Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center, Columbus, Ohio, United States"	https://ClinicalTrials.gov/show/NCT04427566
219	NCT04432766	A Phase 1 Study to Assess BAT2020 in Hospitalized Patients Infected With SARS-CoV-2 (COVID-19)	Not yet recruiting	No Results Available	COVID-19	Drug: BAT2020	Phase 1	Interventional		https://ClinicalTrials.gov/show/NCT04432766
220	NCT04429711	Ivermectin vs. Placebo for the Treatment of Patients With Mild to Moderate COVID-19	Recruiting	No Results Available	COVID-19	Drug: Ivermectin Oral Product	Not Applicable	Interventional	"Sheba Medical Center, Ramat-Gan, Israel"	https://ClinicalTrials.gov/show/NCT04429711
221	NCT04385849	Study of the Safety of Therapeutic Treatment With an Immunomodulatory Agent (N-803) in Adults With COVID-19	Not yet recruiting	No Results Available	COVID-19	Biological: N-803|Other: Saline	Phase 1	Interventional		https://ClinicalTrials.gov/show/NCT04385849
222	NCT04344236	Gargling and Nasal Rinses to Reduce Oro- and Nasopharyngeal Viral Load in Patients With COVID-19	Recruiting	No Results Available	COVID-19	Drug: Saline oral/nasal rinse|Drug: 0.5% Povidone/Iodine oral/nasal rinse|Drug: 0.12% Chlorhexidine oral/nasal rinse	Phase 2	Interventional	"NYU Langone Health, New York, New York, United States"	https://ClinicalTrials.gov/show/NCT04344236
223	NCT04307693	Comparison of Lopinavir/Ritonavir or Hydroxychloroquine in Patients With Mild Coronavirus Disease (COVID-19)	Terminated	No Results Available	COVID-19	Drug: Lopinavir/ritonavir|Drug: Hydroxychloroquine sulfate	Phase 2	Interventional	"Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea, Republic of"	https://ClinicalTrials.gov/show/NCT04307693
224	NCT04381052	Study for the Use of the IL-6 Inhibitor Clazakizumab in Patients With Life-threatening COVID-19 Infection	Not yet recruiting	No Results Available	COVID-19	Drug: Clazakizumab|Other: Placebo	Phase 2	Interventional	"Columbia University Medical Center / New York Presbyerian Hospital, New York, New York, United States"	https://ClinicalTrials.gov/show/NCT04381052
225	NCT04363814	Clinical Impact of BACTEK-R in Subject With Mild Pneumonia Due to COVID-19 Infection	Recruiting	No Results Available	COVID-19	Biological: Bactek-R	Phase 3	Interventional	"Hospital Metropolitano Santiago, Santiago De Los Caballeros, Dominican Republic"	https://ClinicalTrials.gov/show/NCT04363814
226	NCT04397562	A Clinical Trial of the Efficacy and Safety of Levilimab (BCD-089) in Patients With Severe COVID-19	"Active, not recruiting"	No Results Available	COVID-19	Drug: Levilimab|Drug: Placebo	Phase 3	Interventional	"State Budgetary Healthcare Institution Kaluga region ""Kaluga Regional Clinical Hospital"", Kaluga, Russian Federation|State Budget Institution of the Republic of Dagestan ""Republican Clinical Hospital"", Machačkala, Russian Federation|A.N. Bakulev National Medical Research Center of Cardiovascular Surgery, Moscow, Russian Federation|City Clinical Hospital No. 40 of the Department of Health of the city of Moscow, Moscow, Russian Federation|City Clinical Hospital No.52, Moscow, Russian Federation|City Clinical Hospital № 15 named. O.M. Filatov, Moscow, Russian Federation|City Clinical Hospital №1 named after N.I. Pirogov, Moscow City Health Department, Moscow, Russian Federation|Federal State Budgetary Institution ""Central Clinical Hospital with Clinic"", Office of the President of the Russian Federation, Moscow, Russian Federation|I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russian Federation|Pirogov Russian National Research Medical University, Moscow, Russian Federation|Railway clinical hospital named after N.A. Semashko, Moscow, Russian Federation|Almazov National Medical Research Centre, Saint Petersburg, Russian Federation|Clinical Infectious Disease Hospital named after S.P. Botkin, Saint Petersburg, Russian Federation|North-western State Medical University named after I.I.Mechnikov, Saint Petersburg, Russian Federation|Federal State Budgetary Educational Institution of Higher Education ""Bashkir State Medical University"" of the Ministry of Healthcare of the Russian Federation, Ufa, Russian Federation|Federal State Budgetary Educational Institution of Higher Education ""North Ossetian State Medical Academy"" of the Ministry of Health of the Russian Federation (FSBEI HE SOGMA of the Ministry of Health of Russia), Vladikavkaz, Russian Federation"	https://ClinicalTrials.gov/show/NCT04397562
227	NCT04345692	A Randomized Controlled Clinical Trial: Hydroxychloroquine for the Treatment of COVID-19 in Hospitalized Patients	Recruiting	No Results Available	COVID-19	Drug: Hydroxychloroquine	Phase 3	Interventional	"Queen's Medical Center, Honolulu, Hawaii, United States"	https://ClinicalTrials.gov/show/NCT04345692
228	NCT04433910	A Clinical Trial of Convalescent Plasma Compared to Best Supportive Care for Treatment of Patients With Severe COVID-19	Recruiting	No Results Available	COVID-19	Drug: Convalesscent Plasma	Phase 2	Interventional	"University Hospital Ulm, Ulm, Baden-Württmberg, Germany|University Hopsital Frankfurt, Frankfurt, Hessia, Germany|Saarland University Hospital, Homburg, Saarland, Germany"	https://ClinicalTrials.gov/show/NCT04433910
229	NCT04364763	A Study to Evaluate the Effect of RBT-9 on Progression of COVID-19 in High-Risk Individuals (The PREVENT Study)	Not yet recruiting	No Results Available	COVID-19	Drug: RBT-9 (90 mg)|Drug: 0.9% sodium chloride (normal saline)	Phase 2	Interventional		https://ClinicalTrials.gov/show/NCT04364763
230	NCT04411628	A Study of LY3819253 (LY-CoV555) in Participants Hospitalized for COVID-19	Recruiting	No Results Available	COVID-19	Drug: LY3819253|Drug: Placebo	Phase 1	Interventional	"Cedars Sinai Medical Center, Los Angeles, California, United States|Veterans Affairs Medical Center San Diego, San Diego, California, United States|Emory University, Atlanta, Georgia, United States|Massachusetts General Hospital, Boston, Massachusetts, United States|University of Michigan, Ann Arbor, Michigan, United States|Quality Clinical Research, Inc., Omaha, Nebraska, United States|Alexandria Center for Life - NYC/ NYCEDC, New York, New York, United States|University of North Carolina, Chapel Hill, North Carolina, United States|Temple University School of Medicine, Philadelphia, Pennsylvania, United States"	https://ClinicalTrials.gov/show/NCT04411628
231	NCT04331899	Single-Blind Study of a Single Dose of Peginterferon Lambda-1a Compared With Placebo in Outpatients With Mild COVID-19	Recruiting	No Results Available	COVID-19	Drug: Peginterferon Lambda-1a|Other: Placebo	Phase 2	Interventional	"Stanford University School of Medicine, Stanford, California, United States"	https://ClinicalTrials.gov/show/NCT04331899
232	NCT04347954	PVP-I Nasal Sprays and SARS-CoV-2 Nasopharyngeal Titers (for COVID-19)	Recruiting	No Results Available	COVID-19	Drug: Povidone-Iodine 2%|Drug: Povidone-Iodine 0.5%|Drug: Isotonic saline 0.9%	Phase 1|Phase 2	Interventional	"Stanford Health Care, Stanford, California, United States"	https://ClinicalTrials.gov/show/NCT04347954
233	NCT04362332	"Chloroquine, Hydroxychloroquine or Only Supportive Care in Patients AdmItted With Moderate to Severe COVID-19"	Terminated	No Results Available	COVID-19	Drug: Chloroquine Sulfate|Drug: Hydroxychloroquine|Other: Standard supportive care	Phase 4	Interventional	"UMCU, Utrecht, Netherlands"	https://ClinicalTrials.gov/show/NCT04362332
234	NCT04434131	Treatment With Investigational Convalescent Plasma and Measure Antibody Levels in Patients Hospitalized With COVID-19	Recruiting	No Results Available	COVID-19	Drug: Convalescent Plasma	Phase 2	Interventional	"University of New Mexico Health Sciences Center, Albuquerque, New Mexico, United States"	https://ClinicalTrials.gov/show/NCT04434131
235	NCT04323631	Hydroxychloroquine for the Treatment of Patients With Mild to Moderate COVID-19 to Prevent Progression to Severe Infection or Death	Withdrawn	No Results Available	COVID-19	Drug: Hydroxychloroquine|Other: The control group will not receive hydroxychloroquine	Early Phase 1	Interventional		https://ClinicalTrials.gov/show/NCT04323631
236	NCT04331834	Pre-Exposure Prophylaxis With Hydroxychloroquine for High-Risk Healthcare Workers During the COVID-19 Pandemic	Recruiting	No Results Available	COVID-19	Drug: Hydroxychloroquine|Drug: Placebos	Phase 3	Interventional	"ISGlobal, Barcelona, Spain"	https://ClinicalTrials.gov/show/NCT04331834
237	NCT04371926	Prophylactic Benefit of Hydroxychloroquine in COVID-19 Cases With Mild to Moderate Symptoms and in Healthcare Workers With High Exposure Risk	Withdrawn	No Results Available	COVID-19	Drug: Hydroxychloroquine Sulfate	Not Applicable	Interventional		https://ClinicalTrials.gov/show/NCT04371926
238	NCT04386252	Phase Ib-II Trial of Dendritic Cell Vaccine to Prevent COVID-19 in Adults	Not yet recruiting	No Results Available	COVID-19	Biological: AV-COVID-19	Phase 1|Phase 2	Interventional	"Hoag Memorial Hospital Presbyterian, Newport Beach, California, United States"	https://ClinicalTrials.gov/show/NCT04386252
239	NCT04456595	Clinical Trial of Efficacy and Safety of Sinovac's Adsorbed COVID-19 (Inactivated) Vaccine in Healthcare Professionals	Not yet recruiting	No Results Available	COVID-19	Biological: Adsorbed COVID-19 (inactivated) Vaccine|Biological: Placebo	Phase 3	Interventional	"Universidade de Brasília, Brasilia, DF, Brazil|Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil|Hospital das Clínicas da Universidade Federal do Paraná, Curitiba, PR, Brazil|Hospital São Lucas da Pontificia Universidade Catolica do Rio Grande do Sul, Porto Alegre, RS, Brazil|Hospital das Clínicas da UNICAMP, Campinas, SP, Brazil|Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo, Ribeirao Preto, SP, Brazil|Instituto de Infectologia Emílio Ribas, Sao Paulo, SP, Brazil|Centro de Pesquisas Clínicas do Instituto Central do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, Sao Paulo, SP, Brazil|Instituto Israelita de Ensino e Pesquisa Albert Einstein, Sao Paulo, SP, Brazil|Universidade Municipal de São Caetano do Sul, São Caetano do Sul, SP, Brazil|Faculdade de Medicina de São José do Rio Preto - FAMERP, São José Do Rio Preto, São Paulo, Brazil|Instituto de Infectologia Evandro Chagas - Fiocruz, Rio De Janeiro, Brazil"	https://ClinicalTrials.gov/show/NCT04456595
240	NCT04313023	The Use PUL-042 to Reduce the Infection Rate and Progression to COVID-19 in Adults Exposed to SARS-CoV-2	Recruiting	No Results Available	COVID-19	Drug: PUL-042 Inhalation Solution|Drug: Placebo	Phase 2	Interventional	"University of California Irvine, Orange, California, United States|Clinical Research of South Florida Alliance for Multispecialty Research, Coral Gables, Florida, United States|Clinical Research Atlanta, Stockbridge, Georgia, United States|Willis-Knighton Physcian Network, Bossier City, Louisiana, United States|Englewood Health, Englewood, New Jersey, United States|Ascension St. John, Tulsa, Oklahoma, United States|MD Anderson Cancer Center, Houston, Texas, United States|Next Level Urgent Care, Houston, Texas, United States"	https://ClinicalTrials.gov/show/NCT04313023
241	NCT04336254	Safety and Efficacy Study of Allogeneic Human Dental Pulp Mesenchymal Stem Cells to Treat Severe COVID-19 Patients	Recruiting	No Results Available	COVID-19	Biological: allogeneic human dental pulp stem cells (BSH BTC & Utooth BTC)|Other: Intravenous saline injection (Placebo)	Phase 1|Phase 2	Interventional	"Renmin Hospital of Wuhan University (East Campus), Wuhan, Hubei, China"	https://ClinicalTrials.gov/show/NCT04336254
242	NCT04332094	"Clinical Trial of Combined Use of Hydroxychloroquine, Azithromycin, and Tocilizumab for the Treatment of COVID-19"	Recruiting	No Results Available	COVID-19	Drug: Tocilizumab|Drug: Hydroxychloroquine|Drug: Azithromycin	Phase 2	Interventional	"Hospital de la Santa Creu i Sant Pau, Barcelona, Spain"	https://ClinicalTrials.gov/show/NCT04332094
243	NCT04292899	Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants With Severe Coronavirus Disease (COVID-19)	"Active, not recruiting"	No Results Available	COVID-19	Drug: Remdesivir|Drug: Standard of Care	Phase 3	Interventional	"Kaiser Permanente Los Angeles Medical Center, 3340 E. La Palma Avenue, Anaheim, California, United States|Alta Bates Summit Medical Center, Berkeley, California, United States|Mills-Peninsula Medical Center, Burlingame, California, United States|Eden Medical Center, Castro Valley, California, United States|Kaiser Permanente Los Angeles Medical Center, 9333 Imperial Highway, Downey, California, United States|Kaiser Permanente Los Angeles Medical Center, 9961 Sierra Ave, Fontana, California, United States|St Joseph Hospital Eureka, Fortuna, California, United States|Kaiser Permanente Los Angeles Medical Center, 25825 S. Vermont Ave., Harbor City, California, United States|Kaiser Permanente Los Angeles Medical Center, Los Angeles, California, United States|Kaiser Permanente Los Angeles Medical Center, 6041 Cadillac Ave., Los Angeles, California, United States|Kaiser Permanente Los Angeles Medical Center, 5601 De Soto Avenue, Los Angeles, California, United States|Mission Hospital Regional Medical Center, Mission Viejo, California, United States|Kaiser Permanente Los Angeles Medical Center, 27300 Iris Avenue, Moreno Valley, California, United States|El Camino Hospital, Mountain View, California, United States|Hoag Memorial Hospital Presbyterian, Newport Beach, California, United States|Kaiser Permanente Oakland Medical Center, Oakland, California, United States|Kaiser Permanente Los Angeles Medical Center, 2295 S. Vineyard Avenue, Ontario, California, United States|The Center for Cancer Prevention and Treatment at St. Joseph Hospital of Orange, Orange, California, United States|Kaiser Permanente Los Angeles Medical Center, 13651 Willard Street, Panorama City, California, United States|Kaiser Permanente Los Angeles Medical Center, 10800 Magnolia Avenue, Riverside, California, United States|Sutter Medical Center Sacramento, One Medical Plaza, Roseville, California, United States|Sutter Medical Center Sacramento, Sacramento, California, United States|Kaiser Permanente Los Angeles Medical Center, 4647 Zion Avenue, San Diego, California, United States|Kaiser Permanente Los Angeles Medical Center, 9455 Clairemont Mesa Blvd, San Diego, California, United States|Kaiser Permanente Oakland Medical Center, 1200 El Camino Real, San Francisco, California, United States|California Pacific Medical Center-Infectious Disease Associates Medical Group, San Francisco, California, United States|Kaiser Permanente Oakland Medical Center, 2425 Geary Blvd, San Francisco, California, United States|Kaiser Permanente Oakland Medical Center, 250 Hospital Parkway, Suite 850, San Jose, California, United States|Kaiser Permanente Oakland Medical Center, 2500 Merced St, San Leandro, California, United States|Kaiser Permanente Oakland Medical Center, 700 Lawrence Expressway, Santa Clara, California, United States|Providence St. Johns Medical Center, Santa Monica, California, United States|Sutter Santa Rosa Regional Hospital, Santa Rosa, California, United States|Stanford Hospital, Stanford, California, United States|University of Colorado Denver, University of Colorado Hospital, Aurora, Colorado, United States|SCL Health St. Joseph Hospital, 1375 East 19th Ave, Denver, Colorado, United States|SCL Health St. Joseph Hospital, Denver, Colorado, United States|Rose Medical Center, Denver, Colorado, United States|SCL Health St. Joseph Hospital, 200 Exempla Circle., Lafayette, Colorado, United States|Yale-New Haven Hospital, New Haven, Connecticut, United States|Kaiser Permanente Hawaii Moanalua Medical Center, Honolulu, Hawaii, United States|John H. Stroger Jr. Hospital of Cook County, Chicago, Illinois, United States|Rush University Medical Center, Chicago, Illinois, United States|University of Chicago, Chicago, Illinois, United States|IU Health Methodist Hospital, Indianapolis, Indiana, United States|University of Iowa Hospitals & Clinics, Iowa City, Iowa, United States|Tulane University, New Orleans, Louisiana, United States|Maine Medical Center, Portland, Maine, United States|Holy Cross Hospital, Silver Spring, Maryland, United States|Tufts Medical Center, Boston, Massachusetts, United States|Brigham & Women's Hospital and Harvard Medical School, Boston, Massachusetts, United States|Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States|The University of Michigan Hospitals and Health Systems, Ann Arbor, Michigan, United States|Henry Ford Health System, Detroit, Michigan, United States|Hennepin Healthcare, Minneapolis, Minnesota, United States|Mayo Clinic, Rochester, Minnesota, United States|Providence St Patrick Hospital and International Heart Institute of MT Foundation, Missoula, Montana, United States|Darmouth-Hitchhock Medical Center, Lebanon, New Hampshire, United States|Hackensack University Medical Center, Hackensack, New Jersey, United States|Robert Wood Johnson University Hospital Somerset, Hillsborough, New Jersey, United States|Robert Wood Johnson University Hospital Somerset, 1 RWJ Place, New Brunswick, New Jersey, United States|Robert Wood Johnson University Hospital Somerset, 201 Lyons Avenue, Newark, New Jersey, United States|St. Joseph's University Medical Center, Paterson, New Jersey, United States|Jacobi Medical Center, Bronx, New York, United States|James J. Peters Veterans Administration Medical Center, Bronx, New York, United States|Jamaica Hospital Medical Center, Jamaica, New York, United States|Danbury Hospital, Lagrangeville, New York, United States|North Shore University Hospital, Manhasset, New York, United States|North Shore University Hospital, 270-05 76th Ave, New Hyde Park, New York, United States|Icahn School of Medicine at Mount Sinai, 350 East 17th Street, New York, New York, United States|Icahn School of Medicine at Mount Sinai, 1000 10th Avenue, New York, New York, United States|Icahn School of Medicine at Mount Sinai, 440 West 114th St., New York, New York, United States|Icahn School of Medicine at Mount Sinai, New York, New York, United States|Columbia University Medical Center-New York Presbyterian Hospital, New York, New York, United States|New York Presbyterian Hospital/Weill Cornell Medical Center, New York, New York, United States|Duke University Medical Center, Durham, North Carolina, United States|University Hospitals Cleveland Medical Center, Cleveland, Ohio, United States|Kaiser Sunnyside Medical Center, 2875 NW Stucki Ave, Hillsboro, Oregon, United States|Providence Portland Medical Center, Portland, Oregon, United States|Providence St. Vincent Medical Center, Portland, Oregon, United States|Kaiser Sunnyside Medical Center, Portland, Oregon, United States|Hospital of the University of Pennsylvania, 51 N. 31st Street, Philadelphia, Pennsylvania, United States|Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, United States|Temple University Hospital, Philadelphia, Pennsylvania, United States|The Miriam Hospital, Providence, Rhode Island, United States|Prisma Health Richland Hospital, Columbia, South Carolina, United States|Prisma Health Richland Hospital, 701 Grove Road, Greenville, South Carolina, United States|The Liver Institute of Methodist Dallas Medical Center, Dallas, Texas, United States|UT Southwestern Medical Center Amelia Court, HIV Research Clinic, Dallas, Texas, United States|Baylor University Medical Center, Dallas, Texas, United States|UT Southwestern Medical Center Amelia Court, HIV Research Clinic, 5201 Harry Hines Blvd., Dallas, Texas, United States|UT Southwestern Medical Center Amelia Court, HIV Research Clinic, 6201 Harry Hines Blvd, Dallas, Texas, United States|Baylor University Medical Center, 1400 8th Ave, Fort Worth, Texas, United States|Houston Methodist Hospital, Houston, Texas, United States|Baylor University Medical Center, 2401 S. 31st St., Temple, Texas, United States|University of Utah Health, Salt Lake City, Utah, United States|Virginia Hospital Center, Arlington, Virginia, United States|Inova Fairfax Medical Campus, Falls Church, Virginia, United States|VCU Health Medical Center, Richmond, Virginia, United States|Providence Regional Medical Center Everett, Everett, Washington, United States|Kadlec Regional Medical Center, Kennewick, Washington, United States|Providence St. Peter Hospital, Olympia, Washington, United States|Virginia Mason Medical Center, Seattle, Washington, United States|Swedish Center for Comprehensive Care, Seattle, Washington, United States|MultiCare Deaconess Hospital, Spokane, Washington, United States|MultiCare Tacoma General Hospital, Tacoma, Washington, United States|St Joseph Medical Center, Tacoma, Washington, United States|The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China|CHU Pellegrin, Bordeaux, France|CHU de Montpellier-Hopital Gui de Chauliac, Montpelier Cedex 5, France|CHU de Nantes-Hotel Dieu, Nantes, France|Hopital Saint-Louis, Paris, France|Hopital Saint Antoine, Paris, France|Charite Universitatsmedizin Berlin, Campus Virchow-Klinikum, Medizinische Klinik Infektiologie Pneumologie, Berlin, Germany|Universitatsklinikum Dusseldorf, Klinik fur Gastroenterologie, Hepatologie und Infektiologie, Düsseldorf, Germany|Universitatsklinikum Hamburg-Eppendorf, Hamburg, Germany|Universitätsklinikum Schleswig-Holstein Campus Kiel, Kiel, Germany|Klinikum St. Georg gGmbH Klinik fur Infektiologie, Tropenmedizin, Nephrologie und Rheumatologie, Leipzig, Germany|Klinikum rechts der Isar der TU Munchen, Klinik und Poliklinik Innere Medizin 2, Munich, Germany|Klinik für Hämatologie, Onkologie, Immunologie, München, Germany|Robert-Bosch-Krankenhaus (RBK), Klinik Schillerhohe (KSH) und Dr. Margarete Fischer-Bosch-Institut fur klinische Pharmakologie (IKP), Stuttgart, Germany|Prince of Wales Hospital, Hong Kong, Hong Kong|Princess Margaret Hospital, Hong Kong, Hong Kong|Queen Mary Hospital, Hong Kong, Hong Kong|UOC Malattie Infettive, ASST Papa Giovanni XXIII, Bergamo, Italy|ASST degli Spedali Civili di Brescia, Brescia, Italy|ASST di Cremona - Azienda Socio Sanitaria Territor, Cremona, Italy|UOC Malattie Infettive, IRCCS Ospedale San Raffaele, Milano, Italy|Dipartimento di Malattie Infettive, Malattie Infettive I- Malattie Infettive III, AssT Fatebenefratelli Sacco Ospedale Luigi Sacco, Milano, Italy|UO Malattie Infettive, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy|UOC Medicina Di Laboratorio, Azienda Ospedaliera di Padova, Padova PD, Italy|Azienda Ospedaliero Universitaria di Parma, Parma, Italy|UOC Malattie Infettive I, Fondazione IRCCS Policlinio San Matteo, Pavia, Italy|Ospedale Guglielmo da Saliceto AUSL di Piacenza, Piacenza, Italy|UOC Malattie Infettive ad Alta Intensita di Cure, Istituto Nazionale Malattie Infettive Lazzaro Spallanzani I.R.C.C.S., Roma, Italy|Clinica Universitaria Malattie Infettive, Ospedale Amedeo di Savoia, Torino, Italy|Yokohama Municipal Citizen's Hospital, Kanagawa, Japan|Nagoya City East Medical Center, Nagoya, Japan|Tokyo Metropolitan Bokutoh Hospital, Tokyo, Japan|Kyungpook National University Hospital, Daegu, Korea, Republic of|Seoul Medical Center, Seoul, Korea, Republic of|National Medical Center, Seoul, Korea, Republic of|Amsterdam University Medical Centre - Location AMC, Amsterdam, Netherlands|Leiden University Medical Center, Leiden, Netherlands|Erasmus Medical Centre, Rotterdam, Netherlands|National University Hospital, Singapore, Singapore|Singapore General Hospital, Singapore, Singapore|National Centre for Infectious Diseases, Tan Tock Seng Hospital, Singapore, Singapore|Hospital Principe de Asturias, Alcalá De Henares, Madrid, Spain|Complejo Hospitalario Universitario A Coruña, A Coruña, Spain|Hospital Universitari Vall d'Hebron, Barcelona, Spain|Hospital Universitari de Bellvitge, Barcelona, Spain|Hospital Clinic de Barcelona, Barcelona, Spain|Hospital Universitario Cruces, Bizkaia, Spain|Hospital Universitario Ramón y Cajal, Madrid, Spain|Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain|Hospital Universitario 12 de Octubre, Madrid, Spain|Hospital Universitario La Paz, Madrid, Spain|Hospital Regional Universitario de Málaga, Málaga, Spain|Hospital Universitario Virgen del Rocio, Sevilla, Spain|Sahlgrenska University Hospital, Ostra, Gothenburg, Sweden|SUS (Skanes University Hospital), Malmo, Sweden|Karolinska University Hospital, Stockholm, Sweden|Hopitaux Universitaires de Genève, Genève 14, Switzerland|Ospedale Regionale di Locarno La Carità, Lugano, Switzerland|Universitätsspital Zürich, Zürich, Switzerland|Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan|China Medical University Hospital, Taichung, Taiwan|National Taiwan University Hospital, Taipei City, Taiwan|Imperial College Healthcare NHS Trust, London, Greater London, United Kingdom|Royal Infirmary of Edinburgh, Edinburgh, United Kingdom|Queen Elizabeth University Hospital, Glasgow, United Kingdom|Hull University Teaching Hospitals NHS Trust, Hull, United Kingdom|Royal Lancaster Hospital, Lancaster, United Kingdom|Liverpool University Hospital, Liverpool, United Kingdom|Northwick Park Hospital, London, United Kingdom|Royal Free London NHS Foundation Trust, London, United Kingdom|King's College Hospital NHS Trust, London, United Kingdom|University College London, London, United Kingdom|Manchester University NHS Foundation Trust, Manchester, United Kingdom|Manchester University NHS Foundation Trust, Manchester, United Kingdom|Pennine Acute Hospitals NHS Trust, Manchester, United Kingdom|Derriford Hospital, Plymouth, United Kingdom|Sheffield Teaching Hospitals, Sheffield, United Kingdom"	https://ClinicalTrials.gov/show/NCT04292899
244	NCT04385264	#StayHome: Early Hydroxychloroquine to Reduce Secondary Hospitalisation and Household Transmission in COVID-19	Not yet recruiting	No Results Available	COVID-19	Drug: Hydroxychloroquine|Drug: Mannitol	Phase 2|Phase 3	Interventional	"Unisanté, Lausanne, Vaud, Switzerland"	https://ClinicalTrials.gov/show/NCT04385264
245	NCT04370782	Hydroxychloroquine and Zinc With Either Azithromycin or Doxycycline for Treatment of COVID-19 in Outpatient Setting	Recruiting	No Results Available	COVID-19	Drug: Hydroxychloroquine|Drug: Azithromycin|Drug: Zinc Sulfate|Drug: Doxycycline	Phase 4	Interventional	"St Francis Hospital, Roslyn, New York, United States"	https://ClinicalTrials.gov/show/NCT04370782
246	NCT04312997	The Use of PUL-042 Inhalation Solution to Reduce the Severity of COVID-19 in Adults Positive for SARS-CoV-2 Infection	Recruiting	No Results Available	COVID-19	Drug: PUL-042 Inhalation Solution|Drug: Placebo	Phase 2	Interventional	"University of California Irvine, Orange, California, United States|Clinical Research of South Florida Alliance for Multispecialty Research, Coral Gables, Florida, United States|St. Elizabeth Healthcare, Edgewood, Kentucky, United States|Ascension St. John, Tulsa, Oklahoma, United States|MD Anderson Cancer Center, Houston, Texas, United States|Next Level Urgent Care, Houston, Texas, United States"	https://ClinicalTrials.gov/show/NCT04312997
247	NCT04334980	"Evaluating the Safety, Tolerability and Immunogenicity of bacTRL-Spike Vaccine for Prevention of COVID-19"	Not yet recruiting	No Results Available	COVID-19	Biological: bacTRL-Spike|Other: Placebo	Phase 1	Interventional	"University of California, San Diego (UCSD), Antiviral Research Center (AVRC), San Diego, California, United States|Vaccine Evaluation Center, BC Children's Hospital Research Institute, University of British Columbia., Vancouver, British Columbia, Canada|Canadian Center for Vaccinology Dalhousie University, IWK Health Centre, Halifax, Nova Scotia, Canada"	https://ClinicalTrials.gov/show/NCT04334980
248	NCT04377711	A Study of the Safety and Efficacy of Ciclesonide in the Treatment of Non-hospitalized COVID-19 Patients	Recruiting	No Results Available	COVID-19	Drug: Ciclesonide|Drug: Placebo	Phase 3	Interventional	"University of Buffalo, Buffalo, New York, United States"	https://ClinicalTrials.gov/show/NCT04377711
249	NCT04348409	Efficacy and Safety of Nitazoxanide for the Treatment of Hospitalized Patients With Moderate COVID-19	Recruiting	No Results Available	COVID-19	Drug: Nitazoxanide Tablets|Drug: Placebo	Not Applicable	Interventional	"Hospital Vera Cruz, Campinas, São Paulo, Brazil|Centro de Genomas, São Paulo, Brazil|Hospital Emílio Ribas, São Paulo, Brazil"	https://ClinicalTrials.gov/show/NCT04348409
250	NCT04353518	Clinical Trial to Evaluate Mycobacterium w in Preventing COVID-19 in Subjects at Risk of Getting Infected With COVID-19	Not yet recruiting	No Results Available	COVID-19	Drug: Suspension of heat killed (autoclaved) Mycobacterium w|Other: Placebo	Phase 3	Interventional		https://ClinicalTrials.gov/show/NCT04353518
251	NCT04360551	Pilot Clinical Trial of the Safety and Efficacy of Telmisartan for the Mitigation of Pulmonary and Cardiac Complications in COVID-19 Patients	Not yet recruiting	No Results Available	COVID-19	Drug: Telmisartan 40mg|Drug: Placebo	Phase 2	Interventional	"University of Hawaii - Manoa, John A Burns School of Medicine UH Clinics at Kakaako, Honolulu, Hawaii, United States"	https://ClinicalTrials.gov/show/NCT04360551
252	NCT04343989	A Randomized Placebo-controlled Safety and Dose-finding Study for the Use of the IL-6 Inhibitor Clazakizumab in Patients With Life-threatening COVID-19 Infection	Recruiting	No Results Available	COVID-19	Drug: Clazakizumab 25 mg|Drug: Clazakizumab 12.5 mg|Other: Placebo	Phase 2	Interventional	"New York University School of Medicine, New York, New York, United States"	https://ClinicalTrials.gov/show/NCT04343989
253	NCT04375046	Recombinant Bacterial ACE2 Receptors -Like Enzyme of B38-CAP Could be Promising COVID-19 Infection- and Lung Injury Preventing Drug Better Than Recombinant Human ACE2	Not yet recruiting	No Results Available	COVID-19	Drug: Recombinant Bacterial ACE2 receptors -like enzyme of B38-CAP (rbACE2)	Phase 1	Interventional		https://ClinicalTrials.gov/show/NCT04375046
254	NCT04348435	"A Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Determine the Safety and Efficacy of Hope Biosciences Allogeneic Mesenchymal Stem Cell Therapy (HB-adMSCs) to Provide Protection Against COVID-19"	Enrolling by invitation	No Results Available	COVID-19	Drug: HB-adMSCs|Drug: Placebos	Phase 2	Interventional	"Hope Biosciences Stem Cell Research Foundation, Sugar Land, Texas, United States"	https://ClinicalTrials.gov/show/NCT04348435
255	NCT04329572	Efficacy and Safety of Hydroxychloroquine and Azithromycin for the Treatment of Hospitalized Patients With Moderate to Severe COVID-19	Suspended	No Results Available	COVID-19	Drug: Hydroxychloroquine Sulfate|Drug: Azithromycin Tablets	Early Phase 1	Interventional	"Prevent Senior Private Operadora de Saúde LTDA., São Paulo, Brazil"	https://ClinicalTrials.gov/show/NCT04329572
256	NCT04431453	"Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of Remdesivir (GS-5734™) in Participants From Birth to < 18 Years of Age With Coronavirus Disease 2019 (COVID-19)"	Not yet recruiting	No Results Available	COVID-19	Drug: Remdesivir	Phase 2|Phase 3	Interventional		https://ClinicalTrials.gov/show/NCT04431453
257	NCT04292730	Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants With Moderate Coronavirus Disease (COVID-19) Compared to Standard of Care Treatment	"Active, not recruiting"	No Results Available	COVID-19	Drug: Remdesivir|Drug: Standard of Care	Phase 3	Interventional	"Kaiser Permanente Los Angeles Medical Center, 3340 E. La Palma Avenue, Anaheim, California, United States|Alta Bates Summit Medical Center, Berkeley, California, United States|Mills-Peninsula Medical Center, Burlingame, California, United States|Eden Medical Center, Castro Valley, California, United States|Kaiser Permanente Los Angeles Medical Center, 9333 Imperial Highway, Downey, California, United States|Kaiser Permanente Los Angeles Medical Center, 9961 Sierra Ave, Fontana, California, United States|St Joseph Hospital Eureka, Fortuna, California, United States|Kaiser Permanente Los Angeles Medical Center, 25825 S. Vermont Ave., Harbor City, California, United States|Kaiser Permanente Los Angeles Medical Center, Los Angeles, California, United States|Kaiser Permanente Los Angeles Medical Center, 6041 Cadillac Ave., Los Angeles, California, United States|Kaiser Permanente Los Angeles Medical Center, 5601 De Soto Avenue, Los Angeles, California, United States|Mission Hospital Regional Medical Center, Mission Viejo, California, United States|Kaiser Permanente Los Angeles Medical Center,27300 Iris Avenue, Moreno Valley, California, United States|El Camino Hospital, Mountain View, California, United States|Hoag Memorial Hospital Presbyterian, Newport Beach, California, United States|Kaiser Permanente Oakland Medical Center, Oakland, California, United States|Kaiser Permanente Los Angeles Medical Center, 2295 S. Vineyard Avenue, Ontario, California, United States|The Center for Cancer Prevention and Treatment at St. Joseph Hospital of Orange, Orange, California, United States|Kaiser Permanente Los Angeles Medical Center,13651 Willard Street, Panorama City, California, United States|Kaiser Permanente Los Angeles Medical Center, 10800 Magnolia Avenue, Riverside, California, United States|Sutter Medical Center Sacramento, One Medical Plaza, Roseville, California, United States|Sutter Medical Center Sacramento, Sacramento, California, United States|Kaiser Permanente Los Angeles Medical Center, 4647 Zion Avenue, San Diego, California, United States|Kaiser Permanente Los Angeles Medical Center, 9455 Clairemont Mesa Blvd, San Diego, California, United States|Kaiser Permanente Oakland Medical Center, 1200 El Camino Real, San Francisco, California, United States|California Pacific Medical Center-Infectious Disease Associates Medical Group, San Francisco, California, United States|Kaiser Permanente Oakland Medical Center, 2425 Geary Blvd, San Francisco, California, United States|Kaiser Permanente Oakland Medical Center, 250 Hospital Parkway, Suite 850, San Jose, California, United States|Kaiser Permanente Oakland Medical Center, 2500 Merced St, San Leandro, California, United States|Kaiser Permanente Oakland Medical Center, 700 Lawrence Expressway, Santa Clara, California, United States|Providence St. Johns Medical Center, Santa Monica, California, United States|Sutter Santa Rosa Regional Hospital, Santa Rosa, California, United States|Stanford Hospital, Stanford, California, United States|University of Colorado Denver, University of Colorado Hospital, Aurora, Colorado, United States|SCL Health St. Joseph Hospital, 1375 East 19th Ave, Denver, Colorado, United States|SCL Health St. Joseph Hospital, Denver, Colorado, United States|Rose Medical Center, Denver, Colorado, United States|SCL Health St. Joseph Hospital, 200 Exempla Circle., Lafayette, Colorado, United States|Yale University, New Haven, Connecticut, United States|Kaiser Permanente Hawaii Moanalua Medical Center, Honolulu, Hawaii, United States|Cook County General Hospital, Chicago, Illinois, United States|Rush University Medical Center, Chicago, Illinois, United States|University of Chicago, Chicago, Illinois, United States|IU Health Methodist Hospital, Indianapolis, Indiana, United States|University of Iowa Hospitals & Clinics, Iowa City, Iowa, United States|Tulane University, New Orleans, Louisiana, United States|Maine Medical Center, Portland, Maine, United States|Holy Cross Hospital, Silver Spring, Maryland, United States|Tufts Medical Center, Boston, Massachusetts, United States|Brigham & Women's Hospital and Harvard Medical School, Boston, Massachusetts, United States|Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States|The University of Michigan Hospitals and Health Systems, Ann Arbor, Michigan, United States|Henry Ford Health System, Detroit, Michigan, United States|Hennepin Healthcare, Minneapolis, Minnesota, United States|Mayo Clinic, Rochester, Minnesota, United States|Providence St Patrick Hospital and International Heart Institute of MT Foundation, Missoula, Montana, United States|Darmouth-Hitchhock Medical Center, Lebanon, New Hampshire, United States|Hackensack Medical Center, Hackensack, New Jersey, United States|Robert Wood Johnson University Hospital Somerset, Hillsborough, New Jersey, United States|Robert Wood Johnson University Hospital Somerset, 1 RWJ Place, New Brunswick, New Jersey, United States|Robert Wood Johnson University Hospital Somerset, 201 Lyons Avenue, Newark, New Jersey, United States|St. Joseph's University Medical Center, Paterson, New Jersey, United States|Jacobi Medical Center, Bronx, New York, United States|James J. Peters Veterans Administration Medical Center, Bronx, New York, United States|Jamaica Hospital Medical Center, Jamaica, New York, United States|Danbury Hospital, Lagrangeville, New York, United States|North Shore University Hospital, Manhasset, New York, United States|North Shore University Hospital, 270-05 76th Ave, New Hyde Park, New York, United States|Icahn School of Medicine at Mount Sinai, 350 East 17th Street, New York, New York, United States|Icahn School of Medicine at Mount Sinai, 1000 10th Avenue, New York, New York, United States|Icahn School of Medicine at Mount Sinai, 440 West 114th St., New York, New York, United States|Icahn School of Medicine at Mount Sinai, New York, New York, United States|Columbia University Irving Medical Center, New York, New York, United States|Weill Cornell Medical College/NYU Presbyterian Hospital, New York, New York, United States|Duke University Medical Center, Durham, North Carolina, United States|University Hospitals Cleveland Medical Center, Cleveland, Ohio, United States|Kaiser Sunnyside Medical Center, 2875 NW Stucki Ave, Hillsboro, Oregon, United States|Providence Portland Medical Center, Portland, Oregon, United States|Providence St. Vincent Medical Center, Portland, Oregon, United States|Kaiser Sunnyside Medical Center, Portland, Oregon, United States|Hospital of the University of Pennsylvania, 51 N. 31st Street, Philadelphia, Pennsylvania, United States|Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, United States|Temple University Hospital, Philadelphia, Pennsylvania, United States|The Miriam Hospital, Providence, Rhode Island, United States|Prisma Health Richland Hospital, Columbia, South Carolina, United States|Prisma Health Richland Hospital, 701 Grove Road, Greenville, South Carolina, United States|The Liver Institute of Methodist Dallas Medical Center, Dallas, Texas, United States|UT Southwestern Medical Center Amelia Court, HIV Research Clinic, Dallas, Texas, United States|Baylor University Medical Center, Dallas, Texas, United States|UT Southwestern Medical Center Amelia Court, HIV Research Clinic, 5201 Harry Hines Blvd., Dallas, Texas, United States|UT Southwestern Medical Center Amelia Court, HIV Research Clinic, 6201 Harry Hines Blvd, Dallas, Texas, United States|Baylor University Medical Center, 1400 8th Ave, Fort Worth, Texas, United States|Houston Methodist Hospital, Houston, Texas, United States|Baylor University Medical Center, 2401 S. 31st St., Temple, Texas, United States|University of Utah Health, Salt Lake City, Utah, United States|Virginia Hospital Center, Arlington, Virginia, United States|Inova Fairfax Hospital, Falls Church, Virginia, United States|VCU Health Medical Center, Richmond, Virginia, United States|Providence Medical Research Center, Everett, Washington, United States|Kadlec Regional Medical Center, Kennewick, Washington, United States|Providence St. Peter Hospital, Olympia, Washington, United States|Virginia Mason Medical Center, Seattle, Washington, United States|Swedish Center for Comprehensive Care, Seattle, Washington, United States|MultiCare Deaconess Hospital, Spokane, Washington, United States|MultiCare Tacoma General Hospital, Tacoma, Washington, United States|St Joseph Medical Center, Tacoma, Washington, United States|The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China|CHU Pellegrin, Bordeaux, France|CHU de Montpellier-Hopital Gui de Chauliac, Montpelier Cedex 5, France|CHU de Nantes-Hotel Dieu, Nantes, France|Hopital Saint-Louis, Paris, France|Hopital Saint Antoine, Paris, France|Charite Universitatsmedizin Berlin, Campus Virchow-Klinikum, Medizinische Klinik Infektiologie Pneumologie, Berlin, Germany|Universitatsklinikum Dusseldorf, Klinik fur Gastroenterologie, Hepatologie und Infektiologie, Düsseldorf, Germany|Universitatsklinikum Hamburg-Eppendorf, Hamburg, Germany|Universitätsklinikum Schleswig-Holstein Campus Kiel, Kiel, Germany|Klinikum St. Georg gGmbH Klinik fur Infektiologie, Tropenmedizin, Nephrologie und Rheumatologie, Leipzig, Germany|Klinikum rechts der Isar der TU Munchen, Klinik und Poliklinik Innere Medizin 2, Munich, Germany|Klinik für Hämatologie, Onkologie, Immunologie, München, Germany|Robert-Bosch-Krankenhaus (RBK), Klinik Schillerhohe (KSH) und Dr. Margarete Fischer-Bosch-Institut fur klinische Pharmakologie (IKP), Stuttgart, Germany|Prince of Wales Hospital, Hong Kong, Hong Kong|Princess Margaret Hospital, Hong Kong, Hong Kong|Queen Mary Hospital, Hong Kong, Hong Kong|UOC Malattie Infettive, ASST Papa Giovanni XXIII, Bergamo, Italy|ASST degli Spedali Civili di Brescia, Brescia, Italy|ASST di Cremona - Azienda Socio Sanitaria Territor, Cremona, Italy|UOC Malattie Infettive, IRCCS Ospedale San Raffaele, Milano, Italy|ASST Fatebenefratelli Sacco, Milano, Italy|UO Malattie Infettive, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy|UOC Malattie Infettive e Tropicali, Azienda Ospedaliera di Padova, Padova PD, Italy|Azienda Ospedaliero Universitaria di Parma, Parma, Italy|Malattie Infettive I, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy|Ospedale Guglielmo da Saliceto AUSL di Piacenza, Piacenza, Italy|UOC Malattie Infettive ad Alta Intensita di Cure, Istituto Nazionale Malattie Infettive Lazzaro Spallanzani I.R.C.C.S., Roma, Italy|Clinica Universitaria Malattie Infettive, Ospedale Amedeo di Savoia, Torino, Italy|Yokohama Municipal Citizen's Hospital, Kanagawa, Japan|Nagoya City East Medical Center, Nagoya, Japan|Tokyo Metropolitan Bokutoh Hospital, Tokyo, Japan|Kyungpook National University Hospital, Daegu, Korea, Republic of|Seoul Medical Center, Seoul, Korea, Republic of|National Medical Center, Seoul, Korea, Republic of|Amsterdam University Medical Centre - Location AMC, Amsterdam, Netherlands|Leiden University Medical Center, Leiden, Netherlands|Erasmus Medical Centre, Rotterdam, Netherlands|National University Hospital, Singapore, Singapore|Singapore General Hospital, Singapore, Singapore|National Centre for Infectious Diseases, Tan Tock Seng Hospital, Singapore, Singapore|Hospital Principe de Asturias, Alcalá De Henares, Madrid, Spain|Complejo Hospitalario Universitario A Coruña, A Coruña, Spain|Hospital Universitario Vall d'Hebron, Barcelona, Spain|Hospital Universitari de Bellvitge, Barcelona, Spain|Hospital Clinic de Barcelona, Barcelona, Spain|Hospital Universitario Cruces, Bizkaia, Spain|Hospital Universitario Ramón y Cajal, Madrid, Spain|Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain|Hospital Universitario 12 de Octubre, Madrid, Spain|Hospital Universitario La Paz, Madrid, Spain|Hospital Regional Universitario de Málaga, Málaga, Spain|Hospital Universitario Virgen del Rocio, Sevilla, Spain|Hospital Universitari i Politecnic La Fe, Valencia, Spain|Sahlgrenska University Hospital, Ostra, Gothenburg, Sweden|SUS (Skanes University Hospital), Malmo, Sweden|Karolinska University Hospital, Stockholm, Sweden|Hopitaux Universitaires de Genève, Genève 14, Switzerland|Ospedale Regionale di Locarno La Carità, Lugano, Switzerland|Universitätsspital Zürich, Zürich, Switzerland|Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan|China Medical University Hospital, Taichung, Taiwan|National Taiwan University Hospital, Taipei City, Taiwan|Imperial College NHS Trust, London, Greater London, United Kingdom|NHS Lothian, Royal lnfirmary of Edinburgh, Edinburgh, United Kingdom|Queen Elizabeth University Hospital, Glasgow, United Kingdom|Hull University Teaching Hospitals NHS Trust, Hull, United Kingdom|Royal Lancaster Hospital, Lancaster, United Kingdom|Liverpool University Hospital, Liverpool, United Kingdom|Northwick Park Hospital, London, United Kingdom|Royal Free London NHS Foundation Trust, London, United Kingdom|King's College Hospital NHS Trust, London, United Kingdom|University College London, London, United Kingdom|Manchester University NHS Foundation Trust, Manchester, United Kingdom|Manchester University NHS Foundation Trust, Manchester, United Kingdom|Pennine Acute Hospitals NHS Trust, Manchester, United Kingdom|Derriford Hospital, Plymouth, United Kingdom|Sheffield Teaching Hospitals, Sheffield, United Kingdom"	https://ClinicalTrials.gov/show/NCT04292730
258	NCT04358549	Study of the Use of Favipiravir in Hospitalized Subjects With COVID-19	Recruiting	No Results Available	COVID-19	Drug: Favipiravir + Standard of Care|Drug: Standard of Care	Phase 2	Interventional	"HonorHealth, Scottsdale, Arizona, United States|Boston Medical Center, Boston, Massachusetts, United States|Brigham and Women's Hospital, Boston, Massachusetts, United States|Massachusetts General Hospital, Boston, Massachusetts, United States|UMass Memorial Health Care, Worcester, Massachusetts, United States|Atlantic Health System / Morristown Medical Center, Morristown, New Jersey, United States|Houston Methodist Hospital, Houston, Texas, United States"	https://ClinicalTrials.gov/show/NCT04358549
259	NCT04428021	Standard or Convalescent Plasma in Patients With Recent Onset of COVID-19 Respiratory Failure	Not yet recruiting	No Results Available	COVID-19	Drug: Standard Therapy Protocol (STP)|Other: STP + Standard Plasma (SP)|Other: STP + COVID-19 Convalescent Plasma (CP)	Phase 2	Interventional		https://ClinicalTrials.gov/show/NCT04428021
260	NCT04421625	Patients and Health Staff of Cancer Centres During the Covid-19 Pandemic	Not yet recruiting	No Results Available	COVID-19	Diagnostic Test: Diagnostic test for SARS-Cov2 for patients and health staff	Not Applicable	Interventional	"Institut de Cancerologie de l'Ouest, Angers, France"	https://ClinicalTrials.gov/show/NCT04421625
261	NCT04345523	Convalescent Plasma Therapy vs. SOC for the Treatment of COVID19 in Hospitalized Patients	Recruiting	No Results Available	COVID-19	Other: Blood and derivatives.|Drug: Standard of Care	Phase 2	Interventional	"Hospital Clínico Universitario Lozano Blesa, Zaragoza, Aragón, Spain|Hospital Universitario Severo Ochoa, Leganés, Madrid, Spain|Hospital Universitario Puerta de Hierro Majadahonda, Majadahonda, Madrid, Spain|Hospital Universitario Príncipe de Asturias, Meco, Madrid, Spain|Hospital Universitario La Princesa, Madrid, Spain|Hospital General Universitario Gregorio Marañón, Madrid, Spain|Hospital Universitario Ramón y Cajal, Madrid, Spain|Hospital Clínico San Carlos, Madrid, Spain|Hospital Universitario 12 de Octubre, Madrid, Spain"	https://ClinicalTrials.gov/show/NCT04345523
262	NCT04382586	Covid-19 Infection and Pulmonary Distress Treatment With Zanubrutinib in Hospitalized Participants	Recruiting	No Results Available	COVID-19 Pulmonary Complications|COVID-19	Drug: Zanubrutinib|Drug: Supportive Care|Drug: Placebo	Phase 2	Interventional	"MedStar Heath Research Institute/ MedStar Washington Hospital Center, Washington, District of Columbia, United States|Loyola University Medical Center, Maywood, Illinois, United States|Massachusetts General Hospital, Boston, Massachusetts, United States|Brigham And Women's Hospital, Boston, Massachusetts, United States|Atlantic Health System Inc. / Morristown Medical Center, Morristown, New Jersey, United States|Rutgers University Hospital, Newark, New Jersey, United States|Overlook Medical Center, Summit, New Jersey, United States|Covenant Health System, Lubbock, Texas, United States|Medical College of Wisconsin, Milwaukee, Wisconsin, United States"	https://ClinicalTrials.gov/show/NCT04382586
263	NCT04313322	Treatment of COVID-19 Patients Using Wharton's Jelly-Mesenchymal Stem Cells	Recruiting	No Results Available	Use of Stem Cells for COVID-19 Treatment	Biological: WJ-MSCs	Phase 1	Interventional	"Stem Cells Arabia, Amman, Jordan"	https://ClinicalTrials.gov/show/NCT04313322
264	NCT04445935	Anticoagulation in Patients Suffering From COVID-19 Disease The ANTI-CO Trial	Recruiting	No Results Available	Anticoagulation in COVID-19 ARDS	Drug: Bivalirudin Injection|Drug: Standard treatment	Phase 4	Interventional	"Hamad Medical Corporation, Doha, Qatar"	https://ClinicalTrials.gov/show/NCT04445935
265	NCT04308317	Tetrandrine Tablets Used in the Treatment of COVID-19	Enrolling by invitation	No Results Available	"Corona Virus Disease 2019,COVID-19"	Drug: Tetrandrine	Phase 4	Interventional	"Tetrandrine Tablets, Jinhua, Zhejiang, China"	https://ClinicalTrials.gov/show/NCT04308317
266	NCT04399317	Flow Controlled Ventilation in ARDS Associated With COVID-19	Recruiting	No Results Available	ARDS Associated With COVID-19	Device: Flow controlled ventilation (Evone-ventilator)	Not Applicable	Interventional	"Hamad Medical Corporation, Doha, Qatar"	https://ClinicalTrials.gov/show/NCT04399317
267	NCT04421404	Effects of COVID-19 Convalescent Plasma (CCP) on Coronavirus-associated Complications in Hospitalized Patients	Recruiting	No Results Available	COVID-19|Sars-CoV2	Biological: COVID-19 Convalescent Plasma (CCP)|Biological: Placebo	Phase 2	Interventional	"San Francisco General Hospital, San Francisco, California, United States|UCSF Medical Center at Mount Zion, San Francisco, California, United States|University of California, San Francisco Medical Center (Parnassus Campus), San Francisco, California, United States"	https://ClinicalTrials.gov/show/NCT04421404
268	NCT04381962	A Multicentre Open-label Two-arm Randomised Superiority Clinical Trial of Azithromycin Versus Usual Care In Ambulatory COVID19 (ATOMIC2)	Recruiting	No Results Available	COVID-19	Drug: Azithromycin Capsule	Phase 3	Interventional	"Horton General Hospital, Banbury, Oxfordshire, United Kingdom|John Radcliffe Hospital, Oxford, Oxfordshire, United Kingdom|Ninewells Hospital, Dundee, Scotland, United Kingdom|Birmingham City Hospital, Birmingham, United Kingdom|Sandwell General Hospital, West Bromwich, United Kingdom"	https://ClinicalTrials.gov/show/NCT04381962
269	NCT04371965	"Povidone Iodine Mouthwash, Gargle, and Nasal Spray to Reduce Naso- Pharyngeal Viral Load in Patients With COVID-19"	Not yet recruiting	No Results Available	COVID-19	Drug: Povidone-Iodine	Phase 2	Interventional	"University Hospital of Poitiers, Poitiers, France"	https://ClinicalTrials.gov/show/NCT04371965
270	NCT04346615	Safety and Efficacy Trial of Zavegepant* Intranasal for Hospitalized Patients With COVID-19 Requiring Supplemental Oxygen	Recruiting	No Results Available	COVID-19 Infection	Drug: Vazegepant (BHV-3500)|Drug: Placebo	Phase 2|Phase 3	Interventional	"Georgetown University Medical Center, Washington, District of Columbia, United States|Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, United States"	https://ClinicalTrials.gov/show/NCT04346615
271	NCT04427098	Enoxaparin in COVID-19 Moderate to Severe Hospitalized Patients	Recruiting	No Results Available	COVID-19	Drug: Enoxaparin 40 Mg/0.4 mL Injectable Solution|Drug: Enoxaparin	Phase 2	Interventional	"Policlinico S. Orsola Malpighi Dipartimento Malattie Infettive, Bologna, Emilia Romagna, Italy|Azienda Ospedaliero-Universitaria di Parma Anestesia e Rianimazione Dipartimento di Medicina e Chirurgia, Parma, Emilia Romagna, Italy|I.R.C.C.S. ""Casa Sollievo della Sofferenza"", San Giovanni Rotondo (FG) UOVD Emostasi e trombosi- Poliambulatorio Giovanni Paolo II Viale Padre Pio n.7 San Giovanni Rotondo (FG), San Giovanni Rotondo, Foggia, Italy|Fondazione Poliambulanza Chirurgia Vascolare, Brescia, Italy|Piazzale Spedali Civili, 1, 25123 Brescia BS Medicina Interna UniBS 2° Medicina ASST Spedali Civili, Brescia, Italy|Azienda Ospedaliero-Universitaria ""Policlinico - V. Emanuele"", Catania Anestesia e Rianimazione UO Malattie Infettive, Catania, Italy|ASST Cremona Unità Operativa di Chirurgia Vascolare Dipartimento di Medicina di Laboratorio e di Radiologia- Centro Emostasi e Trombosi, Cremona, Italy|Ospedale Morgagni Pierantoni U.O.C. Malattie Infettive, Forlì, Italy|Ospedale Carlo Poma di Mantova MALATTIE INFETTIVE Padiglione 37 Str. Lago Paiolo, 10, 46100 Mantova, Mantova, Italy|AZIENDA OSPEDALIERA Regionale S CARLO POTENZA Struttura Complessa Interaziendale ""Malattie Infettive"", Matera, Italy|Ospedale San Raffaele Unità Funzionale dell'Unità Operativa di Malattie Infettive Osp. San Raffaele, Milano, Italy|Ospedale Amedeo di Savoia Torino Università di Torino Malattie Infettive, Torino, Italy|Azienda Ospedaliera Universitaria Integrata Verona UOC Malattie Infettive e Tropicali, Verona, Italy"	https://ClinicalTrials.gov/show/NCT04427098
272	NCT04389411	The COvid-19 Symptom MOntelukast Trial	Not yet recruiting	No Results Available	COVID-19	Drug: Montelukast 10mg	Phase 3	Interventional		https://ClinicalTrials.gov/show/NCT04389411
273	NCT04379479	Clinical Effect of Dialyzable Leukocyte Extract in Suspected or Confirmed Cases of COVID-19 (FUTURE-T)	Not yet recruiting	No Results Available	COVID-19|SARS-CoV-2 Infection	Drug: Dialyzable Leukocyte Extract|Drug: Placebo oral	Phase 2	Interventional	"Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, Mexico City, Mexico"	https://ClinicalTrials.gov/show/NCT04379479
274	NCT04371822	Efficacy of Sunlight Activated Synthetic Porphyrin in COVID-19 Infected Patients	Not yet recruiting	No Results Available	COVID-19	Drug: SnPP Protoporphyrin plus Sunlight exposure|Drug: Sulfonatoporphyrin(TPPS) plus Sunlight exposure.|Other: placebo	Phase 1	Interventional	"Kafr El-sheikh University, Cairo, Kafr El-sheikh, Egypt"	https://ClinicalTrials.gov/show/NCT04371822
275	NCT04408209	Convalescent Plasma for the Treatment of Patients With Severe COVID-19 Infection	Recruiting	No Results Available	COVID-19 Infection	Procedure: Convalescent Plasma	Not Applicable	Interventional	"Evangelismos General Hospital, Athens, Attiki, Greece|""Agios Savas"" Oncology Hospital, Athens, Attiki, Greece|""Alexandra"" General Hospital, Athens, Attiki, Greece|""Sotiria"" General Hospital, Athens, Attiki, Greece|Attikon"" University General Hospital, Athens, Chaidari, Greece|University General Hospital of Patras, Patra, Rio, Greece"	https://ClinicalTrials.gov/show/NCT04408209
276	NCT04381858	Convalescent Plasma vs Human Immunoglobulin to Treat COVID-19 Pneumonia	Recruiting	No Results Available	COVID-19 Pneumonia	Drug: Plasma from COVID-19 convalescent patient|Drug: Human immunoglobulin	Phase 3	Interventional	"Centenario Hospital Miguel Hidalgo, Aguascalientes, Mexico"	https://ClinicalTrials.gov/show/NCT04381858
277	NCT04417335	Reducing COVID-19 Related Hospital Admission in Elderly by BCG Vaccination	"Active, not recruiting"	No Results Available	COVID-19	Biological: BCG vaccine|Biological: Placebo	Phase 4	Interventional	"Radboud University, Nijmegen, Gelderland, Netherlands|UMC Utrecht, Utrecht, Netherlands"	https://ClinicalTrials.gov/show/NCT04417335
278	NCT04346355	Efficacy of Early Administration of Tocilizumab in COVID-19 Patients	Terminated	No Results Available	COVID-19 Pneumonia	Drug: Tocilizumab	Phase 2	Interventional	"Ospedale di Guastalla, Guastalla, RE, Italy|Azienda Unità Sanitaria Locale-IRCCS di Reggio Emilia, Reggio Emilia, RE, Italy|Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo, Alessandria, Italy|Policlinico Sant'Orsola Malpighi, Bologna, Italy|ASST Cremona, Cremona, Italy|Azienda Ospedaliera S. Croce e Carle, Cuneo, Italy|Azienda Ospedaliero Universitaria Ferrara, Ferrara, Italy|Azienda Ospedaliero Universitaria Careggi, Firenze, Italy|Ospedale Evangelico Internazionale di Genova, Genova, Italy|Azienda Sociosanitaria ASL 1 ,Imperia, Imperia, Italy|Azienda Sociosanitaria ASL 5 La Spezia, La Spezia, Italy|ASST Mantova - Ospedale Carlo Poma, Mantova, Italy|IRCCS Istituto Auxologico Italiano Milano, Milano, Italy|Azienda Ospedaliero-Universitaria ""Maggiore della Carità"" di Novara, Novara, Italy|Ospedali Riuniti Padova Sud - ULSS 6 Euganea, Padova, Italy|Azienda Ospedaliero-Universitaria Parma, Parma, Italy|Azienda Unità Sanitaria Locale di Piacenza, Piacenza, Italy|Azienda Ospedaliera Universitaria Pisana, Pisa, Italy|AO Ordine Mauriziano di Torino, Torino, Italy|ASST Bergamo Ovest -Treviglio, Treviglio, Italy|AULSS 2 Marca Trevigiana, Treviso, Italy|AULSS2 Marca Trevigiana - Ospedale Vittorio Veneto, Treviso, Italy|AULSS 3 Serenissima Ospedale ""Dell'Angelo"", Venezia, Italy|Azienda Ospedaliera Universitaria Integrata di Verona, Verona, Italy|IRCCS Sacro Cuore Don Calabria, Verona, Italy"	https://ClinicalTrials.gov/show/NCT04346355
279	NCT04448119	Control of COVID-19 Outbreaks in Long Term Care	Not yet recruiting	No Results Available	COVID-19|SARS-CoV-2	Drug: Favipiravir|Drug: Favipiravir Placebo	Phase 2	Interventional		https://ClinicalTrials.gov/show/NCT04448119
280	NCT04305106	Bevacizumab in Severe or Critically Severe Patients With COVID-19 Pneumonia-RCT	Recruiting	No Results Available	COVID-19 Pneumonia	Drug: Bevacizumab	Not Applicable	Interventional	"Qilu Hospital of Shandong University, Jinan, Shandong, China"	https://ClinicalTrials.gov/show/NCT04305106
281	NCT04315987	NestaCell® Mesenchymal Stem Cell to Treat Patients With Severe COVID-19 Pneumonia	Not yet recruiting	No Results Available	COVID-19 Pneumonia	Biological: NestaCell®|Biological: Placebo	Phase 2	Interventional	"Hospital Vera Cruz, Campinas, São Paulo, Brazil|Hospital de Barueri, São Paulo, Brazil|IncCOR, São Paulo, Brazil|UNIFESP, São Paulo, Brazil"	https://ClinicalTrials.gov/show/NCT04315987
282	NCT04374279	Trial to Promote Recovery From COVID-19 With Ivermectin or Endocrine Therapy	Not yet recruiting	No Results Available	COVID-19|SARS-CoV 2	Drug: Bicalutamide 150 Mg Oral Tablet|Drug: Ivermectin 3Mg Tab	Phase 2	Interventional	"Johns Hopkins Hospital, Baltimore, Maryland, United States"	https://ClinicalTrials.gov/show/NCT04374279
283	NCT04244591	Glucocorticoid Therapy for COVID-19 Critically Ill Patients With Severe Acute Respiratory Failure	Completed	No Results Available	COVID-19 Infections	Drug: methylprednisolone therapy|Other: Standard care	Phase 2|Phase 3	Interventional	"Medical ICU,Peking Union Medical College Hospital, Beijing, Beijing, China"	https://ClinicalTrials.gov/show/NCT04244591
284	NCT04320615	A Study to Evaluate the Safety and Efficacy of Tocilizumab in Patients With Severe COVID-19 Pneumonia	"Active, not recruiting"	No Results Available	COVID-19 Pneumonia	Drug: Tocilizumab (TCZ)|Drug: Placebo	Phase 3	Interventional	"University of California San Diego, La Jolla, California, United States|eStudySite, La Mesa, California, United States|David Geffen School of Medicine UCLA, Los Angeles, California, United States|Stanford University, Stanford, California, United States|Denver Health Medical Center, Denver, Colorado, United States|University of Miami Miller School of Medicine, Miami, Florida, United States|Rush University Medical Center, Chicago, Illinois, United States|University of Chicago, Chicago, Illinois, United States|Ochsner Clinic Foundation, Baton Rouge, Louisiana, United States|Baystate Health System, Springfield, Massachusetts, United States|Mayo Clinic - PPDS, Rochester, Minnesota, United States|Hackensack University Medical Center, Hackensack, New Jersey, United States|Robert Wood Johnson University Hospital/Rutgers, New Brunswick, New Jersey, United States|James J Peters Veterans Administration Medical Center - NAVREF, Bronx, New York, United States|Duke University Medical Center, Durham, North Carolina, United States|Cleveland Clinic Foundation; Pulmonary, Allergy & Critical Care Medicine, Cleveland, Ohio, United States|Thomas Jefferson University, Philadelphia, Pennsylvania, United States|Baylor St. Luke's Medical Center, Houston, Texas, United States|Ben Taub General Hospital - HCHD, Houston, Texas, United States|Intermountain Medical Group, Saint George, Utah, United States|Intermountain LDS Hospital, Salt Lake City, Utah, United States|Evergreen Health Infectious Disease, Kirkland, Washington, United States|Swedish Hospital Medical Center, Seattle, Washington, United States|Hamilton General Hospital; Pharmacy, Hamilton, Ontario, Canada|St. Joseph's Healthcare Hamilton, Hamilton, Ontario, Canada|University Health Network, Toronto, Ontario, Canada|Clinical Research Institute of Montreal, Montreal, Quebec, Canada|Rigshospitalet Copenhagen University Hospital, Copenhagen, Denmark|Hvidovre Hospital, Hvidovre, Denmark|Odense Universitetshospital, Odense C, Denmark|Sjællands Universitetshospital, Roskilde, Roskilde, Denmark|Centre Hospitalier Departemental de Vendee, La Roche Sur Yon, France|Centre Hospitalier et Universitaire de Limoges, Limoges, France|Hôpital de La Croix Rousse, Lyon, France|Hotel Dieu - Nantes, Nantes, France|Hopital de la Pitie Salpetriere, Paris, France|HOPITAL COCHIN university hospital, Paris, France|CHRU de Tours, Pharmacie, Tours, France|Universitatsklinikum Dusseldorf, Dusseldorf, Germany|Medizinische Hochschule Hannover, Hannover, Germany|Uniklinik Köln, Köln, Germany|LMU Klinikum der Universitat Munchen, Munchen, Germany|Azienda Ospedaliera Dei Colli, Napoli, Campania, Italy|Istituto Nazionale Malattie Infettive Lazzaro Spallanzani IRCCS, Roma, Lazio, Italy|ASST Papa Giovanni XXIII; Dipartimento Interaziendale di Farmacia Clinica, Bergamo, Lombardia, Italy|ASST Fatebenefratelli Sacco - Ospedale Luigi Sacco, Milano, Lombardia, Italy|Azienda Ospedaliera San Gerardo di Monza, Monza MI, Lombardia, Italy|Fondazione IRCCS Policlinico San Matteo di Pavia; S.S. Fisiopatologia Respiratoria, Pavia, Lombardia, Italy|Amphia Ziekenhuis, Breda, Netherlands|St. Antonius Ziekenhuis Nieuwegein, Nieuwegein, Netherlands|Erasmus MC, Rotterdam, Netherlands|Universitair Medisch Centrum Utrecht, Utrecht, Netherlands|Hospital Universitario de Bellvitge, Hospitalet de Llobregat, Barcelona, Spain|Hospital Universitari Vall d'Hebron, Barcelona, Spain|Hospital Clinic de Barcelona, Barcelona, Spain|Hospital Universitario La Paz, Madrid, Spain|Hospital Universitario Ramon y Cajal, Madrid, Spain|Hospital General Universitario Gregorio Maranon, Madrid, Spain|Hospital Universitario HM Sanchinarro-CIOCC, Madrid, Spain|Greater Glasgow and Clyde Health Board, Glasgow, United Kingdom|Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom|University College Hospital, London, United Kingdom|Royal Free Hospital, London, United Kingdom|St George's Clinical Research Facility, London, United Kingdom|Imperial College London, London, United Kingdom|North Manchester General Hospital, Manchester, United Kingdom|Salford Royal Hospital, Salford, United Kingdom"	https://ClinicalTrials.gov/show/NCT04320615
285	NCT04363866	A Pilot Study to Assess Hydroxychloroquine in Patients With SARS-CoV-2 (COVID-19)	Not yet recruiting	No Results Available	COVID-19|SARS-CoV-2	Drug: Hydroxychloroquine|Drug: Placebo	Phase 4	Interventional	"Oregon Health and Science University, Portland, Oregon, United States"	https://ClinicalTrials.gov/show/NCT04363866
286	NCT04407130	Efficacy and Safety of Ivermectin and Doxycycline in Combination or IVE Alone in Patients With COVID-19 Infection.	Enrolling by invitation	No Results Available	COVID-19 Patients	Drug: Ivermectin + Doxycycline + Placebo|Drug: Ivermectin + Placebo|Drug: Placebo	Phase 2	Interventional	"Icddr,B, Dhaka, Bangladesh"	https://ClinicalTrials.gov/show/NCT04407130
287	NCT04372186	A Study to Evaluate the Efficacy and Safety of Tocilizumab in Hospitalized Participants With COVID-19 Pneumonia	Recruiting	No Results Available	COVID-19 Pneumonia	Drug: Placebo|Drug: Tocilizumab	Phase 3	Interventional	"Banner - University Medical Center Phoenix; In-Patient Pharmacy, Phoenix, Arizona, United States|Univ of AZ Coll of Med, Tucson, Arizona, United States|Scripps Mercy Hospital, Chula Vista, California, United States|El Centro Regional Medical Center, El Centro, California, United States|Harper University Hospital, Fountain Valley, California, United States|eStudySite, La Mesa, California, United States|Riverside University Health System-Medical Center, Moreno Valley, California, United States|Highland Hospital Oakland, Oakland, California, United States|St. Joseph'S Hospital, Orange, California, United States|Desert Regional Medical Center, Palm Springs, California, United States|San Leandro Hospital; Inpatient Pharmacy, San Leandro, California, United States|Poudre Valley Hospital, Fort Collins, Colorado, United States|UCHealth Greeley Hospital, Greeley, Colorado, United States|Medical Center of The Rockies, Loveland, Colorado, United States|Yale University School Of Medicine, New Haven, Connecticut, United States|Howard University, Washington, District of Columbia, United States|Suncoast Research Associates LLC - ERN - PPDS, Doral, Florida, United States|Miami Veterans Administration Healthcare System - NAVREF, Miami, Florida, United States|University of Miami Pulmonary, Miami, Florida, United States|Westchester General Hospital, Miami, Florida, United States|Larkin Community Hospital, South Miami, Florida, United States|Emory University, Atlanta, Georgia, United States|Columbus Regional Research Institute, Columbus, Georgia, United States|St. Lukes Boise Medical Center, Boise, Idaho, United States|Uni of Kansas Medical Center, Kansas City, Kansas, United States|Ochsner Clinic, New Orleans, Louisiana, United States|LSU-Shreveport, Shreveport, Louisiana, United States|Holy Cross Germantown Hospital, Germantown, Maryland, United States|Holy Cross Hospital, Silver Spring, Maryland, United States|Detroit Receiving Hospital, Detroit, Michigan, United States|Henry Ford Health System, Detroit, Michigan, United States|Sinai Grace Hospital, Detroit, Michigan, United States|Optum Health Care, Las Vegas, Nevada, United States|St. Joseph'S Regional Medical Center, Paterson, New Jersey, United States|San Juan Oncology Associates, Farmington, New Mexico, United States|St. Barnabas Hospital, Bronx, New York, United States|Kings County Hospital Center, Brooklyn, New York, United States|SUNY Downstate Medical Center., Brooklyn, New York, United States|Elmhurst Hospital Center, Elmhurst, New York, United States|Flushing Hospital, Flushing, New York, United States|Jamaica Hospital Medical Center, Jamaica, New York, United States|NYC Health and Hospitals Queens, Jamaica, New York, United States|Harlem Hospital, New York, New York, United States|Canton-Potsdam Hospital, Potsdam, New York, United States|Novant Health Presbyterian Medical Center (Presbyterian Hospital), Charlotte, North Carolina, United States|Cape Fear Valley Medical Center, Fayetteville, North Carolina, United States|Novant Health Rowan Medical Center, Salisbury, North Carolina, United States|Novant Health Foryth Medical Center, Winston-Salem, North Carolina, United States|Temple University Hospital, Philadelphia, Pennsylvania, United States|Sanford Health System, Sioux Falls, South Dakota, United States|JPS Health Network, Fort Worth, Texas, United States|Valley Baptist Medical Center, Harlingen, Texas, United States|Michael E Debakey VA Medical Center, Houston, Texas, United States|McAllen Medical Center, McAllen, Texas, United States|Crossroads Clinical Research, LLC, Victoria, Texas, United States|Froedtert and The Medical College of Wisconsin, Milwaukee, Wisconsin, United States|Aga Khan University Hospital, Nairobi, Kenya|Organismo Publico Descentralizado Hospital Juarez de Mexico, Ciudad De México, Mexico|Hospital General de Culiacan, Culiacan, Mexico|Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Mexico, Mexico|Hospital Militar Central, Jesus Maria, Peru|Hospital Nacional Dos de Mayo, Lima, Peru|University of the Free State, Bloemfontein, South Africa|George Provincial Hospital, George, South Africa|Mzansi Ethical Research Centre, Middelburg, South Africa|Milpark Hospital, Parktown West, South Africa|University of Stellenbosch; Respiratory Research, Parow, South Africa|Phoenix Pharma, Port Elizabeth, South Africa"	https://ClinicalTrials.gov/show/NCT04372186
288	NCT04382625	Hydroxychloroquine in SARS-CoV-2 (COVID-19) Pneumonia Trial	Not yet recruiting	No Results Available	SARS-CoV-2 Pneumonia|COVID-19	Drug: Hydroxychloroquine	Phase 4	Interventional	"Kootenai Health, Coeur d'Alene, Idaho, United States"	https://ClinicalTrials.gov/show/NCT04382625
289	NCT04329650	Efficacy and Safety of Siltuximab vs. Corticosteroids in Hospitalized Patients With COVID-19 Pneumonia	Recruiting	No Results Available	COVID-19	Drug: Siltuximab|Drug: Methylprednisolone	Phase 2	Interventional	"Hospital Germans Trias i Pujol, Badalona, Spain|Hospital Clínic de Barcelona, Barcelona, Spain|Hospital Universitario de Salamanca, Salamanca, Spain|Hospital Universitari Mútua de Terrassa, Terrassa, Spain"	https://ClinicalTrials.gov/show/NCT04329650
290	NCT04331470	Evaluation of Efficacy of Levamisole and Formoterol+Budesonide in Treatment of COVID-19	Recruiting	No Results Available	COVID-19	Drug: Levamisole Pill + Budesonide+Formoterol inhaler|Drug: Lopinavir/Ritonavir + hydoxychloroquine	Phase 2|Phase 3	Interventional	"Vali-Asr Hospital, Fasa, Fars, Iran, Islamic Republic of"	https://ClinicalTrials.gov/show/NCT04331470
291	NCT04386616	A Study to Evaluate the Safety and Efficacy of MSTT1041A (Astegolimab) or UTTR1147A in Patients With Severe COVID-19 Pneumonia	Recruiting	No Results Available	COVID-19 Pneumonia	Drug: MSTT1041A|Drug: MSTT1041A-matched Placebo|Drug: UTTR1147A|Drug: UTTR1147A-matched Placebo	Phase 2	Interventional	"eStudySite - Chula Vista - PPDS, Chula Vista, California, United States|eStudySite, La Mesa, California, United States|Torrance Memorial Medcal Center, Torrance, California, United States|MedPharmics, Metairie, Louisiana, United States|Southeast Louisiana Veterans Health Care System - NAVREF, New Orleans, Louisiana, United States|Henry Ford Health System, Detroit, Michigan, United States|St. Joseph'S Regional Medical Center, Paterson, New Jersey, United States|Albany Medical Center, Albany, New York, United States|Lincoln Medical Mental Health Center, Bronx, New York, United States|Staten Island University Hospital; Department of Pharmacy, Staten Island, New York, United States|Cape Fear Valley Health System, Fayetteville, North Carolina, United States|Mercy St. Vincent Medical Center, Toledo, Ohio, United States|Lehigh Valley Health Network, Allentown, Pennsylvania, United States|Temple Uni Medical Center; Pulmonary & Critical Care Medicine, Philadelphia, Pennsylvania, United States|Parkland Health & Hospital System, Dallas, Texas, United States|University of Texas Southwestern Medical Center, Dallas, Texas, United States|Virginia Commonwealth University, Richmond, Virginia, United States|Virginia Mason Medical Center, Seattle, Washington, United States|MultiCare Institute for Research and Innovation; Clinic/Outpatient Facility, Tacoma, Washington, United States"	https://ClinicalTrials.gov/show/NCT04386616
292	NCT04363736	A Study to Investigate Intravenous Tocilizumab in Participants With Moderate to Severe COVID-19 Pneumonia	"Active, not recruiting"	No Results Available	COVID-19 Pneumonia	Drug: Tociliuzumab	Phase 2	Interventional	"Mayo Clinic - Arizona, Phoenix, Arizona, United States|St. Jude Medical Center, Fullerton, California, United States|LAC + USC Medical Center, Los Angeles, California, United States|USC Keck Medical Center of USC, Los Angeles, California, United States|Norwalk Hospital, Norwalk, Connecticut, United States|Medstar Georgetown University Hospital, Washington, District of Columbia, United States|University of Florida; Health Science Center, Jacksonville, Florida, United States|Mayo Clinic, Jacksonville, Florida, United States|Advocate Christ Medical Center, Oak Lawn, Illinois, United States|Advocate Lutheran General Hospital, Park Ridge, Illinois, United States|MedPharmics, Metairie, Louisiana, United States|University of Maryland, Baltimore, Maryland, United States|Renown Institute for Heart & Vascular Health, Reno, Nevada, United States|St Joseph's Regional Medical Center, Wayne, New Jersey, United States|SUNY Downstate Medical Center., Brooklyn, New York, United States|Jamaica Hospital Medical Center, Jamaica, New York, United States|Vassar Brothers Medical Center, Poughkeepsie, New York, United States|Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States|University Hospitals Cleveland Medical Center, Cleveland, Ohio, United States|Mercy St. Vincent Medical Center, Toledo, Ohio, United States|Lehigh Valley Health Network, Allentown, Pennsylvania, United States|Temple University Hospital, Philadelphia, Pennsylvania, United States|Allegheny Health Network (Pittsburg PA), Pittsburgh, Pennsylvania, United States|Medical University of South Carolina, Charleston, South Carolina, United States|Houston Methodist Hospital, Houston, Texas, United States|Michael E. DeBakey VA Medical Center, Houston, Texas, United States|Houston Methodist Sugar Land Hospital, Sugar Land, Texas, United States"	https://ClinicalTrials.gov/show/NCT04363736
293	NCT04417257	Study of LAU-7b for the Treatment of COVID-19 Disease in Adults	Recruiting	No Results Available	COVID-19 Disease	Drug: LAU-7b|Drug: Placebo oral capsule	Phase 2	Interventional	"St-Paul's Hospital, Vancouver, British Columbia, Canada|Centre d'études cliniques CIUSS SLJ, Hôpital Chicoutimi, Chicoutimi, Quebec, Canada|CIUSSSS de l'Est-de-l'Ile-de-Montréal, Hôpital Maisonneuve-Rosemont, Montréal, Quebec, Canada|Centre Hospitalier de l'Université de Montréal, Montréal, Quebec, Canada|McGill University Health Centre, Montréal, Quebec, Canada|CISSS Ds Laurentides, Saint-Jérôme, Quebec, Canada"	https://ClinicalTrials.gov/show/NCT04417257
294	NCT04455815	A Trial Looking at the Use of Camostat to Reduce Progression of Symptoms of Coronavirus (COVID-19) in People Who Have Tested Positive But Are Able to Stay at Home	Not yet recruiting	No Results Available	COVID-19 Infection	Drug: Camostat	Phase 2|Phase 3	Interventional	"The University of Edinburgh, Edinburgh, United Kingdom|Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom"	https://ClinicalTrials.gov/show/NCT04455815
295	NCT04353596	Stopping ACE-inhibitors in COVID-19	Recruiting	No Results Available	SARS-CoV-2|COVID-19	"Drug: ACE inhibitor, angiotensin receptor blocker"	Phase 4	Interventional	"Medical University Innsbruck, University Hospital of Internal Medicine III, Innsbruck, Tyrol, Austria|Landeskrankenhaus Hall, Hall In Tirol, Austria|Medical University Innsbruck, Intensive Care and Emergency Medicine Department, Innsbruck, Austria|Medical University Innsbruck, University Hospital of Internal Medicine II, Innsbruck, Austria|Medical University Innsbruck, University Hospital of Internal Medicine IV, Innsbruck, Austria|Medical University Innsbruck, University Hospital of Internal Medicine I, Innsbruck, Austria|Medical University Innsbruck, University Hospital of Internal Medicine V, Innsbruck, Austria|Klinikum Klagenfurt, Klagenfurt, Austria|Bezirkskrankenhaus Kufstein, Kufstein, Austria|Bezirkskrankenhaus St. Johann, Sankt Johann In Tirol, Austria|Bezirkskrankenhaus Schwaz, Schwaz, Austria|Krankenhaus St. Vinzenz Zams, Zams, Austria|LMU Klinikum, Medizinische Klinik I, Munich, Bavaria, Germany|Asklepios Stadtklinik Bad Tölz, Bad Tölz, Germany|Klinikum Landkreis Erding, Erding, Germany|Klinikum Memmingen, Memmingen, Germany|Deutsches Herzzentrum München, Munich, Germany|Klinikum rechts der Isar, Medizinische Klinik und Poliklinik I, Munich, Germany|LMU Klinikum, Medizinische Klinik III, Munich, Germany|LMU Klinikum, Medizinische Klinik II, Munich, Germany|LMU Klinikum, Medizinische Klinik IV, Munich, Germany|München Klinik Bogenhausen und Schwabing, Munich, Germany|Universitätsklinik der Paracelsus Medizinischen Privatuniversität, Nürnberg, Germany|Klinikum Starnberg, Starnberg, Germany|Klinik für Innere Medizin Weilheim, Weilheim, Germany"	https://ClinicalTrials.gov/show/NCT04353596
296	NCT04358809	"Clinical Trial of Mycobacterium w in COVID-19 Positive Patients, Hospitalized But Not Critically Ill"	Not yet recruiting	No Results Available	COVID-19	Drug: Suspension of heat killed (autoclaved) Mycobacterium w|Other: Placebo	Phase 3	Interventional		https://ClinicalTrials.gov/show/NCT04358809
297	NCT04394117	Controlled evaLuation of Angiotensin Receptor Blockers for COVID-19 respIraTorY Disease	Recruiting	No Results Available	SARS-Cov-2|COVID-19	Drug: Angiotensin Receptor Blockers	Phase 4	Interventional	"Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia|Canterbury Hospital, Campsie, New South Wales, Australia|Concord Hospital, Concord, New South Wales, Australia|St George Hospital, Kogarah, New South Wales, Australia|Prince of Wales Hospital, Randwick, New South Wales, Australia|Royal North Shore Hospital, St Leonards, New South Wales, Australia"	https://ClinicalTrials.gov/show/NCT04394117
298	NCT04409262	A Study to Evaluate the Efficacy and Safety of Remdesivir Plus Tocilizumab Compared With Remdesivir Plus Placebo in Hospitalized Participants With Severe COVID-19 Pneumonia	Recruiting	No Results Available	COVID-19 Pneumonia	Drug: Remdesivir|Drug: Tocilizumab|Drug: Placebo	Phase 3	Interventional	"Valleywise Health Medical Center, Phoenix, Arizona, United States|eStudySite - Chula Vista - PPDS, Chula Vista, California, United States|Hoag Hospital Irvine, Irvine, California, United States|Providence St. John's Health Center, Santa Monica, California, United States|Holy Cross Hospital Inc, Fort Lauderdale, Florida, United States|University of Miami Miller School of Medicine; Clinical Reseach Building, Miami, Florida, United States|St Luke's Health System; Rheumatology Research, Boise, Idaho, United States|Rush University Medical Center, Chicago, Illinois, United States|Ochsner Clinic Foundation, New Orleans, Louisiana, United States|Louisiana State University Health Sciences Center/Ochsner, Shreveport, Louisiana, United States|University of Maryland School of Medicine, Baltimore, Maryland, United States|Boston Medical Center, Boston, Massachusetts, United States|Baystate Medical Center, Springfield, Massachusetts, United States|Henry Ford Hospital, Detroit, Michigan, United States|Saint Elizabeth Regional Medical Center, Lincoln, Nebraska, United States|Hackensack University Medical Center, Hackensack, New Jersey, United States|St. Michael'S Medical Center, Newark, New Jersey, United States|Wyckoff Heights Medical Center, Staten Island, New York, United States|Novant Health Clinical Research, Charlotte, North Carolina, United States|Cone Health Medical Group, Greensboro, North Carolina, United States|OhioHealth Research Institute, Columbus, Ohio, United States|Thomas Jefferson University, Philadelphia, Pennsylvania, United States|Allegheny Health Network (Pittsburg PA), Pittsburgh, Pennsylvania, United States|Baylor St. Luke's Medical Center, Houston, Texas, United States|Intermountain LDS Hospital, Salt Lake City, Utah, United States|The Providence Regional Medical Center Everett, Everett, Washington, United States|West Virginia University Hospital, Morgantown, West Virginia, United States|Santa Casa de Misericordia de Belo Horizonte, Belo Horizonte, MG, Brazil|Instituto de Pesquisa Clinica Evandro Chagas - IPEC FIOCRUZ, Rio de Janeiro, RJ, Brazil|Faculdade de Medicina do ABC - FMABC, Santo Andre, SP, Brazil|Instituto de Infectologia Emilio Ribas, Sao Paulo, SP, Brazil|Instituto do Coração - HCFMUSP, Sao Paulo, SP, Brazil"	https://ClinicalTrials.gov/show/NCT04409262
299	NCT04273529	The Efficacy and Safety of Thalidomide in the Adjuvant Treatment of Moderate New Coronavirus (COVID-19) Pneumonia	Not yet recruiting	No Results Available	COVID-19 Thalidomide	Drug: thalidomide|Drug: placebo	Phase 2	Interventional		https://ClinicalTrials.gov/show/NCT04273529
300	NCT04273581	The Efficacy and Safety of Thalidomide Combined With Low-dose Hormones in the Treatment of Severe COVID-19	Not yet recruiting	No Results Available	COVID-19 Thalidomide	Drug: placebo|Drug: Thalidomide	Phase 2	Interventional		https://ClinicalTrials.gov/show/NCT04273581
301	NCT04328441	Reducing Health Care Workers Absenteeism in Covid-19 Pandemic Through BCG Vaccine	Recruiting	No Results Available	COVID-19	Drug: BCG Vaccine|Drug: Placebo	Phase 3	Interventional	"Jeroen Bosch ziekenhuis, Den Bosch, Brabant, Netherlands|Canisius Wilhelmina Ziekenhuis, Nijmegen, Gelderland, Netherlands|Radboud UMC, Nijmegen, Gelderland, Netherlands|Sint Maartenskliniek, Nijmegen, Gelderland, Netherlands|Noordwest Ziekenhuisgroep locatie Alkmaar, Alkmaar, Noord Holland, Netherlands|Hagaziekenhuis, Den Haag, Zuid-Holland, Netherlands|Leiden University Medical Center, Leiden, Zuid-Holland, Netherlands|Erasmus Medical Center, Rotterdam, Zuid-Holland, Netherlands|University Medical Center Utrecht, Utrecht, Netherlands"	https://ClinicalTrials.gov/show/NCT04328441
302	NCT04374032	Clinical Trial to Evaluate the Efficacy and Safety of an Immunomodulatory Therapy for the Treatment of Patients With Moderate to Severe COVID-19 Infection	Recruiting	No Results Available	COVID-19 Infection	Drug: metenkefalin + tridecactide|Drug: The standard of care	Phase 2|Phase 3	Interventional	"Clinical Center University of Sarajevo, Sarajevo, Sarajevo Canton, Bosnia and Herzegovina"	https://ClinicalTrials.gov/show/NCT04374032
303	NCT04425460	"A Multi-center,Randomized,Double-blind,Placebo-controlled,Phase 3 Study Evaluating Favipiravir in Treatment of COVID19"	Not yet recruiting	No Results Available	COVID-19	Drug: Favipiravir|Other: Placebo	Phase 3	Interventional	"The First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Shangcheng District, China|Peking University First Hospital, Beijing, Xicheng District, China|Department of Internal Medicine Pneumology and infectious diseases Neukölln Clinic, Berlin, Germany|Medical clinic and polyclinic IV Hospital of the University of Munich, München, Germany|Infectious Diseases Hospital Cluj-Napoca, Cluj-Napoca, Cluj, Romania|National Institute of Infectious Diseases ""Prof.Dr.Matei Bals"", Bucharest, Ilfov, Romania|""Dr.Victor Babes"" Infectious Diseases and Pneumoftiziology Clinical Hospital Timisoara, Timisoara, Timis, Romania|""Dr.Victor Babes"" Infectious Diseases and Pneumoftiziology Clinical Hospital Timisoara, Timişoara, Timis, Romania|Dr.Victor Babes Infectious Diseases and Pneumoftiziology Clinical Hospital Timisoara, Timişoara, Timis, Romania|Emergency County Hospital ""Pius Brinzeu""Timisoara, Timişoara, Timis, Romania"	https://ClinicalTrials.gov/show/NCT04425460
304	NCT04354870	COVID-19 PrEP HCW HCQ Study	Recruiting	No Results Available	COVID-19	Drug: Hydroxychloroquine (HCQ)	Phase 2	Interventional	"NYU Langone Health, New York, New York, United States"	https://ClinicalTrials.gov/show/NCT04354870
305	NCT04402892	COVID-19: SARS-CoV-2 Specific Memory B and T-CD4+ Cells	Not yet recruiting	No Results Available	COVID-19|SARS-CoV-2 Infection	"Other: 35 ml blood, 5 tubes LITHIUM HEPARINATE at each time (hospitalized Patients )|Other: 35 ml blood, 5 tubes LITHIUM HEPARINATE at each time (cured Patients)"	Not Applicable	Interventional		https://ClinicalTrials.gov/show/NCT04402892
306	NCT04345679	Anti COVID-19 Convalescent Plasma Therapy	Not yet recruiting	No Results Available	COVID 19	Biological: anti-SARS-CoV-2 convalescent plasma	Early Phase 1	Interventional		https://ClinicalTrials.gov/show/NCT04345679
307	NCT04428268	Chloroquine + Losartan Compared to Chloroquine Alone for the Treatment of COVID-19 Pneumonia	Recruiting	No Results Available	COVID-19 Pneumonia	Drug: Chloroquine Phosphate Tablets	Phase 2	Interventional	"Hospital Universitario José E. Gonzalez, Monterrey, Nuevo Leon, Mexico"	https://ClinicalTrials.gov/show/NCT04428268
308	NCT04414098	Ruxolitinib in the Treatment of Covid-19	Not yet recruiting	No Results Available	COVID-19	Drug: INC424 / Ruxolitinib	Phase 2	Interventional		https://ClinicalTrials.gov/show/NCT04414098
309	NCT04449380	Clinical Study for the Treatment With Interferon-ß-1a (IFNß-1a) of COVID-19 Patients	Not yet recruiting	No Results Available	COVID-19 Virus Infection	Drug: Interferon-ß-1a|Combination Product: Standard of Care (SOC)	Phase 2	Interventional	"IRCCS Ospedale San Raffaele, Milano, Italy"	https://ClinicalTrials.gov/show/NCT04449380
310	NCT04376593	PET/CT Imaging in COVID-19 Patients	Enrolling by invitation	No Results Available	COVID-19|SARS-CoV-2 Infection	Drug: 18F-αvβ6-BP	Early Phase 1	Interventional	"University of California Davis, Sacramento, California, United States"	https://ClinicalTrials.gov/show/NCT04376593
311	NCT04342221	Hydroxychloroquine for COVID-19	Recruiting	No Results Available	"COVID-19, Hydroxychloroquine Sulfate"	Drug: Hydroxychloroquine Sulfate|Drug: Placebo	Phase 3	Interventional	"Zollernalb Klinikum Balingen, Balingen, Germany|Klinikum Darmstadt, Darmstadt, Germany|Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany|Johannes Wesling Klinikum Minden, Minden, Germany|Klinikum am Steinenberg, Reutlingen, Germany|Robert-Bosch-Krankenhaus, Stuttgart, Germany|Institute for Tropical Medicine, Tübingen, Germany"	https://ClinicalTrials.gov/show/NCT04342221
312	NCT04355533	Immunity Against SARS-CoV2 in Children and Their Parents / COVID-19	Not yet recruiting	No Results Available	COVID-19 Infection	Biological: serology test|Diagnostic Test: NG Biotech|Biological: nasopharyngeal swab|Biological: rectal swab|Biological: saliva sample	Not Applicable	Interventional	"Hôpital necker Enfants-Malades, ¨Paris, France"	https://ClinicalTrials.gov/show/NCT04355533
313	NCT04382729	Neuromuscular Electrical Stimulation in Patients With COVID19 Associated Pneumonia	Recruiting	No Results Available	COVID-19 Pneumonia	Other: Neuromuscular Electrical Stimulation|Other: Physical Therapy Exercise	Not Applicable	Interventional	"San Luigi Gonzaga Hospital, Orbassano, TO, Italy"	https://ClinicalTrials.gov/show/NCT04382729
314	NCT04315896	Hydroxychloroquine Treatment for Severe COVID-19 Pulmonary Infection (HYDRA Trial)	Recruiting	No Results Available	COVID-19|Severe Acute Respiratory Syndrome	Drug: Hydroxychloroquine|Drug: Placebo oral tablet	Phase 3	Interventional	"Instituto Nacional de Enfermedades Respiratorias, ""Ismael Cosío Villegas"", Mexico, City, Mexico"	https://ClinicalTrials.gov/show/NCT04315896
315	NCT04411680	Study of Sargramostim in Patients With COVID-19	Not yet recruiting	No Results Available	COVID-19|Sars-CoV2	Drug: Sargramostim|Drug: Standard of care	Phase 2	Interventional		https://ClinicalTrials.gov/show/NCT04411680
316	NCT04325061	Efficacy of Dexamethasone Treatment for Patients With ARDS Caused by COVID-19	Recruiting	No Results Available	Acute Respiratory Distress Syndrome Caused by COVID-19	Drug: Dexamethasone	Phase 4	Interventional	"ICU, Hospital Universitari Mutua Terrassa, Terrassa, Barcelona, Spain|Hospital Universitario Dr. Negrin, Las Palmas de Gran Canaria, Las Palmas, Spain|Department of Anesthesia, Hospital Universitario de Cruces, Barakaldo, Vizcaya, Spain|Intensive Care Unit, Hospital Universitario de Cruces, Barakaldo, Vizcaya, Spain|AVI, Hospital Clinic, Barcelona, Spain|Cardiac ICU, Hospital Clinic, Barcelona, Spain|Department of Anesthesia, Hospital Clinic, Barcelona, Spain|Hepatic ICU, Hospital Clínic, Barcelona, Spain|UVIR, Hospital Clinic, Barcelona, Spain|Intensive Care Unit, Hospital General de Ciudad Real, Ciudad Real, Spain|Department of Anesthesia, Hospital Universitario La Princesa, Madrid, Spain|Intensive Care Unit, Hospital Universitario La Princesa, Madrid, Spain|Intensive Care Unit, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain|Department of Anesthesia, Hospital Universitario La Paz, Madrid, Spain|Intensive Care Unit, Hospital Universitario La Paz, Madrid, Spain|Department of Anesthesia, Hospital Universitario Virgen de Arrixaca, Murcia, Spain|Intensive Care Unit, Hospital Universitario Virgen de la Arrixaca, Murcia, Spain|Department of Anesthesia, Hospital Unversitario Montecelo, Pontevedra, Spain|Anesthesia, Hospital General Universitario de Valencia, Valencia, Spain|Department of Anesthesia, Hospital Clinico Universitario, Valencia, Spain|Intensive Care Unit, Hospital Clinico Universitario, Valencia, Spain|Department of Anesthesia, Hospital Clínico Universitario, Valladolid, Spain|Anesthesia, Hospital Universitario Río Hortega, Valladolid, Spain|Intensive Care Unit, Hospital Universitario Río Hortega, Valladolid, Spain"	https://ClinicalTrials.gov/show/NCT04325061
317	NCT04368000	Prone Positioning in Awake Patients With COVID-19 Requiring Hospitalization	Recruiting	No Results Available	Respiratory Failure|COVID-19	Behavioral: Intermittent prone positioning instructions|Behavioral: Usual care positioning with no instructions	Not Applicable	Interventional	"University of Utah Health Sciences Center, Salt Lake City, Utah, United States"	https://ClinicalTrials.gov/show/NCT04368000
318	NCT04413838	Efficiency and Security of NIVOLUMAB Therapy in Obese Individuals With COVID-19(COrona VIrus Disease) Infection	Not yet recruiting	No Results Available	"Obesity, COVID-19 Infection"	Drug: NIVOLUMAB|Other: Routine standard of care	Phase 2	Interventional	"Hôpital Lyon Sud Service Endocrinologie, Diabète et Nutrition, Pierre-Bénite, France"	https://ClinicalTrials.gov/show/NCT04413838
319	NCT04335201	Defibrotide in COVID-19 Pneumonia	Not yet recruiting	No Results Available	Patients With COVID-19 Pneumonia Will Allow to Detect an Absolute Reduction in the Rate of Respiratory-failure	Drug: Defibrotide Injection	Phase 2	Interventional		https://ClinicalTrials.gov/show/NCT04335201
320	NCT04429724	Health Professional Exposure Assessment to Covid-19	Not yet recruiting	No Results Available	COVID-19	Diagnostic Test: Diagnostic test Covid-19	Not Applicable	Interventional		https://ClinicalTrials.gov/show/NCT04429724
321	NCT04445285	Phase 2 Trial Using rhDNase to Reduce Mortality in COVID-19 Patients With Respiratory Failure	Recruiting	No Results Available	Covid19	Drug: Pulmozyme/ Recombinant human deoxyribonuclease (rh-DNase)|Drug: 0.9%sodium chloride	Phase 2	Interventional	"University of South Alabama, Mobile, Alabama, United States"	https://ClinicalTrials.gov/show/NCT04445285
322	NCT04350476	COVID-19 Remote Monitoring	Not yet recruiting	No Results Available	COVID-19|Cardiac Arrhythmias	Diagnostic Test: VitalConnect Vital Sign Patch	Not Applicable	Interventional	"Icahn School of Medicine at Mount Sinai, New York, New York, United States"	https://ClinicalTrials.gov/show/NCT04350476
323	NCT04385017	Role of Inflammasomes in COVID-19 Disease	Recruiting	No Results Available	COVID-19 by SARS-CoV-2 Infection	Other: COVID-19 patients	Not Applicable	Interventional	"Ch Cannes, Réanimation, Cannes, Alpes Maritimes, France|CHU de nice, Nice, Alpes-Maritimes, France"	https://ClinicalTrials.gov/show/NCT04385017
324	NCT04280588	Fingolimod in COVID-19	Recruiting	No Results Available	Coronavirus Disease (COVID-19)	Drug: Fingolimod 0.5 mg	Phase 2	Interventional	"Wan-Jin Chen, Fuzhou, China"	https://ClinicalTrials.gov/show/NCT04280588
325	NCT04412538	Safety and Immunogenicity Study of an Inactivated SARS-CoV-2 Vaccine for Preventing Against COVID-19	Recruiting	No Results Available	COVID-19	Biological: Low dosage Inactivated SARS-CoV-2 Vaccine on a 0- and 28-day schedule|Biological: Low dosage Inactivated SARS-CoV-2 Vaccine on a 0- and 14-day schedule|Biological: Medium dosage Inactivated SARS-CoV-2 Vaccine on a 0- and 28-day schedule|Biological: Medium dosage Inactivated SARS-CoV-2 Vaccine on a 0- and 14-day schedule|Biological: High dosage Inactivated SARS-CoV-2 Vaccine on a 0- and 28-day schedule|Biological: High dosage Inactivated SARS-CoV-2 Vaccine on a 0- and 14-day schedule|Biological: Placebo on a 0- and 28-day schedule|Biological: Placebo on a 0- and 14-day schedule	Phase 1|Phase 2	Interventional	"West China Second University Hospital, Sichuan University / West China women's and children's Hospital, Chengdu, Sichuan, China"	https://ClinicalTrials.gov/show/NCT04412538
326	NCT04368728	"Study to Describe the Safety, Tolerability, Immunogenicity, and Potential Efficacy of RNA Vaccine Candidates Against COVID-19 in Healthy Adults"	Recruiting	No Results Available	SARS-CoV-2 Infection|COVID-19	Biological: BNT162a1|Biological: BNT162b1|Biological: BNT162b2|Biological: BNT162c2|Other: Placebo	Phase 1|Phase 2	Interventional	"Diablo Clinical Research, Inc., Walnut Creek, California, United States|Research Centers of America, Hollywood, Florida, United States|Clinical Neuroscience Solutions, Inc, Orlando, Florida, United States|Meridian Clinical Research, LLC, Savannah, Georgia, United States|Clinical Research Atlanta, Stockbridge, Georgia, United States|Kentucky Pediatric/ Adult Research, Bardstown, Kentucky, United States|University of Maryland, Center for Vaccine Development and Global Health, Baltimore, Maryland, United States|Boston Medical Center, Boston, Massachusetts, United States|Investigational Pharmacy Service, Boston, Massachusetts, United States|Sundance Clinical Research, LLC, Saint Louis, Missouri, United States|Meridian Clinical Research, LLC, Norfolk, Nebraska, United States|Quality Clinical Research, Inc., Omaha, Nebraska, United States|NYU Langone Health, New York, New York, United States|Rochester Clinical Research, Inc., Rochester, New York, United States|Rochester Regional Health/Rochester General Hospital, Rochester, New York, United States|M3 Wake Research, Inc., Raleigh, North Carolina, United States|PMG Research of Wilmington, LLC, Wilmington, North Carolina, United States|Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States|Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States|Aventiv Research Inc., Columbus, Ohio, United States|Benchmark Research, Austin, Texas, United States|Ventavia Research Group, LLC, Fort Worth, Texas, United States|Texas Center For Drug Development, Inc., Houston, Texas, United States|J. Lewis Research, Inc. / Foothill Family Clinic, Salt Lake City, Utah, United States|J. Lewis Research, Inc. / Foothill Family Clinic South, Salt Lake City, Utah, United States"	https://ClinicalTrials.gov/show/NCT04368728
327	NCT04435808	Efficacy of Hydroxychloroquine Prophylaxis for Health Care Workers at High Risk for COVID-19	Recruiting	No Results Available	COVID-19	Drug: Hydroxychloroquine	Phase 1|Phase 2	Interventional	"University of New Mexico Health Sciences Center, Albuquerque, New Mexico, United States"	https://ClinicalTrials.gov/show/NCT04435808
328	NCT04382651	Study of Efficacy and Safety of MAS825 in Patients With COVID-19	Recruiting	No Results Available	"COVID-19 Pneumonia, Impaired Respiratory Function"	Drug: MAS825|Drug: Matching placebo	Phase 2	Interventional	"Novartis Investigative Site, Chula Vista, California, United States|Novartis Investigative Site, La Mesa, California, United States|Novartis Investigative Site, Mission Hills, California, United States|Novartis Investigative Site, Santa Monica, California, United States|Novartis Investigative Site, Torrance, California, United States|Novartis Investigative Site, Columbus, Ohio, United States"	https://ClinicalTrials.gov/show/NCT04382651
329	NCT04359680	Trial to Evaluate the Efficacy and Safety of Nitazoxanide (NTZ) for Post Exposure Prophylaxis of COVID-19 and Other Viral Respiratory Illnesses (VRI) in Healthcare Workers	Recruiting	No Results Available	COVID-19|Viral Respiratory Illnesses	Drug: Nitazoxanide|Drug: Placebo|Dietary Supplement: Vitamin Super B-Complex	Phase 3	Interventional	"Clinical Neuroscience Solutions, Inc., Orlando, Florida, United States|Integrative Clinical Trials LLC, Brooklyn, New York, United States|Centex Studies, Inc., Houston, Texas, United States"	https://ClinicalTrials.gov/show/NCT04359680
330	NCT04383574	Safety and Immunogenicity Study of Inactivated Vaccine for Prevention of SARS-CoV-2 Infection(COVID-19)	Not yet recruiting	No Results Available	COVID-19	"Biological: Two doses of low dosage inactivated SARS-CoV-2 vaccine at the schedule of day 0,28|Biological: Two doses of medium dosage inactivated SARS-CoV-2 vaccine at the schedule of day 0,28|Biological: Two doses of high dosage inactivated SARS-CoV-2 vaccine at the schedule of day 0,28|Other: Two doses of placebo at the schedule of day 0,28"	Phase 1|Phase 2	Interventional	"Renqiu City Center for Disease Control and Prevention, Renqiu, Hebei, China"	https://ClinicalTrials.gov/show/NCT04383574
331	NCT04352608	Safety and Immunogenicity Study of Inactivated Vaccine for Prophylaxis of SARS CoV-2 Infection (COVID-19)	Recruiting	No Results Available	COVID-19	Biological: Two doses of medium dosage inactivated SARS-CoV-2 vaccine at the emergency vaccination schedule|Biological: Two doses of high dosage inactivated SARS-CoV-2 vaccine at the emergency vaccination schedule|Biological: Two doses of placebo at the emergency vaccination schedule|Biological: Two doses of medium dosage inactivated SARS-CoV-2 vaccine at the routine vaccination schedule|Biological: Two doses of high dosage inactivated SARS-CoV-2 vaccine at the routine vaccination schedule|Biological: Two doses of placebo at the routine vaccination schedule	Phase 1|Phase 2	Interventional	"Suining County Center for Disease Control and Prevention, Xuzhou, Jiangsu, China"	https://ClinicalTrials.gov/show/NCT04352608
332	NCT04338074	TXA and Corona Virus 2019 (COVID19) in Outpatients	Recruiting	No Results Available	COVID-19	Drug: Tranexamic acid tablets|Drug: Placebo oral tablet	Phase 2	Interventional	"University of Alabama at Birmingham, Birmingham, Alabama, United States"	https://ClinicalTrials.gov/show/NCT04338074
333	NCT04379154	Analysis of Volatile Organic Compounds by Electronic Noses in Hospitalised Patients for an Infection by SARS-CoV-2 (COVID-19)	Recruiting	No Results Available	COVID-19	Device: Volatile Organic Compounds analysis	Not Applicable	Interventional	"Hôpital Foch, Suresnes, France"	https://ClinicalTrials.gov/show/NCT04379154
334	NCT04331600	Chloroquine as Antiviral Treatment in Coronavirus Infection 2020	Recruiting	No Results Available	COVID-19	Drug: Chloroquine phosphate|Other: Telemedicine	Phase 4	Interventional	"Uniwersytecki Szpital Kliniczny, Wrocław, Ul. Borowska 213, Poland|Wielospecjalistyczny Szpital Miejski, Poznań, Ul. Szwajcarska 3, Poland"	https://ClinicalTrials.gov/show/NCT04331600
335	NCT04366960	Comparison of Two Doses of Enoxaparin for Thromboprophylaxis in Hospitalized COVID-19 Patients	Recruiting	No Results Available	Covid19	Drug: Enoxaparin	Phase 3	Interventional	"Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda, Milano, Italy"	https://ClinicalTrials.gov/show/NCT04366960
336	NCT04344457	"Evaluate the Efficacy and Safety of Oral Hydroxychloroquine, Indomethacin and Zithromax in Subjects With Mild Symptoms of COVID-19"	Recruiting	No Results Available	COVID-19	Drug: Hydroxychloroquine|Drug: Indomethacin|Drug: Zithromax Oral Product	Phase 1|Phase 2	Interventional	"Perseverance Research Center, Scottsdale, Arizona, United States|Covidcraz 19, Llc, New Orleans, Louisiana, United States"	https://ClinicalTrials.gov/show/NCT04344457
337	NCT04346017	Evaluation of Interleukine 6 (and Other Cytokines and Inflammatory Markers) in COVID-19 Patients With a Systemic Inflammatory Response Syndrome	Recruiting	No Results Available	COVID-19	Diagnostic Test: Cytokines dosage|Diagnostic Test: Complement dosage	Not Applicable	Interventional	"CHU Brugmann, Brussels, Belgium"	https://ClinicalTrials.gov/show/NCT04346017
338	NCT04368988	Evaluation of the Safety and Immunogenicity of a SARS-CoV-2 rS (COVID-19) Nanoparticle Vaccine With/Without Matrix-M Adjuvant	Recruiting	No Results Available	COVID-19	Biological: SARS-CoV-2 rS|Other: Matrix-M Adjuvant|Other: NSS Saline Placebo	Phase 1	Interventional	"Investigational Research Site 1, Herston, Queensland, Australia|Investigational Research Site 2, Melbourne, Victoria, Australia"	https://ClinicalTrials.gov/show/NCT04368988
339	NCT04451174	Early Use of Corticosteroids in Hospitalized Patients With Moderate COVID19 Pneumonia	Not yet recruiting	No Results Available	COVID-19	Drug: Prednisone	Phase 3	Interventional		https://ClinicalTrials.gov/show/NCT04451174
340	NCT04343248	Trial to Evaluate the Efficacy and Safety of Nitazoxanide (NTZ) for Post-Exposure Prophylaxis of COVID-19 and Other Viral Respiratory Illnesses in Elderly Residents of Long-Term Care Facilities (LTCF)	Recruiting	No Results Available	COVID-19|Viral Respiratory Illnesses	Drug: Nitazoxanide|Drug: Placebo|Dietary Supplement: Vitamin Super B-Complex	Phase 3	Interventional	"The Chappel Group Research, Kissimmee, Florida, United States|Clinical Trial Specialists, Inc., Acworth, Georgia, United States|Centex Studies, Inc., Lake Charles, Louisiana, United States|Centex Studies, Inc., Houston, Texas, United States"	https://ClinicalTrials.gov/show/NCT04343248
341	NCT04342182	Convalescent Plasma as Therapy for Covid-19 Severe SARS-CoV-2 Disease (CONCOVID Study)	Recruiting	No Results Available	COVID-19	Biological: Convalescent plasma	Phase 2|Phase 3	Interventional	"Erasmus Medical Center, Rotterdam, Zuid-Holland, Netherlands|NoordWest Ziekenhuisgroep, Alkmaar, Netherlands|Onze Lieve Vrouwen Gasthuis, Amsterdam, Netherlands|Rijnstate Ziekenhuis, Arnhem, Netherlands|Reinier de Graaf Gasthuis, Delft, Netherlands|Haaglanden Medisch Centrum, Den Haag, Netherlands|Catharina Ziekenhuis, Eindhoven, Netherlands|Medisch Spectrum Twente, Enschede, Netherlands|Groene Hart Ziekenhuis, Gouda, Netherlands|Martini Hospital, Groningen, Netherlands|Spaarna Gasthuis, Haarlem, Netherlands|Alrijne Ziekenhuis, Leiderdorp, Netherlands|Sint Antonius Ziekenhuis, Nieuwegein, Netherlands|Canisius-Wilhelmina Hospital, Nijmegen, Netherlands|Maasstad Ziekenhuis, Rotterdam, Netherlands|ZorgSaam Hospital, Terneuzen, Netherlands|Bernhoven Hospital, Uden, Netherlands|VieCuri, Venlo, Netherlands"	https://ClinicalTrials.gov/show/NCT04342182
342	NCT04347174	A Clinical Trial of Mycobacterium w in Critically Ill COVID 19 Patients	Recruiting	No Results Available	COVID-19	Drug: Suspension of heat killed (autoclaved) Mycobacterium w|Drug: Standard therapy of COVID-19	Not Applicable	Interventional	"All India Institute of Medical Science, Raipur, Raipur, Chhattisgarh, India|All India Institute of Medical Sciences, Bhopal, Bhopal, Madhya Pradesh, India|Postgraduate Institute of Medical Education and Research, Chandigarh, India|All lndia Institute of Medical Science, Delhi, Delhi, India"	https://ClinicalTrials.gov/show/NCT04347174
343	NCT04409522	Evaluation of Therapeutic Effects of Melatonin by Inhibition of NLRP3 Inflammasome in COVID19 Patients	Recruiting	No Results Available	COVID-19	Drug: Melatonin|Drug: The usual treatment	Not Applicable	Interventional	"Mohammad Sadegh Bagheri Baghdasht, Tehran, Iran, Islamic Republic of"	https://ClinicalTrials.gov/show/NCT04409522
344	NCT04360980	The Effects of Standard Protocol With or Without Colchicine in Covid-19 Infection	Recruiting	No Results Available	COVID-19	Drug: Colchicine Tablets	Phase 2	Interventional	"SBMU, Tehran, Iran, Islamic Republic of|Nooshin Dalili, Tehran, Iran, Islamic Republic of"	https://ClinicalTrials.gov/show/NCT04360980
345	NCT04393246	mulTi-Arm Therapeutic Study in Pre-ICu Patients Admitted With Covid-19 - Experimental Drugs and Mechanisms	Not yet recruiting	No Results Available	COVID-19	Drug: EDP1815|Drug: Dapagliflozin|Drug: Ambrisentan|Other: Standard of care	Phase 2|Phase 3	Interventional	"Cambridge University Hospitals NHS Foundation Trust, Cambridge, Cambridgeshire, United Kingdom"	https://ClinicalTrials.gov/show/NCT04393246
346	NCT04414124	A Clinical Study to Assess the Natural History of COVID-19 and Effects of KB109 and Supportive Self-care in Outpatients With Mild-to-moderate COVID-19	Recruiting	No Results Available	Mild-to-moderate COVID-19	Other: KB109 + Self Supportive Care (SSC)|Other: Self Supportive Care (SSC) Alone	Not Applicable	Interventional	"Medical Center for Clinical Research, San Diego, California, United States|Mount Vernon Clinical Research, Atlanta, Georgia, United States|University of Massachusetts Medical School, Worcester, Massachusetts, United States|Wake Research - Clinical Research Center of Nevada, LLC, Las Vegas, Nevada, United States|Carolina Institute For Clinical Research, Fayetteville, North Carolina, United States|M3 Wake Research, Inc, Raleigh, North Carolina, United States|ClinSearch LLC, Chattanooga, Tennessee, United States|Global Medical Research, DeSoto, Texas, United States"	https://ClinicalTrials.gov/show/NCT04414124
347	NCT04420182	COVID-19 Virtual Care at Home	Not yet recruiting	No Results Available	Covid-19	Other: Virtual Care at Home	Not Applicable	Interventional	"London Health Sciences Centre, London, Ontario, Canada"	https://ClinicalTrials.gov/show/NCT04420182
348	NCT04426344	Core Warming of COVID-19 Patients	Not yet recruiting	No Results Available	COVID 19	Device: ensoETM device	Not Applicable	Interventional	"Barnes-Jewish Hospital, Saint Louis, Missouri, United States"	https://ClinicalTrials.gov/show/NCT04426344
349	NCT04374084	Moxibustion Plus Cupping in Convalescent Patients With COVID-19	Recruiting	No Results Available	COVID-19|Convalescence	Other: Moxibustion plus Cupping	Not Applicable	Interventional	"Hubei Province Hospital, Wuhan, Hubei, China"	https://ClinicalTrials.gov/show/NCT04374084
350	NCT04443881	Clinical Trial of the Use of Anakinra in Cytokine Storm Syndrome Secondary to Covid-19 (ANA-COVID-GEAS)	Recruiting	No Results Available	COVID-19 Pnemonia	Drug: Anakinra 149 MG/ML Prefilled Syringe [Kineret]	Phase 2|Phase 3	Interventional	"Hospital Clinic, Barcelona, Cataluña, Spain|Hospital Universitario Vall d´Hebron, Barcelona, Cataluña, Spain|Complexo Hospitalario Universitario de Santiago, Santiago De Compostela, Galicia, Spain|Hospital Universitario Son Espases, Palma De Mallorca, Mallorca, Spain|Complejo Hospitalario de Navarra, Pamplona, Navarra, Spain|Hospital Universitario La Paz, Madrid, Spain|Hospital Universitario Ramon y Cajal, Madrid, Spain|Hospital Universitario y Politecnico La Fe, Valencia, Spain|Complejo Hospitalario Universitario de Vigo, Vigo, Spain|Hospital Clínico Universitario Lozano Blesa, Zaragoza, Spain"	https://ClinicalTrials.gov/show/NCT04443881
351	NCT04363060	Azithromycin+Amoxicillin/Clavulanate vs Amoxicillin/Clavulanate in COVID19 Patients With Pneumonia in Non-intensive Unit	Not yet recruiting	No Results Available	COVID-19 Pneumonia	Combination Product: Azithromycin with amoxicillin/clavulanate|Drug: amoxicillin/clavulanate	Phase 3	Interventional	"Chu Angers, Angers, France|CHD Vendée, La Roche-sur-Yon, France|CHU Poitiers, Poitiers, France"	https://ClinicalTrials.gov/show/NCT04363060
352	NCT04273646	Study of Human Umbilical Cord Mesenchymal Stem Cells in the Treatment of Severe COVID-19	Not yet recruiting	No Results Available	2019 Novel Coronavirus Pneumonia|COVID-19	Biological: UC-MSCs|Drug: Placebo	Not Applicable	Interventional	"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China"	https://ClinicalTrials.gov/show/NCT04273646
353	NCT04332107	Azithromycin for COVID-19 Treatment in Outpatients Nationwide	Recruiting	No Results Available	COVID-19|SARS-CoV-2	Drug: Azithromycin|Drug: Placebos	Phase 3	Interventional	"University of California San Francisco, San Francisco, California, United States"	https://ClinicalTrials.gov/show/NCT04332107
354	NCT04444596	Conjunctival Swab vs Nasopharyngeal Swab in Patients With COVID-19	Recruiting	No Results Available	COVID-19|SARS-CoV 2	Diagnostic Test: Conjunctival swab and nasopharyngeal swab	Not Applicable	Interventional	"Medical University Innsbruck, Innsbruck, Tirol, Austria"	https://ClinicalTrials.gov/show/NCT04444596
355	NCT04345991	"Efficacy of Convalescent Plasma to Treat COVID-19 Patients, a Nested Trial in the CORIMUNO-19 Cohort"	Recruiting	No Results Available	Covid19	Drug: Transfusion of COVID-19 convalescent plasma	Phase 2	Interventional	"SMIT, Saint Antoine hospital, Paris, France"	https://ClinicalTrials.gov/show/NCT04345991
356	NCT04341389	A Phase II Clinical Trial to Evaluate the Recombinant Vaccine for COVID-19 (Adenovirus Vector)	"Active, not recruiting"	No Results Available	COVID-19	Biological: Recombinant novel coronavirus vaccine (Adenovirus type 5 vector)|Other: Placebo	Phase 2	Interventional	"Hubei Provincial Center for Disease Control and Prevention, Wuhan, Hubei, China"	https://ClinicalTrials.gov/show/NCT04341389
357	NCT04334044	Treatment of SARS Caused by COVID-19 With Ruxolitinib	Recruiting	No Results Available	COVID-19|Severe Acute Respiratory Syndrome Coronavirus 2	Drug: Ruxolitinib Oral Tablet	Phase 1|Phase 2	Interventional	"Grupo Cooperativo de Hemopatías Malignas, Huixquilucan, Estado De México, Mexico"	https://ClinicalTrials.gov/show/NCT04334044
358	NCT04420741	Infusion of Prostacyclin (Iloprost) vs Placebo for 72-hours in COVID-19 Patients With Respiratory Failure	Recruiting	No Results Available	COVID-19|Respiratory Failure	Drug: Iloprost|Drug: Isotonic saline	Phase 2	Interventional	"Dept. of Anaesthesia and Intensive Care, Bispebjerg Hospital, Copenhagen, Denmark|Dept. of Intensive Care, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark|Dept. of Intensive Care, Copenhagen University Hospital Herlev, Herlev, Denmark|Dept. of Anaesthesia and Intensive Care, Nordsjaelands Hospital, Hillerød, Denmark|Dept. of Anaesthesia and Intensive Care, Hvidovre Hospital, Hvidovre, Denmark"	https://ClinicalTrials.gov/show/NCT04420741
359	NCT04365127	Progesterone for the Treatment of COVID-19 in Hospitalized Men	Recruiting	No Results Available	COVID-19|Sars-CoV2	Drug: Progesterone 100 MG	Phase 1	Interventional	"Cedars Sinai Medical Center, Los Angeles, California, United States"	https://ClinicalTrials.gov/show/NCT04365127
360	NCT04390503	Convalescent Plasma for COVID-19 Close Contacts	Recruiting	No Results Available	SARS-CoV 2|COVID-19	Biological: Convalescent Plasma (anti-SARS-CoV-2 plasma)|Biological: Control (albumin 5%)	Phase 2	Interventional	"Columbia University Irving Medical Center/NYP, New York, New York, United States"	https://ClinicalTrials.gov/show/NCT04390503
361	NCT04371510	Blood Biomarkers as Predictors of COVID-19 Disease Progression in Recently Infected Chronic Haemodialysis Patients	Recruiting	No Results Available	COVID-19 by SARS-CoV-2 Infection	Other: blood sample	Not Applicable	Interventional	"CHU de nice, Nice, Alpes-Maritimes, France"	https://ClinicalTrials.gov/show/NCT04371510
362	NCT04349241	Efficacy and Safety of Favipiravir in Management of COVID-19	Completed	No Results Available	Coronavirus Disease (COVID-19)	Drug: favipiravir|Drug: Standard of care therapy	Phase 3	Interventional	"Faculty of Medicine Ain Shams University Research Institute- Clinical Research Center, Cairo, Non-US, Egypt"	https://ClinicalTrials.gov/show/NCT04349241
363	NCT04372017	Hydroxychloroquine as Post-Exposure Prophylaxis Against COVID-19 Infection	"Active, not recruiting"	No Results Available	COVID-19|SARS-CoV 2	Drug: Hydroxychloroquine|Dietary Supplement: Vitamin D	Phase 3	Interventional	"Sanford Health, Sioux Falls, South Dakota, United States"	https://ClinicalTrials.gov/show/NCT04372017
364	NCT04449965	Povidone-Iodine Rinses in the Management of COVID-19	Not yet recruiting	No Results Available	Covid19	Drug: Povidone-iodine|Drug: Placebo	Early Phase 1	Interventional		https://ClinicalTrials.gov/show/NCT04449965
365	NCT04328493	The Vietnam Chloroquine Treatment on COVID-19	Recruiting	No Results Available	SARS-CoV-2 Infection|COVID-19	Drug: Chloroquine phosphate	Phase 2	Interventional	"National Hospital for Tropical Diseases, Hanoi, Vietnam|Can Gio COVID Hospital, Ho Chi Minh City, Vietnam|Cho Ray Hospital, Ho Chi Minh City, Vietnam|Cu Chi COVID Hospital, Ho Chi Minh City, Vietnam|Hospital for Tropical Diseases, Ho Chi Minh City, Vietnam"	https://ClinicalTrials.gov/show/NCT04328493
366	NCT04363203	VA Remote and Equitable Access to COVID-19 Healthcare Delivery (VA-REACH TRIAL)	Suspended	No Results Available	SARS-CoV-2|COVID-19	Drug: Hydroxychloroquine|Drug: Azithromycin|Drug: Placebo oral tablet	Phase 3	Interventional	"San Francisco VA, San Francisco, California, United States"	https://ClinicalTrials.gov/show/NCT04363203
367	NCT04252664	A Trial of Remdesivir in Adults With Mild and Moderate COVID-19	Suspended	No Results Available	COVID-19|SARS-CoV-2	Drug: Remdesivir|Drug: Remdesivir placebo	Phase 3	Interventional	"Jin Yin-tan hospital, Wuhan, Hubei, China"	https://ClinicalTrials.gov/show/NCT04252664
368	NCT04405492	"Evaluation of Rapid Diagnostic Solutions, Serological and Molecular Tests for COVID-19"	Not yet recruiting	No Results Available	SARS-CoV 2|COVID-19	"Device: Taking blood samples (capillary and venous), saliva sampling and nasopharyngeal sampling.|Device: Capillary and salivary sampling"	Not Applicable	Interventional		https://ClinicalTrials.gov/show/NCT04405492
369	NCT04446065	Protection of Health Workers Against COVID-19	Not yet recruiting	No Results Available	COVID-19|SARS-CoV2	Drug: Previfenon®|Drug: Placebo	Phase 2|Phase 3	Interventional		https://ClinicalTrials.gov/show/NCT04446065
370	NCT04412668	Study to Evaluate the Safety and Efficacy of ATYR1923 In Patients With Severe Pneumonia Related to COVID-19	Recruiting	No Results Available	SARS-CoV-2 (COVID-19) Severe Pneumonia	Drug: ATYR1923 1 mg/kg|Drug: ATYR1923 3 mg/kg|Drug: Placebo	Phase 2	Interventional	"University of Alabama at Birmingham, Birmingham, Alabama, United States|aTyr Investigative Site, Washington, District of Columbia, United States|University of Iowa, Iowa City, Iowa, United States|aTyr Investigative Site, Vineland, New Jersey, United States|Inova Fairfax Medical Campus, Falls Church, Virginia, United States"	https://ClinicalTrials.gov/show/NCT04412668
371	NCT04380532	Tableted COVID-19 Therapeutic Vaccine	"Active, not recruiting"	No Results Available	Covid19	Biological: V-SARS	Phase 1|Phase 2	Interventional	"Immunitor Inc, Vancouver, BC - British Columbia, Canada|Aldar Bourinbayar, Ulaanbaatar, BZD, 3-khoroo, Mongolia"	https://ClinicalTrials.gov/show/NCT04380532
372	NCT04394208	Silymarin in COVID-19 Pneumonia	Not yet recruiting	No Results Available	COVID-19|Viral Pneumonia Human Coronavirus	Drug: Silymarin|Drug: Placebo	Phase 3	Interventional	"Cairo University, Giza, Cairo, Egypt"	https://ClinicalTrials.gov/show/NCT04394208
373	NCT04362124	Performance Evaluation of BCG Vaccination in Healthcare Personnel to Reduce the Severity of SARS-COV-2 Infection	Not yet recruiting	No Results Available	COVID-19	Biological: vaccine BCG|Other: Placebo	Phase 3	Interventional	"Program for Research and Control in Tropical Diseases - PECET, Medellín, Antioquia, Colombia"	https://ClinicalTrials.gov/show/NCT04362124
374	NCT04346628	Oral Favipiravir Compared to Placebo in Subjects With Mild COVID-19	Not yet recruiting	No Results Available	Sars-CoV2|COVID-19	Drug: Favipiravir|Drug: Placebo|Other: Standard of care treatment	Phase 2	Interventional	"Stanford University, Stanford, California, United States"	https://ClinicalTrials.gov/show/NCT04346628
375	NCT04358068	Evaluating the Efficacy of Hydroxychloroquine and Azithromycin to Prevent Hospitalization or Death in Persons With COVID-19	"Active, not recruiting"	No Results Available	COVID-19|SARS-CoV 2	Drug: Hydroxychloroquine (HCQ)|Drug: Azithromycin (Azithro)|Drug: Placebo for Hydroxychloroquine|Drug: Placebo for Azithromycin	Phase 2	Interventional	"Alabama CRS, Birmingham, Alabama, United States|UCSD Antiviral Research Center CRS, San Diego, California, United States|Harbor-UCLA CRS, Torrance, California, United States|Whitman-Walker Health CRS, Washington, District of Columbia, United States|Northwestern University CRS, Chicago, Illinois, United States|Rush University CRS, Chicago, Illinois, United States|Greensboro CRS, Greensboro, North Carolina, United States|Cincinnati Clinical Research Site, Cincinnati, Ohio, United States|University of Pittsburgh CRS, Pittsburgh, Pennsylvania, United States|Trinity Health and Wellness Center CRS, Dallas, Texas, United States|University of Washington AIDS CRS, Seattle, Washington, United States"	https://ClinicalTrials.gov/show/NCT04358068
376	NCT04351152	Phase 3 Study to Evaluate Efficacy and Safety of Lenzilumab in Hospitalized Patients With COVID-19 Pneumonia	Recruiting	No Results Available	Coronavirus Disease 2019 (COVID-19) Pneumonia	Biological: Lenzilumab|Drug: Standard of Care	Phase 3	Interventional	"Mayo Clinic, Phoenix, Arizona, United States|Mayo Clinic, Jacksonville, Florida, United States|AdventHealth Orlando, Orlando, Florida, United States|Emory University, Atlanta, Georgia, United States|Mayo Clinic, Rochester, Minnesota, United States|Dartmouth-Hitchcock, Lebanon, New Hampshire, United States|Atrium Health, Charlotte, North Carolina, United States|Texas Health, Dallas, Texas, United States"	https://ClinicalTrials.gov/show/NCT04351152
377	NCT04341116	Study of TJ003234 (Anti-GM-CSF Monoclonal Antibody) in Subjects With Severe Coronavirus Disease 2019 (COVID-19)	Recruiting	No Results Available	Coronavirus Disease 2019 COVID-19	Drug: TJ003234|Drug: Placebo	Phase 1|Phase 2	Interventional	"The GW Medical Faculty Associates, Washington, District of Columbia, United States|OSF Healthcare Saint Francis Medical Center, Peoria, Illinois, United States|Indiana University Health, Indianapolis, Indiana, United States|Medpharmics, LLC, Metairie, Louisiana, United States|Ochsner Medical Center, New Orleans, Louisiana, United States|University of Mississippi Medical Center, Jackson, Mississippi, United States|Oregon Health and Science University, Portland, Oregon, United States|Temple Univeristy Hospital, Philadelphia, Pennsylvania, United States|Houston Methodist Hospital, Houston, Texas, United States"	https://ClinicalTrials.gov/show/NCT04341116
378	NCT04360122	Levamisole and Isoprinosine in Immune-prophylaxis of Egyptian Healthcare Workers Facing COVID-19	Not yet recruiting	No Results Available	Coronavirus Disease (COVID-19)	Drug: Levamisole|Drug: Isoprinosine|Drug: Levamisole and Isoprinosine	Phase 3	Interventional	"Faculty of Medicine Ain Shams University Research Institute- Clinical Research Center, Cairo, Non-US, Egypt"	https://ClinicalTrials.gov/show/NCT04360122
379	NCT04347889	Preventing COVID-19 in Healthcare Workers With HCQ: A RCT	Not yet recruiting	No Results Available	Covid-19	Drug: Hydroxychloroquine|Other: Vitamin C	Phase 2	Interventional		https://ClinicalTrials.gov/show/NCT04347889
380	NCT04366180	Evaluation of the Probiotic Lactobacillus Coryniformis K8 on COVID-19 Prevention in Healthcare Workers	Recruiting	No Results Available	Covid-19	Dietary Supplement: Probiotic|Dietary Supplement: Control	Not Applicable	Interventional	"Raquel Rodriguez Blanque, Granada, Spain"	https://ClinicalTrials.gov/show/NCT04366180
381	NCT04389944	Amotosalen-Ultraviolet A Pathogen-Inactivated Convalescent Plasma in Addition to Best Supportive Care and Antiviral Therapy on Clinical Deterioration in Adults Presenting With Moderate to Severe COVID-19	Recruiting	No Results Available	Coronavirus Disease 2019 Infectious Disease (COVID-19 Infection)	Other: convalescent plasma application to SARS-CoV-2 infected patients	Not Applicable	Interventional	"Blutspendezentrum SRK beider Basel, University Hospital Basel, Basel, Switzerland"	https://ClinicalTrials.gov/show/NCT04389944
382	NCT04283461	Safety and Immunogenicity Study of 2019-nCoV Vaccine (mRNA-1273) for Prophylaxis of SARS-CoV-2 Infection (COVID-19)	Recruiting	No Results Available	COVID-19|COVID-19 Immunisation	Biological: mRNA-1273	Phase 1	Interventional	"Emory Vaccine Center - The Hope Clinic, Decatur, Georgia, United States|National Institutes of Health - Clinical Center - Vaccine Research Center Clinical Trials Program, Bethesda, Maryland, United States|Kaiser Permanente Washington Health Research Institute - Vaccines and Infectious Diseases, Seattle, Washington, United States"	https://ClinicalTrials.gov/show/NCT04283461
383	NCT04364802	COVID-19: Povidone-Iodine Intranasal Prophylaxis in Front-line Healthcare Personnel and Inpatients	Recruiting	No Results Available	COVID-19|SARS-CoV 2	Drug: Povidone-Iodine Nasal Spray and Gargle	Phase 2	Interventional	"University of Kentucky, Lexington, Kentucky, United States"	https://ClinicalTrials.gov/show/NCT04364802
384	NCT04350931	Application of BCG Vaccine for Immune-prophylaxis Among Egyptian Healthcare Workers During the Pandemic of COVID-19	Not yet recruiting	No Results Available	Coronavirus Disease (COVID-19)	Biological: intradermal injection of BCG Vaccine|Other: placebo	Phase 3	Interventional	"Faculty of Medicine Ain Shams University Research Institute- Clinical Research Center, Cairo, Non-US, Egypt"	https://ClinicalTrials.gov/show/NCT04350931
385	NCT04411433	Efficacy and Safety of Hydroxychloroquine and Favipiravir in the Treatment of Mild to Moderate COVID-19	Recruiting	No Results Available	Sars-CoV2|COVID-19	Drug: Favipiravir (3200 mg + 1200 mg)|Drug: Favipiravir (3600 mg + 1600 mg)|Drug: Favipiravir (3200 mg + 1200 mg) combined with Hydroxychloroquine|Drug: Favipiravir (3200 mg + 1200 mg) combined with Azithromycin|Drug: Hydroxychloroquine|Drug: Hydroxychloroquine combined with Azithromycin	Phase 3	Interventional	"Hacettepe University, School of Medicine, Ankara, Turkey"	https://ClinicalTrials.gov/show/NCT04411433
386	NCT04420299	Clinical Trial on the Efficacy and Safety of Bemiparin in Patients Hospitalized Because of COVID-19	Recruiting	No Results Available	Covid-19	Drug: Bemiparin	Phase 2	Interventional	"Hospital Universitario HM Montepríncipe, Boadilla Del Monte, Madrid, Spain|Hospital Universitario HM Puerta del Sur, Móstoles, Madrid, Spain"	https://ClinicalTrials.gov/show/NCT04420299
387	NCT04373044	"Baricitinib, Placebo and Antiviral Therapy for the Treatment of Patients With Moderate and Severe COVID-19"	Recruiting	No Results Available	Symptomatic COVID-19 Infection Laboratory-Confirmed	Drug: Baricitinib|Drug: Hydroxychloroquine|Drug: Placebo Administration	Phase 2	Interventional	"Los Angeles County-USC Medical Center, Los Angeles, California, United States|USC / Norris Comprehensive Cancer Center, Los Angeles, California, United States"	https://ClinicalTrials.gov/show/NCT04373044
388	NCT04336332	Randomized Comparison of Combination Azithromycin and Hydroxychloroquine vs. Hydroxychloroquine Alone for the Treatment of Confirmed COVID-19	Recruiting	No Results Available	SARS-CoV-2|COVID-19	Combination Product: Hydroxychloroquine Sulfate + Azithromycin|Drug: Hydroxychloroquine Sulfate	Phase 2	Interventional	"Saint Barnabas Medical Center, Livingston, New Jersey, United States|Monmouth Medical Center, Long Branch, New Jersey, United States|Morristown Medical Center, Morristown, New Jersey, United States|Robert Wood Johnson University Hopsital, New Brunswick, New Jersey, United States|Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, United States|The University Hospital, Newark, New Jersey, United States|Overlook Hospital, Summit, New Jersey, United States"	https://ClinicalTrials.gov/show/NCT04336332
389	NCT04360876	Targeted Steroids for ARDS Due to COVID-19 Pneumonia: A Pilot Randomized Clinical Trial	Not yet recruiting	No Results Available	COVID-19|ARDS	Drug: Dexamethasone injection|Drug: Placebos	Phase 2	Interventional		https://ClinicalTrials.gov/show/NCT04360876
390	NCT04357444	Low Dose of IL-2 In Acute Respiratory DistrEss Syndrome Related to COVID-19	Not yet recruiting	No Results Available	COVID 19	Drug: 1: ILT101|Drug: 2: Placebo Comparator	Phase 2	Interventional	"Service Anesthésie Réanimation - Groupe Hospitalier Pitié-Salpêtrière, Paris, France"	https://ClinicalTrials.gov/show/NCT04357444
391	NCT04346147	Clinical Trial to Evaluate Efficacy of 3 Types of Treatment in Patients With Pneumonia by COVID-19	Recruiting	No Results Available	COVID-19 Pneumonia	Drug: Hidroxicloroquine|Drug: Lopinavir/ritonavir|Drug: Imatinib tablets|Drug: Baricitinib Oral Tablet	Phase 2	Interventional	"Hospital Universitario de Fuenlabrada, Fuenlabrada, Madrid, Spain"	https://ClinicalTrials.gov/show/NCT04346147
392	NCT04432103	Treatment of Severe and Critical COVID-19 Pneumonia With Convalescent Plasma	Not yet recruiting	No Results Available	Covid-19	Biological: Anti SARS-CoV 2 Convalescent Plasma in severe COVID-19 patients|Biological: Anti SARS-CoV 2 Convalescent Plasma in critical COVID-19 patients	Phase 3	Interventional		https://ClinicalTrials.gov/show/NCT04432103
393	NCT04402840	Stellate Ganglion Block (SGB) for COVID-19 Acute Respiratory Distress Syndrome (ARDS)	Recruiting	No Results Available	Acute Respiratory Distress Syndrome|COVID-19	Procedure: Stellate Ganglion Block	Not Applicable	Interventional	"West Virginia University Rockefeller Neuroscience Institute, Morgantown, West Virginia, United States"	https://ClinicalTrials.gov/show/NCT04402840
394	NCT04452812	Statistical and Epidemiological Study Based on the Use of Convalescent Plasma for the Management of Patients With COVID-19	Not yet recruiting	No Results Available	COVID-19 Pneumonia|Convalescent Plasma	Biological: Convalescent plasma	Phase 1|Phase 2	Interventional		https://ClinicalTrials.gov/show/NCT04452812
395	NCT04408456	Efficacy of Hydroxychloroquine (HCQ) as Post Exposure Prophylaxis (PEP) for Prevention of COVID-19	Recruiting	No Results Available	CoVID-19	Drug: HCQ|Other: Standard therapy	Phase 3	Interventional	"Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India|Post Graduate Institute of Medical Education and Research, Chandigarh, India"	https://ClinicalTrials.gov/show/NCT04408456
396	NCT04402866	TD-0903 for ALI Associated With COVID-19	Recruiting	No Results Available	Acute Lung Injury (ALI) Associated With COVID-19|Lung Inflammation Associated With COVID-19	Drug: TD-0903|Drug: Placebo	Phase 2	Interventional	"Theravance Biopharma Investigational Site, Manchester, United Kingdom"	https://ClinicalTrials.gov/show/NCT04402866
397	NCT04374526	Early transfusIon of Convalescent Plasma in Elderly COVID-19 Patients. to Prevent Disease Progression.	Recruiting	No Results Available	Coronavirus Disease 2019 )COVID-19)	Biological: COVID-19 Convalescent Plasma	Phase 2|Phase 3	Interventional	"Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, RM, Italy|Ospedale SS Annunziata, Chieti, Italy|Istituto Nazionale Malattie Infettive Lazzaro Spallanzani, Rome, Italy"	https://ClinicalTrials.gov/show/NCT04374526
398	NCT04342897	A Study of LY3127804 in Participants With COVID-19	Recruiting	No Results Available	COVID-19|Pneumonia	Drug: LY3127804|Drug: Placebo	Phase 2	Interventional	"National Jewish Medical and Research Center, Denver, Colorado, United States|Nuvance Danbury Hospital, Danbury, Connecticut, United States|NorthShore University HealthSystem, Evanston, Illinois, United States|Parkview Research Center, Fort Wayne, Indiana, United States|Franciscan St. Francis Health, Indianapolis, Indiana, United States|Ochsner Clinic Foundation, New Orleans, Louisiana, United States|Lahey Hospital and Medical Center, Burlington, Massachusetts, United States|Henry Ford Hospital Detroit, Detroit, Michigan, United States|Allina Hospital Network, Minneapolis, Minnesota, United States|State University of New York Hospital, Syracuse, New York, United States|East Carolina University, Greenville, North Carolina, United States"	https://ClinicalTrials.gov/show/NCT04342897
399	NCT04432805	Descriptive and Evaluation Study of the Use of Pulmonary Ultrasound in the Initial Management of Pregnant Women in the Context of COVID-19	Recruiting	No Results Available	Pregnant Women Suspected of COVID-19	Device: Performing of lung ultrasound	Not Applicable	Interventional	"Assistance Publique Hôpitaux de Marseille, Marseille, France"	https://ClinicalTrials.gov/show/NCT04432805
400	NCT04317040	CD24Fc as a Non-antiviral Immunomodulator in COVID-19 Treatment	Recruiting	No Results Available	Severe Coronavirus Disease (COVID-19)	Drug: CD24Fc|Drug: Placebo	Phase 3	Interventional	"Baptist Health Research Institute, Jacksonville, Florida, United States|Martin Army Community Hospital, Fort Benning, Georgia, United States|Anne Anundel Medical Center, Annapolis, Maryland, United States|Institute of Human Virology, University of Maryland Baltimore, Baltimore, Maryland, United States|Shady Grove Medical Center, Rockville, Maryland, United States|White Oak Medical Center, Silver Spring, Maryland, United States|Henry Ford Health System, Detroit, Michigan, United States|Cooper University Hospital, Camden, New Jersey, United States|Atlantic Health System, Morristown, New Jersey, United States|University Hospitals of Cleveland, Cleveland, Ohio, United States|The Ohio State University Medical Center, Columbus, Ohio, United States|Thomas Jefferson University Medical Center, Philadelphia, Pennsylvania, United States"	https://ClinicalTrials.gov/show/NCT04317040
401	NCT04455308	COVID-19 and Chilblains	Not yet recruiting	No Results Available	Chilblains|COVID-19	Diagnostic Test: Biological sample collection	Not Applicable	Interventional	"CHU Angers, Angers, France|CHRU Brest, Brest, France|CHU Nantes, Nantes, France|CHU Rennes, Rennes, France|CHRU Tours, Tours, France"	https://ClinicalTrials.gov/show/NCT04455308
402	NCT04365231	Hydroxychloroquine Azithromycin COVID-19 Pregnancy Trial	Not yet recruiting	No Results Available	COVID19	Drug: Hydroxychloroquine and azithromycin treatment|Other: conventional management of patients	Phase 3	Interventional	"Hopital Saint Joseph, Marseille, Paca, France"	https://ClinicalTrials.gov/show/NCT04365231
403	NCT04303299	"Various Combination of Protease Inhibitors, Oseltamivir, Favipiravir, and Hydroxychloroquine for Treatment of COVID-19 : A Randomized Control Trial"	Not yet recruiting	No Results Available	SARS-COV-2 Infections|COVID-19	Drug: Oral	Phase 3	Interventional	"Assistant Professor Subsai Kongsaengdao, Bangkok, Thailand"	https://ClinicalTrials.gov/show/NCT04303299
404	NCT04346368	Bone Marrow-Derived Mesenchymal Stem Cell Treatment for Severe Patients With Coronavirus Disease 2019 (COVID-19)	Not yet recruiting	No Results Available	Coronavirus Disease 2019 (COVID-19)	Biological: BM-MSCs|Biological: Placebo	Phase 1|Phase 2	Interventional	"Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China"	https://ClinicalTrials.gov/show/NCT04346368
405	NCT04395170	Convalescent Plasma Compared to Anti-COVID-19 Human Immunoglobulin and Standard Treatment (TE) in Hospitalized Patients	Not yet recruiting	No Results Available	Coronavirus Disease 2019 (COVID-19)	Biological: COVID-19 convalescent plasma|Biological: Anti-COVID-19 human immunoglobulin|Drug: Standard (specific) therapy for COVID-19	Phase 2|Phase 3	Interventional	"LifeFactors Zona Franca SAS, Medellín, Antioquia, Colombia"	https://ClinicalTrials.gov/show/NCT04395170
406	NCT04422678	The Safety & Efficacy of Imatinib for the Treatment of SARS-COV-2 Induced Pneumonia	Not yet recruiting	No Results Available	COVID-19	Drug: Imatinib Mesylate|Drug: Standard of Care	Phase 3	Interventional		https://ClinicalTrials.gov/show/NCT04422678
407	NCT04371406	Efficacy of Azithromycin-associated Hydroxychloroquine Therapy Given in General Practice in Early-stage Disease in COVID-19 Patients	Not yet recruiting	No Results Available	Covid-19	Drug: Hydroxychloroquine and Azithromycin|Dietary Supplement: Azinc	Phase 3	Interventional		https://ClinicalTrials.gov/show/NCT04371406
408	NCT04358939	Prone Position in Patients on High-flow Nasal Oxygen Therapy for COVID-19 (HIGH-PRONE-COVID-19)	Recruiting	No Results Available	Acute Respiratory Distress Syndrome|COVID-19	Other: Prone decubitus	Not Applicable	Interventional	"Intensive Care Unit, Hospital, Argenteuil, Argenteuil, France|Medical Intensive Care Unit, University Hospital, Brest, Brest, France|Intensive Care Unit, Louis Mourier-APHP, Colombes, France|Intensive Care Unit, Hospital, Le Mans, Le Mans, France|Intensive Care Unit, University Hospital, Lille, Lille, France|Medical Intensive Care Unit, University Hospital, Nantes, Nantes, France|Medical Intensive Care Unit, University Hospital, Nice, NIce, France|Medical Intensive Care Unit, Hospital, Orléans, Orléans, France|Medical Intensive Care Unit, Tenon-APHP, Paris, France|Medical Intensive Care Unit, University Hospital, Poitiers, Poitiers, France|Medical Intensive Care Unit, University Hospital, Tours, Tours, France|Surgical Intensive Care Unit, University Hospital, Tours, Tours, France|Intensive Care Unit, Hospital, Vannes, Vannes, France"	https://ClinicalTrials.gov/show/NCT04358939
409	NCT04438980	Glucocorticoids in COVID-19 (CORTIVID)	Recruiting	No Results Available	Covid-19 Pneumonia	Drug: Methylprednisolone|Other: Placebo	Phase 3	Interventional	"Hospital Sant Joan Despí Moisès Broggi, Sant Joan Despí, Barcelona, Spain|Complejo Hospitalario de Navarra, Pamplona, Navarra, Spain"	https://ClinicalTrials.gov/show/NCT04438980
410	NCT04334005	Vitamin D on Prevention and Treatment of COVID-19	Not yet recruiting	No Results Available	Patients Infected With COVID-19	Dietary Supplement: Vitamin D	Not Applicable	Interventional	"Universidad de Granada, Granada, Andalucia, Spain|Medicine Faculty, Granada, Spain"	https://ClinicalTrials.gov/show/NCT04334005
411	NCT04351243	A Study to Assess the Efficacy and Safety of Gimsilumab in Subjects With Lung Injury or Acute Respiratory Distress Syndrome Secondary to COVID-19 (BREATHE).	Recruiting	No Results Available	Lung Injury or Acute Respiratory Distress Syndrome Due to COVID-19	Drug: Gimsilumab|Drug: Placebo	Phase 2	Interventional	"UCLA Ronald Reagan Medical Center, Los Angeles, California, United States|Piedmont Healthcare, Atlanta, Georgia, United States|Emory University School of Medicine, Atlanta, Georgia, United States|NorthShore University HealthSystem, Evanston, Illinois, United States|East Jefferson General Hospital, Metairie, Louisiana, United States|Brigham and Women's Hospital, Boston, Massachusetts, United States|Botsford General Hospital, Farmington Hills, Michigan, United States|Beaumont Hospital - Royal Oak, Royal Oak, Michigan, United States|Jamaica Hospital Medical Center, Jamaica, New York, United States|Mount Sinai Beth Israel, New York, New York, United States|Mount Sinai West, New York, New York, United States|Icahn School of Medicine at Mount Sinai, New York, New York, United States|University Hospitals Cleveland Medical Center, Cleveland, Ohio, United States|Temple University Hospital, Philadelphia, Pennsylvania, United States|Baylor University Medical Center, Dallas, Texas, United States|Baylor Scott & White Heart Hospital, Plano, Texas, United States|Baylor Scott & White Medical Center - Temple, Temple, Texas, United States"	https://ClinicalTrials.gov/show/NCT04351243
412	NCT04379336	BCG Vaccination for Healthcare Workers in COVID-19 Pandemic	Recruiting	No Results Available	COVID-19|Sars-CoV2	Biological: Bacille Calmette-Guérin (BCG)|Other: Placebo Comparator	Phase 3	Interventional	"TASK Foundation, Cape Town, Western Cape, South Africa"	https://ClinicalTrials.gov/show/NCT04379336
413	NCT04386850	Oral 25-hydroxyvitamin D3 and COVID-19	Recruiting	No Results Available	COVID 19	Drug: Oral 25-Hydroxyvitamin D3	Phase 2|Phase 3	Interventional	"Tehran University of Medical Sciences, Tehran, Iran, Islamic Republic of"	https://ClinicalTrials.gov/show/NCT04386850
414	NCT04286503	The Clinical Study of Carrimycin on Treatment Patients With COVID-19	Not yet recruiting	No Results Available	Novel Coronavirus Infectious Disease (COVID-19)	Drug: Carrimycin|Drug: lopinavir/ritonavir tablets or Arbidol or chloroquine phosphate|Drug: basic treatment	Phase 4	Interventional		https://ClinicalTrials.gov/show/NCT04286503
415	NCT04288102	Treatment With Human Umbilical Cord-derived Mesenchymal Stem Cells for Severe Corona Virus Disease 2019 (COVID-19)	"Active, not recruiting"	No Results Available	Corona Virus Disease 2019(COVID-19)	Biological: UC-MSCs|Biological: Saline containing 1% Human serum albumin（solution without UC-MSCs）	Phase 2	Interventional	"General Hospital of Central Theater Command, Wuhan, Hubei, China|Maternal and Child Hospital of Hubei Province, Wuhan, Hubei, China|Wuhan Huoshenshan Hospital, Wuhan, Hubei, China"	https://ClinicalTrials.gov/show/NCT04288102
416	NCT04350736	"First in Human SAD and MAD Study of Inhaled TD-0903, a Potential Treatment for ALI Associated With COVID-19"	Recruiting	No Results Available	Acute Lung Injury (ALI) Associated With COVID-19|Inflammatory Lung Conditions Associated With COVID-19	Drug: TD-0903|Drug: Placebo	Phase 1	Interventional	"Theravance Biopharma Investigational Site, Manchester, United Kingdom"	https://ClinicalTrials.gov/show/NCT04350736
417	NCT04351581	Effects of Discontinuing Renin-angiotensin System Inhibitors in Patients With COVID-19	Recruiting	No Results Available	Covid-19	Other: Discontinuation of ACEi/ARB|Other: Continuation of ACEi/ARB	Not Applicable	Interventional	"Department of Medicine, Gentofte Hospital, University of Copenhagen, Hellerup, Capital Region Of Denmark, Denmark|Department of Medicine, Herlev Hospital, University of Copenhagen, Herlev, Capital Region Of Denmark, Denmark"	https://ClinicalTrials.gov/show/NCT04351581
418	NCT04425837	Effectiveness and Safety of Convalescent Plasma in Patients With High-risk COVID-19	Not yet recruiting	No Results Available	Sars-CoV2|Covid-19	Biological: SARS-CoV-2 convalescent plasma treatment|Other: Standard care	Phase 2|Phase 3	Interventional	"Fundación Santa Fe de Bogotá, Bogotá, Cundinamarca, Colombia"	https://ClinicalTrials.gov/show/NCT04425837
419	NCT04427254	Study of the Sars-Cov2 Neuroinvasiveness - COVID19	Not yet recruiting	No Results Available	COVID19	"Drug: Cerebrospinal fluid sampling, meningeal and brain parenchyma biopsies"	Not Applicable	Interventional	"Fondation A de Rothschild, Paris, France"	https://ClinicalTrials.gov/show/NCT04427254
420	NCT04339816	Azithromycin Added to Hydrochloroquine in Patients Admitted to Intensive Care With COVID-19: Randomised Controlled Trial	Recruiting	No Results Available	COVID-19|Respiratory Failure	Drug: Azithromycin|Drug: Hydroxychloroquine|Drug: Placebo	Phase 3	Interventional	"František Duška, Praha, Česká Republika, Czechia"	https://ClinicalTrials.gov/show/NCT04339816
421	NCT04347980	Dexamethasone Treatment for Severe Acute Respiratory Distress Syndrome Induced by COVID-19	Recruiting	No Results Available	"Respiratory Distress Syndrome, Adult|COVID-19"	Drug: Dexamethasone and Hydroxychloroquine|Drug: Hydroxychloroquine	Phase 3	Interventional	"Reanimation adulte. Hopital Marie Lannelongue, Le Plessis-Robinson, France"	https://ClinicalTrials.gov/show/NCT04347980
422	NCT04347512	EVALUATION OF THE EFFICACY OF THE HYDROXYCHLOROQUINE-AZITHROMYCIN COMBINATION IN THE IN THE PREVENTION OF COVID-19 RELATED SDRA	Withdrawn	No Results Available	"Sars-CoV-2, Community-Acquired Pneumonia,COVID-19"	Drug: Hydroxychloroquine and azithromycin treatment arm.|Drug: Hydroxychloroquine|Drug: Control arm	Phase 3	Interventional		https://ClinicalTrials.gov/show/NCT04347512
423	NCT04451291	Study of Decidual Stromal Cells to Treat COVID-19 Respiratory Failure	Not yet recruiting	No Results Available	COVID-19|Acute Respiratory Distress Syndrome	Biological: Decidual Stromal Cells (DSC)	Not Applicable	Interventional	"Toronto General Hospital, Toronto, Ontario, Canada"	https://ClinicalTrials.gov/show/NCT04451291
424	NCT04397523	Efficacy and Safety of COVID-19 Convalescent Plasma	Recruiting	No Results Available	Convalescent Plasma|COVID-19|SARS-CoV 2	Biological: anti-SARS-CoV-2 convalescent plasma	Not Applicable	Interventional	"Institute for Transfusion Medicine of RNM, Skopje, North Macedonia"	https://ClinicalTrials.gov/show/NCT04397523
425	NCT04404426	CACOLAC : Citrulline Administration in the Hospital Patient in Intensive Care for COVID-19 Acute Respiratory Distress Syndrome	Not yet recruiting	No Results Available	ARDS Secondary to COVID-19 Pneumonia	Dietary Supplement: L-citrulline|Other: Placebo	Not Applicable	Interventional	"Brest University Hospital, Brest, Britanny, France|Rennes University Hospital, Rennes, Britanny, France|Saint-Malo Hospital, Saint-Malo, Britanny, France|Vannes Hospital, Vannes, Britanny, France|Angers University Hospital, Angers, France"	https://ClinicalTrials.gov/show/NCT04404426
426	NCT04368845	Telerehabilitation in Patients With COVID-19 After Hospitalization. The ATHLOS Study	Recruiting	No Results Available	COVID-19|Comorbidities and Coexisting Conditions	Device: Telerehabilitation	Not Applicable	Interventional	"Clinical exercise Physiology and rehabilitation research laboratory, Lamia, Greece"	https://ClinicalTrials.gov/show/NCT04368845
427	NCT04405271	TAF/FTC for Pre-exposure Prophylaxis of COVID-19 in Healthcare Workers (CoviPrep Study)	Not yet recruiting	No Results Available	Healthcare Workers|COVID-19|SARS-CoV 2	Drug: Emtricitabine/Tenofovir Alafenamide 200 MG-25 MG Oral Tablet|Drug: Placebo	Phase 3	Interventional	"Sociedad Argentina de Infectología, A. J. Carranza 974, Ciudad Autonoma de Buenos Aires, Capital Federal, Argentina"	https://ClinicalTrials.gov/show/NCT04405271
428	NCT04386694	Photobiomodulation Therapy Combined With Static Magnetic Field in Patients With COVID-19	Recruiting	No Results Available	COVID-19|Respiratory Failure	Device: Active PBMT/sMF|Device: Placebo PBMT/sMF	Not Applicable	Interventional	"Hospital Tacchini, Bento Gonçalves, RS, Brazil"	https://ClinicalTrials.gov/show/NCT04386694
429	NCT04357808	Efficacy of Subcutaneous Sarilumab in Hospitalised Patients With Moderate-severe COVID-19 Infection (SARCOVID)	Recruiting	No Results Available	Covid-19	Drug: Sarilumab|Other: Standar of care	Phase 2	Interventional	"Hospital Universitario de la Princesa, Madrid, Spain"	https://ClinicalTrials.gov/show/NCT04357808
430	NCT04333472	Piclidenoson for Treatment of COVID-19	Not yet recruiting	No Results Available	COVID-19|Coronavirus Infection	Drug: Piclidenoson	Phase 2	Interventional	"Rabin Medical Center, Petah tikva, Israel"	https://ClinicalTrials.gov/show/NCT04333472
431	NCT04377750	The Use of Tocilizumab in the Management of Patients Who Have Severe COVID-19 With Suspected Pulmonary Hyperinflammation	Recruiting	No Results Available	Covid19 Pneumonia	Drug: Tocilizumab	Phase 4	Interventional	"Hadassah Medical Orginisation, Jerusalem, Please Select:, Israel|Barzilai Medical Center, Ashkelon, Israel|Wolfson Medical Center, H̱olon, Israel|Sheba Medical Center, Ramat Gan, Israel"	https://ClinicalTrials.gov/show/NCT04377750
432	NCT04362176	Passive Immunity Trial of Nashville II for COVID-19	Recruiting	No Results Available	COVID-19|Coronavirus|SARS-CoV-2	Biological: pathogen reduced SARS-CoV-2 convalescent plasma|Biological: Placebo	Phase 3	Interventional	"Vanderbilt University Medical Center, Nashville, Tennessee, United States"	https://ClinicalTrials.gov/show/NCT04362176
433	NCT04313127	Phase I Clinical Trial of a COVID-19 Vaccine in 18-60 Healthy Adults	"Active, not recruiting"	No Results Available	COVID-19	Biological: Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector)	Phase 1	Interventional	"Hubei Provincial Center for Disease Control and Prevention, Wuhan, Hubei, China"	https://ClinicalTrials.gov/show/NCT04313127
434	NCT04395768	International ALLIANCE Study of Therapies to Prevent Progression of COVID-19	Not yet recruiting	No Results Available	COVID19	Dietary Supplement: Vitamin C|Drug: Hydroxychloroquine|Drug: Azithromycin|Dietary Supplement: Zinc Citrate|Dietary Supplement: Vitamin D3|Dietary Supplement: Vitamin B12	Phase 2	Interventional		https://ClinicalTrials.gov/show/NCT04395768
435	NCT04344431	Management by Hyperbaric Oxygen Therapy of Patients With Hypoxaemic Pneumonia With SARS-CoV-2 (COVID-19)	Recruiting	No Results Available	Covid-19	Combination Product: Hyperbaric oxygen treatment (HBOT) i.e. inhalation of pressurized oxygen delivered by a hyperbaric chamber (drug/device)	Phase 2|Phase 3	Interventional	"Sainte Anne Military Teaching Hospital, Toulon, France"	https://ClinicalTrials.gov/show/NCT04344431
436	NCT04353674	Modulation of Hyperinflammation in COVID-19	Recruiting	No Results Available	COVID-19|SARS	Device: Control group|Device: SLEDD with a L-MOD	Phase 1	Interventional	"University Hospital, London, Ontario, Canada|Victoria Hospital - Critical Care Trauma Centre, London, Ontario, Canada"	https://ClinicalTrials.gov/show/NCT04353674
437	NCT04420390	Low Dose Radiotherapy for COVID-19 Pneumonitis	Recruiting	No Results Available	Covid19	Radiation: Radiotherapy	Not Applicable	Interventional	"Servicio de Oncología Radioterápica. Hospital Clínico San Carlos, Madrid, Spain"	https://ClinicalTrials.gov/show/NCT04420390
438	NCT04412291	"A Study in Patients With COVID-19 and Respiratory Distress Not Requiring Mechanical Ventilation, to Compare Standard-of-care With Anakinra and Tocilizumab Treatment The Immunomodulation-CoV Assessment (ImmCoVA) Study"	Recruiting	No Results Available	Covid-19	Drug: Anakinra Prefilled Syringe|Drug: Tocilizumab Prefilled Syringe|Drug: Standard-of-care treatment	Phase 2	Interventional	"Karolinska University Hospital, Huddinge, Stockholm, Sweden"	https://ClinicalTrials.gov/show/NCT04412291
439	NCT04341688	A Clinical Trial of Gargling Agents in Reducing Intraoral Viral Load Among COVID-19 Patients	Not yet recruiting	No Results Available	Covid-19	Drug: Gargle/Mouthwash	Not Applicable	Interventional		https://ClinicalTrials.gov/show/NCT04341688
440	NCT04353336	Efficacay of Chloroquine in COVID-19 Treatment	Recruiting	No Results Available	COVID-19|Coronavirus Infection	Drug: Chloroquine	Phase 2|Phase 3	Interventional	"Tanta University, Tanta, Egypt"	https://ClinicalTrials.gov/show/NCT04353336
441	NCT04355247	Prophylactic Corticosteroid to Prevent COVID-19 Cytokine Storm	Recruiting	No Results Available	Covid-19	Drug: MethylPREDNISolone 80 Mg/mL Injectable Suspension	Phase 2	Interventional	"San Juan City Hospital / Puerto Rico Medical Center, San Juan, Puerto Rico|Hospital Auxilio Mutuo Cancer Center, San Juan, Puerto Rico"	https://ClinicalTrials.gov/show/NCT04355247
442	NCT04361435	Lung Recruitment Device for COVID-19	Not yet recruiting	No Results Available	COVID-19|Physiotherapy	Procedure: Chest physiotherapy using a non-invasive oscillating device	Not Applicable	Interventional		https://ClinicalTrials.gov/show/NCT04361435
443	NCT04353206	Convalescent Plasma in ICU Patients With COVID-19-induced Respiratory Failure	Recruiting	No Results Available	Covid-19|Sars-CoV2	Biological: Multiple Doses of Anti-SARS-CoV-2 convalescent plasma	Early Phase 1	Interventional	"8700 Beverly Blvd., Los Angeles, California, United States|Johns Hopkins University, Baltimore, Maryland, United States"	https://ClinicalTrials.gov/show/NCT04353206
444	NCT04374591	Home-based Treatment of Computed Tomography and Clinically Suspected Novel COVID-19 With Adjuvant Inhalable Sodium Bicarbonate: A Preliminary Case Series	"Active, not recruiting"	No Results Available	Pneumonia|Covid19	Drug: Sodium Bicarbonate	Early Phase 1	Interventional	"Gomhoria Street, Mansoura, Outside U.S./Canada, Egypt"	https://ClinicalTrials.gov/show/NCT04374591
445	NCT04358926	Hyperbaric Oxygen Therapy Effect in COVID-19 RCT (HBOTCOVID19)	Recruiting	No Results Available	COVID-19|Desaturation of Blood	Device: Hyperbaric oxygen therapy|Device: Normobaric oxygen therapy	Not Applicable	Interventional	"Amir Hadanny, Zerifin, Israel"	https://ClinicalTrials.gov/show/NCT04358926
446	NCT04388527	COVID-19 Convalescent Plasma for Mechanically Ventilated Population	Recruiting	No Results Available	Covid-19	Biological: COVID-19 Convalescent Plasma	Phase 1	Interventional	"Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, United States"	https://ClinicalTrials.gov/show/NCT04388527
447	NCT04386239	Study on the Use of Sarilumab in Patients With COVID-19 Infection	Not yet recruiting	No Results Available	COVID19	Drug: Sarilumab Prefilled Syringe	Early Phase 1	Interventional		https://ClinicalTrials.gov/show/NCT04386239
448	NCT04335305	Checkpoint Blockade in COVID-19 Pandemic	Recruiting	No Results Available	"COVID-19|Pneumonia, Viral"	Drug: Tocilizumab|Biological: Pembrolizumab (MK-3475)	Phase 2	Interventional	"Hospital Quirónsalud Barcelona, Barcelona, Spain|Hospital de la Santa Creu i Sant Pau, Barcelona, Spain|Hospital Universitari Arnau de Vilanova de Lleida, Lleida, Spain|Hospital Universitario Ramón y Cajal, Madrid, Spain|Hospital Ruber Juan Bravo, Madrid, Spain|Hospital Ruber Internacional, Madrid, Spain|Hospital Arnau de Vilanova-Lliria, Valencia, Spain|Hospital Universitario Doctor Peset, Valencia, Spain"	https://ClinicalTrials.gov/show/NCT04335305
449	NCT04338828	Nitric Oxide Inhalation Therapy for COVID-19 Infections in the ED	Recruiting	No Results Available	COVID19	Drug: Nitric Oxide Gas|Other: Inhaled Supplemental Oxygen	Phase 2	Interventional	"Massachusetts General Hospital, Boston, Massachusetts, United States"	https://ClinicalTrials.gov/show/NCT04338828
450	NCT04435275	Virtual Assistant for COVID-19 PPE	Not yet recruiting	No Results Available	COVID-19	"Other: Virtual Assistant first, then Human Coach|Other: Human Coach first, then Virtual Assistant"	Not Applicable	Interventional		https://ClinicalTrials.gov/show/NCT04435275
451	NCT04353180	Assessment the Activity Value of Isotretinoin (13- Cis-Retinoic Acid ) in the Treatment of COVID-19 (Randomized)	Not yet recruiting	No Results Available	COVID19	Drug: Drug Isotretinoin (13 cis retinoic acid ) capsules+standard treatment|Drug: Isotretinoin(Aerosolized 13 cis retinoic acid) +standard treatment|Drug: Standard treatment	Phase 3	Interventional	"Faculty of Medicine, Kafr El-sheikh University, Cairo, Kafr El-sheikh, Egypt|Faculty of Medicine, Kafr El-sheikh University, Cairo, Egypt"	https://ClinicalTrials.gov/show/NCT04353180
452	NCT04371952	DYNAMIC Study (DoxycYcliNe AMbulatoIre COVID-19)	Not yet recruiting	No Results Available	COVID19	Drug: Doxycycline|Drug: Placebo	Phase 3	Interventional	"CHU Avicenne - APHP, Bobigny, France|CHU Bordeaux, Bordeaux, France|CHU Caen, Caen, France|CHU Dijon, Dijon, France|CHU Grenoble, Grenoble, France|CHU Nantes, Nantes, France"	https://ClinicalTrials.gov/show/NCT04371952
453	NCT04372589	Antithrombotic Therapy to Ameliorate Complications of COVID-19 ( ATTACC )	Recruiting	No Results Available	COVID-19|Pneumonia	Drug: Heparin	Phase 2|Phase 3	Interventional	"University of Chicago, Chicago, Illinois, United States|Ochsner Clinic, Jefferson, Louisiana, United States|Maine Medical Center, Portland, Maine, United States|Beaumont Hospital, Royal Oak, Michigan, United States|Saint Louis University School of Medicine/Saint Louis Veterans Affairs Medical Center, Saint Louis, Missouri, United States|Deborah Heart and Lung Center, Browns Mills, New Jersey, United States|Albany Medical College, Albany, New York, United States|Mount Sinai Health System, New York, New York, United States|Montefiore-Einstein Center for Heart and Vascular Care, New York, New York, United States|Vanderbilt University Medical Center, Nashville, Tennessee, United States|University of São Paulo, São Paulo, Brazil|Victoria General Hospital, Victoria, British Columbia, Canada|Health Sciences Center Winnipeg, Winnipeg, Manitoba, Canada|Grace General Hospital, Winnipeg, Manitoba, Canada|St. Boniface General Hospital, Winnipeg, Manitoba, Canada|Hamilton Health Sciences, Hamilton, Ontario, Canada|The Ottawa Hospital, Ottawa, Ontario, Canada|University Health Network, Toronto, Ontario, Canada|Sunnybrook Hospital, Toronto, Ontario, Canada|McGill University Health Centre, Montréal, Quebec, Canada|Centre Hospitalier de l'université de Montréal (CHUM), Montréal, Quebec, Canada|Jewish General Hospital, Montréal, Quebec, Canada|CHU de Quebec-University Laval, Québec, Quebec, Canada|Institut universitaire de cardiologie et de pneumologie de Québec (CRIUCPQ), Québec, Quebec, Canada|Regina General Hospital, Regina, Saskatchewan, Canada|Unidad de Investigación en Epidemiología Clínica, Instituto Mexicano del Seguro Social, Mexico City, Mexico"	https://ClinicalTrials.gov/show/NCT04372589
454	NCT04438694	Use of Convalescent Plasma for Treatment of Patients With COVID-19 Infection	Recruiting	No Results Available	COVID19	Drug: Convalescent Plasma	Phase 1|Phase 2	Interventional	"Cairo University Hospital, Cairo, Egypt"	https://ClinicalTrials.gov/show/NCT04438694
455	NCT04273321	Efficacy and Safety of Corticosteroids in COVID-19	Completed	No Results Available	COVID-19|Novel Coronavirus Pneumonia	Drug: Methylprednisolone	Not Applicable	Interventional	"Hubei province hospital of integrated Chinese & Western Medicine, Wuhan, Hubei, China|Yichang first people's Hospital, Yichang, Hubei, China|Beijing YouAn Hospital, Beijing, China|Renmin Hospital of Wuhan University, Wuhan, China|Tianyou Hospital Affiliated to Wuhan University of science and technology, Wuhan, China|Union Hospital Affiliated to Tongji Medical College of Huazhong University of science and technology, Wuhan, China|the first peopel hospital of Xiangyang, Xiangyang, China"	https://ClinicalTrials.gov/show/NCT04273321
456	NCT04390477	Study to Evaluate the Effect of a Probiotic in COVID-19	Recruiting	No Results Available	COVID-19|Coronavirus Infection	Dietary Supplement: Probiotic	Not Applicable	Interventional	"Hospital Universitario del Vinalopó, Elche, Alicante, Spain|Hospital Universitario de Torrevieja, Torrevieja, Alicante, Spain"	https://ClinicalTrials.gov/show/NCT04390477
457	NCT04409483	Evaluation of Additional Treatments for COVID-19: a Randomized Trial in Niger	Withdrawn	No Results Available	Covid-19	Drug: Lopinavir-Ritonavir Drug Combination|Combination Product: Standard Care	Phase 3	Interventional		https://ClinicalTrials.gov/show/NCT04409483
458	NCT04366141	COVID-19 (Coronavirus Disease 2019) Intubation Barrier Box	Recruiting	No Results Available	COVID-19	Device: COVID-19 barrier box	Not Applicable	Interventional	"Providence Health Care, Vancouver, British Columbia, Canada"	https://ClinicalTrials.gov/show/NCT04366141
459	NCT04344730	Dexamethasone and Oxygen Support Strategies in ICU Patients With Covid-19 Pneumonia	Recruiting	No Results Available	Acute Hypoxemic Respiratory Failure|COVID-19	Drug: Dexamethasone injection|Drug: placebo|Procedure: conventional oxygen|Procedure: CPAP|Procedure: HFNO|Procedure: mechanical ventilation	Not Applicable	Interventional	"Hopital Bichat - Aphp, Paris, France"	https://ClinicalTrials.gov/show/NCT04344730
460	NCT04347538	Impact of Nasal Saline Irrigations on Viral Load in Patients With COVID-19	Recruiting	No Results Available	COVID 19	Other: Saline Nasal Irrigation|Other: Saline with Baby Shampoo Nasal Irrigation	Not Applicable	Interventional	"Vanderblt University Medical Center, Nashville, Tennessee, United States"	https://ClinicalTrials.gov/show/NCT04347538
461	NCT04343976	Pegylated Interferon Lambda Treatment for COVID-19	Enrolling by invitation	No Results Available	COVID-19|COVID	Drug: Pegylated interferon lambda	Phase 2	Interventional	"Massachusetts General Hospital, Boston, Massachusetts, United States"	https://ClinicalTrials.gov/show/NCT04343976
462	NCT04355026	Use of Bromhexine and Hydroxychloroquine for Treatment of COVID-19 Pneumonia	Recruiting	No Results Available	Covid-19	Drug: Bromhexine Oral Tablet and/or hydroxychloroquine tablet	Phase 4	Interventional	"SB Celje, Celje, Slovenia"	https://ClinicalTrials.gov/show/NCT04355026
463	NCT04400058	Octagam 10% Therapy in COVID-19 Patients With Severe Disease Progression	Recruiting	No Results Available	Covid-19	Biological: Octagam 10%|Other: Placebo	Phase 3	Interventional	"Octapharma Research Site, Loma Linda, California, United States|Octapharma Research Site, San Diego, California, United States|Octapharma Research Site, Iowa City, Iowa, United States|Octapharma Research Site, Covington, Louisiana, United States"	https://ClinicalTrials.gov/show/NCT04400058
464	NCT04363541	Local Thermotherapy for Patients With Moderate Symptoms of COVID-19	Not yet recruiting	No Results Available	COVID-19|Thermotherapy	Device: Electric pad for human external pain therapy	Not Applicable	Interventional		https://ClinicalTrials.gov/show/NCT04363541
465	NCT04374461	A Study of N-acetylcysteine in Patients With COVID-19 Infection	Recruiting	No Results Available	Covid-19	Drug: N-acetylcysteine|Other: Peripheral Blood	Phase 2	Interventional	"Memorial Sloan Kettering Cancer Center, New York, New York, United States"	https://ClinicalTrials.gov/show/NCT04374461
466	NCT04377802	Safe Return to Regular Clinical Operation After COVID-19 Pandemic	Not yet recruiting	No Results Available	COVID 19	Diagnostic Test: molecular testing for virus RNA using RT-PCR	Not Applicable	Interventional	"king Fahad specialist hospital, Dammam, Eastern Province, Saudi Arabia"	https://ClinicalTrials.gov/show/NCT04377802
467	NCT04341142	Assessment of Serological Techniques for Screening Patients Regarding COVID-19-COVID-SER	Recruiting	No Results Available	Covid19	Diagnostic Test: Serological tests will be applied on patients blood sampling	Not Applicable	Interventional	"Hôpital Lyon Sud,Sainte Eugénie bat 4M,5, Chemin du Grand Revoyet, Pierre-Bénite cedex, France"	https://ClinicalTrials.gov/show/NCT04341142
468	NCT04418206	Validating an ELISpot for Early Detection of an Active Immune Response Against COVID-19	Not yet recruiting	No Results Available	Covid 19	Other: patients COVID 19	Not Applicable	Interventional	"CH Antibes, Antibes, Alpes Maritimes, France|Ch Cannes, Pneumologie, Cannes, Alpes Maritimes, France|Ch Grasse, Grasse, Alpes Maritimes, France|CHU de nice, Nice, Alpes-Maritimes, France"	https://ClinicalTrials.gov/show/NCT04418206
469	NCT04339426	Atovaquone and Azithromycin Combination for Confirmed COVID-19 Infection	Recruiting	No Results Available	Covid19	Drug: Atovaquone/Azithromycin	Phase 2	Interventional	"HonorHealth, Scottsdale, Arizona, United States"	https://ClinicalTrials.gov/show/NCT04339426
470	NCT04437693	Post Exposure Prophylaxis in Healthcare Workers Exposed to COVID-19 Patients	Not yet recruiting	No Results Available	COVID 19	Drug: Hydroxychloroquine	Phase 3	Interventional		https://ClinicalTrials.gov/show/NCT04437693
471	NCT04293692	Therapy for Pneumonia Patients iInfected by 2019 Novel Coronavirus	Withdrawn	No Results Available	COVID-19	Biological: UC-MSCs|Other: Placebo	Not Applicable	Interventional	"Puren Hospital Affiliated to Wuhan University of Science and Technology, Wuhan, Hubei, China"	https://ClinicalTrials.gov/show/NCT04293692
472	NCT04350320	Trial to Study the Benefit of Colchicine in Patients With COVID-19	Recruiting	No Results Available	COVID19	Drug: Colchicine Tablets|Drug: Standard therapy for COVID-19 according to the stablished hospital protocols.	Phase 3	Interventional	"Virgen de la Arrixaca University Clinical Hospital, Murcia, Spain"	https://ClinicalTrials.gov/show/NCT04350320
473	NCT04391309	IC14 (Anti-CD14) Treatment in Patients With SARS-CoV-2 (COVID-19)	Not yet recruiting	No Results Available	SARS-CoV2	Biological: IC14|Other: Placebo	Phase 2	Interventional	"University of Washington, Seattle, Washington, United States"	https://ClinicalTrials.gov/show/NCT04391309
474	NCT04343794	Using Biovitals® Sentinel to Monitor Disease Progression in Subjects Quarantined for Suspected COVID-19	Recruiting	No Results Available	COVID19	Device: BIOVITALS	Not Applicable	Interventional	"The University of Hong Kong, Queen Mary Hospital, Hong Kong, Hong Kong"	https://ClinicalTrials.gov/show/NCT04343794
475	NCT04341285	Early Versus Late ECMO Therapy in COVID-19 Induced ARDS (ECMO-VID)	Not yet recruiting	No Results Available	"ARDS, Human|COVID-19"	Procedure: ECMO Implantation	Not Applicable	Interventional	"University Hospital Tuebingen, Tuebingen, Germany"	https://ClinicalTrials.gov/show/NCT04341285
476	NCT04389840	Dociparstat for the Treatment of Severe COVID-19 in Adults at High Risk of Respiratory Failure	Recruiting	No Results Available	COVID-19|Acute Lung Injury|SARS-CoV-2	Drug: Dociparastat sodium|Drug: Placebo	Phase 2|Phase 3	Interventional	"Our Lady of the Lake, Baton Rouge, Louisiana, United States|University Medical Center, New Orleans, Louisiana, United States"	https://ClinicalTrials.gov/show/NCT04389840
477	NCT04331665	Study of the Efficacy and Safety of Ruxolitinib to Treat COVID-19 Pneumonia	Not yet recruiting	No Results Available	COVID-19|Pneumonia	Drug: Ruxolitinib	Not Applicable	Interventional	"Princess Margaret Cancer Centre, Toronto, Ontario, Canada"	https://ClinicalTrials.gov/show/NCT04331665
478	NCT04368260	Clinical Validation of New Injection Molded Flocked Nasopharyngeal Swabs in Response to the COVID-19 Pandemic	Recruiting	No Results Available	COVID19	Device: Control swab|Device: Prototype swab	Not Applicable	Interventional	"University of Virginia, Charlottesville, Virginia, United States"	https://ClinicalTrials.gov/show/NCT04368260
479	NCT04373096	Enhanced Hood PPE to Minimize COVID-19 Transmission to Front-line Health Care Workers	Not yet recruiting	No Results Available	Covid19	Device: current IPAC-UHN PPE|Device: modified IPAC-UHN PPE	Not Applicable	Interventional		https://ClinicalTrials.gov/show/NCT04373096
480	NCT04345276	Efficacy and Safety of Ganovo (Danoprevir) Combined With Ritonavir in the Treatment of SARS-CoV-2 Infection	Completed	No Results Available	COVID-19	Drug: Danoprevir+Ritonavir	Phase 4	Interventional	"Huoshenshan Hostipal, Wuhan, Hubei, China"	https://ClinicalTrials.gov/show/NCT04345276
481	NCT04379375	Nudges to Improve Health Behaviors That Limit COVID-19 Spread	Not yet recruiting	No Results Available	Health Behavior|COVID-19	Behavioral: Nudge	Not Applicable	Interventional		https://ClinicalTrials.gov/show/NCT04379375
482	NCT04389671	The Safety and Preliminary Efficacy of Lucinactant in Adults With COVID-19	Not yet recruiting	No Results Available	COVID-19|Acute Lung Injury/Acute Respiratory Distress Syndrome (ARDS)	Drug: Lucinactant	Phase 1|Phase 2	Interventional		https://ClinicalTrials.gov/show/NCT04389671
483	NCT04318444	Hydroxychloroquine Post Exposure Prophylaxis for Coronavirus Disease (COVID-19)	Recruiting	No Results Available	COVID-19|Corona Virus Infection	Drug: Hydroxychloroquine|Drug: Placebo oral tablet	Phase 2|Phase 3	Interventional	"Columbia University Irving Medical Center, New York, New York, United States"	https://ClinicalTrials.gov/show/NCT04318444
484	NCT04291729	Evaluation of Ganovo （Danoprevir ） Combined With Ritonavir in the Treatment of SARS-CoV-2 Infection	Completed	No Results Available	COVID-19	Drug: Ganovo+ritonavir+/-Interferon nebulization	Phase 4	Interventional	"The Ninth Hospital of Nanchang, Nanchang, Jiangxi, China"	https://ClinicalTrials.gov/show/NCT04291729
485	NCT04435717	Efficacy of Tocilizumab in Modifying the Inflammatory Parameters of Patients With COVID-19 (COVITOZ-01)	Recruiting	No Results Available	Covid19	Drug: Tocilizumab 20 MG/ML Intravenous Solution [ACTEMRA]_#1|Drug: Tocilizumab 20 MG/ML Intravenous Solution [ACTEMRA]_#1 (2 doses)	Phase 2	Interventional	"Hospital Universitario Ramón y Cajal, Madrid, Spain"	https://ClinicalTrials.gov/show/NCT04435717
486	NCT04402203	Study on Safety and Efficacy of Favipiravir (Favipira) for COVID-19 Patient in Selected Hospitals of Bangladesh	Recruiting	No Results Available	COVID-19|Favipiravir (Favipira)	Drug: Favipiravir|Drug: Only Standard Treatment	Phase 2|Phase 3	Interventional	"Mahanagar General Hospital, Dhaka (Site-1), Mugda Medical College Hospital, Dhaka (Site-2), Kurmitola General Hospital, Dhaka (Site-3), Dhaka Medical College Hospital, Dhaka (Site-4), Dhaka, Bangladesh"	https://ClinicalTrials.gov/show/NCT04402203
487	NCT04328272	Effectiveness of Hydroxychloroquine in Covid-19 Patients	Not yet recruiting	No Results Available	COVID19	Drug: Hydroxychloroquine 200 Mg Oral Tablet|Drug: Azithromycin 500Mg Oral Tablet|Dietary Supplement: Glucose tablets	Phase 3	Interventional	"Ayub Teaching Institution, Abbottābād, K.p.k, Pakistan"	https://ClinicalTrials.gov/show/NCT04328272
488	NCT04387292	Ocular Sequelae of Patients Hospitalized for Respiratory Failure During the COVID-19 Epidemic	Recruiting	No Results Available	COVID19|Ophthalmopathy	Procedure: Ophthalmologic exam	Not Applicable	Interventional	"Fondation A de Rothschild, Paris, France"	https://ClinicalTrials.gov/show/NCT04387292
489	NCT04352751	Experimental Use of Convalescent Plasma for Passive Immunization in Current COVID-19 Pandemic in Pakistan in 2020	Recruiting	No Results Available	Covid-19	Other: convalescent plasma	Not Applicable	Interventional	"National Institute of Blood Diseases and Bone Marrow Transplantation (NIBD), Karachi, Sindh, Pakistan"	https://ClinicalTrials.gov/show/NCT04352751
490	NCT04435314	Efficacy and Safety of Nitazoxanide for Post Exposure Prophylaxis of COVID-19	Not yet recruiting	No Results Available	covid19	Drug: Nitazoxanide|Drug: Placebo	Phase 2	Interventional		https://ClinicalTrials.gov/show/NCT04435314
491	NCT04373161	Home Pulse Oximeter Use in Patients With COVID-19	Completed	No Results Available	Sars-CoV2|COVID-19|COVID	Device: Home Pulse Oximetry Monitoring	Not Applicable	Interventional	"Swedish Hospital, Chicago, Illinois, United States"	https://ClinicalTrials.gov/show/NCT04373161
492	NCT04384731	Curosurf® in Adult Acute Respiratory Distress Syndrome Due to COVID-19	Not yet recruiting	No Results Available	"COVID-19|ARDS, Human"	Drug: poractant alfa	Phase 2	Interventional		https://ClinicalTrials.gov/show/NCT04384731
493	NCT04397718	Hormonal Intervention for the Treatment in Veterans With COVID-19 Requiring Hospitalization	Not yet recruiting	No Results Available	CoVID19	Drug: Degarelix|Other: Saline	Phase 2	Interventional	"VA Greater Los Angeles Healthcare System, West Los Angeles, CA, West Los Angeles, California, United States|Brooklyn Campus of the VA NY Harbor Healthcare System, Brooklyn, NY, Brooklyn, New York, United States|Manhattan Campus of the VA NY Harbor Healthcare System, New York, NY, New York, New York, United States|VA Puget Sound Health Care System Seattle Division, Seattle, WA, Seattle, Washington, United States"	https://ClinicalTrials.gov/show/NCT04397718
494	NCT04412018	An Investigation on the Effects of Icosapent Ethyl (VascepaTM) on Inflammatory Biomarkers in Individuals With COVID-19	Recruiting	No Results Available	COVID-19|Inflammatory Response	Drug: Icosapent ethyl	Phase 2	Interventional	"North York Diagnostic and Cardiology Clinic, Toronto, Ontario, Canada"	https://ClinicalTrials.gov/show/NCT04412018
495	NCT04418128	Clinical Efficacy of Nafamostat Mesylate for COVID-19 Pneumonia	Not yet recruiting	No Results Available	Corona Virus Infection|COVID-19	Drug: Nafamostat Mesylate	Phase 2|Phase 3	Interventional		https://ClinicalTrials.gov/show/NCT04418128
496	NCT04454398	Study to Evaluate STI-1499 (COVI-GUARD) in Hospitalized Patients With COVID-19	Not yet recruiting	No Results Available	Covid-19	Biological: STI-1499|Other: Standard of Care|Drug: Placebo	Phase 1	Interventional		https://ClinicalTrials.gov/show/NCT04454398
497	NCT04318015	Hydroxychloroquine Chemoprophylaxis in Healthcare Personnel in Contact With COVID-19 Patients (PHYDRA Trial)	Recruiting	No Results Available	COVID-19|Severe Acute Respiratory Syndrome	Drug: Hydroxychloroquine|Drug: Placebo oral tablet	Phase 3	Interventional	"Instituto Nacional de Enfermedades Respiratorias, ""Ismael Cosío Villegas"", Mexico, City, Mexico"	https://ClinicalTrials.gov/show/NCT04318015
498	NCT04341038	Clinical Trial to Evaluate Methylprednisolone Pulses and Tacrolimus in Patients With COVID-19 Lung Injury	Recruiting	No Results Available	COVID-19|Lung Injury	Drug: Tacrolimus|Drug: Methylprednisolone	Phase 3	Interventional	"Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain"	https://ClinicalTrials.gov/show/NCT04341038
499	NCT04354428	Treatment for COVID-19 in High-Risk Adult Outpatients	Recruiting	No Results Available	COVID-19|SARS-CoV-2	Drug: Ascorbic Acid|Drug: Hydroxychloroquine Sulfate|Drug: Azithromycin|Drug: Folic Acid	Phase 2|Phase 3	Interventional	"Ruth M. Rothstein CORE Center - Cook County Health, Chicago, Illinois, United States|Tulane University, New Orleans, Louisiana, United States|Boston University, Boston, Massachusetts, United States|NYU Langone Health, New York, New York, United States|SUNY Upstate Medical University, Syracuse, New York, United States|University of Washington Coordinating Center, Seattle, Washington, United States|UW Virology Research Clinic, Seattle, Washington, United States"	https://ClinicalTrials.gov/show/NCT04354428
500	NCT04441398	Efficacy and Safety of Nitazoxanide 600 mg to Treat Mild Ambulatory COVID-19 Patients	Not yet recruiting	No Results Available	covid19	Drug: Nitazoxanide|Drug: Placebo	Phase 2|Phase 3	Interventional		https://ClinicalTrials.gov/show/NCT04441398
501	NCT04440007	Study of the Efficacy and Safety of STI-5656 (Abivertinib Maleate) With SOC Versus SOC in Subjects With COVID-19	Not yet recruiting	No Results Available	Covid-19	Drug: Abivertinib|Other: Standard of Care	Phase 2	Interventional		https://ClinicalTrials.gov/show/NCT04440007
502	NCT04381013	Emergency Ventilator Splitting Between Two or More Patients (COVID-19)	Not yet recruiting	No Results Available	COVID-19	Device: Emergency Ventilator Splitter	Not Applicable	Interventional	"Stanford University, Stanford, California, United States"	https://ClinicalTrials.gov/show/NCT04381013
503	NCT04416139	Mesenchymal Stem Cell for Acute Respiratory Distress Syndrome Due for COVID-19	Recruiting	No Results Available	Covid 19	Biological: Infusion IV of Mesenchymal Stem cells	Phase 2	Interventional	"Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico"	https://ClinicalTrials.gov/show/NCT04416139
504	NCT04423861	Efficacy and Safety of Nitazoxanide 600 mg TID for the Treatment of Hospitalized Patients With COVID-19	Not yet recruiting	No Results Available	covid19	Drug: Nitazoxanide|Drug: Placebo	Phase 2	Interventional		https://ClinicalTrials.gov/show/NCT04423861
505	NCT04380376	Low-doses Melphalan Inhalation in Patients With COVID-19 (CoronavIrus Disease 2019) Pneumonia	Recruiting	No Results Available	COVID-19|Viral Pneumonia	Drug: Melphalan|Other: Standard of care	Phase 2	Interventional	"Kirill Zykov, Moscow, Russian Federation|Clinical hospital, Moscow, Russian Federation"	https://ClinicalTrials.gov/show/NCT04380376
506	NCT04356677	Study to Evaluate the Safety and Efficacy of VIRAZOLE® in Hospitalized Adult Participants With Respiratory Distress Due to COVID-19	Not yet recruiting	No Results Available	COVID19	Drug: 50 mg/mL Virazole|Drug: 100 mg/mL Virazole	Phase 1	Interventional		https://ClinicalTrials.gov/show/NCT04356677
507	NCT04407689	InterLeukin-7 to Improve Clinical Outcomes in Lymphopenic pAtients With COVID-19 Infection FR BL Cohort	Recruiting	No Results Available	COVID-19|Lymphocytopenia	Drug: Interleukin-7|Drug: Placebo	Phase 2	Interventional	"University Hospital of Limoges, Limoges, France|Hôpital Edouard Herriot, Lyon, France"	https://ClinicalTrials.gov/show/NCT04407689
508	NCT04379076	InterLeukin-7 (CYT107) to Improve Clinical Outcomes in Lymphopenic pAtients With COVID-19 Infection UK Cohort	Recruiting	No Results Available	COVID-19|Lymphocytopenia	Drug: Interleukin-7|Drug: Placebos	Phase 2	Interventional	"Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom"	https://ClinicalTrials.gov/show/NCT04379076
509	NCT04370288	Clinical Application of Methylene Blue for Treatment of Covid-19 Patients	Recruiting	No Results Available	Covid-19	"Drug: MCN (Methylene blue, vitamin C, N-acetyl cysteine)"	Phase 1	Interventional	"Imam Reza Hospital, Mashhad, Razavi Khorasan, Iran, Islamic Republic of"	https://ClinicalTrials.gov/show/NCT04370288
510	NCT04372628	Trial of Early Therapies During Non-hospitalized Outpatient Window for COVID-19	Recruiting	No Results Available	COVID-19	Drug: Hydroxychloroquine|Drug: Lopinavir/ritonavir 400 mg/100 mg|Other: Placebo	Phase 2	Interventional	"University of Colorado School of Medicine, Aurora, Colorado, United States|Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States|Vanderbilt University Medical Center, Nashville, Tennessee, United States"	https://ClinicalTrials.gov/show/NCT04372628
511	NCT04374487	"A Phase II, Open Label, Randomized Controlled Trial to Assess the Safety and Efficacy of Convalescent Plasma to Limit COVID-19 Associated Complications"	Not yet recruiting	No Results Available	COVID 19	Drug: Convalescent Plasma|Other: Standard Care Therapy	Phase 2	Interventional	"Max Super Speciality hospital, Saket (A unit of Devki Devi Foundation), New Delhi, Delhi, India"	https://ClinicalTrials.gov/show/NCT04374487
512	NCT04445220	A Study of Cell Therapy in COVID-19 Subjects With Acute Kidney Injury Who Are Receiving Renal Replacement Therapy	Not yet recruiting	No Results Available	COVID-19|Acute Kidney Injury	Biological: SBI-101|Device: Sham	Phase 1|Phase 2	Interventional		https://ClinicalTrials.gov/show/NCT04445220
513	NCT04377997	Safety and Efficacy of Therapeutic Anticoagulation on Clinical Outcomes in Hospitalized Patients With COVID-19	Not yet recruiting	No Results Available	Cardiovascular Diseases|COVID-19	Drug: Enoxaparin	Phase 2	Interventional		https://ClinicalTrials.gov/show/NCT04377997
514	NCT04429334	"Safety, Tolerability and Efficacy of Nangibotide in Mechanically Ventilated Patients With COVID-19 and Features of Systemic Inflammation"	Not yet recruiting	No Results Available	COVID19	Drug: nangibotide|Drug: placebo	Phase 2	Interventional	"Réanimation Médicale, Hôpital Central, Nancy, France"	https://ClinicalTrials.gov/show/NCT04429334
515	NCT04338568	Screening COVID-19 by Point-of-care Lung Ultrasound: a Validation Study	Recruiting	No Results Available	COVID-19 Pneumonia|Lung Ultrasound	Diagnostic Test: Lung ultrasound	Not Applicable	Interventional	"Ziekenhuis Oost Limburg, Genk, Limburg, Belgium"	https://ClinicalTrials.gov/show/NCT04338568
516	NCT04348474	Efficacy and Safety of Hydroxychloroquine and Azithromycin for the Treatment of Ambulatory Patients With Mild COVID-19	Suspended	No Results Available	Covid-19	Drug: Hydroxychloroquine Sulfate|Drug: Azithromycin Tablets	Early Phase 1	Interventional	"Prevent Senior Private Operadora de Saúde LTDA., São Paulo, Brazil"	https://ClinicalTrials.gov/show/NCT04348474
517	NCT04386668	Let It Out (LIO) and COVID19: Testing an Online Emotional Disclosure-based Intervention During the COVID19 Pandemic	Not yet recruiting	No Results Available	COVID19	Other: Let It Out (LIO)-C|Other: Neutral writing control	Not Applicable	Interventional		https://ClinicalTrials.gov/show/NCT04386668
518	NCT04401475	"A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of EB05 + SOC vs. Placebo + SOC in Adult Hospitalized Patients With Moderate to Severe COVID-19 Pneumonia"	Not yet recruiting	No Results Available	COVID-19|ARDS	Biological: SOC plus 15mg/kg EB05 IV|Other: SOC plus Placebo IV	Phase 2|Phase 3	Interventional		https://ClinicalTrials.gov/show/NCT04401475
519	NCT04390061	TOFAcitinib Plus Hydroxycloroquine vs Hydroxycloroquine in Patients With COVID-19 Interstitial Pneumonia	Not yet recruiting	No Results Available	"Pneumonitis, Interstitial|COVID-19"	Drug: Tofacitinib|Drug: Hydroxychloroquine	Phase 2	Interventional		https://ClinicalTrials.gov/show/NCT04390061
520	NCT03891420	"A Study to Evaluate the Safety, Pharmacokinetics and Antiviral Effects of Galidesivir in Yellow Fever or COVID-19"	Recruiting	No Results Available	COVID-19|Yellow Fever	Drug: Galidesivir|Drug: Placebo	Phase 1	Interventional	"Clinical Research Unit and Department of Infectious and Parasitic Diseases Hospital das Clínicas, School of Medicine, USP, São Paulo, SP, Brazil"	https://ClinicalTrials.gov/show/NCT03891420
521	NCT04436471	"An Open Study of the Safety, Tolerability and Immunogenicity of the Drug ""Gam-COVID-Vac"" Vaccine Against COVID-19"	Recruiting	No Results Available	Preventive Immunization COVID-19	Biological: Gam-COVID-Vac	Phase 1|Phase 2	Interventional	"Main military clinical hospital named after academician N. N. Burdenko, Moscow, Russian Federation"	https://ClinicalTrials.gov/show/NCT04436471
522	NCT04349631	A Clinical Trial to Determine the Safety and Efficacy of Hope Biosciences Autologous Mesenchymal Stem Cell Therapy (HB-adMSCs) to Provide Protection Against COVID-19	Enrolling by invitation	No Results Available	COVID-19	Drug: HB-adMSCs	Phase 2	Interventional	"Hope Biosciences Stem Cell Research Foundation, Sugar Land, Texas, United States"	https://ClinicalTrials.gov/show/NCT04349631
523	NCT04442178	InterLeukin-7 to Improve Clinical Outcomes in Lymphopenic pAtients With COVID-19 Infection ( ILIAD-7-US-I )	Not yet recruiting	No Results Available	COVID-19|Lymphocytopenia	Drug: CYT107|Drug: Placebo	Phase 2	Interventional		https://ClinicalTrials.gov/show/NCT04442178
524	NCT04426201	InterLeukin-7 to Improve Clinical Outcomes in Lymphopenic pAtients With COVID-19 Infection ( ILIAD-7-US-O )	Not yet recruiting	No Results Available	COVID-19|Lymphocytopenia	Drug: CYT107|Drug: Placebo	Phase 2	Interventional		https://ClinicalTrials.gov/show/NCT04426201
525	NCT04415060	SedAting With Volatile Anesthetics Critically Ill COVID-19 Patients in ICU: Effects On Ventilatory Parameters And Survival	Not yet recruiting	No Results Available	Covid19	Drug: Isoflurane Inhalant Product|Drug: Sevoflurane inhalant product	Phase 3	Interventional	"University of Alberta Hospital, Edmonton, Alberta, Canada|London Health Sciences Centre - University Hospital, London, Ontario, Canada|London Health Sciences Centre - Victoria Hospital, London, Ontario, Canada|Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada|University Health Network - Toronto General Hospital, Toronto, Ontario, Canada|Centre hospitalier de l'Université de Montréal, Montréal, Quebec, Canada|Universite de Sherbrooke, Sherbrooke, Quebec, Canada|University Health Network - Toronto Western Hopsital, Toronto, Canada"	https://ClinicalTrials.gov/show/NCT04415060
526	NCT04379271	"A Study to Evaluate the Efficacy, Safety and Tolerability of IMU-838 as Addition to Investigator's Choice of Standard of Care Therapy, in Patients With Coronavirus Disease 19 (COVID-19)"	Recruiting	No Results Available	COVID-19	Drug: IMU-838|Other: Placebo	Phase 2|Phase 3	Interventional	"Military Medical Academy, Clinic of Infectious Diseases, Sofia, Bulgaria|UMHATEM N.I.Pirogov, Clinic of internal diseases, Sofia, Bulgaria|University Hospital Frankfurt, Infectious Diseases, Frankfurt, Germany|Clinic of the Hannover Medical School, Pneumology Clinic, Hannover, Germany"	https://ClinicalTrials.gov/show/NCT04379271
527	NCT04350580	Polyvalent Immunoglobulin in COVID-19 Related ARds	Recruiting	No Results Available	Acute Respiratory Distress Syndrome|COVID-19	Drug: Human immunoglobulin|Drug: Placebo	Phase 3	Interventional	"Centre Hospitalier Sainte-Anne, Paris, France"	https://ClinicalTrials.gov/show/NCT04350580
528	NCT04362137	"Phase 3 Randomized, Double-blind, Placebo-controlled Multi-center Study to Assess the Efficacy and Safety of Ruxolitinib in Patients With COVID-19 Associated Cytokine Storm (RUXCOVID)"	Recruiting	No Results Available	Cytokine Storm (Covid-19)	Drug: Ruxolitinib|Drug: Placebo	Phase 3	Interventional	"Novartis Investigative Site, Aurora, Colorado, United States|Novartis Investigative Site, Stamford, Connecticut, United States|Novartis Investigative Site, Boston, Massachusetts, United States|Novartis Investigative Site, Ann Arbor, Michigan, United States|Novartis Investigative Site, Newark, New Jersey, United States|Novartis Investigative Site, New York, New York, United States|Novartis Investigative Site, Seattle, Washington, United States|Novartis Investigative Site, Madison, Wisconsin, United States|Novartis Investigative Site, Aachen, Germany|Novartis Investigative Site, Lubeck, Germany|Novartis Investigative Site, Muenchen, Germany|Novartis Investigative Site, Nuernberg, Germany|Novartis Investigative Site, Bologna, BO, Italy|Novartis Investigative Site, Firenze, FI, Italy|Novartis Investigative Site, Milano, MI, Italy|Novartis Investigative Site, Rozzano, MI, Italy|Novartis Investigative Site, Barnaul, Russian Federation|Novartis Investigative Site, Moscow, Russian Federation|Novartis Investigative Site, Ryazan, Russian Federation|Novartis Investigative Site, Saint Petersburg, Russian Federation|Novartis Investigative Site, Sestroretsk, Russian Federation|Novartis Investigative Site, St Petersburg, Russian Federation|Novartis Investigative Site, Salamanca, Castilla Y Leon, Spain|Novartis Investigative Site, Barcelona, Cataluna, Spain|Novartis Investigative Site, Madrid, Spain|Novartis Investigative Site, Blackpool, United Kingdom|Novartis Investigative Site, Harrow, United Kingdom|Novartis Investigative Site, Leeds, United Kingdom|Novartis Investigative Site, London, United Kingdom|Novartis Investigative Site, London, United Kingdom|Novartis Investigative Site, Manchester, United Kingdom"	https://ClinicalTrials.gov/show/NCT04362137
529	NCT04438837	Hydroxychloroquine Post-Exposure Prophylaxis for Coronavirus Disease (COVID-19) Among Health-Care Workers	Not yet recruiting	No Results Available	Coronavirus Disease 2019 (COVID-19)|Post-Exposure Prophylaxis	Drug: Hydroxychloroquine	Not Applicable	Interventional	"Rambam Health Care Campus, Haifa, Israel"	https://ClinicalTrials.gov/show/NCT04438837
530	NCT04394793	Low Dose Radiation Therapy for Covid-19 Pneumonia	Recruiting	No Results Available	COVID-19|Pneumonia	Radiation: Low dose radiation therapy	Not Applicable	Interventional	"All India Institute of Medical Sciences, New Delhi, New Delhi, Delhi, India"	https://ClinicalTrials.gov/show/NCT04394793
531	NCT04348877	Plasma Rich Antibodies From Recovered Patients From COVID19	Not yet recruiting	No Results Available	Coronavirus Disease (COVID-19)	Other: Antibody-Rich Plasma from COVID-19 recovered patients	Not Applicable	Interventional	"Faculty of Medicine Ain Shams University Research Institute- Clinical Research Center, Cairo, Non-US, Egypt"	https://ClinicalTrials.gov/show/NCT04348877
532	NCT04328480	The ECLA PHRI COLCOVID Trial. Effects of Colchicine on Moderate/High-risk Hospitalized COVID-19 Patients.	Recruiting	No Results Available	COVID-19	Drug: Colchicine|Other: Local standard of care	Phase 3	Interventional	"Sanatorio Parque, Rosario, Santa Fe, Argentina"	https://ClinicalTrials.gov/show/NCT04328480
533	NCT04357327	Rapid Salivary Test to Detect SARS-CoV-2 (COVID-19)	Recruiting	No Results Available	COVID-19|SARS-CoV 2|Corona Virus Infection	Diagnostic Test: rapid salivary test	Not Applicable	Interventional	"ASST dei Sette Laghi, Varese, VA, Italy"	https://ClinicalTrials.gov/show/NCT04357327
534	NCT04437719	"Prospective Cohort Study to Describe the Clinical Characteristics of COVID-19, the Acquired Immune Response and the Biological and Clinical Parameters of Patients Followed in Oncology by the Saint-Joseph Hospital Group for a Period of 6 Months During the COVID-19 Pandemic"	Not yet recruiting	No Results Available	Oncology|COVID-19	Other: Obvio-19 app	Not Applicable	Interventional	"Groupe Hospitalier Paris Saint-Joseph, Paris, France"	https://ClinicalTrials.gov/show/NCT04437719
535	NCT04355897	CoVID-19 Plasma in Treatment of COVID-19 Patients	Recruiting	No Results Available	COVID 19	Biological: Convalescent COVID 19 Plasma	Early Phase 1	Interventional	"The Christ Hospital, Cincinnati, Ohio, United States|University Hospitals Cleveland Medical Center, Cleveland, Ohio, United States"	https://ClinicalTrials.gov/show/NCT04355897
536	NCT04344756	"Trial Evaluating Efficacy and Safety of Anticoagulation in Patients With COVID-19 Infection, Nested in the Corimmuno-19 Cohort"	Not yet recruiting	No Results Available	COVID19 Pneumonia	Drug: Tinzaparin or unfractionated heparin	Phase 2	Interventional	"Réanimation hôpital Louis Mourier, Colombes, Hauts De Seine, France|réanimation hôpital Cochin, Paris, France|Médecine vasculaire, Hôpital Européen Georges Pompidou, Paris, France"	https://ClinicalTrials.gov/show/NCT04344756
537	NCT04366232	Efficacy of Intravenous Anakinra and Ruxolitinib During COVID-19 Inflammation (JAKINCOV)	Not yet recruiting	No Results Available	Covid-19	Drug: Anakinra alone (stages 2b/3)|Drug: Anakinra and Ruxolitinib (overcome stage 3)|Other: Standard of care	Phase 2	Interventional	"AP-HM, Hôpital de la Conception, Marseille, Bouches-du-Rhône, France|Hôpital Sainte-Musse, Toulon, VAR, France|Sainte Anne Teaching Military Hospital, Toulon, Var, France"	https://ClinicalTrials.gov/show/NCT04366232
538	NCT04383535	Convalescent Plasma and Placebo for the Treatment of COVID-19 Severe Pneumonia	Recruiting	No Results Available	SARS Virus|SARS-CoV-2|COVID-19	Other: Convalescent SARS COVID-19 plasma|Other: Placebo	Not Applicable	Interventional	"Hospital Italiano de Buenos Aires, Ciudad Autonoma de Buenos Aire, Ciudad Autonoma De Buenos Aires, Argentina"	https://ClinicalTrials.gov/show/NCT04383535
539	NCT04364893	Angiotensin Receptor Blockers and Angiotensin-converting Enzyme Inhibitors and Adverse Outcomes in Patients With COVID19	Recruiting	No Results Available	Corona Virus Infection|COVID-19	Other: Suspension or Maintenance of Angiotensin Receptor Blockers and Angiotensin-converting Enzyme Inhibitors	Not Applicable	Interventional	"Idor, São Paulo, Brazil"	https://ClinicalTrials.gov/show/NCT04364893
540	NCT04400032	Cellular Immuno-Therapy for COVID-19 Acute Respiratory Distress Syndrome - Vanguard	Not yet recruiting	No Results Available	Acute Respiratory Distress Syndrome|Covid19	Biological: Mesenchymal Stromal Cells	Phase 1	Interventional	"The Ottawa Hospital, Ottawa, Ontario, Canada"	https://ClinicalTrials.gov/show/NCT04400032
541	NCT04371640	Sirolimus in COVID-19 Phase 1	Recruiting	No Results Available	SARS-CoV-2|Covid-19	Drug: Sirolimus 1 MG/ML|Drug: Placebo	Phase 1	Interventional	"Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, United States"	https://ClinicalTrials.gov/show/NCT04371640
542	NCT04344782	"Trial Evaluating Efficacy and Safety of Bevacizumab (Avastin®/Zeribev®) in Patients With COVID-19 Infection, Nested in the Corimmuno-19 Cohort"	Not yet recruiting	No Results Available	COVID19 Pneumonia	Drug: Bevacizumab Injection	Phase 2	Interventional		https://ClinicalTrials.gov/show/NCT04344782
543	NCT04342663	"A Double-blind, Placebo-controlled Clinical Trial of Fluvoxamine for Symptomatic Individuals With COVID-19 Infection"	Recruiting	No Results Available	COVID 19|Coronavirus	Drug: Fluvoxamine|Drug: Placebo	Phase 2	Interventional	"BJC, Belleville, Illinois, United States|Washington University School of Medicine, Saint Louis, Missouri, United States"	https://ClinicalTrials.gov/show/NCT04342663
544	NCT04405921	"Hydroxychloroquine, Azithromycin in the Treatment of Covid-19"	Not yet recruiting	No Results Available	SARS-CoV-2 Pneumonia|COVID-19	Drug: Hydroxychloroquine 200 Mg Oral Tablet|Drug: Azithromycin 250 MG	Phase 3	Interventional	"University Hospital Farhat Hached, Sousse, Tunisia"	https://ClinicalTrials.gov/show/NCT04405921
545	NCT04401202	Nigella Sativa in COVID-19	Recruiting	No Results Available	COVID-19|SARS-CoV-2	Dietary Supplement: Nigella sativa	Phase 2	Interventional	"King Abdulaziz University Hospital, Jeddah, Saudi Arabia"	https://ClinicalTrials.gov/show/NCT04401202
546	NCT04382053	Study of Efficacy and Safety of DV890 in Patients With COVID-19 Pneumonia	Recruiting	No Results Available	"COVID 19 Pneumonia, Impaired Respiratory Function"	Drug: DFV890|Drug: Standard of Care (SoC)	Phase 2	Interventional	"Novartis Investigative Site, Copenhagen, Denmark|Novartis Investigative Site, Hvidovre, Denmark|Novartis Investigative Site, Heidelberg, Baden-Württemberg, Germany|Novartis Investigative Site, Regensburg, Bavaria, Germany|Novartis Investigative Site, Bonn, Germany|Novartis Investigative Site, Hannover, Germany|Novartis Investigative Site, Wuerzburg, Germany|Novartis Investigative Site, Budapest, Hungary|Novartis Investigative Site, Budapest, Hungary"	https://ClinicalTrials.gov/show/NCT04382053
547	NCT04416113	Photodynamic Therapy for the Treatment of COVID-19	Not yet recruiting	No Results Available	Photodynamic Therapy& Low Level Laser in Management of COVID 19	Procedure: photobiomodulation and photodynamic therapy	Not Applicable	Interventional		https://ClinicalTrials.gov/show/NCT04416113
548	NCT04435795	Inhaled Ciclesonide for Outpatients With COVID19	Not yet recruiting	No Results Available	COVID 19	Drug: Ciclesonide	Phase 2|Phase 3	Interventional		https://ClinicalTrials.gov/show/NCT04435795
549	NCT04363749	COVID-19 Infection: Exploration of Respiratory Control Center Abnormalities	Not yet recruiting	No Results Available	Covid19|Neurological Complication	"Other: hypoxia : 14.3 and 12.7% FIO2, hypercapnia 7% CO2, inspiratory mechanical constraint"	Not Applicable	Interventional		https://ClinicalTrials.gov/show/NCT04363749
550	NCT04429854	Donated Antibodies Working Against nCoV	Recruiting	No Results Available	COVID-19	Biological: Convalescent Plasma|Drug: Standard of care	Phase 2	Interventional	"ZNA, Antwerpen, Belgium|Institut Bordet, Brussel, Belgium|UMC Sint-Pieter, Brussel, Belgium|CHU Brugmann, Brussel, Belgium|Erasmus Ziekenhuis, Brussel, Belgium|UZ Brussel, Brussel, Belgium|Cliniques Universitaires St Luc, Brussel, Belgium|AZ Groeninge, Kortrijk, Belgium|UZ Leuven, Leuven, Belgium|CHC Liège Mont Légia, Liège, Belgium|CHR Citadelle Liège, Liège, Belgium|CHU Liège Sart-Tilman, Liège, Belgium|CHR Jolimont Mons-Hainaut, Mons, Belgium|AZ Delta, Roeselare, Belgium"	https://ClinicalTrials.gov/show/NCT04429854
551	NCT04336774	CAPTION AI to Minimize Risk of COVID Exposure	Recruiting	No Results Available	COVID-19	Device: Caption AI	Not Applicable	Interventional	"Duke Health, Durham, North Carolina, United States|Duke University Medical Center, Durham, North Carolina, United States"	https://ClinicalTrials.gov/show/NCT04336774
552	NCT04395976	Ayurveda as Prophylaxis for Suspected COVID-19 Patients	Not yet recruiting	No Results Available	Covid-19	Other: Ayurveda	Not Applicable	Interventional	"British Ayurvedic Medical Council, London, United Kingdom"	https://ClinicalTrials.gov/show/NCT04395976
553	NCT04362813	Study of Efficacy and Safety of Canakinumab Treatment for CRS in Participants With COVID-19-induced Pneumonia	Recruiting	No Results Available	Pneumonia and Cytokine Release Syndrome (Covid-19)	Drug: Canakinumab|Drug: Placebo	Phase 3	Interventional	"Novartis Investigative Site, Glendale, California, United States|Novartis Investigative Site, San Francisco, California, United States|Novartis Investigative Site, San Francisco, California, United States|Novartis Investigative Site, Chicago, Illinois, United States|Novartis Investigative Site, Baltimore, Maryland, United States|Novartis Investigative Site, Boston, Massachusetts, United States|Novartis Investigative Site, Boston, Massachusetts, United States|Novartis Investigative Site, Brooklyn, New York, United States|Novartis Investigative Site, Chapel Hill, North Carolina, United States|Novartis Investigative Site, Philadelphia, Pennsylvania, United States|Novartis Investigative Site, Houston, Texas, United States|Novartis Investigative Site, Richmond, Virginia, United States|Novartis Investigative Site, Lyon cedex 04, Rhone, France|Novartis Investigative Site, Marseille, France|Novartis Investigative Site, Nantes Cedex 1, France|Novartis Investigative Site, Paris, France|Novartis Investigative Site, Toulouse Cedex 4, France|Novartis Investigative Site, Lubeck, Germany|Novartis Investigative Site, Mainz, Germany|Novartis Investigative Site, Muenchen, Germany|Novartis Investigative Site, Bergamo, BG, Italy|Novartis Investigative Site, Milano, MI, Italy|Novartis Investigative Site, Milano, MI, Italy|Novartis Investigative Site, Rozzano, MI, Italy|Novartis Investigative Site, Moscow, Russian Federation|Novartis Investigative Site, Sestroretsk, Russian Federation|Novartis Investigative Site, St Petersburg, Russian Federation|Novartis Investigative Site, Barcelona, Catalunya, Spain|Novartis Investigative Site, San Sebastian de los Reyes, Madrid, Spain|Novartis Investigative Site, Madrid, Spain|Novartis Investigative Site, Madrid, Spain|Novartis Investigative Site, Madrid, Spain|Novartis Investigative Site, Barnet, United Kingdom|Novartis Investigative Site, Coventry, United Kingdom|Novartis Investigative Site, Leeds, United Kingdom|Novartis Investigative Site, London, United Kingdom|Novartis Investigative Site, London, United Kingdom"	https://ClinicalTrials.gov/show/NCT04362813
554	NCT04323345	Efficacy of Natural Honey Treatment in Patients With Novel Coronavirus	Recruiting	No Results Available	COVID-19	Dietary Supplement: Natural Honey|Other: Standard Care	Phase 3	Interventional	"Mahmoud Tantawy, Cairo, Egypt"	https://ClinicalTrials.gov/show/NCT04323345
555	NCT04437875	"An Open Study of the Safety, Tolerability and Immunogenicity of ""Gam-COVID-Vac Lyo"" Vaccine Against COVID-19"	Recruiting	No Results Available	Preventive Immunization COVID-19	Biological: Gam-COVID-Vac Lyo	Phase 1|Phase 2	Interventional	"Sechenov First Moscow State Medical University, Moscow, Russian Federation"	https://ClinicalTrials.gov/show/NCT04437875
556	NCT04387955	Analysis of Chilblains pROfile During coVID-19 Epidemic (ACROVID)	Not yet recruiting	No Results Available	COVID-19|Chilblains	Diagnostic Test: Biological Sample Collection	Not Applicable	Interventional		https://ClinicalTrials.gov/show/NCT04387955
557	NCT04405986	Exploring Brain Damages After COVID-19 Infection	Recruiting	No Results Available	SARS-CoV 2	Procedure: Auditory Evoked Potentials (AEP)|Procedure: Blink and Masseter Inhibitory Reflex	Not Applicable	Interventional	"CHU de Bordeaux, Bordeaux, France"	https://ClinicalTrials.gov/show/NCT04405986
558	NCT04438850	COVidIVERmectin: Ivermectin for Treatment of Covid-19	Not yet recruiting	No Results Available	Covid19	Drug: Ivermectin|Other: Placebo	Phase 2	Interventional	"IRCCS Sacro Cuore Don Calabria hospital, Negrar, Verona, Italy|Policlinico S. Orsola, Bologna, Italy|Ospedale Luigi Sacco, Milan, Italy|Ospedale di Rovereto, Rovereto, Italy|Ospedale Amedeo di Savoia, Turin, Italy|Hospital Clinic/ISGlobal, Barcelona, Spain|Hospital La Paz-Carlos III, Madrid, Spain"	https://ClinicalTrials.gov/show/NCT04438850
559	NCT04377646	A Study of Hydroxychloroquine and Zinc in the Prevention of COVID-19 Infection in Military Healthcare Workers	Not yet recruiting	No Results Available	Sars-CoV2|COVID19	Drug: Hydroxychloroquine|Drug: Hydroxychloroquine (placebo)|Drug: Zinc|Drug: Zinc (Placebo)	Phase 3	Interventional	"Military Hospital of Tunis, Tunis, Tunisia"	https://ClinicalTrials.gov/show/NCT04377646
560	NCT04356534	Convalescent Plasma Trial in COVID -19 Patients	Recruiting	No Results Available	SARS-CoV 2|COVID-19	Other: plasma therapy using convalescent plasma with antibody against SARS-CoV-2|Other: Routine care for COVID-19 patients	Not Applicable	Interventional	"Royal College of Surgeons in Ireland - Bahrain, Manama, Bahrain"	https://ClinicalTrials.gov/show/NCT04356534
561	NCT04381988	A Study of Hydroxychloroquine vs Placebo to Prevent COVID-19 Infection in Patients Receiving Radiotherapy	Recruiting	No Results Available	COVID-19|Cancer	Drug: Hydroxychloroquine|Other: Placebo|Radiation: Radiation therapy	Phase 2	Interventional	"Memoral Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge, New Jersey, United States|Memoral Sloan Kettering Monmouth (All protocol activities), Middletown, New Jersey, United States|Memorial Sloan Kettering Bergen (All protocol Activities), Montvale, New Jersey, United States|Memorial Sloan Kettering Commack (All Protocol Activities), Commack, New York, United States|Memoral Sloan Kettering Westchester (All protocol activities), Harrison, New York, United States|Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York, New York, United States|Memorial Sloan Kettering Nassau (All Protocol Activities), Uniondale, New York, United States"	https://ClinicalTrials.gov/show/NCT04381988
562	NCT04375735	London's Exogenous Surfactant Study for COVID19	Not yet recruiting	No Results Available	"ARDS, Human|COVID-19"	Drug: Bovine Lipid Extract Surfactant	Phase 1|Phase 2	Interventional		https://ClinicalTrials.gov/show/NCT04375735
563	NCT04377308	Fluoxetine to Reduce Intubation and Death After COVID19 Infection	Recruiting	No Results Available	COVID-19|Cytokine Storm	Drug: Fluoxetine	Phase 4	Interventional	"University of Toledo, Toledo, Ohio, United States"	https://ClinicalTrials.gov/show/NCT04377308
564	NCT04343001	Coronavirus Response - Active Support for Hospitalised Covid-19 Patients	Not yet recruiting	No Results Available	Covid-19	Drug: Aspirin|Drug: Losartan|Drug: Simvastatin	Phase 3	Interventional	"University College Hospital, Ibadan, Oyo, Nigeria|Shifa Tameer-e-Millat University, Rawalpindi, Pakistan"	https://ClinicalTrials.gov/show/NCT04343001
565	NCT04354259	Interferon Lambda for Immediate Antiviral Therapy at Diagnosis in COVID-19	Recruiting	No Results Available	Sars-CoV2|Covid-19	Drug: Peginterferon Lambda-1A|Other: placebo	Phase 2	Interventional	"Toronto General Hospital, Toronto, Ontario, Canada"	https://ClinicalTrials.gov/show/NCT04354259
566	NCT04409327	Phase 3 Study to Determine if RTB101 Reduces the Severity of COVID-19 in Older Adults Residing in Nursing Homes	Recruiting	No Results Available	COVID19	Drug: RTB101|Drug: Placebo	Phase 3	Interventional	"Nursing Home, Middletown, Rhode Island, United States"	https://ClinicalTrials.gov/show/NCT04409327
567	NCT04355351	Study of Immune Response During SARS-CoV-2 Infection - (COVID-19)	Recruiting	No Results Available	"New Coronavirus Disease (COVID-19), Infection With SARS-CoV-2"	Other: blood sampling|Other: additional blood tubes	Not Applicable	Interventional	"Antibes Hospital, Antibes, France|Cannes Hospital, Cannes, France|Nice Hospital, Nice, France"	https://ClinicalTrials.gov/show/NCT04355351
568	NCT04348500	Clazakizumab (Anti-IL- 6 Monoclonal) Compared to Placebo for COVID19 Disease	Recruiting	No Results Available	COVID19	Drug: Clazakizumab	Phase 2	Interventional	"Cedars-Sinai Medical Center, Los Angeles, California, United States"	https://ClinicalTrials.gov/show/NCT04348500
569	NCT04393961	At-Home COVID-19 Antibody Test Usability Assessment & Behavior Change Study	Recruiting	No Results Available	COVID19|COVID-19|Coronavirus	Device: Premier Biotech COVID-19 IgG/IgM Rapid test Cassette	Not Applicable	Interventional	"ProofPilot Online App (https://p.proofpilot.com), New York, New York, United States"	https://ClinicalTrials.gov/show/NCT04393961
570	NCT04344288	Corticosteroids During Covid-19 Viral Pneumonia Related to SARS-Cov-2 Infection	Recruiting	No Results Available	Viral Pneumonia Human Coronavirus|COVID-19	Drug: Prednisone|Other: Control group	Phase 2	Interventional	"Hôpital Pneumologique et Cardiovasculaire Louis Pradel, Bron, France|Groupement Hospitalier Nord, Lyon, France|Groupement Hospitalier Nord, Lyon, France|Hôpital Edouard Herriot, Lyon, France|Hôpital St Joseph Saint Luc, Lyon, France|Hôpital St Joseph, Marseille, France|Centre hospitalier Lyon Sud, Pierre-Bénite, France|Centre hospitalier Lyon Sud, Pierre-Bénite, France|CHU St Etienne, Saint-Étienne, France|Clinique Charcot, Sainte-Foy-lès-Lyon, France|CHG Vienne, Vienne, France|Médipôle, Villeurbanne, France|Clinique des Portes du Sud, Vénissieux, France|CH Annecy-Genevois, Épagny, France"	https://ClinicalTrials.gov/show/NCT04344288
571	NCT04398290	iNOPulse for COVID-19	Not yet recruiting	No Results Available	COVID-19|Hypoxemia|Hypoxemic Respiratory Failure	Drug: Inhaled nitric oxide (iNO)|Drug: Nitrogen gas|Drug: Oxygen gas	Phase 2	Interventional	"University of Miami Hospitals & Clinics, Miami, Florida, United States"	https://ClinicalTrials.gov/show/NCT04398290
572	NCT04410549	Pulmonary Optical Coherence Tomography in COVID-19 Patients	Recruiting	No Results Available	Covid19|Pulmonary Embolism	Diagnostic Test: Optical Coherence Tomography (OCT)	Not Applicable	Interventional	"IRCCS San Raffaele, Milano, Italy"	https://ClinicalTrials.gov/show/NCT04410549
573	NCT04456049	Randomized Open Label Phase II Study to Evaluate the Efficacy of Enzalutamide in High Risk Male Outpatients With COVID-19	Not yet recruiting	No Results Available	COVID-19 Infection	Drug: Enzalutamide	Phase 2	Interventional	"Oncology Institute of Southern Switzerland (IOSI), Bellinzona, Switzerland"	https://ClinicalTrials.gov/show/NCT04456049
574	NCT04341870	"Study of Immune Modulatory Drugs and Other Treatments in COVID-19 Patients: Sarilumab, Azithromycin, Hydroxychloroquine Trial - CORIMUNO-19 - VIRO"	Suspended	No Results Available	COVID19|SARS-CoV-2 Infection	Drug: Sarilumab|Drug: Azithromycin|Drug: Hydroxychloroquine	Phase 2|Phase 3	Interventional	"AP-HP Hôpital Avicenne, Bobigny, France|AP-HP Hôpital Ambroise Paré, Boulogne-Billancourt, France|AP-HP Hôpital Beaujon, Clichy, France|AP-HP Hôpital Pitié Salpétrière, Paris, France|AP-HP Hôpital Saint Antoine, Paris, France"	https://ClinicalTrials.gov/show/NCT04341870
575	NCT04348383	Defibrotide as Prevention and Treatment of Respiratory Distress and Cytokine Release Syndrome of Covid 19.	Recruiting	No Results Available	COVID19	Drug: Defibrotide 25 mg/kg 24 hours continuous infusion for 15 days|Drug: Placebo 250 cc 24 hours continuous infusion for 15 days	Phase 2	Interventional	"Virgen de la Arrixaca University Clinical Hospital, Murcia, Spain"	https://ClinicalTrials.gov/show/NCT04348383
576	NCT04344951	"Chloroquine Phosphate Against Infection by the Novel Coronavirus SARS-CoV-2 (COVID-19): The HOPE Open-Label, Non Randomized Clinical Trial"	Recruiting	No Results Available	"Pneumonia, Viral|Covid-19"	Drug: UNIKINON (Chloroquine phosphate) 200mg tablets	Phase 2	Interventional	"Divine Providence Hospital ""Pammakaristos"", Athens, Greece|Athens General Hospital ""Hippokrateio"", Athens, Greece|Athens General Hospital of Thoracic Diseases ""SOTIRIA"", 1st University Pulmonary Clinic, Athens, Greece|Athens General Hospital of Thoracic Diseases ""SOTIRIA"", 3rd University Pathology Clinic, Athens, Greece|Corfu General Hospital Agia Irini, Corfu, Greece|University General Hospital of Ioannina, Ioánnina, Greece|General Hospital of Athens ""Sismanoglio"", Maroúsi, Greece|University General Hospital of Thessaloniki AHEPA, Thessaloníki, Greece"	https://ClinicalTrials.gov/show/NCT04344951
577	NCT04352400	Efficacy of Nafamostat in Covid-19 Patients (RACONA Study)	Not yet recruiting	No Results Available	COVID19	Drug: Nafamostat Mesilate|Drug: Placebo	Phase 2|Phase 3	Interventional		https://ClinicalTrials.gov/show/NCT04352400
578	NCT04392128	Study Evaluating the Efficacy of Hydroxychloroquine and Azithromycine in Patients With COVID-19 and Hematological Malignancies (HYACINTHE)	Not yet recruiting	No Results Available	COVID19|Hematologic Malignancy	Drug: Hydroxychloroquine Sulfate 200 MG [Plaquenil]|Drug: Azithromycin 250 MG Oral Capsule|Drug: Placebo oral tablet|Drug: Placebo oral capsule	Phase 2	Interventional	"Institut de Cancérologie Strasbourg Europe, Strasbourg, France"	https://ClinicalTrials.gov/show/NCT04392128
579	NCT04261517	Efficacy and Safety of Hydroxychloroquine for Treatment of COVID-19	Completed	No Results Available	"Pneumonia, Pneumocystis|Coronavirus|COVID-19"	Drug: Hydroxychloroquine	Phase 3	Interventional	"Shanghai Public Health Clinical Center, Shanghai, Shanghai, China|Shanghai Public Health Clinical Center, Shanghai, Shanghai, China"	https://ClinicalTrials.gov/show/NCT04261517
580	NCT04360824	Covid-19 Associated Coagulopathy	Recruiting	No Results Available	COVID 19 Associated Coagulopathy	Drug: Intermediate dose thromboprophylaxis|Drug: Standard of Care thromboprophylaxis	Phase 4	Interventional	"University of Iowa, Iowa City, Iowa, United States|Gundersen Health System, La Crosse, Wisconsin, United States"	https://ClinicalTrials.gov/show/NCT04360824
581	NCT04369469	Efficacy and Safety Study of IV Ravulizumab in Patients With COVID-19 Severe Pneumonia	Recruiting	No Results Available	"COVID-19 Severe Pneumonia, Acute Lung Injury, or Acute Respiratory Distress Syndrome|Pneumonia, Viral"	Biological: Ravulizumab|Other: Best Supportive Care	Phase 3	Interventional	"Clinical Trial Site, Washington, District of Columbia, United States|Clinical Trial Site, Boston, Massachusetts, United States|Clinical Trial Site, Detroit, Michigan, United States|Clinical Trial Site, Créteil, France|Clinical Trial Site, Garches, France|Clinical Trial Site, Le Kremlin-Bicêtre, France|Clinical Trial Site, Paris, France|Clinical Trial Site, Barcelona, Spain|Clinical Trial Site, Barcelona, Spain|Clinical Trial Site, Madrid, Spain|Clinical Trial Site, Madrid, Spain|Clinical Trial Site, London, Greater London, United Kingdom|Clinical Trial Site, London, Greater London, United Kingdom|Clinical Trial Site, Leeds, United Kingdom"	https://ClinicalTrials.gov/show/NCT04369469
582	NCT04367831	Intermediate or Prophylactic-Dose Anticoagulation for Venous or Arterial Thromboembolism in Severe COVID-19	Recruiting	No Results Available	COVID-19|Venous Thromboses|Arterial Thrombosis	Drug: Enoxaparin Prophylactic Dose|Drug: Heparin Infusion|Drug: Heparin SC|Drug: Enoxaparin/Lovenox Intermediate Dose	Phase 4	Interventional	"Columbia University Medical Center, New York, New York, United States"	https://ClinicalTrials.gov/show/NCT04367831
583	NCT04359251	Different PEEP Settings of COVID-19 Induced ARDS	Completed	No Results Available	COVID-19|Mechanical Ventilation Pressure High|Acute Respiratory Distress Syndrome	Other: Gas exchanges at different PEEP|Other: lung mechanics at different PEEP|Other: Hemodynamics changes at different PEEP	Not Applicable	Interventional	"Zhongda Hospital, Southeast University, Nanjing, Jiangsu, China"	https://ClinicalTrials.gov/show/NCT04359251
584	NCT04424901	Trial of Open Label Dipyridamole- In Hospitalized Patients With COVID-19	Recruiting	No Results Available	COVID-19 Pneumonia|Vascular Complications	Drug: Dipyridamole	Phase 2	Interventional	"UConn Health, Farmington, Connecticut, United States"	https://ClinicalTrials.gov/show/NCT04424901
585	NCT04411667	Study of Standard of Care Plus Intravenous Immunoglobulin (IVIG) Compared to Standard of Care Alone in the Treatment of COVID-19 Infection	Recruiting	No Results Available	Sars-CoV2	Drug: Octagam	Phase 4	Interventional	"Sharp Grossmont Hospital, La Mesa, California, United States|Sharp Memorial Hospital, San Diego, California, United States"	https://ClinicalTrials.gov/show/NCT04411667
586	NCT04398004	Anti-inflammatory Clarithromycin for Improving COVID-19 Infection Early	Recruiting	No Results Available	COVID-19|Virus Diseases|Corona Virus Infection	Drug: Clarithromycin	Phase 2	Interventional	"COVID-19 Department, General Hospital of Attica SISMANOGLEIO-AMALIA FLEMING, Marousi, Athens, Greece|2nd Department of Internal Medicine, General Hospital of Nikaia, Piraeus, Attica, Greece|2nd Department of Internal Medicine, University General Hospital of Alexandroupolis, Alexandroupolis, Greece|1st University Department of Internal Medicine, LAIKO General Hospital of Athens, Athens, Greece|2nd University Department of Internal Medicine, IPPOKRATEION General Hospital of Athens, Athens, Greece|3rd University Department of Internal Medicine, General Hospital of Chest Diseases of Athens I SOTIRIA, Athens, Greece|1st Department of Internal Medicine, General University Hospital of Ioannina, Ioánnina, Greece|2nd Department of Internal Medicine, General Hospital of Piraeus ""Tzaneio"", Piraeus, Greece|1st Department of Internal Medicine, AHEPA University General Hospital of Thessaloniki, Thessaloníki, Greece"	https://ClinicalTrials.gov/show/NCT04398004
587	NCT04375098	Efficacy and Safety of Early COVID-19 Convalescent Plasma in Patients Admitted for COVID-19 Infection	Recruiting	No Results Available	Severe Acute Respiratory Syndrome Coronavirus 2	Biological: COVID-19 convalescent plasma	Phase 2	Interventional	"Hospital Clínico Universidad Católica, Santiago, Chile"	https://ClinicalTrials.gov/show/NCT04375098
588	NCT04330144	Hydroxychloroquine as Post Exposure Prophylaxis for SARS-CoV-2(HOPE Trial)	Not yet recruiting	No Results Available	Contact Person From COVID-19 Confirmed Patient	Drug: Hydroxychloroquine as post exposure prophylaxis|Other: Others(No intervention)	Phase 3	Interventional		https://ClinicalTrials.gov/show/NCT04330144
589	NCT04406532	Home-Based Covid-19 Rehabilitation Program	Not yet recruiting	No Results Available	Covid-19	Behavioral: PT-Pal|Behavioral: Self-guided exercises	Not Applicable	Interventional		https://ClinicalTrials.gov/show/NCT04406532
590	NCT04299724	Safety and Immunity of Covid-19 aAPC Vaccine	Recruiting	No Results Available	Treat and Prevent Covid-19 Infection	Biological: Pathogen-specific aAPC	Phase 1	Interventional	"Shenzhen Geno-immune Medical Institute, Shenzhen, Guangdong, China"	https://ClinicalTrials.gov/show/NCT04299724
591	NCT04251767	Washed Microbiota Transplantation for Patients With 2019-nCoV Infection	Withdrawn	No Results Available	COVID-19 Complicated With Refractory Intestinal Infections	Other: washed microbiota transplantation|Other: placebo	Not Applicable	Interventional	"Medical Center for Digestive Diseases, The Second Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China"	https://ClinicalTrials.gov/show/NCT04251767
592	NCT04348513	Triiodothyronine for the Treatment of Critically Ill Patients With COVID-19 Infection	Recruiting	No Results Available	Pulmonary Infection|Covid-19	Drug: T3 solution for injection|Drug: Placebo	Phase 2	Interventional	"Attikon University General Hospital, Haidari/Athens, Greece"	https://ClinicalTrials.gov/show/NCT04348513
593	NCT04361344	Neurodegeneration Markers and Neurological Course in Severe Covid-19 Infection	Recruiting	No Results Available	COVID-19 Infection|Encephalitis	Biological: blood samples	Not Applicable	Interventional	"CH de Pau, Pau, France"	https://ClinicalTrials.gov/show/NCT04361344
594	NCT04347681	Potential Efficacy of Convalescent Plasma to Treat Severe COVID-19 and Patients at High Risk of Developing Severe COVID-19	Recruiting	No Results Available	Convalescent Plasma for COVID 19	Other: convalescent plasma from recovered COVID 19 donor	Phase 2	Interventional	"John Hopkins Aramco Healthcare, Dhahran, Eastern Provence, Saudi Arabia|Dammam Medical Complex, Dammam, Saudi Arabia|Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia|king Fahad specialist hospital, Dammam, Saudi Arabia|DHahran Military Medical Complex, Dhahran, Saudi Arabia|International Medical Center, Jeddah, Saudi Arabia|Madinah General Hospital, Medina, Saudi Arabia|Ohud Hospital, Medina, Saudi Arabia|Taibah University, Medina, Saudi Arabia|Qatif Central Hospital, Qatif, Saudi Arabia|King Abdulaziz Medical City, Riyadh, Saudi Arabia|King Fahad Medical City, Riyadh, Saudi Arabia|King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia|King Khalid University Hospital, Riyadh, Saudi Arabia"	https://ClinicalTrials.gov/show/NCT04347681
595	NCT04368923	Management of Covid-19 Patients During Home Isolation	"Active, not recruiting"	No Results Available	Covid 19	Device: Oxygen Therapy|Procedure: Physical Therapy	Not Applicable	Interventional	"M. Sedky, Cairo, Egypt"	https://ClinicalTrials.gov/show/NCT04368923
596	NCT04403646	Tannin Specific Natural Extract for COVID-19 Infection	Not yet recruiting	No Results Available	COVID-19|SARS-CoV 2|Coronavirus Infection	Dietary Supplement: ARBOX|Other: PLACEBO	Not Applicable	Interventional		https://ClinicalTrials.gov/show/NCT04403646
597	NCT04343144	"Trial Evaluating Efficacy and Safety of Nivolumab (Optivo®) in Patients With COVID-19 Infection, Nested in the Corimmuno-19 Cohort."	Not yet recruiting	No Results Available	COVID19- Infection With SARS-CoV-2 Virus	Drug: Nivolumab Injection	Phase 2	Interventional	"Pneumologie hôpital Tenon, Paris, France"	https://ClinicalTrials.gov/show/NCT04343144
598	NCT04409925	DISmantling COvid iNduced Neutrophil ExtraCellular Traps (DISCONNECT-1)	Not yet recruiting	No Results Available	COVID-19 Infection	Drug: rhDNase I	Phase 1	Interventional		https://ClinicalTrials.gov/show/NCT04409925
599	NCT04377568	Efficacy of Human Coronavirus-immune Convalescent Plasma for the Treatment of COVID-19 Disease in Hospitalized Children	Not yet recruiting	No Results Available	Hospitalized Children|Covid-19 Infection	Biological: Convalescent plasma (CP)	Phase 2	Interventional	"Alberta Children's Hospital, Calgary, Alberta, Canada|Stollery Children's Hospital, Edmonton, Alberta, Canada|BC Children's Hospital, Vancouver, British Columbia, Canada|Winnipeg Children's Hospital, Winnipeg, Manitoba, Canada|IWK Health Centre, Halifax, Nova Scotia, Canada|McMaster Children's Hospital, Hamilton, Ontario, Canada|Kingston Health Sciences Centre, Kingston, Ontario, Canada|Children's Hospital, London, Ontario, Canada|Children's Hospital of Eastern Ontario, Ottawa, Ontario, Canada|The Hospital for Sick Children, Toronto, Ontario, Canada|CHU Sainte-Justine, Montréal, Quebec, Canada|McGill Univ Health Ctr - Montreal Children's Hospital, Montréal, Quebec, Canada|Royal University Hospital, Saskatoon, Saskatchewan, Canada"	https://ClinicalTrials.gov/show/NCT04377568
600	NCT04392531	Clinical Trial to Assess Efficacy of cYclosporine Plus Standard of Care in Hospitalized Patients With COVID19	Recruiting	No Results Available	COVID19 Infection	Drug: Cyclosporine|Drug: Standard treatment	Phase 4	Interventional	"Complejo Hospitalario Universitario La Coruña, La Coruña, Galicia, Spain|Hospital Quiron La Coruña, La Coruña, Galicia, Spain|Hospital Rey Juan Carlos, Mostoles, Madrid, Spain|Hospital Infanta Elena, Valdemoro, Madrid, Spain|Hospital General de Villalba, Villalba, Madrid, Spain|Fundacion Jimenez Diaz, Madrid, Spain|Clinica Universitaria de Navarra, Madrid, Spain"	https://ClinicalTrials.gov/show/NCT04392531
601	NCT04425707	Ivermectin In Treatment of COVID 19 Patients	Recruiting	No Results Available	Covid19	Drug: Ivermectin	Not Applicable	Interventional	"isolation and referal hospitals for COVID 19 patients, Cairo, Egypt"	https://ClinicalTrials.gov/show/NCT04425707
602	NCT04346797	"CORIMUNO19-ECU: Trial Evaluating Efficacy and Safety of Eculizumab (Soliris) in Patients With COVID-19 Infection, Nested in the CORIMUNO-19 Cohort"	Recruiting	No Results Available	SARS-CoV-2|COVID19	Drug: Eculizumab	Phase 2	Interventional	"Saint Louis, Paris, Ile De France, France|Réanimation médicale, Paris, France|saint Louis, Paris, France"	https://ClinicalTrials.gov/show/NCT04346797
603	NCT04410328	Aggrenox To Treat Acute Covid-19	Not yet recruiting	No Results Available	Covid19	Drug: Dipyridamole ER 200mg/ Aspirin 25mg orally/enterally|Other: Standard of care	Phase 3	Interventional		https://ClinicalTrials.gov/show/NCT04410328
604	NCT04257656	A Trial of Remdesivir in Adults With Severe COVID-19	Terminated	No Results Available	COVID-19|Remdesivir|SARS-CoV-2	Drug: Remdesivir|Drug: Remdesivir placebo	Phase 3	Interventional	"Bin Cao, Beijing, Beijing, China"	https://ClinicalTrials.gov/show/NCT04257656
605	NCT04385095	Trial of Inhaled Anti-viral (SNG001) for SARS-CoV-2 (COVID-19) Infection	Recruiting	No Results Available	SARS-CoV-2	Drug: Interferon beta 1a|Drug: Placebo	Phase 2	Interventional	"Belfast City Hospital, Belfast, United Kingdom|Queen Elizabeth Hospital,, Birmingham, United Kingdom|Bradford Royal Infirmary, Bradford, United Kingdom|Hull and East Yorkshire NHS Trust, Castle Hill Hospital,, Hull, United Kingdom|Glenfield Hospital,, Leicester, United Kingdom|Wythenshawe Hospital, Manchester, United Kingdom|City Campus of Nottingham University, Nottingham, United Kingdom|John Radcliffe Hospital, Oxford, United Kingdom|University Hospital Southampton Nhs Foundation Trust, Southampton, United Kingdom"	https://ClinicalTrials.gov/show/NCT04385095
606	NCT04452643	Efficacy of BACMUNE (MV130) in the Prevention of Disease Due to COVID-19 Infection in Healthcare Personnel	Not yet recruiting	No Results Available	Covid19	Biological: BACMUNE (MV130)|Other: Placebo	Phase 3	Interventional	"Instituto Nacional de Enfermedades Respiratorias (INER), Ciudad de México, Mexico|Hospital General de Pachuca, Pachuca de Soto, Mexico|Hospital de Ciudad Valles, San Luis Potosí, Mexico"	https://ClinicalTrials.gov/show/NCT04452643
607	NCT04359654	Nebulised Dornase Alfa for Treatment of COVID-19	Not yet recruiting	No Results Available	COVID19|Hypoxia	Drug: Dornase Alfa Inhalation Solution [Pulmozyme]	Phase 2	Interventional	"University College London Hospital, London, United Kingdom"	https://ClinicalTrials.gov/show/NCT04359654
608	NCT04338958	Ruxolitinib in Covid-19 Patients With Defined Hyperinflammation	Recruiting	No Results Available	Covid-19	Drug: Ruxolitinib	Phase 2	Interventional	"Universitätsmedizin Göttingen - Klinik für Hämatologie und Onkologie, Göttingen, Germany|University Hospital Jena, Jena, Germany|Klinikum der Landeshauptstadt Stuttgart gKöR, Stuttgart, Germany|Universitätsklinikum Ulm, Ulm, Germany|Schwarzwald-Baar Klinikum Villingen-Schwenningen GmbH, Villingen-Schwenningen, Germany|Universitätsklinikum Würzburg, Würzburg, Germany"	https://ClinicalTrials.gov/show/NCT04338958
609	NCT04452773	Clinical Trial to Evaluate the Efficacy of Food Supplement Manremyc® Against SARS- COV-2 Infection (COVID-19) in Healthcare Workers	Not yet recruiting	No Results Available	COVID19	Dietary Supplement: Manremyc|Dietary Supplement: Placebo	Not Applicable	Interventional	"Cap Sant Fèlix, Sabadell, Barcelona, Spain|Hospital Universitari Germans Trias i Pujol UBP Riscos Laborals, Badalona,, Badalona, Spain"	https://ClinicalTrials.gov/show/NCT04452773
610	NCT04343092	Efficacy of Ivermectin as Add on Therapy in COVID19 Patients	Completed	No Results Available	COVID 19	Drug: Ivermectin (IVM)	Phase 1	Interventional	"General Directorate of Medical City, Bagdad, Baghdad, Iraq"	https://ClinicalTrials.gov/show/NCT04343092
611	NCT04338126	Tranexamic Acid (TXA) and Corona Virus 2019 (COVID19) in Inpatients	Not yet recruiting	No Results Available	COVID19	Drug: Tranexamic acid|Drug: Placebo oral tablet	Phase 2	Interventional	"University of Alabama at Birmingham, Birmingham, Alabama, United States"	https://ClinicalTrials.gov/show/NCT04338126
612	NCT04446104	A Preventive Treatment for Migrant Workers at High-risk of Covid-19	Recruiting	No Results Available	Covid-19	Drug: Hydroxychloroquine Sulfate Tablets|Drug: Ivermectin 3Mg Tab|Drug: Zinc|Drug: Povidone-Iodine|Dietary Supplement: Vitamin C	Phase 3	Interventional	"Tuas South Dormitory, Singapore, Singapore"	https://ClinicalTrials.gov/show/NCT04446104
613	NCT04363385	Collection of Biological Samples With Clinical Characterization of Covid-19 Patients	Recruiting	No Results Available	Covid-19	Biological: Biological test	Not Applicable	Interventional	"Centre hospitalier intercommunal de Créteil, Créteil, France"	https://ClinicalTrials.gov/show/NCT04363385
614	NCT04390464	mulTi-Arm Therapeutic Study in Pre-ICu Patients Admitted With Covid-19 - Repurposed Drugs (TACTIC-R)	Recruiting	No Results Available	COVID19	Drug: Ravulizumab|Drug: Baricitinib|Other: Standard of care	Phase 4	Interventional	"Cambridge University Hospitals NHS Foundation Trust, Cambridge, Cambridgeshire, United Kingdom"	https://ClinicalTrials.gov/show/NCT04390464
615	NCT04335071	Tocilizumab in the Treatment of Coronavirus Induced Disease (COVID-19)	Recruiting	No Results Available	SARS-CoV-2 Infection	Drug: Tocilizumab (TCZ)|Drug: Placebo	Phase 2	Interventional	"University Hospital Bern (Inselspital), Bern, Switzerland|Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland|Ospedale Regionale di Lugano (EOC), Viganello, Switzerland|University Hospital Zurich, Zurich, Switzerland"	https://ClinicalTrials.gov/show/NCT04335071
616	NCT04324190	DIgital Online SuPport for COVID-19 StrEss	Recruiting	No Results Available	COVID-19|Psychosocial Stress|Mental Health	Behavioral: Guided online support program|Behavioral: WHO recommendations (waiting condition)	Not Applicable	Interventional	"Selfapy GmbH, Berlin, Germany"	https://ClinicalTrials.gov/show/NCT04324190
617	NCT04334850	Use of a Respiratory Multiplex PCR and Procalcitonin to Reduce Antibiotics Exposure in Patients With Severe Confirmed COVID-19 Pneumonia	Recruiting	No Results Available	Covid19|Pneumonia	Procedure: Combined use of a respiratory broad panel multiplex PCR and procalcitonin|Other: Usual antibiotic treatment	Not Applicable	Interventional	"Intensive care department-Hospital Tenon, Paris, France"	https://ClinicalTrials.gov/show/NCT04334850
618	NCT04368156	Study Assessing Vagus Nerve Stimulation in CoViD-19 Respiratory Symptoms	Recruiting	No Results Available	Covid-19	Device: gammaCore® (Vagus nerve stimulation)	Not Applicable	Interventional	"Hospital Clínico Universitario de Valencia, Valencia, Spain"	https://ClinicalTrials.gov/show/NCT04368156
619	NCT04392323	Incidence of COVID-19 Test Conversion in Post-surgical Patients	Recruiting	No Results Available	Sars-CoV2	Diagnostic Test: COVID-19 PCR and Serology	Not Applicable	Interventional	"North Shore University Hospital, Manhasset, New York, United States|Long Island Jewish Medical Center, New Hyde Park, New York, United States"	https://ClinicalTrials.gov/show/NCT04392323
620	NCT04445376	Effect of Physical Therapy Exercises on Cardiorespiratory Fitness Level in COVID19 Patients After Recovery.	Not yet recruiting	No Results Available	Covid19	Other: Physical Exercises	Not Applicable	Interventional		https://ClinicalTrials.gov/show/NCT04445376
621	NCT04359537	Efficacy of Various Doses of Hydroxychloroquine in Pre-Exposure Prophylaxis for COVID 19	Recruiting	No Results Available	COVID 19	Drug: Hydroxychloroquine Sulfate 200 MG|Other: Placebo	Phase 2	Interventional	"Shaheed Zulfiaqar Ali Bhutto Medical University, Islamabad, Federal Capital, Pakistan"	https://ClinicalTrials.gov/show/NCT04359537
622	NCT04335097	Sensor Based Vital Signs Monitoring of Covid 19 Patients During Home Isolation	Recruiting	No Results Available	COVID 19	Device: Biosensors	Not Applicable	Interventional	"Lillestrom legevakt, Lillestrom, Norway"	https://ClinicalTrials.gov/show/NCT04335097
623	NCT04390139	Efficacy and Safety Evaluation of Mesenchymal Stem Cells for the Treatment of Patients With Respiratory Distress Due to COVID-19	Recruiting	No Results Available	COVID-19|SARS-CoV 2|Adult Respiratory Distress Syndrome	Drug: XCEL-UMC-BETA|Other: Placebo	Phase 1|Phase 2	Interventional	"Hospital de Bellvitge, Hospitalet de Llobregat, Barcelona, Spain|Mútua de Terrassa, Terrassa, Barcelona, Spain|Hospital del Mar, Barcelona, Spain|Hospital Vall d'Hebron, Barcelona, Spain|Hospital Clínic de Barcelona, Barcelona, Spain"	https://ClinicalTrials.gov/show/NCT04390139
624	NCT04348305	Hydrocortisone for COVID-19 and Severe Hypoxia	"Active, not recruiting"	No Results Available	Covid-19|Hypoxia	Drug: Hydrocortisone|Drug: Sodium Chloride 9mg/mL	Phase 3	Interventional	"Aarhus University Hospital - Dept of Intensive care, Aarhus, Denmark|Rigshospitalet, Copenhagen, Denmark|Dept of Infectious diseases, Rigshospitalet, Copenhagen, Denmark|Herlev Hospital - Dept. of Intensive Care, Herlev, Denmark|North Zealand Hospital, Hillerød, Denmark|Hvidovre Hospital - Dept of Infectious diseases, Hvidovre, Denmark|Hvidovre Hospital - Dept of Intensive Care, Hvidovre, Denmark|Hvidovre Hospital - Dept of Pulmonary Medicine, Hvidovre, Denmark|Kolding Hospital, Kolding, Denmark|Køge Hospital, Køge, Denmark|Dept of Intensive Care, Odense University Hospital, Odense, Denmark|Roskilde Hospital, Roskilde, Denmark|Slagelse Hospital, Slagelse, Denmark|Viborg Hospital, Viborg, Denmark"	https://ClinicalTrials.gov/show/NCT04348305
625	NCT04390191	Early CPAP in COVID-19 Confirmed or Suspected Patients	Recruiting	No Results Available	COVID-19|COVID|Coronavirus	Device: Continuous Positive Airway Pressure	Not Applicable	Interventional	"Icahn School of Medicine at Mount Sinai, New York, New York, United States"	https://ClinicalTrials.gov/show/NCT04390191
626	NCT04381871	Potential Role of Gum Arabic as Immunomodulatory Agent Among COVID 19 Patients	Not yet recruiting	No Results Available	COVID 19	Dietary Supplement: Acacia Senegal|Dietary Supplement: Pectin	Phase 2|Phase 3	Interventional	"Omdurman Teaching Hospital, Khartoum, Omdurman, Sudan|Jabra Hospital,, Khartoum, Sudan"	https://ClinicalTrials.gov/show/NCT04381871
627	NCT04389801	Use of Desferal for Prevention of ARDS in Hospitalised Cases Documented With Covid 19 Infection	Not yet recruiting	No Results Available	Covid 19	Drug: Desferal 500 MG Injection	Phase 4	Interventional		https://ClinicalTrials.gov/show/NCT04389801
628	NCT04445337	Stellate Ganglion Blockade in COVID-19 Positive Patients	Not yet recruiting	No Results Available	COVID 19|ARDS	Procedure: Stellate Ganglion Block	Not Applicable	Interventional		https://ClinicalTrials.gov/show/NCT04445337
629	NCT04386447	Phase II RCT to Assess Efficacy of Intravenous Administration of Oxytocin in Patients Affected by COVID-19	Not yet recruiting	No Results Available	Covid-19|Corona Virus Infection|SARS-CoV 2	Drug: Oxytocin|Drug: Standard of Care	Phase 2	Interventional	"CNRS, Lyon, France|Azienda Ospedaliero Universitaria di Parma, Parma, PR, Italy|Ospedale San Francesco, Nuoro, Italy"	https://ClinicalTrials.gov/show/NCT04386447
630	NCT04362111	Early Identification and Treatment of Cytokine Storm Syndrome in Covid-19	Not yet recruiting	No Results Available	Cytokine Storm|COVID-19	Drug: Anakinra|Drug: Normal saline	Phase 3	Interventional		https://ClinicalTrials.gov/show/NCT04362111
631	NCT04377334	Mesenchymal Stem Cells (MSCs) in Inflammation-Resolution Programs of Coronavirus Disease 2019 (COVID-19) Induced Acute Respiratory Distress Syndrome (ARDS)	Not yet recruiting	No Results Available	ARDS|COVID-19	Biological: MSC	Phase 2	Interventional	"University Hospital Tuebingen, Tuebingen, Germany"	https://ClinicalTrials.gov/show/NCT04377334
632	NCT04354610	Cardiovascular and Renal Biomarkers to Predict Acute Heart or Kidney Injury in Severe Covid-19 Infection	Recruiting	No Results Available	COVID 19	Procedure: Biological samples specific to research|Procedure: Clinical examination|Procedure: Telephone follow-up	Not Applicable	Interventional	"CHRU de Nancy, Nancy, France|CHRU de Nancy, Vandœuvre-lès-Nancy, France"	https://ClinicalTrials.gov/show/NCT04354610
633	NCT04352803	Adipose Mesenchymal Cells for Abatement of SARS-CoV-2 Respiratory Compromise in COVID-19 Disease	Not yet recruiting	No Results Available	Covid-19 Pneumonia|Cyotokine Storm	Biological: Autologous Adipose MSC's	Phase 1	Interventional		https://ClinicalTrials.gov/show/NCT04352803
634	NCT04424056	"A Trial Using ANAKINRA, TOCILIZUMAB Alone or in Association With RUXOLITINIB in Severe Stage 2b and 3 of COVID19-associated Disease"	Not yet recruiting	No Results Available	Covid19	Drug: Anakinra +/- Ruxolitinib (stages 2b/3)|Drug: Anakinra and Ruxolitinib (Advanced stage 3)|Drug: Tocilizumab +/- ruxolitinib (stages 2b/3)|Drug: Tocilizumab and Ruxolitinib (Advanced stage 3)|Other: Standard of care	Phase 3	Interventional	"Assistance Publique Hôpitaux de Marseille, Marseille, France"	https://ClinicalTrials.gov/show/NCT04424056
635	NCT04276896	Immunity and Safety of Covid-19 Synthetic Minigene Vaccine	Recruiting	No Results Available	Pathogen Infection Covid-19 Infection	Biological: Injection and infusion of LV-SMENP-DC vaccine and antigen-specific CTLs	Phase 1|Phase 2	Interventional	"Shenzhen Geno-immune Medical Institute, Shenzhen, Guangdong, China|Shenzhen Second People's Hospital, Shenzhen, Guangdong, China|Shenzhen Third People's Hospital, Shenzhen, Guangdong, China"	https://ClinicalTrials.gov/show/NCT04276896
636	NCT04355364	Efficacy and Safety of Aerosolized Intra-tracheal Dornase Alfa Administration in Patients With COVID19-induced ARDS (COVIDORNASE)	Recruiting	No Results Available	COVID-19|Acute Respiratory Distress Syndrome	Drug: Dornase Alfa Inhalation Solution [Pulmozyme]|Procedure: standard procedure	Phase 3	Interventional	"Hôpital Fondation A. de Rotschhild, Paris, France"	https://ClinicalTrials.gov/show/NCT04355364
637	NCT04373460	Convalescent Plasma to Limit SARS-CoV-2 Associated Complications	Recruiting	No Results Available	SARS-CoV 2	Biological: SARS-CoV-2 convalescent plasma|Biological: Plasma from a volunteer donor	Phase 2	Interventional	"University of Alabama at Birmingham, Birmingham, Alabama, United States|University of California, Los Angeles, Los Angeles, California, United States|University of California, Irvine Health, Orange, California, United States|NorthShore University HealthSystem, Evanston, Illinois, United States|Anne Arundel Medical Center, Annapolis, Maryland, United States|JHSPH Center for American Indian Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States|The Johns Hopkins University, Baltimore, Maryland, United States|MedStar Washington Hospital Center, Hyattsville, Maryland, United States|University of Massachusetts Worcester, Worcester, Massachusetts, United States|University of Rochester, Rochester, New York, United States|University of Cincinnati Medical Center, Cincinnati, Ohio, United States|Lifespan/BrownUniversity (Rhode Island Hospital), Providence, Rhode Island, United States|University of Texas Health Science Center at Houston, Houston, Texas, United States"	https://ClinicalTrials.gov/show/NCT04373460
638	NCT04371029	Impact of Neck Inspiratory Muscle Activation During Sleep in ICU Patients After a COVID 19 ARDS	Recruiting	No Results Available	ARDS|COVID-19	Other: PSG	Not Applicable	Interventional	"Hopital Pellegrin, Bordeaux, France"	https://ClinicalTrials.gov/show/NCT04371029
639	NCT04377503	Tocilizumab Versus Methylprednisolone in the Cytokine Release Syndrome of Patients With COVID-19	Not yet recruiting	No Results Available	Cytokine Release Syndrome|Covid-19	Drug: Tocilizumab 180 MG/ML|Drug: Methylprednisolone Sodium Succinate	Phase 2	Interventional		https://ClinicalTrials.gov/show/NCT04377503
640	NCT04343963	Pyridostigmine in Severe SARS-CoV-2 Infection	Recruiting	No Results Available	COVID-19|SARS-CoV-2	Drug: Pyridostigmine Bromide|Drug: Placebo	Phase 2|Phase 3	Interventional	"Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Ciudad de México, Tlalpan, Mexico"	https://ClinicalTrials.gov/show/NCT04343963
641	NCT04395456	A Phase 2 Study of the C3 Inhibitor AMY-101 in Patients With ARDS Due to COVID-19 (SAVE)	Not yet recruiting	No Results Available	Acute Respiratory Distress Syndrome Due to SARS-CoV-2 Infection (Severe COVID19)	Drug: AMY-101|Other: WFI 5% glucose	Phase 2	Interventional		https://ClinicalTrials.gov/show/NCT04395456
642	NCT04403477	Convalescent Plasma Therapy in Severe COVID-19 Infection	Recruiting	No Results Available	Covid19|Convalescence	Biological: Convalescent plasma	Phase 2	Interventional	"Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh"	https://ClinicalTrials.gov/show/NCT04403477
643	NCT04383548	Clinical Study for Efficacy of Anti-Corona VS2 Immunoglobulins Prepared From COVID19 Convalescent Plasma Prepared by VIPS Mini-Pool IVIG Medical Devices in Prevention of SARS-CoV-2 Infection in High Risk Groups as Well as Treatment of Early Cases of COVID19 Patients	Not yet recruiting	No Results Available	COVID19	Other: hyper immunoglobulins containing anti-Corona VS2 immunoglobulin	Not Applicable	Interventional		https://ClinicalTrials.gov/show/NCT04383548
644	NCT04407507	"Efficacy, Safety and Tolerability of Ivermectin in Subjects Infected With SARS-CoV-2 With or Without Symptoms"	Not yet recruiting	No Results Available	COVID-19	Drug: Ivermectin|Drug: Placebo	Phase 2	Interventional		https://ClinicalTrials.gov/show/NCT04407507
645	NCT03376854	Pilot RCT of Therapeutic Hypothermia Plus Neuromuscular Blockade in COVID-19 Patients With ARDS	Recruiting	No Results Available	"Respiratory Distress Syndrome, Adult|Sars-CoV2"	Device: Hypothermia|Drug: Neuromuscular Blocking Agents|Device: Standard of Care	Phase 2	Interventional	"University of Maryland Medical Center, Baltimore, Maryland, United States"	https://ClinicalTrials.gov/show/NCT03376854
646	NCT04351490	Impact of Zinc and Vitamin D3 Supplementation on the Survival of Aged Patients Infected With COVID-19	Not yet recruiting	No Results Available	SARS-CoV 2	Dietary Supplement: Zinc gluconate|Dietary Supplement: 25-OH cholecalciferol	Not Applicable	Interventional		https://ClinicalTrials.gov/show/NCT04351490
647	NCT04349410	The Fleming [FMTVDM] Directed CoVid-19 Treatment Protocol	Enrolling by invitation	No Results Available	CoVid 19 Positive	"Drug: Hydroxychloroquine, Azithromycin|Drug: Hydroxychloroquine, Doxycycline|Drug: Hydroxychloroquine, Clindamycin|Drug: Hydroxychloroquine, Clindamycin, Primaquine - low dose.|Drug: Hydroxychloroquine, Clindamycin, Primaquine - high dose.|Drug: Remdesivir|Drug: Tocilizumab|Drug: Methylprednisolone|Drug: Interferon-Alpha2B|Drug: Losartan|Drug: Convalescent Serum"	Phase 2|Phase 3	Interventional	"FHHI-OI-Camelot; QME, Los Angeles, California, United States"	https://ClinicalTrials.gov/show/NCT04349410
648	NCT04429529	"Safety of TY027, a Treatment for COVID-19, in Humans"	Recruiting	No Results Available	Coronavirus Disease-2019 (COVID-19)	Biological: TY027|Other: 0.9% Saline	Phase 1	Interventional	"SingHealth Investigational Medicine Unit, Singapore, Singapore"	https://ClinicalTrials.gov/show/NCT04429529
649	NCT04395105	"Dexamethasone for COVID-19 Related ARDS: a Multicenter, Randomized Clinical Trial"	Recruiting	No Results Available	"Respiratory Distress Syndrome, Adult|Covid-19"	Drug: Dexamethasone	Phase 3	Interventional	"CEMIC (Centro de Educación Médica e Investigaciones Clínicas), Caba, Argentina"	https://ClinicalTrials.gov/show/NCT04395105
650	NCT04383587	Seroprevalence of SARS CoV 2 Antibodies in Previously Undiagnosed Healthcare Workers	Enrolling by invitation	No Results Available	SARS-CoV 2|COVID-19	Other: Serologic testing	Not Applicable	Interventional	"Mayo Clinic in Florida, Jacksonville, Florida, United States"	https://ClinicalTrials.gov/show/NCT04383587
651	NCT04401527	Treatment of Lung Injury From COVID-19 Infection With Intravenous Sodium Nitrite	Not yet recruiting	No Results Available	COVID-19|Acute Respiratory Distress Syndrome|Acute Respiratory Failure	Drug: Sodium Nitrite|Drug: Normal Saline	Phase 2	Interventional		https://ClinicalTrials.gov/show/NCT04401527
652	NCT04378920	A Study of Trans Crocetin in Patients With Acute Respiratory Distress Syndrome Due to COVID-19 Disease (LEAF-4L7520/4L6715)	Recruiting	No Results Available	COVID19|Acute Respiratory Distress Syndrome	Drug: LEAF-4L6715|Drug: LEAF-4L7520	Phase 1|Phase 2	Interventional	"Hôpitaux Universitaires de Strasbourg, Strasbourg, France|Institut de Cancerologie Strasbourg Europe, Strasbourg, France"	https://ClinicalTrials.gov/show/NCT04378920
653	NCT04341415	Impact of Auricular Vagus Nerve Neuromodulation on COVID-19 Positive Inpatients Outcome	Recruiting	No Results Available	Covid19|SARS-CoV Infection	Procedure: Auricular neuromodulation|Procedure: Control	Not Applicable	Interventional	"Fondation Adolphe de Rothschild, Paris, France"	https://ClinicalTrials.gov/show/NCT04341415
654	NCT04373200	Human Ab Response & immunoMONItoring of COVID-19 Patients	Recruiting	No Results Available	SARS-CoV-2 Coronavirus|Acute Respiratory Distress Syndrome	Biological: Blood samples collection|Other: Saliva collection	Not Applicable	Interventional	"CHU Rennes, Rennes, France"	https://ClinicalTrials.gov/show/NCT04373200
655	NCT04456361	Use of Mesenchymal Stem Cells in Acute Respiratory Distress Syndrome Caused by COVID-19	"Active, not recruiting"	No Results Available	"ARDS, Human|Covid-19"	Biological: Mesenchymal Stem Cells derived from Wharton Jelly of Umbilical cords	Early Phase 1	Interventional	"Instituto de Medicina Regenerativa, Tijuana, Baja California, Mexico"	https://ClinicalTrials.gov/show/NCT04456361
656	NCT04387760	Favipiravir vs Hydroxychloroquine in COVID -19	Not yet recruiting	No Results Available	SARS-CoV 2|COVID-19	Drug: Hydroxychloroquine|Drug: Favipiravir|Other: Routine care for COVID-19 patients	Phase 2|Phase 3	Interventional	"Royal College of Surgeons in Ireland - Bahrain, Manama, Bahrain"	https://ClinicalTrials.gov/show/NCT04387760
657	NCT04375397	Study of Oral Ibrutinib Capsules to Assess Respiratory Failure in Adult Participants With Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) and Pulmonary Injury	Recruiting	No Results Available	CoronaVirus Induced Disease-2019 (COVID-19)	Drug: Ibrutinib|Drug: Placebo	Phase 2	Interventional	"Stanford Univ School Medicine /ID# 221954, Stanford, California, United States|Medstar Washington Hospital Center /ID# 221886, Washington, District of Columbia, United States|GW Medical Faculty Associates /ID# 222023, Washington, District of Columbia, United States|Midway Immunology and Research /ID# 222004, Fort Pierce, Florida, United States|Brigham & Women's Hospital /ID# 221847, Boston, Massachusetts, United States|Intermountain Healthcare /ID# 221955, Salt Lake City, Utah, United States"	https://ClinicalTrials.gov/show/NCT04375397
658	NCT04393948	Lung Irradiation for COVID-19 Pneumonia	Recruiting	No Results Available	SARS-CoV 2	Radiation: Phase 1|Radiation: Phase 2	Not Applicable	Interventional	"Brigham and Women's Hospital, Boston, Massachusetts, United States"	https://ClinicalTrials.gov/show/NCT04393948
659	NCT04323514	Use of Ascorbic Acid in Patients With COVID 19	Recruiting	No Results Available	Hospitalized Patients With Covid-19 Pneumonia	Dietary Supplement: Vitamin C	Not Applicable	Interventional	"A.R.N.A.S. Civico - Di Cristina - Benfratelli, Palermo, Italy"	https://ClinicalTrials.gov/show/NCT04323514
660	NCT04374552	Asymptomatic COVID-19 Trial	Not yet recruiting	No Results Available	SARS-CoV-2 Infection	Drug: Hydroxychloroquine sulfate &Azithromycin|Drug: Placebo	Phase 2	Interventional	"Robert Wood Johnson University Hospital, New Brunswick, New Jersey, United States"	https://ClinicalTrials.gov/show/NCT04374552
661	NCT04421508	A Study to Assess Pulsed Inhaled Nitric Oxide vs Placebo in Subjects With Mild or Moderate COVID-19	Not yet recruiting	No Results Available	COVID-19|Coronavirus|Coronavirus Infection	Combination Product: INOpulse|Combination Product: Placebo	Phase 3	Interventional	"Houston Methodist, Houston, Texas, United States"	https://ClinicalTrials.gov/show/NCT04421508
662	NCT04387240	Evaluating the Efficacy of Artesunate in Adults With Mild Symptoms of COVID-19	Not yet recruiting	No Results Available	Covid 19 Positive|Corona Virus Infection	Drug: Artemisinin / Artesunate|Other: placebo	Phase 2	Interventional	"Princess Nourah Bint Abdulrahman Univeristy, Riyadh, Central, Saudi Arabia"	https://ClinicalTrials.gov/show/NCT04387240
663	NCT04374149	Therapeutic Plasma Exchange Alone or in Combination With Ruxolitinib in COVID-19 Associated CRS	Not yet recruiting	No Results Available	Cytokine Release Syndrome|COVID19	Procedure: Therapeutic Plasma Exchange|Drug: Ruxolitinib	Phase 2	Interventional		https://ClinicalTrials.gov/show/NCT04374149
664	NCT04356508	COVID-19: A Pilot Study of Adaptive Immunity and Anti-PD1	Not yet recruiting	No Results Available	"COVID-19|SARS-CoV-2|2019-nCoV|Pneumonia, Viral"	Drug: Nivolumab	Phase 2	Interventional		https://ClinicalTrials.gov/show/NCT04356508
665	NCT04363853	Tocilizumab Treatment in Patients With COVID-19	Recruiting	No Results Available	Sars-CoV2	Drug: Tocilizumab	Phase 2	Interventional	"National Cancer Institute of Mexico, Mexico city, Distrito Federal, Mexico"	https://ClinicalTrials.gov/show/NCT04363853
666	NCT04304690	"COVID-19 Seroconversion Among Front Line Medical and Paramedical Staff in Emergency, Intensive Care Units and Infectious Disease Departments During the 2020 Epidemic"	Recruiting	No Results Available	Sars-CoV2	Other: blood sample	Not Applicable	Interventional	"Hopital Pitié Salpetrière, Paris, France"	https://ClinicalTrials.gov/show/NCT04304690
667	NCT04445246	Inhaled Iloprost for Suspected COVID-19 Respiratory Failure	Recruiting	No Results Available	"COVID-19|ARDS, Human|Hypoxemic Respiratory Failure"	Drug: Inhaled ILOPROST	Phase 2	Interventional	"Hamad Medical Corporation, Doha, Qatar"	https://ClinicalTrials.gov/show/NCT04445246
668	NCT04345653	Hydroxychloroquine as Chemoprevention for COVID-19 for High Risk Healthcare Workers	"Active, not recruiting"	No Results Available	COVID19	Drug: Hydroxychloroquine Sulfate (HCQ)	Phase 2	Interventional	"Hackensack Meridian Health - JFK Medical Center, Edison, New Jersey, United States"	https://ClinicalTrials.gov/show/NCT04345653
669	NCT04445597	Unraveling the Mechanisms of Olfactory Dysfunction in COVID-19	Recruiting	No Results Available	SARS-CoV 2	Diagnostic Test: Sampling of tissue	Not Applicable	Interventional	"UZ Leuven, Leuven, Vlaams-Brabant, Belgium"	https://ClinicalTrials.gov/show/NCT04445597
670	NCT04441918	"Tolerability,Safety,Pharmacokinetic Profile and Immunogenicity of a Recombinant Humanized Anti-SARS-CoV-2 Monoclonal Antibody (JS016) for Injection in Chinese Health Subjects"	Recruiting	No Results Available	COVID-19; and High Infection Risk of SARS-CoV-2	Combination Product: JS016 (anti-SARS-CoV-2 monoclonal antibody)	Phase 1	Interventional	"Huashan Hospital affiliated to Fudan University, Shanghai, China"	https://ClinicalTrials.gov/show/NCT04441918
671	NCT04405739	The Effect of EIDD-2801 on Viral Shedding of SARS-CoV-2 (COVID-19)	Recruiting	No Results Available	SARS-CoV 2	Drug: 200 mg EIDD-2801|Drug: 300 mg EIDD-2801|Drug: Placebo (PBO)	Phase 2	Interventional	"Johns Hopkins Bayview Medical Center, Baltimore, Maryland, United States|John Hopkins Hospital, Baltimore, Maryland, United States|Suburban Hospital, Bethesda, Maryland, United States|Howard County General Hospital, Columbia, Maryland, United States"	https://ClinicalTrials.gov/show/NCT04405739
672	NCT04344600	Peginterferon Lambda-1a for the Prevention and Treatment of SARS-CoV-2 (COVID-19) Infection	Recruiting	No Results Available	Sars-CoV2	Drug: Peginterferon lambda alfa-1a subcutaneous injection|Other: Saline	Phase 2	Interventional	"Johns Hopkins Hospital, Baltimore, Maryland, United States"	https://ClinicalTrials.gov/show/NCT04344600
673	NCT04397666	RT-PCR on Conjunctival Sample for the Detection of SARS-CoV-2 in Patients With Covid-19	Recruiting	No Results Available	"Covid 19 , Conjunctivitus"	Diagnostic Test: conjunctival RT PCR	Not Applicable	Interventional	"Centre Hospitalier de versailles, Le Chesnay, France"	https://ClinicalTrials.gov/show/NCT04397666
674	NCT04356937	Efficacy of Tocilizumab on Patients With COVID-19	Recruiting	No Results Available	SARS-CoV 2	Drug: Tocilizumab|Drug: Placebos	Phase 3	Interventional	"Massachusetts General Hospital, Boston, Massachusetts, United States|Brigham and Women's Hospital, Boston, Massachusetts, United States|Newton-Wellesley Hospital, Newton, Massachusetts, United States"	https://ClinicalTrials.gov/show/NCT04356937
675	NCT04385810	Description of Ophthalmologic Injuries in Intensive Care During the SARS-CoV2 Epidemic - COVID19	Recruiting	No Results Available	Covid19|Sars-CoV2	Procedure: Ophthalmologic exam	Not Applicable	Interventional	"Fondation Adolphe de Rothschild, Paris, France"	https://ClinicalTrials.gov/show/NCT04385810
676	NCT04361032	"Assessment of Efficacy and Safety of Tocilizumab Compared to DefeROxamine, Associated With Standards Treatments in COVID-19 (+) Patients Hospitalized In Intensive Care in Tunisia"	Not yet recruiting	No Results Available	COVID19|Intensive Care Unit	Drug: Tocilizumab Injection|Drug: Deferoxamine	Phase 3	Interventional	"Eshmoun Clinical Research Centre/ Hôpital Abderrahmane Mami-Ariana, Ariana, Tunisia"	https://ClinicalTrials.gov/show/NCT04361032
677	NCT04341207	Epidemiology of SARS-CoV-2 and Mortality to Covid19 Disease in French Cancer Patients	Recruiting	No Results Available	Cancer & COVID 19	Drug: Hydroxychloroquine|Drug: Azithromycin	Phase 2	Interventional	"Gustave Roussy, Villejuif, Val De Marne, France"	https://ClinicalTrials.gov/show/NCT04341207
678	NCT04364594	COVID-19 Search in Conjunctival Cells	"Active, not recruiting"	No Results Available	COVID 19|Pulmonary Disease	Diagnostic Test: conjunctival swab	Not Applicable	Interventional	"Maria Cristina Savastano, Roma, Italy"	https://ClinicalTrials.gov/show/NCT04364594
679	NCT04379661	SUNLIGHT Study: Online Support Groups for MS to Address COVID-19	Recruiting	No Results Available	MS (Multiple Sclerosis)|COVID-19|Support Groups	Behavioral: Online support Group	Not Applicable	Interventional	"Columbia University Medical Center, New York, New York, United States"	https://ClinicalTrials.gov/show/NCT04379661
680	NCT04353271	Trial of Hydroxychloroquine In Covid-19 Kinetics	"Active, not recruiting"	No Results Available	Covid 19|Corona Virus Infection	Drug: Hydroxychloroquine|Other: Placebo	Phase 2|Phase 3	Interventional	"University of South Alabama, Mobile, Alabama, United States"	https://ClinicalTrials.gov/show/NCT04353271
681	NCT04318431	Prevalence of SARS -Cov2 Carriage in Asymptomatic and Mildly-symptomatic Children	"Active, not recruiting"	No Results Available	Covid19	Diagnostic Test: Data collection and rhinopharyngeal swab	Not Applicable	Interventional	"Cabinet du Dr Belaroussi, Boulogne, France|Cabinet du Dr Derkx, Champigny-sur-Marne, France|Cabinet du Dr Coicadan, Chennevières-sur-Marne, France|14 Av rené Samuel, Clamart, France|Cabinet du Dr Corrard, Combs-la-Ville, France|10 rue Delambre, Lagny-sur-Marne, France|157 Avenue du Général Leclerc, Maisons-Alfort, France|21 Grande Rue Charles de Gaulle, Nogent-sur-Marne, France|Cabinet du Dr Deberdt, Nogent-sur-Marne, France|Cabinet du Dr Wollner, Nogent-sur-Marne, France|4 allée des Norottes, Noisy-le-Grand, France|Cabinet du Dr D'acremont, Paris, France|146 Avenue Ledru Rollin, Paris, France|132 Boulevard du Montparnasse, Paris, France|Cabinet du Dr Romain, Paris, France|Cabinet du Dr Turberg-Romain, Paris, France|15 Quai Louis Blériot, Paris, France|Cabinet du Dr Michot, Paris, France|24 rue Volta, Puteaux, France|Cabinet du Dr Cohen, Saint-Maur-des-Fossés, France|Cabinet de Pédiatrie des Docteurs Ravilly et Bessa, Villejuif, France|13 Villa Beauséjour, Vincennes, France"	https://ClinicalTrials.gov/show/NCT04318431
682	NCT04364009	Anakinra for COVID-19 Respiratory Symptoms	Recruiting	No Results Available	COVID-19 Infection|ANAKINRA Treatment|Optimized Standard of Care (oSOC)	Drug: Anakinra plus oSOC|Drug: oSOC	Phase 3	Interventional	"CHRU de TOURS, Tours, France"	https://ClinicalTrials.gov/show/NCT04364009
683	NCT04452097	Use of hUC-MSC Product (BX-U001) for the Treatment of COVID-19 With ARDS	Not yet recruiting	No Results Available	COVID-19|ARDS|Acute Respiratory Distress Syndrome	Biological: Human umbilical cord mesenchymal stem cells + best supportive care	Phase 1	Interventional		https://ClinicalTrials.gov/show/NCT04452097
684	NCT04393051	Baricitinib Compared to Standard Therapy in Patients With COVID-19	Not yet recruiting	No Results Available	Covid-19|SARS-CoV 2|SARS Pneumonia	Drug: Baricitinib Oral Tablet	Phase 2	Interventional	"Azienda Ospedaliero Universitaria Pisana, Pisa, Italy"	https://ClinicalTrials.gov/show/NCT04393051
685	NCT04364737	Convalescent Plasma to Limit COVID-19 Complications in Hospitalized Patients	Recruiting	No Results Available	COVID-19|Coronavirus|Coronavirus Infection	Biological: Convalescent Plasma|Other: Saline solution	Phase 2	Interventional	"Yale University School of Medicine, New Haven, Connecticut, United States|Montefiore Medical Center, Bronx, New York, United States|NYU Langone Health, New York, New York, United States"	https://ClinicalTrials.gov/show/NCT04364737
686	NCT04423991	Identification of a Responsive Subpopulation to Hydroxychloroquine in COVID-19 Patients Using Machine Learning	Completed	No Results Available	COVID-19|Coronavirus|Mortality	Device: COViage	Not Applicable	Interventional	"Dascena, Oakland, California, United States"	https://ClinicalTrials.gov/show/NCT04423991
687	NCT04421391	QuadraMune(TM) for Prevention of COVID-19	Recruiting	No Results Available	Covid19|Coronavirus|SARS-CoV 2	Dietary Supplement: QuadraMune(TM)	Not Applicable	Interventional	"Therapeutic Solutions International, Oceanside, California, United States"	https://ClinicalTrials.gov/show/NCT04421391
688	NCT04360837	PEEP Incremental and Decremental Alveolar Recruitment of Critically Ill Corona Virus Disease-19 (COVID-19) Patients	Recruiting	No Results Available	COVID-19|Virus; Pneumonia|Atelectasis	Procedure: alveolar recruitment	Not Applicable	Interventional	"University of Szeged, Szeged, Hungary"	https://ClinicalTrials.gov/show/NCT04360837
689	NCT04439071	A Study to Evaluate Efficacy and Safety of PTC299 in Hospitalized Participants With Coronavirus (COVID-19)	Not yet recruiting	No Results Available	Pneumonia|COVID-19|Coronavirus	Drug: PTC299|Other: SOC|Drug: Placebo	Phase 2|Phase 3	Interventional	"Augusta University, Augusta, Georgia, United States|Johns Hopkins Hospital, Baltimore, Maryland, United States|Hospital Del Mar, Barcelona, Spain|Hospital Universitario Infanta Leonor, Madrid, Spain|Hospital 12 de Octubre, Madrid, Spain"	https://ClinicalTrials.gov/show/NCT04439071
690	NCT04390217	LB1148 for Pulmonary Dysfunction Associated With COVID-19 Pneumonia	Not yet recruiting	No Results Available	COVID-19|Coronavirus Disease 2019|Covid19|COVID-19 Pneumonia	Drug: LB1148|Drug: Placebo	Phase 2	Interventional		https://ClinicalTrials.gov/show/NCT04390217
691	NCT04442048	Immunization With IMM-101 vs Observation for Prevention of Respiratory and Severe COVID-19 Related Infections in Cancer Patients at Increased Risk of Exposure	Not yet recruiting	No Results Available	Cancer|Covid-19	Biological: IMM-101|Other: Observation	Phase 3	Interventional		https://ClinicalTrials.gov/show/NCT04442048
692	NCT04409834	Prevention of Arteriovenous Thrombotic Events in Critically-Ill COVID-19 Patients Trial	Not yet recruiting	No Results Available	COVID-19|Venous Thromboembolism|Arterial Thrombosis	Drug: Unfractionated Heparin IV|Drug: Enoxaparin 1 mg/kg|Drug: Clopidogrel|Drug: Unfractionated heparin SC|Drug: Enoxaparin 40 Mg/0.4 mL Injectable Solution	Phase 4	Interventional		https://ClinicalTrials.gov/show/NCT04409834
693	NCT04334460	Safety and Antiviral Activity of BLD-2660 in COVID-19 Hospitalized Subjects	Recruiting	No Results Available	Sars-CoV2	Drug: BLD-2660	Phase 2	Interventional	"Blade Research Site, Montgomery, Alabama, United States|Blade Research Site, Irvine, California, United States|Blade Research Site, Los Angeles, California, United States|Blade Reseach Site, San Jose, California, United States|Blade Research Site, Washington, District of Columbia, United States|Blade Research Site, Brandon, Florida, United States|Blade Research Site, Fort Pierce, Florida, United States|Blade Research Site, Panama City, Florida, United States|Blade Research Site, Tampa, Florida, United States|Blade Research Site, Marietta, Georgia, United States|Blade Research Site, Idaho Falls, Idaho, United States|Blade Research Site, Elmhurst, Illinois, United States|Blade Research Site, Peoria, Illinois, United States|Blade Research Site, Ames, Iowa, United States|Blade Research Site, Baltimore, Maryland, United States|Blade Research Site, Detroit, Michigan, United States|Blade Research Site, Farmington Hills, Michigan, United States|Blade Research Site, Chesterfield, Missouri, United States|Blade Research Site, Saint Louis, Missouri, United States|Blade Research Site, North Las Vegas, Nevada, United States|Blade Research Site, Ridgewood, New Jersey, United States|Blade Research Site, Durham, North Carolina, United States|Blade Research Site, Fayetteville, North Carolina, United States|Blade Research Site, Philadelphia, Pennsylvania, United States|Vanderbilt University Medical Center, Nashville, Tennessee, United States|Blade Research Site, Dallas, Texas, United States"	https://ClinicalTrials.gov/show/NCT04334460
694	NCT04397510	Nebulized Heparin for the Treatment of COVID-19 Induced Lung Injury	Enrolling by invitation	No Results Available	"Covid-19|ARDS, Human|Acute Lung Injury"	Drug: Heparin|Drug: 0.9% Sodium-chloride	Phase 4	Interventional	"Frederick Health Hospital, Frederick, Maryland, United States"	https://ClinicalTrials.gov/show/NCT04397510
695	NCT04351919	Assessment of Efficacy and Safety of HCQ and Antibiotics Administrated to Patients COVID19(+)	Not yet recruiting	No Results Available	Patients With COVID19	Drug: Hydroxychloroquine|Drug: Azithromycin	Phase 4	Interventional	"Eshmoun Clinical Research Centre/ Hôpital Abderrahmen Mami-Ariana, Tunis, Tunisia"	https://ClinicalTrials.gov/show/NCT04351919
696	NCT04426292	SARS-COV-2 Seroprevalence and Seroconversion Among Employees of the Universitair Ziekenhuis Brussel During the 2020 COVID-19 Outbreak	Recruiting	No Results Available	Sars-CoV2	Diagnostic Test: Serological testing	Not Applicable	Interventional	"UZ Brussel, Jette, Brussel, Belgium"	https://ClinicalTrials.gov/show/NCT04426292
697	NCT04403269	"NORMAL HUMAN IMMUNOGLOBULINS (IVIG) IN PATIENTS AGED 75 YEARS AND OVER, COVID-19 WITH SEVERE ACUTE RESPIRATORY FAILURE"	Recruiting	No Results Available	Sars-CoV2	Drug: IgIV	Phase 2	Interventional	"Centre Hospitalier de Versailles, Le Chesnay, France"	https://ClinicalTrials.gov/show/NCT04403269
698	NCT04445389	"Safety and Immunogenicity Study of GX-19, a COVID-19 Preventive DNA Vaccine in Healthy Adults"	Recruiting	No Results Available	SARS-CoV-2	Drug: GX-19|Drug: Saline	Phase 1|Phase 2	Interventional	"Severance hospital, Seoul, Korea, Republic of"	https://ClinicalTrials.gov/show/NCT04445389
699	NCT04390022	Sars-CoV-2/COVID-19 Ivermectin Navarra-ISGlobal Trial	Recruiting	No Results Available	Covid-19|Coronavirus Infection|SARS-CoV-2 Infection	Drug: Ivermectin|Drug: Placebo	Phase 2	Interventional	"Clinica Universidad de Navarra, Pamplona, Navarra, Spain"	https://ClinicalTrials.gov/show/NCT04390022
700	NCT04355728	Use of UC-MSCs for COVID-19 Patients	Recruiting	No Results Available	"Corona Virus Infection|ARDS|ARDS, Human|Acute Respiratory Distress Syndrome|COVID-19"	Biological: Umbilical Cord Mesenchymal Stem Cells + Heparin along with best supportive care.|Other: Vehicle + Heparin along with best supportive care	Phase 1|Phase 2	Interventional	"Diabetes Research Institute, University of Miami Miller School of Medicine, Miami, Florida, United States"	https://ClinicalTrials.gov/show/NCT04355728
701	NCT04378712	Hydrogen/Oxygen Mixed Gas Inhalation for Coronavirus Disease 2019 (COVID-19)	Completed	No Results Available	Covid-19|Hydrogen/Oxygen Mixed Gas|Dyspnea	Device: Hydrogen Oxygen Generator with Nebulizer|Other: Standard-of-care	Not Applicable	Interventional	"First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China"	https://ClinicalTrials.gov/show/NCT04378712
702	NCT04405570	"A Safety, Tolerability and Efficacy of EIDD-2801 to Eliminate Infectious Virus Detection in Persons With COVID-19"	Recruiting	No Results Available	SARS-CoV 2	Drug: 200 mg EIDD-2801|Drug: Placebo	Phase 2	Interventional	"University of North Carolina School of Medicine, Chapel Hill, North Carolina, United States|Wake Forest Baptist Health, Winston-Salem, North Carolina, United States"	https://ClinicalTrials.gov/show/NCT04405570
703	NCT04341441	Will Hydroxychloroquine Impede or Prevent COVID-19	Recruiting	No Results Available	COVID-19|Coronavirus|Coronavirus Infections|SARS-CoV 2	Drug: Hydroxychloroquine - Daily Dosing|Drug: Hydroxychloroquine - Weekly Dosing|Other: Placebo oral tablet|Diagnostic Test: Monitoring Visit - Baseline|Diagnostic Test: Monitoring Visit - Week 4|Diagnostic Test: Monitoring Visit - Week 8|Other: Weekly Assessment	Phase 3	Interventional	"Henry Ford Hospital, Detroit, Michigan, United States|Detroit Department of Transportation (DDOT), Detroit, Michigan, United States|Detroit Fire Department & Detroit EMS, Detroit, Michigan, United States|Detroit Police Department, Detroit, Michigan, United States"	https://ClinicalTrials.gov/show/NCT04341441
704	NCT04357457	Efficacy of Intravenous Almitrine in Reducing the Need for Mechanical Ventilation in Patients With Hypoxemic Acute Respiratory Failure Due to Covid-19-related Pneumonia	Not yet recruiting	No Results Available	Covid 19|Hypoxemic Respiratory Failure	Drug: Almitrine|Drug: Placebo	Phase 3	Interventional	"Hospital Pitié-Salpêtrière, Paris, France"	https://ClinicalTrials.gov/show/NCT04357457
705	NCT04366245	Clinical Trial to Evaluate the Efficacy of Treatment With Hyperimmune Plasma Obtained From Convalescent Antibodies of COVID-19 Infection	Recruiting	No Results Available	SARS-CoV 2	Biological: Hyperimmune plasma|Drug: Standard of care for SARS-CoV-2 infection	Phase 1|Phase 2	Interventional	"Hospital U. Jerez de la Frontera, Jerez de la Frontera, Cádiz, Spain|Hospital U. Puerto Real, Puerto Real, Cádiz, Spain|Hospital Costa del Sol, Marbella, Málaga, Spain|Hospital U. Torrecárdenas, Almería, Spain|Hospital U. Puerta del Mar, Cádiz, Spain|Hospital U. Virgen de las Nieves, Granada, Spain|Hospital U. San Cecilio, Granada, Spain|Hospital Juan Ramón Jiménez, Huelva, Spain|Hospital Regional U. de Málaga, Málaga, Spain|Hospital U. Virgen de la Victoria, Málaga, Spain|Hospital Unversitario Virgen Macarena, Sevilla, Spain|Hospital Universitario Virgen del Rocío, Sevilla, Spain|Hospital U. Nuestra Señora de Valme, Sevilla, Spain|Hospital San Juan de Dios, Sevilla, Spain"	https://ClinicalTrials.gov/show/NCT04366245
706	NCT04435015	The Utility of Camostat Mesylate in Patients With COVID-19 Associated Coagulopathy (CAC) and Cardiovascular Complications	Not yet recruiting	No Results Available	Coagulopathy|Cardiovascular Complication|COVID-19	"Drug: Camostat Mesylate|Drug: Microcrystalline Cellulose, NF"	Phase 1|Phase 2	Interventional		https://ClinicalTrials.gov/show/NCT04435015
707	NCT04415879	Effects of a N95 Respirator vs Cloth Mask on Exercise Capacity During Treadmill Exercise.	Recruiting	No Results Available	COVID-19	Device: N-95 Respirator|Device: Cloth Face Mask|Diagnostic Test: Graded exercise test	Not Applicable	Interventional	"Cleveland Clinic, Cleveland, Ohio, United States"	https://ClinicalTrials.gov/show/NCT04415879
708	NCT04379037	Vagus Nerve Stimulation ARDS Prevention Trial for COVID-19 Hospitalized Patients	Not yet recruiting	No Results Available	Severe Acute Respiratory Syndrome Coronavirus 2	Device: Transcutaneous Auricular Vagus Nerve Stimulation	Not Applicable	Interventional		https://ClinicalTrials.gov/show/NCT04379037
709	NCT04427878	Is Adipose Tissue a Reservoir for SARS-Cov2 Spread in Covid-19 Patients?	Not yet recruiting	No Results Available	Covid-19 Patients	Procedure: biopsies of subcutaneous adipose tissue	Not Applicable	Interventional	"CHU de Nice, Nice, France"	https://ClinicalTrials.gov/show/NCT04427878
710	NCT04366323	Clinical Trial to Assess the Safety and Efficacy of Intravenous Administration of Allogeneic Adult Mesenchymal Stem Cells of Expanded Adipose Tissue in Patients With Severe Pneumonia Due to COVID-19	Recruiting	No Results Available	Sars-CoV2	Drug: ALLOGENEIC AND EXPANDED ADIPOSE TISSUE-DERIVED MESENCHYMAL STEM CELLS	Phase 1|Phase 2	Interventional	"Hospital Universitario de Jerez de la Frontera, Jerez de la Frontera, Cádiz, Spain|Hospital Reina Sofía, Córdoba, Spain|Hospital Universitario Virgen de las Nieves, Granada, Spain|Hospital Universitario Virgen Macarena, Sevilla, Spain|Hospital Unversitario Virgen del Rocío, Sevilla, Spain|Hospital Nuestra Señora de Valme, Sevilla, Spain"	https://ClinicalTrials.gov/show/NCT04366323
711	NCT04439045	Efficacy and Safety of VPM1002 in Reducing SARS-CoV-2 (COVID-19) Infection Rate and Severity	Not yet recruiting	No Results Available	SARS-CoV-2 Infection	Biological: VPM1002|Other: Placebo	Phase 3	Interventional		https://ClinicalTrials.gov/show/NCT04439045
712	NCT04352959	COVID-19: Nasal and Salivary Detection of the SARS-CoV-2 Virus After Antiviral Mouthrinses	Not yet recruiting	No Results Available	COVID19|Mouthwash|Saliva	Device: mouthrinse with bêta-cyclodextrin and citrox|Device: mouthrinse without bêta-cyclodextrin and citrox	Not Applicable	Interventional		https://ClinicalTrials.gov/show/NCT04352959
713	NCT04350086	Use of Dexmedetomidine in Light to Moderate Sedation in the Patient in the Palliative Situation of a Sars-cov-2 / COVID-19 Infection	Not yet recruiting	No Results Available	COVID-19 Infection|Sars-cov-2|Respiratory Failure|Palliative Situation	Drug: Treatment with Dexmedetomidine	Phase 4	Interventional	"University Hospital, Limoges, France"	https://ClinicalTrials.gov/show/NCT04350086
714	NCT04433949	Best Supportive Care With or Without Low Dose Whole Lung Radiation Therapy for the Treatment of COVID-19	Recruiting	No Results Available	Pneumonia|Severe Acute Respiratory Syndrome|Symptomatic COVID-19 Infection Laboratory-Confirmed	Other: Best Practice|Radiation: Low Dose Radiation Therapy	Phase 3	Interventional	"Emory University Hospital/Winship Cancer Institute, Atlanta, Georgia, United States"	https://ClinicalTrials.gov/show/NCT04433949
715	NCT04408183	GLS-1200Topical Nasal Spray to Prevent SARS-CoV-2 Infection (COVID-19) in Health Care Personnel	Recruiting	No Results Available	SARS-CoV 2|Infection	Drug: GLS-1200|Drug: Placebo	Phase 2	Interventional	"University of Pennsylvania, Philadelphia, Pennsylvania, United States"	https://ClinicalTrials.gov/show/NCT04408183
716	NCT04399980	Mavrilimumab to Reduce Progression of Acute Respiratory Failure in COVID-19 Pneumonia and Systemic Hyper-inflammation	Recruiting	No Results Available	COVID 19|SARS-CoV 2|Pneumonia	Drug: Mavrilimumab|Drug: Placebos	Phase 2	Interventional	"Cleveland Clinic Health System, Cleveland, Ohio, United States"	https://ClinicalTrials.gov/show/NCT04399980
717	NCT04399356	Niclosamide for Mild to Moderate COVID-19	Not yet recruiting	No Results Available	COVID (SARS-CoV-2)	Drug: Niclosamide|Drug: Placebo|Other: Telehealth monitoring	Phase 2	Interventional		https://ClinicalTrials.gov/show/NCT04399356
718	NCT04378244	CORONA: A Study Using DeltaRex-G Gene Therapy for Symptomatic COVID-19	Not yet recruiting	No Results Available	COVID-19|Cytokine Storm|Acute Respiratory Distress Syndrome	Drug: DeltaRex-G	Phase 1|Phase 2	Interventional		https://ClinicalTrials.gov/show/NCT04378244
719	NCT04333914	Prospective Study in Patients With Advanced or Metastatic Cancer and SARS-CoV-2 Infection	Suspended	No Results Available	SARS-CoV-2 (COVID-19) Infection|Advanced or Metastatic Hematological or Solid Tumor	Drug: Chloroquine analog (GNS651)|Drug: Nivolumab|Drug: Tocilizumab|Other: Standard of care|Drug: Avdoralimab|Drug: Monalizumab	Phase 2	Interventional	"Centre Léon Bérard, Lyon, Rhône, France|CHU Clermont Ferrand, Clermont Ferrand, France|Centre Oscar Lambret, Lille, France|AP-HP Hôpital Saint Antoine, Paris, France|AP-HP La Pitié Salpétrière, Paris, France|Hôpital Saint-Joseph, Paris, France|AP-HP Tenon, Paris, France|AP-HP Hôpital Bichat Claude Bernard, Paris, France|GH Diaconesses Croix Saint Simon, Paris, France|Gustave Roussy, Villejuif, France"	https://ClinicalTrials.gov/show/NCT04333914
720	NCT04330300	Coronavirus (COVID-19) ACEi/ARB Investigation	Suspended	No Results Available	Hypertension|COVID-19	Drug: Thiazide or Thiazide-like diuretics|Drug: Calcium Channel Blockers|Drug: ACE inhibitor|Drug: Angiotensin receptor blocker	Phase 4	Interventional	"University Hospital Galway, Galway, Ireland"	https://ClinicalTrials.gov/show/NCT04330300
721	NCT04333732	CROWN CORONATION: Chloroquine RepurpOsing to healthWorkers for Novel CORONAvirus mitigaTION	Not yet recruiting	No Results Available	COVID 19	Drug: Low-dose chloroquine|Drug: Mid-dose chloroquine|Drug: High-dose chloroquine|Drug: Placebo	Phase 3	Interventional	"Washington University School of Medicine, Saint Louis, Missouri, United States|Population Health Resarch Institute, Hamilton, Ontario, Canada|University of Toronto, Toronto, Ontario, Canada|St James's Hospital, Dublin, Leinster, Ireland|Universitas Academic Hospital, Bloemfontein, Free State, South Africa|Wits RHI, University of the Witwatersrand, Johannesburg, Gauteng, South Africa|Steve Biko Academic Hospital, Pretoria, Gauteng, South Africa|Tygerberg Hospital, Cape Town, Western Cape, South Africa|Groote Schuur Hospital, Cape Town, Western Cape, South Africa|University College London, London, United Kingdom|Levy Mwanawasa University Teaching Hospital, Lusaka, Zambia|Centre for Infectious Disease Research in Zambia [CIDRZ], Lusaka, Zambia"	https://ClinicalTrials.gov/show/NCT04333732
722	NCT04351191	PRophylaxis of Exposed COVID-19 Individuals With Mild Symptoms Using choloroquinE Compounds	Recruiting	No Results Available	Sars-CoV2|Symptomatic Condition|Covid-19	Drug: Hydroxychloroquine Sulfate Regular dose|Drug: Hydroxychloroquine Sulfate Loading Dose|Drug: Chloroquine|Drug: Placebo	Phase 4	Interventional	"Expo Covid Isolation Center / Mayo Hospital Field Hospital, Lahore, Punjab, Pakistan|Mayo Hospital / King Edward Medical University, Lahore, Punjab, Pakistan|Pakistan Kidney and Liver Institute, Lahore, Punjab, Pakistan|Services Hospital, Lahore, Punjab, Pakistan"	https://ClinicalTrials.gov/show/NCT04351191
723	NCT04365153	Canakinumab in Covid-19 Cardiac Injury (The Three C Study)	Recruiting	No Results Available	COVID-19|SARS-CoV 2	Drug: Canakinumab Injection 600mg|Drug: Canakinumab Injection 300mg|Drug: Placebos	Phase 2	Interventional	"Cleveland Clinic Florida, Weston, Florida, United States|Cleveland Clinic, Cleveland, Ohio, United States"	https://ClinicalTrials.gov/show/NCT04365153
724	NCT04388709	Interferon Lambda Therapy for COVID-19	Not yet recruiting	No Results Available	SARS-CoV-2	Drug: Peginterferon Lambda-1A	Phase 2	Interventional	"Icahn School of Medicine at Mount Sinai, New York, New York, United States"	https://ClinicalTrials.gov/show/NCT04388709
725	NCT04410562	Hydroxychloroquine Efficacy and Safety in Preventing SARS-CoV-2 Infection and COVID-19 Disease Severity During Pregnancy	Recruiting	No Results Available	Pregnancy Related|COVID|Covid-19	Drug: Hydroxychloroquine|Drug: Placebo	Phase 3	Interventional	"Hospital Sant Creu i Sant Pau, Barcelona, Catalunya, Spain|Hospital Clínic Maternity, Barcelona, Catalunya, Spain|University hospital of Torrejón, Madrid, Spain|HM Puerta del Sur, Madrid, Spain"	https://ClinicalTrials.gov/show/NCT04410562
726	NCT04441684	"Seroprevalence of SARS-CoV-2 in Strasbourg University Hospital, Strasbourg, France (COVID-19)"	Recruiting	No Results Available	SARS-CoV-2 Serological Status|SARS-CoV-2 Seroprevalence	Diagnostic Test: Blood sample for serological test	Not Applicable	Interventional	"Hôpitaux Universitaires de Strasbourg - Centre d'Investigation Clinique - Nouvel Hôpital Civil et Hautepierre, Strasbourg, France"	https://ClinicalTrials.gov/show/NCT04441684
727	NCT04358406	Rhu-pGSN for Severe Covid-19 Pneumonia	Not yet recruiting	No Results Available	Sars-CoV2	Drug: Recombinant human plasma gelsolin (Rhu-pGSN)|Other: Placebo	Phase 2	Interventional		https://ClinicalTrials.gov/show/NCT04358406
728	NCT04327206	BCG Vaccination to Protect Healthcare Workers Against COVID-19	Recruiting	No Results Available	Coronavirus Disease 2019 (COVID-19)|Respiratory Illness|Corona Virus Infection|COVID-19	Drug: BCG Vaccine|Drug: 0.9%NaCl	Phase 3	Interventional	"St Vincent's Hospital, Sydney, Sydney, New South Wales, Australia|Prince of Wales Hospital, Sydney, New South Wales, Australia|Sydney Children's Hospital, Randwick, Sydney, New South Wales, Australia|The Children's Hospital at Westmead, Sydney, New South Wales, Australia|Westmead Hospital, Sydney, New South Wales, Australia|Royal Adelaide Hospital, Adelaide, South Australia, Australia|South Australian Health and Medical Research Institute, Adelaide, South Australia, Australia|Women's and Children's Hospital, North Adelaide, South Australia, Australia|Epworth Victoria Parade, Melbourne, Victoria, Australia|Royal Children's Hospital, Melbourne, Victoria, Australia|Epworth Richmond, Melbourne, Victoria, Australia|Epworth Eastern, Melbourne, Victoria, Australia|Monash Health- Monash Medical Centre, Melbourne, Victoria, Australia|Fiona Stanley Hospital, Murdoch, Western Australia, Australia|Perth Children's Hospital, Perth, Western Australia, Australia|Sir Charles Gairdner Hospital, Perth, Western Australia, Australia"	https://ClinicalTrials.gov/show/NCT04327206
729	NCT04347382	Honey & Nigella Sativa Trial Against COVID-19	Recruiting	No Results Available	Coronavirus Infection|Sars-CoV2	Drug: Honey|Drug: Nigella Sativa / Black Cumin|Drug: Placebos	Phase 3	Interventional	"Kingedward Medical University, Mayo Hospital, Lahore, Punjab, Pakistan|Federal Post-Graduate Medical Institute, Shaikh Zayed Hospital, Lahore, Punjab, Pakistan|Services Institute of Medical Sciences, Services Hospital, Lahore, Punjab, Pakistan"	https://ClinicalTrials.gov/show/NCT04347382
730	NCT04416334	PREEMPTIVE THERAPY WITH COLCHICINE IN PATIENTS OLDER THAN 70 YEARS WITH HIGH RISK OF SEVERE PNEUMONIAE DUE TO CORONAVIRUS	Recruiting	No Results Available	SARS-CoV-2 Infection (COVID-19)	Drug: Colchicine plus symptomatic treatment (paracetamol)|Drug: Symptomatic treatment (paracetamol or best symptomatic treatment based on doctor recommendations)	Phase 3	Interventional	"Atención primaria (Área 2), Laredo, Cantabria, Spain|Gerencia de atención primaria (Área 3), Reinosa, Cantabria, Spain|Atencion primaria (AREA 1), Santander, Cantabria, Spain|Gerencia de atención primaria (área 4), Torrelavega, Cantabria, Spain"	https://ClinicalTrials.gov/show/NCT04416334
731	NCT04426006	Serological Response to SARS-Cov-2 Virus in Personnel of the Institut Bergonié in the Context of the COVID-19 Pandemic - PRO-SERO-COV	Not yet recruiting	No Results Available	Sars-CoV2|Serum; Disease	Other: PRO-SERO-COV	Not Applicable	Interventional	"Institut Bergonié, Bordeaux, France"	https://ClinicalTrials.gov/show/NCT04426006
732	NCT04391829	Detection of SARS-CoV-2 in Semen of COVID-19 Positive Males	Not yet recruiting	No Results Available	COVID-19|Sars-CoV2|Corona Virus Infection|Semen	Diagnostic Test: Ejaculated semen sample	Not Applicable	Interventional		https://ClinicalTrials.gov/show/NCT04391829
733	NCT04391101	Convalescent Plasma for the Treatment of Severe SARS-CoV-2 (COVID-19)	Not yet recruiting	No Results Available	SARS-Cov-2	Drug: Convalescent plasma	Phase 3	Interventional	"Hospital San Vicente Fundacion, Medellín, Antioquia, Colombia"	https://ClinicalTrials.gov/show/NCT04391101
734	NCT04445623	Prasugrel in Severe COVID-19 Pneumonia	Not yet recruiting	No Results Available	COVID19|Thrombosis	Drug: Prasugrel Hydrochloride 10 MG Oral Tablet|Drug: Placebo	Phase 3	Interventional	"Azienda Ospedaliera Universitaria Integrata Verona, Verona, Italy"	https://ClinicalTrials.gov/show/NCT04445623
735	NCT04409509	Treatment With CSL312 in Adults With Coronavirus Disease 2019 (COVID‑19)	Recruiting	No Results Available	Coronavirus Disease 2019 (COVID‑19)	"Biological: Garadacimab, Factor XIIa Antagonist Monoclonal Antibody|Drug: Placebo"	Phase 2	Interventional	"Inspira Health Center Vineland, Vineland, New Jersey, United States"	https://ClinicalTrials.gov/show/NCT04409509
736	NCT04413864	Immunomodulatory Profile of Dexmedetomidine Sedation in Patients Recovering After ARDS Covid-19	Recruiting	No Results Available	SARS-CoV 2	Other: Inflammatory cytokines and chemokines profiles of patients with dexmedetomidine administration	Not Applicable	Interventional	"Intensive Care Unit and Respiratory division ; Groupe hospitalier Pitie-Salpetriere and Universite Pierre et Marie Curie Paris 6, Paris, France"	https://ClinicalTrials.gov/show/NCT04413864
737	NCT04326790	The GReek Study in the Effects of Colchicine in Covid-19 cOmplications Prevention	Recruiting	No Results Available	Corona Virus Disease 19 (Covid 19)	Drug: Colchicine|Drug: Standard treatment	Phase 2	Interventional	"AHEPA Hospital, Thessaloniki, Gibraltar"	https://ClinicalTrials.gov/show/NCT04326790
738	NCT04372082	Hydroxychloroquine or Diltiazem-Niclosamide for the Treatment of COVID-19	Not yet recruiting	No Results Available	Sars-CoV2	Other: Standard of care (SOC)|Drug: Hydroxychloroquine|Drug: Association of diltiazem and niclosamide	Phase 3	Interventional		https://ClinicalTrials.gov/show/NCT04372082
739	NCT04357782	Administration of Intravenous Vitamin C in Novel Coronavirus Infection (COVID-19) and Decreased Oxygenation	Recruiting	No Results Available	COVID-19|Hypoxia	Drug: L-ascorbic acid	Phase 1|Phase 2	Interventional	"Hunter Holmes Mcguire Veteran Affairs Medical Center, Richmond, Virginia, United States"	https://ClinicalTrials.gov/show/NCT04357782
740	NCT04345601	Mesenchymal Stromal Cells for the Treatment of SARS-CoV-2 Induced Acute Respiratory Failure (COVID-19 Disease)	Not yet recruiting	No Results Available	Sars-CoV2|Acute Respiratory Distress Syndrome|COVID-19	Genetic: Mesenchymal Stromal Cells	Early Phase 1	Interventional	"Houston Methodist Hospital, Houston, Texas, United States"	https://ClinicalTrials.gov/show/NCT04345601
741	NCT04392973	FAvipiravir and HydroxyChloroquine Combination Therapy	Recruiting	No Results Available	COVID19	Combination Product: Favipiravir and Hydroxychloroquine	Not Applicable	Interventional	"King Abdulaziz Hospital, Hasa, Eastern Region, Saudi Arabia|AlMadina General Hospital, Al Madīnah, Saudi Arabia|King Abdulaziz Medical City, Jeddah, Saudi Arabia|King Abdulaziz Hospital, Mecca, Saudi Arabia|King Abdulaziz Medical City, National Guard Health Affairs, Riyadh, Saudi Arabia|Imam Abdulrahman Alfaisal Hospital, Riyadh, Saudi Arabia"	https://ClinicalTrials.gov/show/NCT04392973
742	NCT04331054	Protective Role of Inhaled Steroids for Covid-19 Infection	Recruiting	No Results Available	Covid-19 Infection|Hospitalization in Respiratory Disease Department	Drug: 2: Usual practice + SYMBICORT RAPIHALER|Other: 1: Usual practice	Phase 3	Interventional	"Hôpital Bichat - Service de Pneumologie, Paris, France"	https://ClinicalTrials.gov/show/NCT04331054
743	NCT04339712	Personalised Immunotherapy for SARS-CoV-2 (COVID-19) Associated With Organ Dysfunction	Recruiting	No Results Available	COVID-19|Virus Diseases|Macrophage Activation Syndrome|Corona Virus Infection	Drug: Anakinra|Drug: Tocilizumab	Phase 2	Interventional	"2nd Department of Critical Care Medicine, ATTIKON University Hospital, Athens, Haidari, Greece|Intensive Care Unit, Ioannina University Hospital, Ioánnina, Ioannina, Greece|Department of Internal Medicine, Patras University Hospital, Patras, Rion, Greece|Department of Internal Medicine, I PAMMAKARISTOS Hospital, Athens, Greece|Intensive Care Unit, General Hospital of Athens KORGIALENIO-BENAKIO E.E.S., Athens, Greece|1st Department of Pulmonary Medicine and Intensive Care Unit, Athens, Greece|Intensive Care Unit, General Hospital of Athens IPPOKRATEIO, Athens, Greece|4th Department of Internal Medicine, Attikon University Hospital, Athens, Greece|Intensive Care Unit, General Hospital ASKLEPIEIO Voulas, Athens, Greece|Intensive Care Unit, ""Latsio"", Thriasio Elefsis General Hospital, Elefsína, Greece|Intensive Care Unit, ""Koutlimbaneio & Triantafylleio"" Larissa General Hospital, Larissa, Greece|Department of Internal Medicine, Larissa University Hospital, Larissa, Greece|Intensive Care Unit, AGIOS DIMITRIOS General Hospital of Thessaloniki, Thessaloniki, Greece|Intensive Care Unit, G. GENNIMATAS General Hospital of Thessaloniki, Thessaloniki, Greece|Intensive Care Unit, Theageneio Oncological Hospital of Thessaloniki, Thessaloniki, Greece|Intensive Care Unit, General Hospital of Thessaloniki IPPOKRATEIO, Thessaloniki, Greece|Department of Anesthesiology and Intensive Care Medicine, University General Hospital of Thessaloniki AHEPA, Thessaloniki, Greece"	https://ClinicalTrials.gov/show/NCT04339712
744	NCT04382040	"A Phase II, Controlled Clinical Study Designed to Evaluate the Effect of ArtemiC in Patients Diagnosed With COVID-19"	Recruiting	No Results Available	COVID-19|Corona Virus Infection|SARS-CoV 2|Coronavirus|Coronavirus Infection	Drug: ArtemiC|Drug: Placebo	Phase 2	Interventional	"Hillel Yaffe Medical Center, Hadera, Haifa, Israel|Nazareth Hospital EMMS, Nazareth, North, Israel|Rambam Health Care Campus, Haifa, Israel"	https://ClinicalTrials.gov/show/NCT04382040
745	NCT04334512	A Study of Quintuple Therapy to Treat COVID-19 Infection	Recruiting	No Results Available	COVID-19|Corona Virus Infection|Coronavirus-19|Sars-CoV2	Drug: Hydroxychloroquine|Drug: Azithromycin|Dietary Supplement: Vitamin C|Dietary Supplement: Vitamin D|Dietary Supplement: Zinc	Phase 2	Interventional	"ProgenaBiome, Ventura, California, United States"	https://ClinicalTrials.gov/show/NCT04334512
746	NCT04335552	"Pragmatic Factorial Trial of Hydroxychloroquine, Azithromycin, or Both for Treatment of Severe SARS-CoV-2 Infection"	Recruiting	No Results Available	SARS-CoV-2	Other: Standard of care|Drug: Hydroxychloroquine|Drug: Azithromycin	Phase 2	Interventional	"Duke Regional Hospital, Durham, North Carolina, United States|Duke University Hospital, Durham, North Carolina, United States|Durham VA Medical Center, Durham, North Carolina, United States|Duke Raleigh Hospital, Raleigh, North Carolina, United States"	https://ClinicalTrials.gov/show/NCT04335552
747	NCT04328961	Hydroxychloroquine for COVID-19 Post-exposure Prophylaxis (PEP)	Recruiting	No Results Available	COVID-19|Corona Virus Infection|SARS (Severe Acute Respiratory Syndrome)|SARS-CoV-2	Drug: Hydroxychloroquine Sulfate|Drug: Ascorbic Acid	Phase 2|Phase 3	Interventional	"University of California Los Angeles, Los Angeles, California, United States|Tulane, New Orleans, Louisiana, United States|University of Maryland, Baltimore, Baltimore, Maryland, United States|Boston University, Boston, Massachusetts, United States|NYU Langone Health, New York, New York, United States|SUNY Upstate Medical University, Syracuse, New York, United States|University of Washington, Coordinating Center, Seattle, Washington, United States|UW Virology Research Clinic, Seattle, Washington, United States"	https://ClinicalTrials.gov/show/NCT04328961
748	NCT04425733	MK-5475 in Participants With Hypoxemia Due to COVID-19 Pneumonia (MK-5475-009)	Not yet recruiting	No Results Available	Coronavirus Disease 2019 (COVID-19)|Pneumonia|Hypoxemia	Drug: MK-5475|Drug: Placebo	Phase 1	Interventional		https://ClinicalTrials.gov/show/NCT04425733
749	NCT04405999	Prevention of Infection and Incidence of COVID-19 in Medical Personnel Assisting Patients With New Coronavirus Disease	Recruiting	No Results Available	Increased Risk of SARS-CoV-2 Infection	Drug: Bromhexine Hydrochloride	Phase 4	Interventional	"Almazov National Medical Research Centre, Saint Petersburg, Russian Federation"	https://ClinicalTrials.gov/show/NCT04405999
750	NCT04450004	"Safety, Tolerability and Immunogenicinity of a Coronavirus-Like Particle COVID-19 Vaccine in Adults Aged 18-55 Years."	Not yet recruiting	No Results Available	SARS-CoV 2	Biological: Intramuscular Vaccine	Phase 1	Interventional		https://ClinicalTrials.gov/show/NCT04450004
751	NCT04400799	Enoxaparin for Primary Thromboprophylaxis in Ambulatory Patients With COVID-19	Not yet recruiting	No Results Available	"COVID-19|Pulmonary Embolism, Deep Vein Thrombosis"	Drug: Enoxaparin 40Mg/0.4Ml Inj Syringe 0.4Ml	Phase 3	Interventional		https://ClinicalTrials.gov/show/NCT04400799
752	NCT04369066	"COVID-19 Study of the Serological Response Against the Severe Acute Respiratory Syndrome (SARS) Coronavirus 2 (CoV-2) Virus in 2 Types of Employees, Hospital and Non-hospital, at Institute Curie"	Recruiting	No Results Available	Volunteers From the Institute Curie Staff Who Are Not Showing Active SARS-CoV-2 Infection	Diagnostic Test: Blood samples (collection of 5 mL of blood in a dry tube)|Diagnostic Test: Nasopharyngeal swabs	Not Applicable	Interventional	"Institut Curie, Paris, France"	https://ClinicalTrials.gov/show/NCT04369066
753	NCT04344184	Early Infusion of Vitamin C for Treatment of Novel COVID-19 Acute Lung Injury (EVICT-CORONA-ALI)	Not yet recruiting	No Results Available	"COVID-19|Lung Injury, Acute"	Drug: L-ascorbic acid|Other: Placebo	Phase 2	Interventional	"Hunter Holmes McGuire VA Medical Center, Richmond, Virginia, United States|Virginia Commonwealth University, Richmond, Virginia, United States"	https://ClinicalTrials.gov/show/NCT04344184
754	NCT04338698	"Hydroxychloroquine, Oseltamivir and Azithromycin for the Treatment of COVID-19 Infection: An RCT"	Not yet recruiting	No Results Available	COVID 19	Drug: Hydroxychloroquine|Drug: Oseltamivir|Drug: Azithromycin	Phase 3	Interventional		https://ClinicalTrials.gov/show/NCT04338698
755	NCT04345848	Preventing COVID-19 Complications With Low- and High-dose Anticoagulation	Recruiting	No Results Available	COVID|Sars-CoV2	Drug: Enoxaparin	Phase 3	Interventional	"Geneva University Hospitals, Geneva, Switzerland"	https://ClinicalTrials.gov/show/NCT04345848
756	NCT04366791	Radiation Eliminates Storming Cytokines and Unchecked Edema as a 1-Day Treatment for COVID-19	Recruiting	No Results Available	Pneumonia|Coronavirus Infection in 2019 (COVID-19)|Severe Acute Respiratory Syndrome (SARS) Pneumonia	Radiation: Low Dose Radiation Therapy	Phase 1|Phase 2	Interventional	"Emory University Hospital Midtown/Winship Cancer Institute, Atlanta, Georgia, United States"	https://ClinicalTrials.gov/show/NCT04366791
757	NCT04435587	Ivermectin vs Combined Hydroxychloroquine and Antiretroviral Drugs (ART) Among Asymptomatic COVID-19 Infection	Not yet recruiting	No Results Available	Asymptomatic Infections|SARS-CoV2 Infection	Drug: Ivermectin Pill|Drug: Combined ART/hydroxychloroquine	Phase 4	Interventional	"Siriraj Hospital, Bangkok Noi, Bangkok, Thailand"	https://ClinicalTrials.gov/show/NCT04435587
758	NCT04455958	Lopinavir/Ritonavir for the Treatment of COVID-19 Positive Patients With Cancer and Immune Suppression in the Last Year	Not yet recruiting	No Results Available	Hematopoietic and Lymphoid Cell Neoplasm|Malignant Solid Neoplasm|Symptomatic COVID-19 Infection Laboratory-Confirmed	Drug: Lopinavir/Ritonavir|Drug: Placebo Administration|Other: Questionnaire Administration	Phase 2	Interventional	"OHSU Knight Cancer Institute, Portland, Oregon, United States"	https://ClinicalTrials.gov/show/NCT04455958
759	NCT04398147	Phase I/II Clinical Trial of Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) in Canada	Not yet recruiting	No Results Available	COVID-19	Biological: Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector)|Biological: Placebo	Phase 1|Phase 2	Interventional	"Canadian Center for Vaccinology, Halifax, Canada"	https://ClinicalTrials.gov/show/NCT04398147
760	NCT04407286	Vitamin D Testing and Treatment for COVID 19	Recruiting	No Results Available	Covid 19|Vitamin D Deficiency	Dietary Supplement: Vitamin D3	Phase 1	Interventional	"Arizona State University, Tempe, Arizona, United States"	https://ClinicalTrials.gov/show/NCT04407286
761	NCT04372680	WeanINg From Mechanical Ventilation for ARDS CovId-19 Patients Guided by Combined Thoracic UltraSound	Recruiting	No Results Available	"COVID-19|ARDS, Human|Mechanical Ventilation"	Diagnostic Test: CTUS examination	Not Applicable	Interventional	"CHU de LIMOGES, Limoges, France|CHU de TOULOUSE, Toulouse, France"	https://ClinicalTrials.gov/show/NCT04372680
762	NCT04357366	suPAR-guided Anakinra Treatment for Validation of the Risk and Management of Respiratory Failure by COVID-19 (SAVE)	Recruiting	No Results Available	COVID-19|Virus Diseases|Corona Virus Infection|Lower Respiratory Tract Infection Viral	Drug: Anakinra|Drug: trimethoprim/sulfamethoxazole	Phase 2	Interventional	"COVID-19 Department, General Hospital of Attica SISMANOGLEIO-AMALIA FLEMING, Marousi, Athens, Greece|2nd Department of Internal Medicine, University General Hospital of Alexandroupolis, Alexandroupolis, Greece|Department of Internal Medicine, I PAMMAKARISTOS Hospital, Athens, Greece|1st Department of Internal Medicine, General Hospital of Athens G. GENNIMATAS, Athens, Greece|1st University Department of Internal Medicine, General Hospital of Athens LAIKO, Athens, Greece|2nd University Department of Internal Medicine, IPPOKRATEION General Hospital of Athens, Athens, Greece|3rd University Department of Internal Medicine, General Hospital of Chest Diseases of Athens I SOTIRIA, Athens, Greece|Department of Internal Medicine, General Hospital of Chest Diseases of Athens I SOTIRIA, Athens, Greece|Department of Clinical Therapeutics, ALEXANDRA General Hospital of Athens, Athens, Greece|Department of Infectious Diseases, General Hospital of Kerkira, Corfu, Greece|1st Department of Internal Medicine, General University Hospital of Ioannina, Ioánnina, Greece|Department of Internal Medicine, University General Hospital of Larissa, Larissa, Greece|Department of Internal Medicine, University General Hospital of Patras PANAGIA I VOITHIA, Patra, Greece|1st Department of Internal Medicine, AHEPA University General Hospital of Thessaloniki, Thessaloníki, Greece"	https://ClinicalTrials.gov/show/NCT04357366
763	NCT04369599	Trans Thoracic Manipulation of Ventilation/Perfusion: the V/Q Vest for COVID-19	Enrolling by invitation	No Results Available	Acute Respiratory Distress Syndrome|COVID-19	Device: V/Q Vest	Not Applicable	Interventional	"Emory University Hospital, Atlanta, Georgia, United States"	https://ClinicalTrials.gov/show/NCT04369599
764	NCT04401293	Full Dose Heparin Vs. Prophylactic Or Intermediate Dose Heparin in High Risk COVID-19 Patients	Recruiting	No Results Available	Sars-CoV2|COVID	Drug: Enoxaparin|Drug: Prophylactic/Intermediate Dose Enoxaparin	Phase 3	Interventional	"Beth Israel Newark, Newark, New Jersey, United States|Southside Hospital, Bay Shore, New York, United States|Huntington Hospital, Huntington, New York, United States|Lenox Hill Hospital, New York, New York, United States|Long Island Jewish Medical Center, Queens, New York, United States|Staten Island University Hospital, Staten Island, New York, United States"	https://ClinicalTrials.gov/show/NCT04401293
765	NCT04365517	The Effect of Sitagliptin Treatment in COVID-19 Positive Diabetic Patients	Not yet recruiting	No Results Available	"Covid19|Diabetes Mellitus, Type 2|CKD"	Drug: Sitagliptin	Phase 3	Interventional	"ASST FBF Sacco, Milan, Italy"	https://ClinicalTrials.gov/show/NCT04365517
766	NCT04412057	Clinical Trial to Evaluate CERC-002 in Adults With COVID-19 Pneumonia and Acute Lung Injury	Recruiting	No Results Available	COVID-19 Pneumonia|Acute Lung Injury|ARDS	Drug: CERC-002|Drug: Placebo	Phase 2	Interventional	"Cape Fear Valley Medical Center, Fayetteville, North Carolina, United States|Carolina Institute for Clinical Research, LLC, Fayetteville, North Carolina, United States"	https://ClinicalTrials.gov/show/NCT04412057
767	NCT04351516	Test and Treat COVID 65plus+	Recruiting	No Results Available	SARS-CoV 2|COVID-19	Drug: Hydroxychloroquine|Other: Placebo	Phase 2|Phase 3	Interventional	"Uniklinikum Tuebingen, Tuebingen, Germany|Uniklinikum Ulm, Ulm, Germany"	https://ClinicalTrials.gov/show/NCT04351516
768	NCT04384588	COVID19-Convalescent Plasma for Treating Patients With Active Symptomatic COVID 19 Infection (FALP-COVID)	Recruiting	No Results Available	COVID-19 Infection|Cancer Patients|General Population	Biological: Convalescent Plasma from COVID-19 donors	Phase 2|Phase 3	Interventional	"Fundacion Arturo Lopez Perez, Providencia, Santiago, Chile"	https://ClinicalTrials.gov/show/NCT04384588
769	NCT04401410	Anti-SARS Cov-2 T Cell Infusions for COVID 19	Not yet recruiting	No Results Available	SARS-CoV 2|Viral Infection|COVID 19	Biological: Partially HLA-matched Virus Specific T cells (VSTs)	Phase 1	Interventional	"Houston Methodist Hospital, Houston, Texas, United States"	https://ClinicalTrials.gov/show/NCT04401410
770	NCT04357860	Clinical Trial of Sarilumab in Adults With COVID-19	Not yet recruiting	No Results Available	SARS-CoV 2|SARS	Drug: Sarilumab 200 MG/1.14 ML Subcutaneous Solution [KEVZARA]|Drug: Sarilumab 400 MG/2.28 ML Subcutaneous Solution [KEVZARA]|Drug: Best available treatment	Phase 2	Interventional	"Hospital Universitario Reina Sofía, Córdoba, Spain"	https://ClinicalTrials.gov/show/NCT04357860
771	NCT04366063	Mesenchymal Stem Cell Therapy for SARS-CoV-2-related Acute Respiratory Distress Syndrome	Recruiting	No Results Available	Covid-19	Biological: Cell therapy protocol 1|Biological: Cell therapy protocol 2	Phase 2|Phase 3	Interventional	"Royan Institute, Tehran, Iran, Islamic Republic of"	https://ClinicalTrials.gov/show/NCT04366063
772	NCT04311697	Intravenous Aviptadil for Critical COVID-19 With Respiratory Failure	Recruiting	No Results Available	Critical COVID-19 With Respiratory Failure|Acute Respiratory Distress Syndrome (ARDS)|Corona Virus Infection|Acute Lung Injury	Drug: Aviptadil by intravenous infusion + standard of care|Drug: Normal Saline Infusion + standard of care	Phase 2	Interventional	"University of California - Irvine, Irvine, California, United States|Miller School of Medicine / University of Miami Medical Center, Miami, Florida, United States|University of Louisville, Louisville, Kentucky, United States|Robert I Grossman School of Medicine / NYU Langone Medical Center, New York, New York, United States|Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, United States|Houston Methodist Hospital, Houston, Texas, United States|Rambam Health Care Campus, Haifa, Israel"	https://ClinicalTrials.gov/show/NCT04311697
773	NCT04354441	Effect of Hydroxychloroquine in COVID-19 Positive Pregnant Women	Withdrawn	No Results Available	COVID-19|SARS-CoV-2|Pregnant Women|Hydroxychloroquine	Drug: hydroxychloroquine sulfate 200 MG|Drug: Placebo oral tablet	Phase 2	Interventional		https://ClinicalTrials.gov/show/NCT04354441
774	NCT04405076	"Dose-Confirmation Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1273 COVID-19 Vaccine in Adults Aged 18 Years and Older"	Recruiting	No Results Available	SARS-CoV-2	Biological: Biological: mRNA-1273: 50 mcg|Other: Placebo|Biological: Biological: mRNA-1273: 100 mcg	Phase 2	Interventional	"Meridian Clinical Research, Savannah, Georgia, United States|Heartland Research Associates, Newton, Kansas, United States|Heartland Research Associates, Kansas City, Missouri, United States|Meridian Clinical Research, Norfolk, Nebraska, United States|Meridian Clinical Research, Omaha, Nebraska, United States|Trial Management Associates, Wilmington, North Carolina, United States|Meridian Clinical Research, Dakota Dunes, South Dakota, United States|Benchmark Research, Austin, Texas, United States|Benchmark Research, San Angelo, Texas, United States|Advanced Clinical Research/Velocity, West Jordan, Utah, United States"	https://ClinicalTrials.gov/show/NCT04405076
775	NCT04356495	Treatments to Decrease the Risk of Hospitalization or Death in Elderly Outpatients With Symptomatic SARS-CoV-2 Infection (COVID-19)	Recruiting	No Results Available	Corona Virus Infection|Sars-CoV2	Dietary Supplement: Vitamins|Drug: Imatinib|Drug: Favipiravir|Drug: Telmisartan	Phase 3	Interventional	"Bordeaux university Hospital, Bordeaux, France"	https://ClinicalTrials.gov/show/NCT04356495
776	NCT04383613	Prone Positioning for Patients on General Medical Wards With COVID19	Recruiting	No Results Available	Covid-19|ARDS	Other: Prone positioning	Not Applicable	Interventional	"William Osler Health System, Brampton, Ontario, Canada|William Osler Health System, Etobicoke, Ontario, Canada|Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada|St. Michael's Hospital, Toronto, Ontario, Canada|Sinai Health System, Toronto, Ontario, Canada|Toronto General Hospital, Toronto, Ontario, Canada|Toronto Western Hospital, Toronto, Ontario, Canada"	https://ClinicalTrials.gov/show/NCT04383613
777	NCT04374019	Novel Agents for Treatment of High-risk COVID-19 Positive Patients	Recruiting	No Results Available	COVID|Sars-CoV2	Drug: Hydroxychloroquine|Drug: Hydroxychloroquine and Azithromycin|Drug: Hydroxychloroquine and Ivermectin|Drug: Camostat Mesilate	Phase 2	Interventional	"University of Kentucky Markey Cancer Center, Lexington, Kentucky, United States"	https://ClinicalTrials.gov/show/NCT04374019
778	NCT04385901	Long Term Functional Outcomes of COVID-19 Patients Treated by Rehabilitation Services viaTelehealth	Recruiting	No Results Available	SARS-CoV 2|SARS Pneumonia	Behavioral: Therapy Intervention	Not Applicable	Interventional	"Missouri Orthopedic Institute, Columbia, Missouri, United States"	https://ClinicalTrials.gov/show/NCT04385901
779	NCT04346667	Post-Exposure Prophylaxis for Asymptomatic SARS-CoV-2 COVID-19 Patients With choloroquinE Compounds	Recruiting	No Results Available	SARS-CoV-2|Coronavirus Infection|Asymptomatic Condition|COVID-19	Drug: Hydroxychloroquine Sulfate Regular dose|Drug: Hydroxychloroquine Sulfate Loading Dose|Drug: Chloroquine|Drug: Placebo	Phase 4	Interventional	"Expo Covid Center, Lahore, Punjab, Pakistan|Mayo Hospital, Lahore, Punjab, Pakistan|Pakistan Kidney and Liver Institute, Lahore, Punjab, Pakistan"	https://ClinicalTrials.gov/show/NCT04346667
780	NCT04360759	Chloroquine Outpatient Treatment Evaluation for HIV-Covid-19	Not yet recruiting	No Results Available	Covid-19|HIV	Drug: Chloroquine or hydroxychloroquine	Phase 3	Interventional	"Khayelitsha Hospital, Cape Town, Western Cape, South Africa|Groote Schuur Hospital, Cape Town, Western Cape, South Africa"	https://ClinicalTrials.gov/show/NCT04360759
781	NCT04278963	Yinhu Qingwen Decoction for the Treatment of Mild / Common CoVID-19	Suspended	No Results Available	CoVID-19|Chinese Medicine	Drug: YinHu QingWen Decoction|Drug: YinHu QingWen Decoction(low dose)|Other: Chinese medicine treatment|Other: standard western medicine treatment	Phase 2|Phase 3	Interventional	"Jingzhou Hospital of Traditional Chinese Medicine, Jingzhou, Hubei, China|Wuhan Leishenshan (Thunder God Mountain) Hospital/The First Affiliated Hospital of Dalian Medical University, Wuhan, Hubei, China|Xiangyang Hospital of Traditional Chinese Medicine, Xiangyang, Hubei, China"	https://ClinicalTrials.gov/show/NCT04278963
782	NCT04410510	P2Et Extract in the Symptomatic Treatment of Subjects With COVID-19	Not yet recruiting	No Results Available	COVID|Coronavirus Infection|SARS-CoV 2|COVID19	Drug: P2Et (Caesalpinia spinosa extract)|Other: Placebo	Phase 2|Phase 3	Interventional		https://ClinicalTrials.gov/show/NCT04410510
783	NCT04379492	A Study of Hydroxycholoroquine Compared to Placebo as Treatment for People With COVID-19	Recruiting	No Results Available	COVID-19|COVID19|Sars-CoV2|SARS-Cov-2	Drug: Hydroxychloroquine|Other: Placebo	Phase 2	Interventional	"Memorial Sloan - Kettering Cancer Center, New York, New York, United States"	https://ClinicalTrials.gov/show/NCT04379492
784	NCT04347226	Anti-Interleukin-8 (Anti-IL-8) for Patients With COVID-19	Recruiting	No Results Available	Solid Tumor|Sars-CoV2|Hematological Malignancy	Drug: BMS-986253	Phase 2	Interventional	"Columbia University Irving Medical Center, New York, New York, United States"	https://ClinicalTrials.gov/show/NCT04347226
785	NCT04328012	COVID MED Trial - Comparison Of Therapeutics for Hospitalized Patients Infected With SARS-CoV-2	Recruiting	No Results Available	SARS-CoV-2 Infection	Drug: lopinavir/ritonavir|Drug: Hydroxychloroquine Sulfate|Drug: Losartan|Drug: Placebos	Phase 2|Phase 3	Interventional	"Bassett Medical Center, Cooperstown, New York, United States"	https://ClinicalTrials.gov/show/NCT04328012
786	NCT04303507	Chloroquine/ Hydroxychloroquine Prevention of Coronavirus Disease (COVID-19) in the Healthcare Setting	"Active, not recruiting"	No Results Available	COVID19|Coronavirus|Acute Respiratory Illnesses	Drug: Chloroquine or Hydroxychloroquine|Drug: Placebo	Not Applicable	Interventional	"Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand|Brighton and Sussex University Hospitals NHS Trust, Brighton, United Kingdom|Oxford University Hospital NHS Foundation Trust, Oxford, United Kingdom"	https://ClinicalTrials.gov/show/NCT04303507
787	NCT04347941	Awake Prone Positioning to Reduce Invasive VEntilation in COVID-19 Induced Acute Respiratory failurE	Not yet recruiting	No Results Available	"ARDS, Human|Mechanical Ventilation Complication|COVID19"	Procedure: Prone Positioning|Procedure: Standard of care.	Not Applicable	Interventional	"Galway University Hospital, Galway, Ireland"	https://ClinicalTrials.gov/show/NCT04347941
788	NCT04356482	CONVALESCENT PLASMA FOR ILL PATIENTS BY COVID-19	Recruiting	No Results Available	COVID-19|SARS-CoV 2|Convalescence|Plasma|Doses	Biological: convalescent plasma	Phase 1|Phase 2	Interventional	"Hospital Del Issste Regional En Guadalajara Jalisco, Guadalajara, Jalisco, Mexico|Secretaria de Salud Del Estado de Sonora, Hospital General Del Estado, Hermosillo, Sonora, Mexico|Hospital Central Norte Pemex, Mexico City, Mexico"	https://ClinicalTrials.gov/show/NCT04356482
789	NCT04357028	Measles Vaccine in HCW	Recruiting	No Results Available	Covid19	Drug: Measles-Mumps-Rubella Vaccine|Drug: Placebos	Phase 3	Interventional	"Cairo University Hospital, Cairo, Egypt"	https://ClinicalTrials.gov/show/NCT04357028
790	NCT04430608	Remote Continues Glucose Monitoring During the COVID-19 Pandemic in Quarantined Hospitalized Patients	Recruiting	No Results Available	Diabetes|Covid-19|Infection	Device: Dexcom G6	Not Applicable	Interventional	"Nordsjællands Hospital, Hillerød, Denmark"	https://ClinicalTrials.gov/show/NCT04430608
791	NCT04420247	Efficacy of Chloroquine or Hydroxychloroquine in Treating Pneumonia Caused by SARS-Cov-2 - COVID-19	Recruiting	No Results Available	COVID|COVID-19|SARS-CoV 2|Coronavirus|Corona Virus Infection	Drug: Chloroquine|Drug: Hydroxychloroquine|Other: standard care	Phase 3	Interventional	"Centro de Estudos e Pesquisa em Emergencias Clinicas e Terapia Intensiva, Curitiba, Parana, Brazil"	https://ClinicalTrials.gov/show/NCT04420247
792	NCT04414267	Bacillus Calmette-guérin Vaccination to Prevent COVID-19	Recruiting	No Results Available	COVID-19|Virus Diseases|Corona Virus Infection|Coronary Heart Disease|Chronic Obstructive Pulmonary Disease	Biological: BCG vaccine|Biological: Placebo	Phase 4	Interventional	"General Hospital of Argolida - Nafplion Unit, Náfplio, Argos, Greece|2nd Department of Internal Medicine, University General Hospital of Alexandroupolis, Alexandroupolis, Greece|1st Department of Internal Medicine, General Hospital of Athens G. GENNIMATAS, Athens, Greece|2nd University Department of Internal Medicine, IPPOKRATEION General Hospital of Athens, Athens, Greece|3rd University Department of Internal Medicine, General Hospital of Chest Diseases of Athens I SOTIRIA, Athens, Greece|4th Department of Internal Medicine, ""Attikon"" University Hospital, National and Kapodistrian University of Athens, Medical School, Athens, Greece|1st Department of Internal Medicine, General University Hospital of Ioannina, Ioánnina, Greece|General Hospital of Korinthos, Kórinthos, Greece|Department of Internal Medicine, Patras University Hospital, Patras, Greece|General Hospital of Ptolemaida MPODOSAKEIO, Ptolemaḯda, Greece|1st Department of Internal Medicine, AHEPA University General Hospital of Thessaloniki, Thessaloníki, Greece|General Hospital of Imathia - Veria Unit, Véria, Greece"	https://ClinicalTrials.gov/show/NCT04414267
793	NCT04365985	Study of Immunomodulation Using Naltrexone and Ketamine for COVID-19	Recruiting	No Results Available	COVID-19|Acute Respiratory Distress Syndrome|Severe Acute Respiratory Syndrome (SARS)|Coronavirus Infections	Drug: Naltrexone|Drug: Ketamine|Other: Placebo	Phase 2	Interventional	"William Beaumont Hospital, Royal Oak, Michigan, United States"	https://ClinicalTrials.gov/show/NCT04365985
794	NCT04335032	EPA-FFA to Treat Hospitalised Patients With COVID-19 (SARS-CoV-2)	Not yet recruiting	No Results Available	SARS-CoV-2	Drug: Eicosapentaenoic acid gastro-resistant capsules	Phase 3	Interventional		https://ClinicalTrials.gov/show/NCT04335032
795	NCT04273763	Evaluating the Efficacy and Safety of Bromhexine Hydrochloride Tablets Combined With Standard Treatment/ Standard Treatment in Patients With Suspected and Mild Novel Coronavirus Pneumonia (COVID-19)	"Active, not recruiting"	No Results Available	Novel Coronavirus Pneumonia|2019-nCoV	Drug: Bromhexine Hydrochloride Tablets|Drug: Arbidol Hydrochloride Granules|Drug: Recombinant Human Interferon α2b Spray	Not Applicable	Interventional	"The Second AffIliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China"	https://ClinicalTrials.gov/show/NCT04273763
796	NCT04453488	Clinical Trial to Evaluate the Efficacy of RUTI® Against SARS- COV-2 Infection in Healthcare Workers	Not yet recruiting	No Results Available	Covid-19|Sars-CoV2	Biological: RUTI® vaccine|Biological: Placebo	Not Applicable	Interventional	"Hospital Universitari Germans Trias i Pujol UBP Riscos Laborals, Badalona, Barcelona, Spain|Hospital de la Santa Creu i Sant Pau, Barcelona, Spain"	https://ClinicalTrials.gov/show/NCT04453488
797	NCT04438070	COVID Screening Strategies in Homeless Shelters	Recruiting	No Results Available	COVID-19	Diagnostic Test: COVID-19 Swab	Not Applicable	Interventional	"Various Homeless Shelters, Hamilton, Ontario, Canada"	https://ClinicalTrials.gov/show/NCT04438070
798	NCT04389580	Combination Therapy With Isotretinoin and Tamoxifen Expected to Provide Complete Protection Against Severe Acute Respiratory Syndrome Coronavirus	Not yet recruiting	No Results Available	COVID-19	Drug: Drug: Isotretinoin plus Tamoxifen|Drug: Aerosolized Isotretinoin plus Tamoxifen	Phase 2	Interventional		https://ClinicalTrials.gov/show/NCT04389580
799	NCT04384445	Organicell Flow for Patients With COVID-19	Not yet recruiting	No Results Available	Corona Virus Infection|COVID-19|SARS|Acute Respiratory Distress Syndrome	Biological: Organicell Flow|Other: Placebo	Phase 1|Phase 2	Interventional	"Landmark Hospital, Naples, Florida, United States|Landmark Hospital, Athens, Georgia, United States"	https://ClinicalTrials.gov/show/NCT04384445
800	NCT04357106	COPLA Study: Treatment of Severe Forms of COronavirus Infection With Convalescent PLAsma	Recruiting	No Results Available	COVID-19	Biological: Convalescent plasma	Phase 2	Interventional	"Centro de Hematología y Medicina Interna, Puebla, Mexico"	https://ClinicalTrials.gov/show/NCT04357106
801	NCT04352946	HEalth Care Worker pROphylaxis Against COVID-19: The HERO Trial	Not yet recruiting	No Results Available	Prophylaxis|COVID-19|Health Care Worker|Hydroxychloroquine	Drug: Hydroxychloroquine Pre-Exposure Prophylaxis|Drug: Placebo oral tablet	Phase 3	Interventional	"The New York Center for Travel and Tropical Medicine, New York, New York, United States"	https://ClinicalTrials.gov/show/NCT04352946
802	NCT04338009	Elimination or Prolongation of ACE Inhibitors and ARB in Coronavirus Disease 2019	Enrolling by invitation	No Results Available	COVID-19	Other: Discontinuation of ARB/ACEI|Other: Continuation of ARB/ACEI	Not Applicable	Interventional	"University of Pennsylvania Health System, Philadelphia, Pennsylvania, United States"	https://ClinicalTrials.gov/show/NCT04338009
803	NCT04334265	Efficacy and Safety of Anluohuaxian in the Treatment of Rehabilitation Patients With Corona Virus Disease 2019	Recruiting	No Results Available	COVID-19	Drug: Anluohuaxian	Not Applicable	Interventional	"The Second People's Hospital of Fuyang, Fuyang, Anhui, China|Ezhou Central Hospital, Wuhan, Hubei, China|Huoshenshan Hospital of Wuhan, Wuhan, Hubei, China|Jinyintan Hospital of Wuhan, Wuhan, Hubei, China|Tongji Hospital of Huazhong University of Science and Technology, Wuhan, Hubei, China|West Hospital Union Hospital Huazhong University of Science and Technology, Wuhan, Hubei, China|Wuhan Pulmonary Hospital, Wuhan, Hubei, China|Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China|Wenzhou Medical University Affiliated First Hospital, Wenzhou, Zhejiang, China"	https://ClinicalTrials.gov/show/NCT04334265
804	NCT04334148	Healthcare Worker Exposure Response and Outcomes of Hydroxychloroquine	Recruiting	No Results Available	COVID-19	Drug: Hydroxychloroquine|Drug: Placebo oral tablet	Phase 3	Interventional	"University of Florida, Gainesville, Florida, United States|University of Florida Jacksonville, Jacksonville, Florida, United States|University of South Florida, Tampa, Florida, United States|University of Kansas Medical Center, Kansas City, Kansas, United States|University Medical Center New Orleans, New Orleans, Louisiana, United States|Ochsner Clinic Foundation, New Orleans, Louisiana, United States|Johns Hopkins, Baltimore, Maryland, United States|Mayo Clinic Hospital Rochester, Rochester, Minnesota, United States|University of Missouri-Columbia, Columbia, Missouri, United States|Hospital for Special Surgery, New York, New York, United States|Weill Cornell Medicine, New York, New York, United States|Duke University Medical Center, Durham, North Carolina, United States|Clinical Trials Center of Middle Tennessee, Franklin, Tennessee, United States|Vanderbilt University Medical Center, Nashville, Tennessee, United States|Baylor Scott & White Medical Center-Temple, Temple, Texas, United States|Seattle Children's Hospital, Seattle, Washington, United States|Marshfield Clinic Health System, Marshfield, Wisconsin, United States"	https://ClinicalTrials.gov/show/NCT04334148
805	NCT04333589	Corona Virus Disease 2019 Patients Whose Nucleic Acids Changed From Negative to Positive	Recruiting	No Results Available	COVID-19	Drug: Favipiravir	Not Applicable	Interventional	"The Second People's Hospital of Fuyang, Fuyang, Anhui, China|Ezhou Hospital of Traditional Chinese Medicine, Ezhou, Hubei, China|Ezhou Central Hospital, Wuhan, Hubei, China|Huoshenshan Hospital of Wuhan, Wuhan, Hubei, China|Jinyintan Hospital of Wuhan, Wuhan, Hubei, China|Wuhan Pulmonary Hospital, Wuhan, Hubei, China|Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China|Wenzhou Medical University Affiliated First Hospital, Wenzhou, Zhejiang, China"	https://ClinicalTrials.gov/show/NCT04333589
806	NCT04371107	Proactive Care of Ambulatory COVID19 Patients	Not yet recruiting	No Results Available	Covid19|Azithromycin|Ambulatory	Other: consultation|Drug: Azithromycin	Phase 3	Interventional	"CHU Amiens, Amiens, France"	https://ClinicalTrials.gov/show/NCT04371107
807	NCT04310228	Favipiravir Combined With Tocilizumab in the Treatment of Corona Virus Disease 2019	Recruiting	No Results Available	COVID-19	Drug: Favipiravir Combined With Tocilizumab|Drug: Favipiravir|Drug: Tocilizumab	Not Applicable	Interventional	"Guiqiang Wang, Beijing, Beijing, China|Peking University First Hospital, Beijing, Beijing, China|Ezhou Central Hospital, Wuhan, Hubei, China|Huoshenshan Hospital of Wuhan, Wuhan, Hubei, China|Jinyintan Hospital of Wuhan, Wuhan, Hubei, China|Wuhan Pulmonary Hospital, Wuhan, Hubei, China"	https://ClinicalTrials.gov/show/NCT04310228
808	NCT04302519	Novel Coronavirus Induced Severe Pneumonia Treated by Dental Pulp Mesenchymal Stem Cells	Not yet recruiting	No Results Available	COVID-19	Biological: Dental pulp mesenchymal stem cells	Early Phase 1	Interventional		https://ClinicalTrials.gov/show/NCT04302519
809	NCT04295551	Multicenter Clinical Study on the Efficacy and Safety of Xiyanping Injection in the Treatment of New Coronavirus Infection Pneumonia (General and Severe)	Not yet recruiting	No Results Available	COVID-19	Drug: Lopinavir / ritonavir tablets combined with Xiyanping injection|Drug: Lopinavir/ritonavir treatment	Not Applicable	Interventional		https://ClinicalTrials.gov/show/NCT04295551
810	NCT04399889	hCT-MSCs for COVID19 ARDS	Recruiting	No Results Available	COVID|Corona Virus Infection|COVID19	Biological: human cord tissue mesenchymal stromal cells	Phase 1|Phase 2	Interventional	"Duke Hospital, Durham, North Carolina, United States"	https://ClinicalTrials.gov/show/NCT04399889
811	NCT04369794	"COVID-19: BCG As Therapeutic Vaccine, Transmission Limitation, and Immunoglobulin Enhancement"	Not yet recruiting	No Results Available	COVID-19|Therapeutic Vaccine|BCG|SARS-CoV 2|Transmission	Biological: BCG|Biological: Placebo	Phase 4	Interventional	"Hospital das Clínicas Unicamp, Campinas, SP, Brazil"	https://ClinicalTrials.gov/show/NCT04369794
812	NCT04402918	Study of Viral Load and Maternal-fetal Serology in the Interpretation of the Vertical Transmission of SARS Cov-2 (COVID-19) During Pregnancy	Recruiting	No Results Available	Sars-CoV2	Diagnostic Test: biological samples day of delivery	Not Applicable	Interventional	"Chu Besancon, Besancon, France"	https://ClinicalTrials.gov/show/NCT04402918
813	NCT04400929	Using GM-CSF as a Host Directed Therapeutic Against COVID-19	Not yet recruiting	No Results Available	"COVID|Sars-CoV2|ARDS, Human"	Drug: Sargramostim|Other: Normal Saline 0.9%	Phase 2	Interventional		https://ClinicalTrials.gov/show/NCT04400929
814	NCT04359862	Sedation With Sevoflurane Versus Propofol in Patients With Acute Respiratory Distress Syndrome Caused by COVID19 Infection	Recruiting	No Results Available	Acute Respiratory Distress Syndrome|COVID19 Infection	Drug: Sevoflurane|Drug: Propofol	Phase 4	Interventional	"Hospital Universitario Ramón y Cajal, Madrid, Spain|Hospital Universitario La Paz, Madrid, Spain|Hospital Clínico Universitario de Valencia, Valencia, Spain|Hospital Clínico Universitario de Valencia, Valencia, Spain|Hospital General Universitario de Valencia, Valencia, Spain"	https://ClinicalTrials.gov/show/NCT04359862
815	NCT04310865	Yinhu Qingwen Granula for the Treatment of Severe CoVID-19	Suspended	No Results Available	COVID-19|Severe Pneumonia|Chinese Medicine	Drug: Yinhu Qingwen Granula|Drug: Yin Hu Qing Wen Granula(low does)|Other: standard medical treatment	Phase 2|Phase 3	Interventional	"Wuhan No.7 Hospital/Jizhong Energy Fengfeng Group Hospital, Wuhan, Hubei, China|Wuhan No.7 Hospital/North China University of Science and Technology Affiliated Hospital, Wuhan, Hubei, China|Zhongnan Hospital of Wuhan University/Tanshan People's Hospital, Wuhan, Hubei, China|Wuhan Leishenshan (Thunder God Mountain) Hospital/The First Affiliated Hospital of Dalian Medical University, Wuhan, Hubei, China"	https://ClinicalTrials.gov/show/NCT04310865
816	NCT04331613	Safety and Efficacy of CAStem for Severe COVID-19 Associated With/Without ARDS	Recruiting	No Results Available	COVID-19|Acute Respiratory Distress Syndrome|Virus; Pneumonia|Acute Lung Injury	Biological: CAStem	Phase 1|Phase 2	Interventional	"Beijing YouAn Hospital, Capital Medical University, Beijing, Beijing, China, China"	https://ClinicalTrials.gov/show/NCT04331613
817	NCT04392232	A Study of COVID 19 Convalescent Plasma in High Risk Patients With COVID 19 Infection	Recruiting	No Results Available	Coronavirus|COVID-19|Convalescent Plasma	Drug: Convalescent Plasma	Phase 2	Interventional	"Good Samaritan Hospital, Cincinnati, Ohio, United States|Bethesda North Hospital, Cincinnati, Ohio, United States"	https://ClinicalTrials.gov/show/NCT04392232
818	NCT04405934	COG-UK Project Hospital-Onset COVID-19 Infections Study	Not yet recruiting	No Results Available	Covid-19|Nosocomial Infection|Coronavirus|Coronavirus Infection|SARS-CoV 2	Other: Use of virus (Covid-19) genome sequence report to inform infection prevention control procedures	Not Applicable	Interventional		https://ClinicalTrials.gov/show/NCT04405934
819	NCT04351789	Impact of a Minimal Psychoeducational Intervention on Anxiety Among Hospitalized COVID-19 Patients in Denmark	Not yet recruiting	No Results Available	COVID-19|Mental Health|Psychoeducation|Anxiety	Other: Psychoeducational intervention	Not Applicable	Interventional		https://ClinicalTrials.gov/show/NCT04351789
820	NCT04324021	Efficacy and Safety of Emapalumab and Anakinra in Reducing Hyperinflammation and Respiratory Distress in Patients With COVID-19 Infection.	Recruiting	No Results Available	SARS-CoV-2	Biological: Emapalumab|Biological: Anakinra	Phase 2|Phase 3	Interventional	"ASST Spedali Civili di Brescia Dipartimento di Reumatologia e Immunologia Clinica, Brescia, Italy|Ospedale Maggiore Policlinico, Dipartimento di Anestesia-Rianimazione e Medicina di Urgenza, Milano, Italy|Azienda Ospedaliero-Universitaria di Parma, Dipartimento di Malattie infettive ed epatologia, Parma, Italy|Ospedale Lazzaro Spallanzani, Dipartimento di Malattie Infettive ad alta Intensità di cura ed altamente contagiose,Ospedale Lazzaro Spallanzani, Roma, Italy"	https://ClinicalTrials.gov/show/NCT04324021
821	NCT04391179	Dipyridamole to Prevent Coronavirus Exacerbation of Respiratory Status (DICER) in COVID-19	Recruiting	No Results Available	COVID|Corona Virus Infection|Covid-19|SARS-CoV-2 Infection	Drug: Dipyridamole 100 Milligram(mg)|Drug: Placebo oral tablet	Phase 2	Interventional	"University of Michigan, Ann Arbor, Michigan, United States"	https://ClinicalTrials.gov/show/NCT04391179
822	NCT04361448	Performance of 3 Sampling Methods for the Detection of SARS-CoV-2 (COVID-19) With Real-time Reverse Transcriptase PCR	Not yet recruiting	No Results Available	Covid-19|SARS-CoV-2|Diagnosis|Polymerase Chain Reaction	Other: samling of oropharynx and nasopharynx	Not Applicable	Interventional	"Jessa Hospital, Hasselt, Belgium"	https://ClinicalTrials.gov/show/NCT04361448
823	NCT04319445	Mindfulness During COVID-19	Recruiting	No Results Available	Migraine Disorders|Stress|Anxiety	Behavioral: Mindfulness session(s)	Not Applicable	Interventional	"Wake Forest Health Sciences, Winston-Salem, North Carolina, United States"	https://ClinicalTrials.gov/show/NCT04319445
824	NCT04350450	Hydroxychloroquine Treatment of Healthcare Workers With COVID19 Illness at Montefiore	Withdrawn	No Results Available	COVID|Coronavirus|COVID-19	Drug: Hydroxychloroquine	Phase 2	Interventional	"Montefiore Medical Center, Bronx, New York, United States"	https://ClinicalTrials.gov/show/NCT04350450
825	NCT04319731	A Pilot Study of Human Amniotic Fluid for COVID19 Associated Respiratory Failure	Recruiting	No Results Available	SARS CoV-2 Infection	Biological: Human Amniotic Fluid	Early Phase 1	Interventional	"University of Utah Health, Salt Lake City, Utah, United States"	https://ClinicalTrials.gov/show/NCT04319731
826	NCT04334967	Hydroxychloroquine in Patients With Newly Diagnosed COVID-19 Compared to Standard of Care	Suspended	No Results Available	COVID-19|Corona Virus Infection|SARS-CoV-2|2019-nCoV|2019 Novel Coronavirus	Drug: Hydroxychloroquine|Dietary Supplement: Vitamin C	Phase 4	Interventional	"Portland Providence Medical Center, Portland, Oregon, United States"	https://ClinicalTrials.gov/show/NCT04334967
827	NCT04321928	Personalized Health Education Against the Health Damage of Novel Coronavirus (COVID-19) Outbreak in Hungary	Recruiting	No Results Available	SARS-CoV-2|Coronavirus|COVID-19|2019-nCoV|2019nCoV	Behavioral: Personalized health education|Behavioral: General health education	Not Applicable	Interventional	"Institute for Translational Medicine, University of Pécs, Pécs, Hungary"	https://ClinicalTrials.gov/show/NCT04321928
828	NCT04355429	Efficacy of Captopril in Covid-19 Patients With Severe Acute Respiratory Syndrome (SARS) CoV-2 Pneumonia (CAPTOCOVID)	Not yet recruiting	No Results Available	Pneumonia|Coronavirus Infection|COVID-19	Drug: captopril 25mg	Phase 2	Interventional	"CH Victor Dupuy- Argenteuil, Argenteuil, France|Hôpital Avicenne,, Bobigny, France|Hôpital Avicenne, Bobigny, France|Hôpital Avicenne, Bobigny, France|Hôpital Antoine Béclère, Clamart, France|CH de Compiègne-Noyon, Compiègne, France|Groupe hospitalier Sud Ile de France, Melun, France|Hôpital de la Pitié- Salpêtrière, Paris, France|Hôpital Tenon, Paris, France|CHRU de Tours, Hôpital Bretonneau, Tours, France|Hôpital de Tours, Tours, France"	https://ClinicalTrials.gov/show/NCT04355429
829	NCT04456088	Inhaled NO for the Treatment of COVID-19 Caused by SARS-CoV-2 (CANADA Trial)	Not yet recruiting	No Results Available	"COVID-19|SARS-CoV 2|Respiratory Disease|Pneumonia, Viral|Corona Virus Infection"	Combination Product: 150 ppm Nitric Oxide delivered through LungFit Delivery System|Combination Product: 80 ppm Nitric Oxide delivered through LungFit Delivery System	Phase 2	Interventional		https://ClinicalTrials.gov/show/NCT04456088
830	NCT04401150	Lessening Organ Dysfunction With VITamin C - COVID-19	Not yet recruiting	No Results Available	Vitamin C|COVID-19|Hospitalized Patients	Drug: Vitamin C|Drug: Control	Phase 3	Interventional	"Research Centre of the CHUS, Sherbrooke, Quebec, Canada"	https://ClinicalTrials.gov/show/NCT04401150
831	NCT04381338	Rehabilitation for People With COVID-19 in ICU	Not yet recruiting	No Results Available	Corona Virus Disease 19 (COVID-19)|COVID|Acute Lung Injury/Acute Respiratory Distress Syndrome (ARDS)|Critical Illness	Other: Pulmonary and Motor Rehabilitation	Not Applicable	Interventional	"Teaching Hospital, University of Padova, Padova, Italy|Teaching Hospital, University of Verona, Verona, Italy"	https://ClinicalTrials.gov/show/NCT04381338
832	NCT04363450	Hydroxychloroquine as Prophylaxis for COVID-19 in Healthcare Workers (HCQPreP)	Recruiting	No Results Available	COVID-19|Corona Virus Infection|Wuhan Coronavirus|Prophylaxis|Healthcare Worker|Sars-CoV2|Hydroxychloroquine	Drug: Hydroxychloroquine|Drug: Placebo	Phase 3	Interventional	"Lafayette General Medical Center, Lafayette, Louisiana, United States|University Hospital and Clinics, Lafayette, Louisiana, United States"	https://ClinicalTrials.gov/show/NCT04363450
833	NCT04414241	Hydroxychloroquine to Prevent SARS-CoV-2 Infection	Not yet recruiting	No Results Available	SARS-CoV-2	Drug: Hydroxychloroquine	Phase 3	Interventional	"Centro Médico Naval ""Cirujano Mayor Santiago Távara"", Callao, Peru|Hospital Nacional Hipólito Unanue, Lima, Peru|Hospital Nacional Arzobispo Loayza, Lima, Peru|Hospital Cayetano Heredia, Lima, Peru"	https://ClinicalTrials.gov/show/NCT04414241
834	NCT04452565	"NA-83, Atazanavir and Dexamethasone Combination Therapy for the Treatment of COVID-19 Infection (NATADEX)"	Recruiting	No Results Available	Coronavirus Infection|Severe Acute Respiratory Infection|Severe Acute Respiratory Syndrome Coronavirus 2	Drug: Drug: NA-831|Combination Product: NA-831 and Atazanavir|Combination Product: NA-831and Dexamethasone|Combination Product: Atazanavir and Dexamethasone	Phase 2|Phase 3	Interventional	"Coronavirus Research Institute, Sunnyvale, California, United States"	https://ClinicalTrials.gov/show/NCT04452565
835	NCT04370015	Hydroxychloroquine Chemoprophylaxis for COVID-19 Infection in High-risk Healthcare Workers.	Not yet recruiting	No Results Available	SARS-CoV-2|Healthcare Workers	Drug: Hydroxychloroquine|Drug: Placebo oral tablet	Not Applicable	Interventional		https://ClinicalTrials.gov/show/NCT04370015
836	NCT04335786	Valsartan for Prevention of Acute Respiratory Distress Syndrome in Hospitalized Patients With SARS-COV-2 (COVID-19) Infection Disease	Recruiting	No Results Available	Acute Respiratory Distress Syndrome|SARS-CoV-2|COVID|COVID-19|Severe Acute Respiratory Syndrome	Drug: Valsartan (Diovan)|Drug: Placebo oral tablet	Phase 4	Interventional	"Jeroen Bosch Ziekenhuis, 's-Hertogenbosch, Netherlands|Rijnstate, Arnhem, Netherlands|Radboudumc, Nijmegen, Netherlands|Laurentius Ziekenhuis, Roermond, Netherlands|Erasmus MC, Rotterdam, Netherlands|Franciscus Gasthuis, Rotterdam, Netherlands|Ikazia Ziekenhuis, Rotterdam, Netherlands"	https://ClinicalTrials.gov/show/NCT04335786
837	NCT04397497	Mavrilimumab in Severe COVID-19 Pneumonia and Hyper-inflammation (COMBAT-19)	Not yet recruiting	No Results Available	"Covid-19|Acute Respiratory Failure|ARDS, Human|Sars-CoV2|Viral Pneumonia"	Drug: Mavrilimumab|Drug: Placebo	Phase 2	Interventional	"IRCCS Policlinico San Donato, San Donato, MI, Italy|IRCCS Ospedale San Raffaele, Milano, Italy|IRCCS Istituto Ortopedico Galeazzi, Milano, Italy"	https://ClinicalTrials.gov/show/NCT04397497
838	NCT04327505	Safety and Efficacy of Hyperbaric Oxygen for ARDS in Patients With COVID-19	Recruiting	No Results Available	"SARS (Severe Acute Respiratory Syndrome)|Cytokine Storm|ARDS, Human|COVID-19|Sars-CoV2|Acute Respiratory Failure"	Drug: Hyperbaric oxygen	Phase 2|Phase 3	Interventional	"Bergmannsheil und Kinderklinik Buer GmbH, Gelsenkirchen, Germany|Krankenhaus St. Joesf, Regensburg, Germany|Blekingesjukhuset, Karlskrona, Blekinge, Sweden"	https://ClinicalTrials.gov/show/NCT04327505
839	NCT04453553	CICERO- A Care Home Study of COVID-19	Not yet recruiting	No Results Available	COVID	Diagnostic Test: Q16 testing|Diagnostic Test: Nasopharyngeal swab and main laboratory	Not Applicable	Interventional	"Queen Mary University London, London, United Kingdom"	https://ClinicalTrials.gov/show/NCT04453553
840	NCT04376476	Host-pathogen Interactions During SARS-CoV-2 Infection	Recruiting	No Results Available	"Infection, Coronavirus|Severe Acute Respiratory Syndrome Coronavirus 2"	Biological: Blood sample|Biological: Low or upper respiratory tract sample|Biological: Stool collection or fecal swab|Genetic: Blood sample for whole genome sequencing|Other: phone call	Not Applicable	Interventional	"Groupement Hospitalier Nord-Daupine, Bourgoin-Jallieu, France|Hôpital femme-mère-enfant, Bron, France|Hôpital Louis Pradel, Bron, France|Hôpital Louis Mourier, Colombes, France|Centre Hospitalo-Universitaire de Grenoble, La Tronche, France|Hopital de la Croix-Rousse, Lyon, France|Hôpital Edouard Herriot, Lyon, France|Hôpital mère - enfant Nantes, Nantes, France|Centre Hospitalier Lyon Sud, Pierre-Bénite, France|Hôpital Nord de Saint Etienne, Saint-Priest-en-Jarez, France|Hôpital Nord-Ouest, Villefranche-sur-Saône, France|Centre Hospitalier D'Annecy-Genevois, Épagny, France"	https://ClinicalTrials.gov/show/NCT04376476
841	NCT04390516	Respiratory Decompensation and Model for the Triage of COVID-19 Patients	Completed	No Results Available	COVID-19|Coronavirus|Mortality|Mechanical Ventilation	Device: COViage	Not Applicable	Interventional	"Dascena, Oakland, California, United States"	https://ClinicalTrials.gov/show/NCT04390516
842	NCT04371601	Safety and Effectiveness of Mesenchymal Stem Cells in the Treatment of Pneumonia of Coronavirus Disease 2019	"Active, not recruiting"	No Results Available	COVID-19 Pneumonia	Drug: Oseltamivir|Drug: hormones|Device: oxygen therapy|Procedure: mesenchymal stem cells	Early Phase 1	Interventional	"Fuzhou General Hospital, Fuzhou, Fujian, China"	https://ClinicalTrials.gov/show/NCT04371601
843	NCT04385199	Convalescent Plasma for Patients With COVID-19	Recruiting	No Results Available	Coronavirus Infection|Coronavirus|COVID	Biological: Convalescent plasma	Phase 2	Interventional	"Henry Ford Hospital, Detroit, Michigan, United States"	https://ClinicalTrials.gov/show/NCT04385199
844	NCT04402879	CORONA (COvid pRONe hypoxemiA): Prone Positioning for Hypoxemic COVID-19 Patients With Do-not-intubate Goals	Recruiting	No Results Available	Severe Acute Respiratory Syndrome Coronavirus 2|COVID-19|Acute Respiratory Distress Syndrome|ARDS|Hypoxemic Respiratory Failure	Procedure: Prone Positioning (PP)	Not Applicable	Interventional	"Peter Lougheed Centre (PLC), Calgary, Alberta, Canada|Foothills Hospital Intensive Care Unit, Calgary, Alberta, Canada|Rockyview General Hospital, Calgary, Alberta, Canada|South Health Campus, Calgary, Alberta, Canada"	https://ClinicalTrials.gov/show/NCT04402879
845	NCT04446429	Anti-Androgen Treatment for COVID-19	Not yet recruiting	No Results Available	COVID-19|SARS-CoV2|Androgenetic Alopecia|Prostate Cancer|Benign Prostatic Hyperplasia|SARS (Severe Acute Respiratory Syndrome)	Drug: Dutasteride|Drug: Ivermectin|Drug: Azithromycin	Not Applicable	Interventional	"Corpometria Institute, Brasilia, Brazil"	https://ClinicalTrials.gov/show/NCT04446429
846	NCT04419025	Efficacy of N-Acetylcysteine (NAC) in Preventing COVID-19 From Progressing to Severe Disease	Not yet recruiting	No Results Available	COVID|Sars-CoV2|SARS-Associated Coronavirus as Cause of Disease Classified Elsewhere	Drug: N-acetylcysteine	Phase 4	Interventional		https://ClinicalTrials.gov/show/NCT04419025
847	NCT04298060	DAS181 for Patients With Severe Hospitalized Flu and SAD-RVs (COVID-19)	Not yet recruiting	No Results Available	Influenza Infection|SAD-RV Infection and COVID-19	Drug: DAS181|Drug: Placebo	Phase 2	Interventional	"Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China"	https://ClinicalTrials.gov/show/NCT04298060
848	NCT04332991	Outcomes Related to COVID-19 Treated With Hydroxychloroquine Among In-patients With Symptomatic Disease	"Active, not recruiting"	No Results Available	Coronavirus|Acute Respiratory Infection|SARS-CoV Infection	Drug: Hydroxychloroquine|Drug: Placebo	Phase 3	Interventional	"University of Arizona, Tucson, Arizona, United States|UCSF Fresno, Fresno, California, United States|Ronald Reagan UCLA Medical Center, Los Angeles, California, United States|UC Davis Medical Center, Sacramento, California, United States|UCSF Medical Center, San Francisco, California, United States|Stanford University, Stanford, California, United States|Medical Center of Aurora, Aurora, Colorado, United States|University of Colorado Hospital, Aurora, Colorado, United States|Denver Health Medical Center, Denver, Colorado, United States|St. Joseph Hospital, Denver, Colorado, United States|University of Florida, Gainesville, Florida, United States|University of Kentucky, Lexington, Kentucky, United States|University Medical Center, New Orleans, Louisiana, United States|Maine Medical Center, Portland, Maine, United States|Massachusetts General Hospital, Boston, Massachusetts, United States|Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States|Brigham and Women's Hospital, Boston, Massachusetts, United States|Baystate Medical Center, Springfield, Massachusetts, United States|St. Vincent's Hospital, Worcester, Massachusetts, United States|University of Michigan Medical Center, Ann Arbor, Michigan, United States|Henry Ford Medical Center, Detroit, Michigan, United States|University of Mississippi Medical Center, Jackson, Mississippi, United States|Montefiore Medical Center-Weiler, Bronx, New York, United States|Montefiore Medical Center-Moses, Bronx, New York, United States|Wake Forest Baptist Medical Center, Winston-Salem, North Carolina, United States|University of Cincinnati Medical Center, Cincinnati, Ohio, United States|Cleveland Clinic Foundation, Cleveland, Ohio, United States|Ohio State University Wexner Medical Center, Columbus, Ohio, United States|Oregon Health and Science University, Portland, Oregon, United States|Penn State Hershey Medical Center, Hershey, Pennsylvania, United States|Temple University Hospital, Philadelphia, Pennsylvania, United States|UPMC Presbyterian/Mercy/Shadyside, Pittsburgh, Pennsylvania, United States|Medical University of South Carolina, Charleston, South Carolina, United States|Vanderbilt University Medical Center, Nashville, Tennessee, United States|University of Texas Health Science Center, Houston, Texas, United States|Intermountain Medical Center, Murray, Utah, United States|University of Utah Hospital, Salt Lake City, Utah, United States|VCU Medical Center, Richmond, Virginia, United States|Harborview Medical Center, Seattle, Washington, United States|Swedish Hospital First Hill, Seattle, Washington, United States"	https://ClinicalTrials.gov/show/NCT04332991
849	NCT04348864	COVID-19 Antibody Self-testing Using Virtual Point-of-care	Recruiting	No Results Available	Communicable Disease|COVID-19|Sars-CoV2|Infectious Disease|Coronavirus|Virus Diseases	"Diagnostic Test: COVID-19 IgM/IgG Rapid Testing, mobile device image capture and telemedicine support|Other: Telemedicine"	Not Applicable	Interventional	"Neuroganics, Northglenn, Colorado, United States"	https://ClinicalTrials.gov/show/NCT04348864
850	NCT04442087	Study of Seroprevalence of Anti-SARS-CoV2 Among Children of Hospital Workers in AP-HP	Not yet recruiting	No Results Available	SARS-CoV2	Biological: Serology SARS-CoV2|Behavioral: Data collection	Not Applicable	Interventional	"Centre d'investigation clinique (CIC) Necker Cochin in Necker Children's Hospital, Paris, France"	https://ClinicalTrials.gov/show/NCT04442087
851	NCT04412395	Clinical Assessment of Oral Lactoferrin as a Safe Antiviral and Immunoregulatory in Treating COVID-19 Disease	Not yet recruiting	No Results Available	Corona Virus Infection|Middle East Respiratory Syndrome (MERS)|Acute Respiratory Distress Syndrome|Coronavirus Infection|COVID-19|SARS-CoV 2	Dietary Supplement: Lactoferrin (Apolactoferrin)|Drug: Placebo of excipient(s) will be administered	Phase 2	Interventional	"National Research Center, Egypt (Clinical and Molecular Pharmacology), Cairo, Giza, Egypt|Clinmax CRO (Clinical Research Organization), Cairo, Egypt|Clinical Trial Unit National Research Center, Cairo, Egypt|Egyptian Military Medical Services (Hospitals), Cairo, Egypt"	https://ClinicalTrials.gov/show/NCT04412395
852	NCT04340050	COVID-19 Convalescent Plasma	"Active, not recruiting"	No Results Available	Coronavirus	Biological: anti-SARS-CoV-2 convalescent plasma	Early Phase 1	Interventional	"University of Chicago Medicine, Chicago, Illinois, United States"	https://ClinicalTrials.gov/show/NCT04340050
853	NCT04363827	Protect: Study With Hydroxychloroquine for Prevention and Early Phase Treatment of Coronavirus Disease (COVID-19)	Recruiting	No Results Available	COVID19|Hydroxychloroquine|Prophylaxis|Treatment|SARS-CoV-2	Drug: Hydroxychloroquine	Phase 2	Interventional	"Irst Irccs, Meldola, FC, Italy"	https://ClinicalTrials.gov/show/NCT04363827
854	NCT04443673	Glycine Supplement for Severe COVID-19	Recruiting	No Results Available	"COVID-19|SARS-CoV Infection|SARS (Severe Acute Respiratory Syndrome)|SARS Pneumonia|ARDS, Human|Pneumonia, Viral"	Dietary Supplement: Glycine	Not Applicable	Interventional	"Instituto Nacional de Enfermedades Respiratorias, Mexico DF, Mexico"	https://ClinicalTrials.gov/show/NCT04443673
855	NCT04324528	Cytokine Adsorption in Severe COVID-19 Pneumonia Requiring Extracorporeal Membrane Oxygenation	Recruiting	No Results Available	Coronavirus|COVID-19|SARS-CoV Infection|Respiratory Failure|Cytokine Storm	Device: vv-ECMO + cytokine adsorption (Cytosorb adsorber)|Device: vv-ECMO only (no cytokine adsorption)	Not Applicable	Interventional	"University Clinic Freiburg, Freiburg, Germany"	https://ClinicalTrials.gov/show/NCT04324528
856	NCT04343651	Study to Evaluate the Efficacy and Safety of Leronlimab for Mild to Moderate COVID-19	Recruiting	No Results Available	Coronavirus Disease 2019	Drug: Placebos|Drug: Leronlimab (700mg)	Phase 2	Interventional	"University of California, Los Angeles, Los Angeles, California, United States|Palmtree Clinical Research, Inc., Palm Springs, California, United States|Eisenhower Health, Rancho Mirage, California, United States|Yale, New Haven, Connecticut, United States|Center for Advanced Research & Education (CARE), Gainesville, Georgia, United States|Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States|Atlantic Health System Hospital, Morristown, New Jersey, United States|Montefiore Medical Center, Bronx, New York, United States|White Plains Hospital, White Plains, New York, United States|Novant Health, Charlotte, North Carolina, United States|Ohio Health, Columbus, Ohio, United States|Oregon Health and Science University, Portland, Oregon, United States"	https://ClinicalTrials.gov/show/NCT04343651
857	NCT04344379	Prevention of SARS-CoV-2 in Hospital Workers s Exposed to the Virus	Suspended	No Results Available	SARS-CoV-2 Infection	Drug: hydroxychloroquine|Drug: azithromycin|Drug: hydroxychloroquine placebo	Phase 3	Interventional	"Hopial Avicenne, Bobigny, France|Hôpital GHU Paris Saclay, Le Kremlin-Bicêtre, France|Hôpital Saint Antoine, Paris, France|Hôpital Broca, Paris, France|Hôpital La Pitié-Salpétrière, Paris, France|Hôpital Cochin, Paris, France|Hôpital européen Georges Pompidou, Paris, France|Hôpital Necker, Paris, France"	https://ClinicalTrials.gov/show/NCT04344379
858	NCT04398277	A Daily Coping Toolkit for Medical Personnel and First-Responders During COVID-19 Pandemic	Recruiting	No Results Available	Psychological Stress	Behavioral: Daily Coping Toolkit	Not Applicable	Interventional	"Akron Children's Hospital, Akron, Ohio, United States|Summa Health Systems, Akron, Ohio, United States|Kent State University, Kent, Ohio, United States"	https://ClinicalTrials.gov/show/NCT04398277
859	NCT04285190	The Effect of T89 on Improving Oxygen Saturation and Clinical Symptoms in Patients With COVID-19	Withdrawn	No Results Available	Coronavirus Disease 2019|Novel Coronavirus Pneumonia	Drug: T89	Not Applicable	Interventional		https://ClinicalTrials.gov/show/NCT04285190
860	NCT04397692	Inhaled NO for the Treatment of COVID-19 Caused by SARS-CoV-2 (US Trial)	Not yet recruiting	No Results Available	"Corona Virus Infection|COVID-19|SARS-CoV 2|Nitric Oxide|Respiratory Disease|Pneumonia, Viral|Inhaled Nitric Oxide"	Device: Nitric Oxide delivered via LungFit™ system	Not Applicable	Interventional	"Baptist Health Center for Clinical Research, Little Rock, Arkansas, United States"	https://ClinicalTrials.gov/show/NCT04397692
861	NCT04409821	Tele-based Psychological Emotional Support for Informal CARegivers of COVID-19 Patients in Intensive Care	Not yet recruiting	No Results Available	Posttraumatic Stress Disorder|Prolonged Grief Disorder|COVID	Behavioral: Tele-delivered psychological intervention	Not Applicable	Interventional		https://ClinicalTrials.gov/show/NCT04409821
862	NCT04384380	Efficacy and Tolerability of Hydroxychloroquine in Adult Patients With COVID-19	Recruiting	No Results Available	Coronavirus Infection	Drug: Hydroxychloroquine Sulfate 200 MG [Plaquenil]	Phase 4	Interventional	"Taoyuan General Hospital, Ministry of Health and Welfare, Taoyuan City, Taiwan"	https://ClinicalTrials.gov/show/NCT04384380
863	NCT04324606	A Study of a Candidate COVID-19 Vaccine (COV001)	"Active, not recruiting"	No Results Available	Coronavirus	Biological: ChAdOx1 nCoV-19|Biological: MenACWY|Biological: ChAdOx1 nCoV-19 boost|Drug: Paracetamol	Phase 1|Phase 2	Interventional	"University Hospital Southampton NHS Foundation Trust, Southampton, Hampshire, United Kingdom|University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, United Kingdom|St Georges University Hospital NHS Foundation Trust, London, United Kingdom|Imperial College Healthcare NHS Trust, London, United Kingdom|CCVTM, University of Oxford, Churchill Hospital, Oxford, United Kingdom|John Radcliffe Hospital, Oxford, United Kingdom"	https://ClinicalTrials.gov/show/NCT04324606
864	NCT04366908	Prevention and Treatment With Calcifediol of COVID-19 Induced Acute Respiratory Syndrome	Not yet recruiting	No Results Available	SARS-CoV 2|COVID19|SARS (Severe Acute Respiratory Syndrome)|Cytokine Release Syndrome|Cytokine Storm	Drug: BAT + Calcifediol|Drug: BAT	Phase 2	Interventional		https://ClinicalTrials.gov/show/NCT04366908
865	NCT04349618	Ultraprotective Ventilation Without Extracorporeal Circulation During COVID 19 Pneumonia	Not yet recruiting	No Results Available	Acute Respiratory Distress Syndrome|COVID19|Sars-CoV2|Pneumonia	Other: PROTECTIVE VENTILATION|Other: ULTRAPROTECTIVE VENTILATION	Not Applicable	Interventional	"Service de Médecine Intensive Réanimation CHU Gabriel Montpied, Clermont-Ferrand, France|Service de Médecine Intensive Réanimation Hôpital Michallon - CHU Grenoble Alpes, La Tronche, France|Service de Médecine Intensive Réanimation Hôpital Edouard Herriot Hospices Civils de Lyon, Lyon, France|Service de Réanimation Chirurgicale Hôpital Edouard Herriot Hospices Civils de Lyon, Lyon, France|Service de Médecine Intensive Réanimation Hôpital de la Croix Rousse Hospices Civils de Lyon, Lyon, France|Service de Réanimation Chirurgicale Hôpital de la Croix Rousse Hospices Civils de Lyon, Lyon, France|Service de réanimation Polyvalente Centre Hospitalier Saint Joseph-Saint Luc, Lyon, France|Service de Réanimation Clinique de la Sauvegarde, Lyon, France|Service de Réanimation Polyvalente Centre Hospitalier Lyon Sud Hospices Civils de Lyon, Pierre-Bénite, France|Service de Réanimation Centre hospitalier Annecy Genevois, Pringy, France|Service de Médecine Intensive Réanimation Hôpital Nord - CHU Saint-Etienne, Saint-Priest-en-Jarez, France"	https://ClinicalTrials.gov/show/NCT04349618
866	NCT04426305	Community Health Workers Against COVID19	Enrolling by invitation	No Results Available	Covid 19|Social Isolation|Mental Health Impairment	Other: community health worker support|Other: care as usual	Not Applicable	Interventional	"Department of Public Health and Primary Care, Ghent, Belgium"	https://ClinicalTrials.gov/show/NCT04426305
867	NCT04409873	Antiseptic Mouthwash / Pre-Procedural Rinse on SARS-CoV-2 Load (COVID-19)	Not yet recruiting	No Results Available	COVID-19|SARS-CoV 2|Severe Acute Respiratory Syndrome Coronavirus 2|Virus Disease|Coronavirus Infections|Pharyngeal Diseases	Drug: Oral-B Mouth Sore mouthwash|Drug: Crest Pro-Health Multi-Protection mouthwash|Drug: CloSYS mouthwash|Drug: Distilled water	Phase 2	Interventional	"University Of California, San Francisco, San Francisco, California, United States"	https://ClinicalTrials.gov/show/NCT04409873
868	NCT04347239	Study to Evaluate the Efficacy and Safety of Leronlimab for Patients With Severe or Critical Coronavirus Disease 2019 (COVID-19)	Recruiting	No Results Available	Coronavirus Disease 2019	Drug: Placebos|Drug: Leronlimab (700mg)	Phase 2	Interventional	"UCLA, Los Angeles, California, United States|Eisenhower Health, Rancho Mirage, California, United States|Yale, New Haven, Connecticut, United States|Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States|St. Barnabas, Livingston, New Jersey, United States|Atlantic Health System Hospital, Morristown, New Jersey, United States|Montefiore Medical Center, Bronx, New York, United States|Novant Health, Winston-Salem, North Carolina, United States|Ohio Health, Columbus, Ohio, United States|Oregon Health and Sciences University, Portland, Oregon, United States|Baylor Scott & White research Institute, Dallas, Texas, United States|University of Texas, Houston, Texas, United States"	https://ClinicalTrials.gov/show/NCT04347239
869	NCT04381377	Efficacy and Safety of Polyoxidonium® in Hospitalized Patients With Coronavirus Disease COVID-19	Recruiting	No Results Available	"Infections, Coronavirus"	Drug: azoximer bromide|Other: Placebo	Phase 2|Phase 3	Interventional	"Regional state budgetary institution of public health ""City hospital No. 5 of Barnaul"", Barnaul, Russian Federation|Central Research Institute of Epidemiology of Rospotrebnadzor, Moscow, Russian Federation|The state healthcare institution of the city of Moscow ""City Clinical Hospital No. 15 named after OM Filatov"" in ""Moscow City Department of Health"", Moscow, Russian Federation|Moscow State Budgetary Healthcare Institution ""Infectious Clinical Hospital No. 1 of the Moscow Department of Healthcare"", Moscow, Russian Federation|Moscow State Budgetary Healthcare Institution ""City Clinical Hospital No. 24 of the Moscow Department of Healthcare"", Moscow, Russian Federation|State budgetary institution ""Research Institute of Emergency Care named after N.V. Sklifosovsky in Department of Health of the city of Moscow"", Moscow, Russian Federation|Moscow State Budgetary Healthcare Institution ""City Clinical Hospital No. 40 of the Moscow Department of Healthcare"", Moscow, Russian Federation|State budgetary institution of health care of the Nizhny Novgorod region ""Infectious clinical hospital No. 2 of Nizhny Novgorod"", Nizhny Novgorod, Russian Federation|Federal State Budgetary Educational Institution of Higher Education ""Orenburg State Medical University"" of the Ministry of Health of the Russian Federation, Orenburg, Russian Federation|Federal State Budgetary Educational Institution of Higher Education ""First St. Petersburg State Medical University named after Academician I.P. Pavlov, Saint Petersburg, Russian Federation|State budgetary health institution of the Vladimir region ""Regional Clinical Hospital"", Vladimir, Russian Federation|Yaroslavl State Medical University of Ministry of Health of the Russian Federation, Yaroslavl, Russian Federation"	https://ClinicalTrials.gov/show/NCT04381377
870	NCT04355962	Sevoflurane in COVID-19 ARDS (SevCov)	Recruiting	No Results Available	"ARDS, Human|Coronavirus"	Drug: Sevoflurane|Drug: Intravenous drug	Phase 3	Interventional	"University Hospital Zuirch, Zurich, Switzerland"	https://ClinicalTrials.gov/show/NCT04355962
871	NCT04403100	"Hydroxychloroquine and Lopinavir/ Ritonavir to Improve the Health of People With COVID-19: ""The Hope Coalition - 1"""	Recruiting	No Results Available	COVID-19|Coronavirus Infection|Virus Disease|Acute Respiratory Infection|SARS-CoV Infection	Drug: Hydroxychloroquine Sulfate Tablets|Drug: Lopinavir/ Ritonavir Oral Tablet|Drug: Hydroxychloroquine Sulfate Tablets plus Lopinavir/ Ritonavir Oral Tablets|Drug: Placebo	Phase 3	Interventional	"CARDRESEARCH - Cardiologia Assistencial e de Pesquisa, Belo Horizonte, Minas Gerais, Brazil|Pontificia Universidade Catolica de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil|Fundo Municipal de Saúde de Betim, Betim, Minas Gerais, Brazil|Universidade Federal de Ouro Preto, Ouro Preto, Minas Gerais, Brazil"	https://ClinicalTrials.gov/show/NCT04403100
872	NCT04363463	Impact of Prone Position in Patients Under Spontaneous Breathing on Intubation or Non-invasive Ventilation or Death Incidence During COVID-19 Acute Respiratory Distress	Not yet recruiting	No Results Available	COVID19|Oxygen Therapy|Prone Position|Spontaneous Ventilation|Respiratory Distress Syndrome	Other: prone position	Not Applicable	Interventional	"CH de DAX, Dax, France|CHD de VENDEE, La Roche sur Yon, France|CH de LA ROCHELLE, La Rochelle, France|CHR d'Orléans - Service Pneumologie, Orléans, France|CHR d'Orleans - Service Maladies Infectieuses, Orléans, France|HOPITAL LARIBOISIERE - Service diabétologie, endocrinologie, nutrition, Paris, France|Hopital Lariboisiere - Medecine Interne, Paris, France|Hopital Lariboisiere, Paris, France|CH de PERPIGNAN - Service Maladies infectieuses, Perpignan, France|CH de Perpignan - pneumologie, Perpignan, France|Centre Hospitalier Intercommunal de Cornouaille - Quimper Concarneau, Quimper, France|CHRU de Tours - Service Médecine interne et immunologie Clinique, Tours, France|CHRU de Tours - Service Pneumologie, Tours, France|CHRU DE TOURS - Service Médecine interne et maladies infectieuses, Tours, France"	https://ClinicalTrials.gov/show/NCT04363463
873	NCT04376814	Favipiravir Plus Hydroxychloroquine and Lopinavir/Ritonavir Plus Hydroxychloroquine in COVID-19	Completed	No Results Available	COVID-19|Favipiravir|Kaletra|Hydroxychloroquine|Lopinavir/Ritonavir	Drug: Favipiravir|Drug: Hydroxychloroquine|Drug: Lopinavir / Ritonavir	Not Applicable	Interventional	"Mohammad Sadegh Bagheri Baghdasht, Tehran, Iran, Islamic Republic of"	https://ClinicalTrials.gov/show/NCT04376814
874	NCT04321096	The Impact of Camostat Mesilate on COVID-19 Infection	Recruiting	No Results Available	Corona Virus Infection	Drug: Camostat Mesilate|Drug: Placebo oral tablet	Phase 1|Phase 2	Interventional	"Department of Infectious Diseases, Aalborg, Denmark|Department for Infectious Diseases, Aarhus University Hospital, Aarhus N, Denmark|Herning Regional Hospital, Herning, Denmark|Northzealands hospital - Hillerød, Hillerød, Denmark|Horsens Regional Hospital, Horsens, Denmark|Bispebjerg hospital, København, Denmark|Dept. of Infectious Diseases, Odense University Hospital, Odense, Denmark|Randers Regional Hospital, Randers, Denmark|Silkeborg Hospital, Silkeborg, Denmark"	https://ClinicalTrials.gov/show/NCT04321096
875	NCT04373291	Using BCG Vaccine to Protect Health Care Workers in the COVID-19 Pandemic	Not yet recruiting	No Results Available	COVID-19|Non-specific Effects of Vaccines|Morbidity|Absenteeism|Heterologous Immunity	Biological: BCG-Denmark|Biological: Saline	Phase 3	Interventional		https://ClinicalTrials.gov/show/NCT04373291
876	NCT04402983	The Effectiveness of Telerehabilitation-Based Physiotherapy in COVID 19 Patients	Recruiting	No Results Available	Covid19|Telerehabilitation|Physical Therapy	Other: Physiotherapy	Not Applicable	Interventional	"University of Health Sciences Turkey, İstanbul, Turkey"	https://ClinicalTrials.gov/show/NCT04402983
877	NCT04268537	Immunoregulatory Therapy for 2019-nCoV	Not yet recruiting	No Results Available	"2019 nCoV, PD-1"	Drug: PD-1 blocking antibody+standard treatment|Drug: Thymosin+standard treatment|Other: standard treatment	Phase 2	Interventional		https://ClinicalTrials.gov/show/NCT04268537
878	NCT04373005	Screening of Cancer Patients to Assess Impact of COVID-19	Not yet recruiting	No Results Available	Covid-19|Cancer	Diagnostic Test: Nasopharyngeal (NP) swab	Not Applicable	Interventional	"Princess Margaret Cancer Centre, Toronto, Ontario, Canada"	https://ClinicalTrials.gov/show/NCT04373005
879	NCT04332380	Convalescent Plasma for Patients With COVID-19: A Pilot Study	Not yet recruiting	No Results Available	Coronavirus|Coronavirus Infection	Drug: Plasma	Phase 2	Interventional	"Universidad del Rosario, Bogota, Cundinamarca, Colombia"	https://ClinicalTrials.gov/show/NCT04332380
880	NCT04431856	CO-PARENT: COVID-19 - Parent Action in Response to Emotions and Needs for Treatment	Recruiting	No Results Available	Anxiety|Depression|Traumatic Stress Disorder	Behavioral: Unified Protocol for COVID-19 Parenting Stress (UP-COVID)|Behavioral: SHG	Not Applicable	Interventional	"University of Miami, Miami, Florida, United States"	https://ClinicalTrials.gov/show/NCT04431856
881	NCT04442230	NasoVAX in Patients With Early Coronavirus Infectious Disease 2019 (COVID-19)	Not yet recruiting	No Results Available	Coronavirus Infection	Biological: NasoVAX|Other: Placebo	Phase 2	Interventional		https://ClinicalTrials.gov/show/NCT04442230
882	NCT04448756	M5049 Study in Participants With Coronavirus Disease 2019 (COVID-19) Pneumonia	Not yet recruiting	No Results Available	Coronavirus Disease 2019	Drug: M5049|Drug: Placebo	Phase 2	Interventional	"University of Alabama-Birmingham Hospital, Birmingham, Alabama, United States|Sharp Medical Center/Healthcare, San Diego, California, United States|Henry Ford Medical Center, Detroit, Michigan, United States"	https://ClinicalTrials.gov/show/NCT04448756
883	NCT04407182	Safety and Efficacy of Viusid and Asbrip in Hospitalized Patients Infected by SARS-Cov-2 With COVID-19	Recruiting	No Results Available	Covid-19|Sars-CoV2|Diabete Mellitus|Cardiopathy|Pulmonary Disease|Renal Disease|Liver Diseases	Dietary Supplement: Viusid and Asbrip	Phase 2	Interventional	"Hospital de Especialidades Dr. Teodoro Maldonado Carbo, Guayaquil, Ecuador"	https://ClinicalTrials.gov/show/NCT04407182
884	NCT04349098	Evaluation of Activity and Safety of Oral Selinexor in Participants With Severe COVID-19 Infection	Recruiting	No Results Available	Coronavirus Infection	Drug: Selinexor|Other: Placebo	Phase 2	Interventional	"UCLA, Los Angeles, California, United States|Kaiser Permanente Oakland, Oakland, California, United States|UC Davis Health, Sacramento, California, United States|Kaiser Permanente Sacramento, Sacramento, California, United States|Kaiser Permanente San Francisco, San Francisco, California, United States|Miami Cancer Institute at Baptist Health, Miami, Florida, United States|Emory University, Atlanta, Georgia, United States|Advocate Christ Medical Center, Oak Lawn, Illinois, United States|University of Kansas Medical Center, Kansas City, Kansas, United States|Norton Healthcare, Louisville, Kentucky, United States|Boston Medical Center, Boston, Massachusetts, United States|Karmanos, Detroit, Michigan, United States|Michigan Center of Medical Research, Farmington Hills, Michigan, United States|Michigan Center of Medical Research, Royal Oak, Michigan, United States|Columbia University, New York, New York, United States|Weill Cornell Medical College, New York, New York, United States|Levine Cancer Institute-Atrium Health University City, Charlotte, North Carolina, United States|Lehigh Valley Hospital, Allentown, Pennsylvania, United States|Baylor Scott & White Dallas, Dallas, Texas, United States|MultiCare Institute for Research & Innovation (Puget Sound), Tacoma, Washington, United States|Hospital Hietzing, 2. Medical department - Center for Diagnosis and Therapy of Rheumatic Diseases, Vienna, Austria|CHU Bordeaux, Bordeaux, France|CHU Lyon, Lyon, France|CHU Nantes, Nantes, France|Hadassah MC, Jerusalem, Israel|Hasharon Medical Center, Petah Tiqva, Israel|Sheba Medical Center, Tel HaShomer, Israel|Hospital Universitari Vall d'Hebron, Barcelona, Spain|Servicio de Medicina Interna, Hospital Universitario de Salamanca, Universidad de Salamanca, Salamanca, Spain|Princess Royal University Hospital, Kent, United Kingdom|Kings College Hospital, London, United Kingdom|The Royal Marsden Hospital, London, United Kingdom|University Hospitals Plymouth NHS Trust, Plymouth, United Kingdom"	https://ClinicalTrials.gov/show/NCT04349098
885	NCT04330495	"Randomized, Controlled, Double-blind Clinical Trial Comparing the Efficacy and Safety of Chemoprophylaxis With Hydroxychloroquine in Patients Under Biological Treatment and / or JAK Inhibitors in the Prevention of SARS-CoV-2 Infection"	Not yet recruiting	No Results Available	COVID 19|Immunomediated Inflammatory Disease in Treatment With Biological Agents and / or Jak Inhibitors	Drug: Hidroxicloroquina|Drug: Control group	Phase 4	Interventional		https://ClinicalTrials.gov/show/NCT04330495
886	NCT04332666	"Angiotensin-(1,7) Treatment in COVID-19: the ATCO Trial"	Not yet recruiting	No Results Available	Coronavirus|Respiratory Failure|Coronavirus Sars-Associated as Cause of Disease Classified Elsewhere|SARS-CoV-2	Drug: Angiotensin 1-7|Drug: Placebos	Phase 2|Phase 3	Interventional		https://ClinicalTrials.gov/show/NCT04332666
887	NCT04388514	Blood Ozonization in Patients With SARS-CoV-2 Respiratory Failure	Recruiting	No Results Available	SARS-CoV-2 Respiratory Failure	Procedure: Medical Ozone procedure	Not Applicable	Interventional	"Dott. Amato De Monte, Udine, Italy"	https://ClinicalTrials.gov/show/NCT04388514
888	NCT04447781	"Safety, Tolerability and Immunogenicity of INO-4800 Followed by Electroporation in Healthy Volunteers for COVID19"	Not yet recruiting	No Results Available	Coronavirus Infection|SARS-CoV 2	Biological: INO-4800|Device: CELLECTRA® 2000|Other: Saline-sodium citrate (SSC) buffer	Phase 1|Phase 2	Interventional		https://ClinicalTrials.gov/show/NCT04447781
889	NCT04353128	Efficacy of Melatonin in the Prophylaxis of Coronavirus Disease 2019 (COVID-19) Among Healthcare Workers.	Recruiting	No Results Available	Covid19|SARS-CoV 2|Coronavirus Infection	Drug: Melatonin 2mg|Drug: Placebo oral tablet	Phase 2|Phase 3	Interventional	"Hospital Universitario La Paz, Madrid, Spain"	https://ClinicalTrials.gov/show/NCT04353128
890	NCT04334928	Randomized Clinical Trial for the Prevention of SARS-CoV-2 Infection (COVID-19) in Healthcare Personnel	Recruiting	No Results Available	Coronavirus Infection	Drug: Emtricitabine/tenofovir disoproxil|Drug: Hydroxychloroquine|Drug: Placebo: Emtricitabine/tenofovir disoproxil Placebo|Drug: Placebo: Hydroxychloroquine	Phase 3	Interventional	"Hospital Universitario de Ferrol, Ferrol, A Coruña, Spain|Hospital Clínico Universitario de Santiago, Santiago De Compostela, A Coruña, Spain|Hospital General de Elche, Elche, Alicante, Spain|Hospital Universitario Central de Asturias, Oviedo, Asturias, Spain|Hospital Sant Joan de Deu de Esplugues, Esplugues De Llobregat, Barcelona, Spain|Parc Sanitari Sant Joan de Déu de Sant Boi, Sant Boi De Llobregat, Barcelona, Spain|Hospital Infanta Margarita, Cabra, Córdoba, Spain|Hospital Insular de Las Palmas, Las Palmas De Gran Canaria, Gran Canaria, Spain|Hospital Universitario de Canarias, Las Palmas De Gran Canaria, Gran Canaria, Spain|Hospital de Donostia, San Sebastián, Guipuzcoa, Spain|Hospital San Pedro, Logroño, La Rioja, Spain|Hospital Principe de Asturias, Alcalá De Henares, Madrid, Spain|Hospital Fundación de Alcorcón, Alcorcón, Madrid, Spain|Hospital Colllado Villalba, Collado-Villalba, Madrid, Spain|Hospital Severo Ochoa, Leganés, Madrid, Spain|Hospital Rey Juan Carlos, Móstoles, Madrid, Spain|Hospital Quirón Pozuelo, Pozuelo De Alarcón, Madrid, Spain|Hospital de Torrejón, Torrejón De Ardoz, Madrid, Spain|Hospital Infanta Elena, Valdemoro, Madrid, Spain|Hospital Virgen del Castillo, Yecla, Murcia, Spain|Hospital Costa del Sol, Marbella, Málaga, Spain|Complejo Hospitalario de Navarra, Pamplona, Navarra, Spain|Hospital Arnau de Vilanova, Llíria, Valencia, Spain|Hospital de Araba, Alava, Vitoria, Spain|Hospital General Universitario de Albacete, Albacete, Spain|Centro Médico Teknon, Barcelona, Spain|Hospital Clinic, Barcelona, Spain|Hospital del Mar, Barcelona, Spain|Hospital Dexeus, Barcelona, Spain|Hospital Quirón Barcelona, Barcelona, Spain|Hospital Sant Pau, Barcelona, Spain|Hospital Universitario Sagrat Cor, Barcelona, Spain|Hospital Universitario de Burgos, Burgos, Spain|Hospital Virgen de la Luz, Cuenca, Spain|Hospital Clínico San Cecilio, Granada, Spain|Hospital Universitario de León, León, Spain|Hospital Universitario Ramón y Cajal, Madrid, Spain|Fundación Jiménez Díaz, Madrid, Spain|Hospital Clinico San Carlos, Madrid, Spain|Hospital Infanta Leonor, Madrid, Spain|Hospital La Princesa, Madrid, Spain|Hospital Universitario 12 de Octubre, Madrid, Spain|Hospital Universitario Gregorio Marañon, Madrid, Spain|Hospital Universitario La Paz, Madrid, Spain|Hospital Universitario Puerta de Hierro, Madrid, Spain|Hospital Reina Sofía, Murcia, Spain|Hospital Universitario Virgen de la Arrixaca, Murcia, Spain|Hospital Virgen de la Victoria, Málaga, Spain|Complejo Asistencial de Palencia, Palencia, Spain|Hospital Universitario de Salamanca, Salamanca, Spain|Hospital General de Segovia, Segovia, Spain|Hospital Virgen del Rocio, Sevilla, Spain|Hospital Virgen Macarena, Sevilla, Spain|Hospital Clinico Universitario, Valencia, Spain|Hospital Dr. Peset, Valencia, Spain|Hospital General de Valencia, Valencia, Spain|Hospital La Fe, Valencia, Spain|Hospital de Valladolid, Valladolid, Spain|Hospital Rio Hortega, Valladolid, Spain|Hospital Lozano Blesa, Zaragoza, Spain|Hospital Miguel Servet, Zaragoza, Spain|Hospital Nuestra Señora de Sonsoles, Ávila, Spain"	https://ClinicalTrials.gov/show/NCT04334928
891	NCT04355676	Evaluation of Activity and Safety of Two Regimens of Low Dose Oral Selinexor in Participants With Moderate or Severe COVID-19	Not yet recruiting	No Results Available	Coronavirus Infection	Drug: Selinexor	Phase 2	Interventional		https://ClinicalTrials.gov/show/NCT04355676
892	NCT04437823	Efficacy of Intravenous Infusions of Stem Cells in the Treatment of COVID-19 Patients	Recruiting	No Results Available	Corona Virus Infection	Biological: Intravenous Infusions of Stem Cells	Phase 2	Interventional	"Jinnah Hospital, Lahore, Punjab, Pakistan"	https://ClinicalTrials.gov/show/NCT04437823
893	NCT04399252	Effect of Lactobacillus on the Microbiome of Household Contacts Exposed to COVID-19	Recruiting	No Results Available	Microbiome	Dietary Supplement: Lactobaciltus rhamnosus GG|Dietary Supplement: Lactobaciltus rhamnosus GG Placebo	Not Applicable	Interventional	"Duke University, Durham, North Carolina, United States"	https://ClinicalTrials.gov/show/NCT04399252
894	NCT04358614	Baricitinib Therapy in COVID-19	Completed	No Results Available	COVID|Pneumonia	Drug: Baricitinib 4 MG Oral Tablet	Phase 2|Phase 3	Interventional	"Fabrizio Cantini, Prato, Tuscany, Italy"	https://ClinicalTrials.gov/show/NCT04358614
895	NCT04419623	A Study of TL-895 With Standard Available Treatment Versus Standard Available Treatment for the Treatment of COVID-19 in Patients With Cancer	Not yet recruiting	No Results Available	COVID-19|Sars-CoV2|Cancer|Solid Tumor|Carcinoma|Blood Cancer	Drug: Part 1 - TL-895|Drug: Part 2 - TL-895|Drug: Part 2 - Placebo	Phase 1|Phase 2	Interventional		https://ClinicalTrials.gov/show/NCT04419623
896	NCT04413968	"COVID-19 Infection and Transmission in Exposed, Confined and Community-based Infants"	Not yet recruiting	No Results Available	Coronavirus|Coronavirus Infection|Covid19|Sars-CoV2	Diagnostic Test: Rapid detection test|Diagnostic Test: Nasopharyngeal swab|Diagnostic Test: Stool collection	Not Applicable	Interventional		https://ClinicalTrials.gov/show/NCT04413968
897	NCT04329533	Effects of Using Mobile App on Perceived Stress During COVID-19 Pandemic	Recruiting	No Results Available	Perceived Stress|Anxiety|Sleep Disturbance	"Other: ""Calm"" is a mindfulness meditation mobile app"	Not Applicable	Interventional	"Banner University Medicine Women's Institute, Phoenix, Arizona, United States"	https://ClinicalTrials.gov/show/NCT04329533
898	NCT04374786	Effects of Mobile App in House Staff Health and Well-being During COVID-19 Pandemic	Enrolling by invitation	No Results Available	Perceived Stress|Anxiety|Sleep Disturbance|Burnout|PTSD	Device: Calm Meditation App	Not Applicable	Interventional	"Banner University Medical Center Phoenix, Phoenix, Arizona, United States"	https://ClinicalTrials.gov/show/NCT04374786
899	NCT04332835	"Convalescent Plasma for Patients With COVID-19: A Randomized, Open Label, Parallel, Controlled Clinical Study"	Not yet recruiting	No Results Available	Coronavirus|Coronavirus Infection	Drug: Plasma|Drug: Hydroxychloroquine	Phase 2|Phase 3	Interventional	"Universidad del Rosario, Bogota, Cundinamarca, Colombia"	https://ClinicalTrials.gov/show/NCT04332835
900	NCT04376840	Prevalence of Long-term Respiratory Complications of Severe SARS-CoV-2 Pneumonia	Not yet recruiting	No Results Available	Severe SARS-CoV2 Pneumonia	Other: Blood sample and data record	Not Applicable	Interventional	"Damien JOLLY, Reims, France"	https://ClinicalTrials.gov/show/NCT04376840
901	NCT04373733	Early Intervention in COVID-19: Favipiravir Verses HydroxycholorquiNe & Azithromycin & Zinc vErsEs Standard CaRe	Recruiting	No Results Available	Coronavirus Infection	Drug: Favipiravir|Drug: Hydroxychloroquine|Drug: Azithromycin|Drug: Zinc Sulfate|Other: Standard of care management	Phase 3	Interventional	"Chelsea and Westminster Hospital, London, United Kingdom|West Middlesex University Hospital, London, United Kingdom"	https://ClinicalTrials.gov/show/NCT04373733
902	NCT04374565	Convalescent Plasma for Treatment of COVID-19 Patients With Pneumonia	Recruiting	No Results Available	Corona Virus Infection|SARS-CoV 2|SARS Pneumonia|Pneumonia	Drug: High-Titer Anti-SARS-CoV-2 (COVID 19) Convalescent Plasma	Phase 2	Interventional	"University of Virginia Medical Center, Charlottesville, Virginia, United States|University of Virginia, Charlottesville, Virginia, United States"	https://ClinicalTrials.gov/show/NCT04374565
903	NCT04381364	Inhalation of Ciclesonide for Patients With COVID-19: A Randomised Open Treatment Study (HALT COVID-19)	Not yet recruiting	No Results Available	"Covid-19|Pneumonia, Viral|ARDS|ARDS, Human|Sars-CoV2|Coronavirus Infection|Corona Virus Infection"	Drug: Ciclesonide Inhalation Aerosol	Phase 2	Interventional	"Danderyd Hospital, Danderyd, Entrévägen 2, Sweden|Capio S:t Görans Hospital, Stockholm, Sankt Göransplan 1, Sweden|Västmanland County Hospital Västerås, Västerås, Sigtunagatan, Sweden|Karolinska University Hospital, Stockholm, Sweden"	https://ClinicalTrials.gov/show/NCT04381364
904	NCT04385771	Cytokine Adsorption in Patients With Severe COVID-19 Pneumonia Requiring Extracorporeal Membrane Oxygenation	Not yet recruiting	No Results Available	Coronavirus Infection|COVID|SARS-CoV 2|Respiratory Failure|Cytokine Storm|Extracorporeal Membrane Oxygenation	Device: vv-ECMO + cytokine adsorption (Cytosorb adsorber)|Device: vv-ECMO only (no cytokine adsorption)	Not Applicable	Interventional	"University Clinic Freiburg, Freiburg, Germany"	https://ClinicalTrials.gov/show/NCT04385771
905	NCT04381923	COVIDNOCHE Trial (HFNO Versus CPAP Helmet) in COVID-19 Pneumonia	Not yet recruiting	No Results Available	"Severe Acute Respiratory Syndrome Coronavirus 2|Hypoxemic Respiratory Failure|Pneumonia, Viral|COVID"	Device: Helmet Continuous Positive Airway Pressure (CPAP)|Device: High Flow Nasal Oxygen (HFNO)	Not Applicable	Interventional		https://ClinicalTrials.gov/show/NCT04381923
906	NCT04366271	Clinical Trial of Allogeneic Mesenchymal Cells From Umbilical Cord Tissue in Patients With COVID-19	Recruiting	No Results Available	COVID	Biological: Mesenchymal cells|Drug: Standard of care	Phase 2	Interventional	"Hospital Universitario de Getafe, Getafe, Madrid, Spain|Hospital Universitario de Cruces, Barakaldo, Spain|Hospital Universitario de La Princesa, Madrid, Spain|Hospital Infantil Universitario Niño Jesus, Madrid, Spain|Hospital Ramón Y Cajal, Madrid, Spain|Complejo Universitario La Paz, Madrid, Spain"	https://ClinicalTrials.gov/show/NCT04366271
907	NCT04361461	Use of Hydroxychloroquine Alone or Associated for Inpatients With SARS-CoV2 Virus (COVID-19)	Withdrawn	No Results Available	Coronavirus Infections|SARS-CoV 2|SARS (Severe Acute Respiratory Syndrome)|Pulmonary Disease	Drug: Hydroxychloroquine Sulfate|Drug: Hydroxychloroquine Sulfate + Azythromycin	Phase 3	Interventional	"Apsen Farmacêutica S.A., São Paulo, Brazil"	https://ClinicalTrials.gov/show/NCT04361461
908	NCT04416399	STerOids in COVID-19 Study	Not yet recruiting	No Results Available	Coronavirus Infection	Drug: Budesonide dry powder inhaler	Phase 2	Interventional		https://ClinicalTrials.gov/show/NCT04416399
909	NCT04422977	Serological Study of the Exposure of Personnel to Sars-cov-2	Not yet recruiting	No Results Available	Sars-CoV2	Diagnostic Test: Sars-Cov-2 serology	Not Applicable	Interventional		https://ClinicalTrials.gov/show/NCT04422977
910	NCT04395599	Risk of Air Contamination During Visceral Surgery in COVID19 Patients	Not yet recruiting	No Results Available	Sars-CoV2|Surgery|COVID	"Other: Cartography of air contamination, environment contamination and biological fluid by Sars-Cov2 during visceral surgery in COVID19 patients."	Not Applicable	Interventional		https://ClinicalTrials.gov/show/NCT04395599
911	NCT04366089	Oxygen-Ozone as Adjuvant Treatment in Early Control of COVID-19 Progression and Modulation of the Gut Microbial Flora	Recruiting	No Results Available	"COVID|SARS-CoV 2|Pneumonia, Viral|Coronavirus Infection"	"Other: Oxygen-ozone therapy, probiotic supplementation and Standard of care|Dietary Supplement: SivoMixx (200 billion)|Drug: Azithromycin|Drug: hydroxychloroquine"	Phase 2	Interventional	"Francesco Pugliese, Rome, RM, Italy"	https://ClinicalTrials.gov/show/NCT04366089
912	NCT04381936	Randomised Evaluation of COVID-19 Therapy	Recruiting	No Results Available	Severe Acute Respiratory Syndrome	Drug: Lopinavir-Ritonavir|Drug: Corticosteroid|Drug: Hydroxychloroquine|Drug: Azithromycin|Biological: Convalescent plasma|Drug: Tocilizumab	Phase 2|Phase 3	Interventional	"Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom"	https://ClinicalTrials.gov/show/NCT04381936
913	NCT04312009	Losartan for Patients With COVID-19 Requiring Hospitalization	Recruiting	No Results Available	Corona Virus Infection|Acute Respiratory Distress Syndrome|SARS-CoV Infection	Drug: Losartan|Other: Placebo	Phase 2	Interventional	"University of Florida Gainesviile, Gainesville, Florida, United States|Hennepin County Medical Center, Minneapolis, Minnesota, United States|M Health Fairview University of Minnesota Medical Center, Minneapolis, Minnesota, United States|University of Minnesota, Minneapolis, Minnesota, United States|North Memorial Health Hospital, Robbinsdale, Minnesota, United States|Univeristy of Mississippi Medical, Jackson, Mississippi, United States"	https://ClinicalTrials.gov/show/NCT04312009
914	NCT04447404	DUR-928 in Subjects With SARS-CoV-2 With Acute Liver or Kidney Injury	Recruiting	No Results Available	SARS-CoV 2	Drug: DUR-928|Drug: Placebo	Phase 2	Interventional	"Site 02, Chicago, Illinois, United States|Site 01, Detroit, Michigan, United States|Site 03, Newark, New Jersey, United States"	https://ClinicalTrials.gov/show/NCT04447404
915	NCT04442152	Impact of COVID-19 on Family Dynamics on Bandebereho Study Participants	Enrolling by invitation	No Results Available	Gender Relations|Partner Communication|Division of Carework|Couple Conflict|Stress	Behavioral: MenCare+/Bandebereho fathers'/couples' group education	Not Applicable	Interventional	"Rwanda Men's Resource Centre (Rwamrec), Kigali, Rwanda"	https://ClinicalTrials.gov/show/NCT04442152
916	NCT04315948	Trial of Treatments for COVID-19 in Hospitalized Adults	Recruiting	No Results Available	Corona Virus Infection	Drug: Remdesivir|Drug: Lopinavir/ritonavir|Drug: Interferon Beta-1A|Drug: Hydroxychloroquine|Other: Standard of care	Phase 3	Interventional	"Centre Hospitalier Universitaire Amiens-Picardie, Amiens, France|Centre Hospitalier Regional Metz-Thionville, Ars-Laquenexy, France|Centre Hospitalier Régional Universitaire de Besançon, Besançon, France|Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France|APHP - hôpital Henri-Mondor, Créteil, France|Centre Hospitalier Universitaire Dijon-Bourgogne, Dijon, France|Centre Hospitalier Universitaire de Martinique, Fort De France, France|AP-HP Hôpital Bicêtre, Kremlin-Bicêtre, France|Centre Hospitalo-Universitaire de Grenoble, La Tronche, France|Centre Hospitalier Régional Universitaire de Lille, Lille, France|Hospices Civils de Lyon, Lyon, France|Centre Hospitalier Universitaire de Montpellier, Montpellier, France|Groupe Hospitalier de la Région de Mulhouse Sud Alsace, Mulhouse, France|Centre Hospitalier Régional et Universitaire de Nancy, Nancy, France|Centre Hospitalier Universitaire de Nantes, Nantes, France|Centre Hospitalo-Universitaire de Nice, Nice, France|APHP - Hôpital Saint Antoine, Paris, France|APHP - Hôpital Universitaire Pitié Salpêtrière, Paris, France|APHP - Hôpital Cochin, Paris, France|Hôpital Paris Saint-Joseph et Marie Lannelongue, Paris, France|APHP- Hôpital Européen Georges-Pompidou, Paris, France|APHP - Hôpital Bichat Claude Bernard, Paris, France|Centre Hospitalier Universitaire de Rennes, Rennes, France|Hopital DELAFONTAINE, Saint-Denis, France|Hôpital d'Instruction des Armées BEGIN, Saint-Mandé, France|Centre Hospitalier Universitaire de Saint Etienne, Saint-Étienne, France|Centre Hospitalier Régional Universitaire de Strasbourg, Strasbourg, France|Centre Hospitalier Universitaire de Toulouse, Toulouse, France|Centre Hospitalier Universitaire de Toulouse, Toulouse, France|Centre Hospitalier de Tourcoing, Tourcoing, France|Centre Hospitalier Universitaire de Tours, Tours, France|Centre Hospitalier Annecy Genevois, Épagny, France|Centre Hospitalier Luxembourg, Luxembourg, Luxembourg|Hôpitaux Robert Schuman, Luxembourg, Luxembourg"	https://ClinicalTrials.gov/show/NCT04315948
917	NCT04311177	Losartan for Patients With COVID-19 Not Requiring Hospitalization	Recruiting	No Results Available	Corona Virus Infection|Acute Respiratory Distress Syndrome|SARS-CoV Infection	Drug: Losartan|Other: Placebo	Phase 2	Interventional	"Hennepin County Medical Center, Minneapolis, Minnesota, United States|M Health Fairview University of Minnesota Medical Center, Minneapolis, Minnesota, United States|University of Minnesota, Minneapolis, Minnesota, United States|Mayo Clinic Health System, Rochester, Minnesota, United States"	https://ClinicalTrials.gov/show/NCT04311177
918	NCT04361474	Trial Evaluating the Efficacy of Local Budesonide Therapy in the Management of Hyposmia in COVID-19 Patients Without Signs of Severity	Recruiting	No Results Available	Budesonide|Olfaction Disorders|SARS-CoV-2|Anosmia	Drug: Budesonide Nasal|Other: Physiological serum	Phase 3	Interventional	"Amélie YAvchitz, Paris, France"	https://ClinicalTrials.gov/show/NCT04361474
919	NCT04261426	The Efficacy of Intravenous Immunoglobulin Therapy for Severe 2019-nCoV Infected Pneumonia	Not yet recruiting	No Results Available	2019-nCoV	Drug: Intravenous Immunoglobulin|Other: Standard care	Phase 2|Phase 3	Interventional		https://ClinicalTrials.gov/show/NCT04261426
920	NCT04402957	LSALT Peptide vs. Placebo to Prevent ARDS and Acute Kidney Injury in Patients Infected With SARS-CoV-2 (COVID-19)	Not yet recruiting	No Results Available	COVID|Severe Acute Respiratory Syndrome|Sars-CoV2|Acute Kidney Injury	Drug: LSALT peptide|Drug: Placebo	Phase 2	Interventional		https://ClinicalTrials.gov/show/NCT04402957
921	NCT04337788	Gerontological Telemonitoring of Older Adults Living in Nursing Homes With COVID-19 Disease	Not yet recruiting	No Results Available	Coronavirus Infection	Other: telehealth applications	Not Applicable	Interventional		https://ClinicalTrials.gov/show/NCT04337788
922	NCT04255017	"A Prospective/Retrospective,Randomized Controlled Clinical Study of Antiviral Therapy in the 2019-nCoV Pneumonia"	Recruiting	No Results Available	2019-nCoV	Drug: Abidol hydrochloride|Drug: Oseltamivir|Drug: Lopinavir/ritonavir	Phase 4	Interventional	"Department and Institute of Infectious Disease, Wuhan, Hubei, China"	https://ClinicalTrials.gov/show/NCT04255017
923	NCT04254874	"A Prospective/Retrospective,Randomized Controlled Clinical Study of Interferon Atomization in the 2019-nCoV Pneumonia"	Recruiting	No Results Available	2019-nCoV	Drug: Abidol hydrochloride|Drug: Abidol Hydrochloride combined with Interferon atomization	Phase 4	Interventional	"Department and Institute of Infectious Disease, Wuhan, Hubei, China"	https://ClinicalTrials.gov/show/NCT04254874
924	NCT04408157	A Research Study to Evaluate the Benefits of a Self-management Booklet to Promote Wellbeing During the COVID-19 Pandemic	Not yet recruiting	No Results Available	COVID	Behavioral: Self-management booklet (SWitCh: Stay well during COVID-19)	Not Applicable	Interventional		https://ClinicalTrials.gov/show/NCT04408157
925	NCT04395716	A Study of ResCure™ to Treat COVID-19 Infection	Not yet recruiting	No Results Available	COVID|Covid-19|Corona Virus Infection|Sars-CoV2|Coronavirus-19|SARS Pneumonia|SARS-Associated Coronavirus as Cause of Disease Classified Elsewhere	Biological: ResCure™	Phase 1	Interventional	"ProgenaBiome, Ventura, California, United States"	https://ClinicalTrials.gov/show/NCT04395716
926	NCT04335084	"A Study of Hydroxychloroquine, Vitamin C, Vitamin D, and Zinc for the Prevention of COVID-19 Infection"	Recruiting	No Results Available	COVID-19|Coronavirus Infection|Sars-CoV2|Corona Virus Infection|COVID|Coronavirus|Coronavirus-19|Coronavirus 19	Drug: Hydroxychloroquine|Dietary Supplement: Vitamin C|Dietary Supplement: Vitamin D|Dietary Supplement: Zinc	Phase 2	Interventional	"ProgenaBiome, Ventura, California, United States"	https://ClinicalTrials.gov/show/NCT04335084
927	NCT04322565	Colchicine Counteracting Inflammation in COVID-19 Pneumonia	Recruiting	No Results Available	"Coronavirus Infections|Pneumonia, Viral"	Drug: Colchicine	Phase 2	Interventional	"Azienda Ospedaliero Universitaria di Parma, Parma, PR, Italy"	https://ClinicalTrials.gov/show/NCT04322565
928	NCT04390412	Low Dose Radiotherapy in COVID-19 Pneumonia	Recruiting	No Results Available	COVID|SARS (Severe Acute Respiratory Syndrome)	Radiation: Low Dose Radiotherapy	Phase 1|Phase 2	Interventional	"Imam Hossein Hospital, Tehran, Iran, Islamic Republic of"	https://ClinicalTrials.gov/show/NCT04390412
929	NCT04385576	"Taiwan ""Aerosol Box"" Versus UMMC ""Intubation Box"""	Recruiting	No Results Available	COVID-19|Airway	Device: Aerosol Box|Device: Intubation Box	Not Applicable	Interventional	"University Malaya Medical Centre, Kuala Lumpur, Selangor, Malaysia"	https://ClinicalTrials.gov/show/NCT04385576
930	NCT04357340	The Effects of Pulmonary Physiotherapy Treatments on Patients With COVID-19	Completed	No Results Available	Covid-19|Pneumonia|SARS Pneumonia	Other: Pulmonary Physiotherapy Techniques	Not Applicable	Interventional	"Imam Khomeini Hospital Complex, Tehran, Iran, Islamic Republic of"	https://ClinicalTrials.gov/show/NCT04357340
931	NCT04371978	Efficacy and Safety of Dipeptidyl Peptidase-4 Inhibitors in Diabetic Patients With Established COVID-19	Not yet recruiting	No Results Available	"COVID 19|Coronavirus|Diabetes Mellitus, Type 2|Diabetes Mellitus|Glucose Metabolism Disorders|Metabolic Disease|Endocrine System Diseases|Dipeptidyl-Peptidase IV Inhibitors|Linagliptin|Severe Acute Respiratory Syndrome Coronavirus 2|Sars-CoV2|Hypoglycemic Agents|Respiratory Tract Diseases|Incretins|Hormones"	Drug: Linagliptin 5 MG	Phase 3	Interventional	"Rabin Medical Center, Petah tikva, Israel"	https://ClinicalTrials.gov/show/NCT04371978
932	NCT04402060	A Study of APL-9 in Adults With Mild to Moderate ARDS Due to COVID-19	Recruiting	No Results Available	COVID|Covid-19|Coronavirus|Coronavirus Infection|Severe Acute Respiratory Syndrome|Severe Acute Respiratory Syndrome Coronavirus 2|Sars-CoV2|Ards|Acute Respiratory Distress Syndrome	Drug: APL-9|Other: Vehicle Control	Phase 1|Phase 2	Interventional	"Westchester General Hospital, Miami, Florida, United States|Norton Women's and Children's Hospital, Louisville, Kentucky, United States|Audobon Hospital, Louisville, Kentucky, United States|University at Buffalo, Buffalo, New York, United States"	https://ClinicalTrials.gov/show/NCT04402060
933	NCT04414293	Low Dose Pulmonary Irradiation in Patients With COVID-19 Infection of Bad Prognosis	Not yet recruiting	No Results Available	"COVID|Pneumonia, Viral"	Radiation: Lung Low Dose Radiation	Not Applicable	Interventional	"Hospital Provincial de Castellon, Castellón De La Plana, Castellon, Spain"	https://ClinicalTrials.gov/show/NCT04414293
934	NCT04370834	Tocilizumab for Patients With Cancer and COVID-19 Disease	Recruiting	No Results Available	Hematopoietic and Lymphoid Cell Neoplasm|Malignant Solid Neoplasm|Pneumonia|Pneumonitis|Severe Acute Respiratory Distress Syndrome|Symptomatic COVID-19 Infection Laboratory-Confirmed	Biological: Tocilizumab	Phase 2	Interventional	"National Cancer Institute, Rockville, Maryland, United States|University Medical Center of Southern Nevada, Las Vegas, Nevada, United States|Summerlin Hospital Medical Center, Las Vegas, Nevada, United States|University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States|Valley Medical Center, Renton, Washington, United States"	https://ClinicalTrials.gov/show/NCT04370834
935	NCT04275414	Bevacizumab in Severe or Critical Patients With COVID-19 Pneumonia	Recruiting	No Results Available	Coronavirus Infections	Drug: Bevacizumab Injection	Phase 2|Phase 3	Interventional	"Renmin Hospital of Wuhan University, Wuhan, Hubei, China|Qilu Hospital of Shandong University, Jinan, Shandong, China|Moriggia-Pelascini Gravedona Hospital, Gravedona, Italy"	https://ClinicalTrials.gov/show/NCT04275414
936	NCT04343053	Pro-thrombotic Status in Patients With SARS-Cov-2 Infection	"Active, not recruiting"	No Results Available	Severe Acute Respiratory Syndrome Coronavirus 2	Other: SARS-Cov-2 infection	Not Applicable	Interventional	"Azienda Ospedaliera Universitaria di Ferrara, Ferrara, Italy"	https://ClinicalTrials.gov/show/NCT04343053
937	NCT04392427	New Antiviral Drugs for Treatment of COVID-19	Not yet recruiting	No Results Available	COVID|Drug Effect	"Drug: Treatment group: will receive a combination of Nitazoxanide, Ribavirin and Ivermectin for a duration of seven days :"	Phase 3	Interventional	"Mansoura University, Mansoura, Select A State Or Province, Egypt"	https://ClinicalTrials.gov/show/NCT04392427
938	NCT04348929	Birth Experience During COVID-19 Confinement	Recruiting	No Results Available	Postpartum Depression	Other: Self-administered questionnaires	Not Applicable	Interventional	"Centre Hospitalier Régional Universitaire de Nancy, Nancy, France"	https://ClinicalTrials.gov/show/NCT04348929
939	NCT04261270	"A Randomized,Open,Controlled Clinical Study to Evaluate the Efficacy of ASC09F and Ritonavir for 2019-nCoV Pneumonia"	Recruiting	No Results Available	2019-nCoV Pneumonia	Drug: ASC09F+Oseltamivir|Drug: Ritonavir+Oseltamivir|Drug: Oseltamivir	Phase 3	Interventional	"Department and Institute of Infectious Disease, Wuhan, Hubei, China"	https://ClinicalTrials.gov/show/NCT04261270
940	NCT04341935	Effects of DPP4 Inhibition on COVID-19	Not yet recruiting	No Results Available	Coronavirus Infection|Type 2 Diabetes	Drug: Linagliptin|Drug: Insulin regimen	Phase 4	Interventional	"University of Miami, Miami, Florida, United States"	https://ClinicalTrials.gov/show/NCT04341935
941	NCT04399967	"COVID-19 Brief Advice and Chat-based Support for Smoking Cessation Via ""Quit to Win"" Contest 2020"	Recruiting	No Results Available	Smoking Cessation	Behavioral: Chat-based support|Behavioral: AWARD plus COVID-specific advice|Behavioral: AWARD advice|Behavioral: COVID-19 related health warning leaflet|Behavioral: Health warning leaflet|Behavioral: SMS-based support|Behavioral: Referral card|Behavioral: COSH Self-help smoking cessation booklet	Not Applicable	Interventional	"Hong Kong Council on Smoking and Health (COSH), Hong Kong, Hong Kong, China"	https://ClinicalTrials.gov/show/NCT04399967
942	NCT04329195	ACE Inhibitors or ARBs Discontinuation in Context of SARS-CoV-2 Pandemic	Recruiting	No Results Available	History of Cardiovascular Disease Treated With RAS Blockers and With SARS-CoV-2 Infection	Drug: 1: discontinuation of RAS blocker therapy|Drug: 2: continuation of RAS blocker therapy	Phase 3	Interventional	"Cardiologie, Groupe Hospitalier Pitié-Salpêtrière, Paris, France"	https://ClinicalTrials.gov/show/NCT04329195
943	NCT04332042	TOFAcitinib in SARS-CoV2 Pneumonia	Not yet recruiting	No Results Available	SARS-COv2 Related Interstitial Pneumonia	Drug: Tofacitinib	Phase 2	Interventional	"Ospedali Riuniti di Ancona, Ancona, Marche, Italy"	https://ClinicalTrials.gov/show/NCT04332042
944	NCT04421664	Preemptive Therapy for SARS-Coronavirus-2 (COVID-19 PEP Canada)	Recruiting	No Results Available	Corona Virus Infection|SARS-CoV Infection|Coronavirus	Drug: Hydroxychloroquine|Drug: Placebo oral tablet	Phase 3	Interventional	"University of Minnesota, Minneapolis, Minnesota, United States|University of Alberta, Edmonton, Alberta, Canada|University of British Columbia, Vancouver, British Columbia, Canada|University of Manitoba, Winnipeg, Manitoba, Canada|Eastern Health, Saint John's, Newfoundland and Labrador, Canada|McMaster University, Hamilton, Ontario, Canada|Lawson Health Research Institute, London, Ontario, Canada|Research Institute of the McGill University Health Centre, Montréal, Quebec, Canada"	https://ClinicalTrials.gov/show/NCT04421664
945	NCT04342169	University of Utah COVID-19 Hydrochloroquine Trial	Recruiting	No Results Available	Coronavirus Infection|Coronavirus|Infectious Disease	Drug: Hydroxychloroquine|Drug: Placebo oral tablet	Phase 2	Interventional	"University of Utah, Salt Lake City, Utah, United States"	https://ClinicalTrials.gov/show/NCT04342169
946	NCT04321616	The Efficacy of Different Anti-viral Drugs in COVID 19 Infected Patients	Recruiting	No Results Available	SARS-CoV Infection|COVID 19|Acute Respiratory Distress Syndrome ARDS	Drug: Hydroxychloroquine|Drug: Remdesivir|Other: (Standard of Care) SoC	Phase 2|Phase 3	Interventional	"Andreas Barratt-Due, Oslo, Norway"	https://ClinicalTrials.gov/show/NCT04321616
947	NCT04371393	MSCs in COVID-19 ARDS	Recruiting	No Results Available	Mesenchymal Stromal Cells|Remestemcel-L|Acute Respiratory Distress Syndrome|COVID	Biological: Remestemcel-L|Drug: Placebo	Phase 3	Interventional	"University of Southern California, Los Angeles, California, United States|Emory University, Atlanta, Georgia, United States|Lutheran Hospital, Fort Wayne, Indiana, United States|Ochsner Clinic, New Orleans, Louisiana, United States|University of Maryland, Baltimore, Maryland, United States|Brigham and Women's Hospital, Boston, Massachusetts, United States|University of Michigan, Ann Arbor, Michigan, United States|Dartmouth-Hitchcock, Lebanon, New Hampshire, United States|Mount Sinai Health, New York, New York, United States|Northwell Health, New York, New York, United States|Duke University Medical Center, Durham, North Carolina, United States|Cleveland Clinic Foundation, Cleveland, Ohio, United States|University of Pennsylvania Health System, Philadelphia, Pennsylvania, United States|Baylor, Smith & White, Plano, Texas, United States|University of Virginia, Charlottesville, Virginia, United States"	https://ClinicalTrials.gov/show/NCT04371393
948	NCT04263402	The Efficacy of Different Hormone Doses in 2019-nCoV Severe Pneumonia	Recruiting	No Results Available	2019-nCoV Severe Pneumonia	Drug: Methylprednisolone	Phase 4	Interventional	"Department and Institute of Infectious Disease, Wuhan, Hubei, China"	https://ClinicalTrials.gov/show/NCT04263402
949	NCT04392778	Clinical Use of Stem Cells for the Treatment of Covid-19	Recruiting	No Results Available	Covid19|Pneumonia|Multiple Organ Failure|Corona Virus Infection	Biological: MSC Treatment|Biological: Saline Control	Phase 1|Phase 2	Interventional	"Istinye University, Istanbul, Turkey|SBÜ Dr. Sadi Konuk Eğitim ve Araştırma Hastanesi, Istanbul, Turkey"	https://ClinicalTrials.gov/show/NCT04392778
950	NCT04373135	"Understanding Community Considerations, Opinions, Values, Impacts, and Decisions for COVID-19"	Recruiting	No Results Available	Covid-19|Critical Illness|Attitude of Health Personnel|Attitude to Health|Health Behavior|Health Care Utilization	Behavioral: Brief educational video	Not Applicable	Interventional	"University of California, Los Angeles, Los Angeles, California, United States"	https://ClinicalTrials.gov/show/NCT04373135
951	NCT04316728	Clinical Performance of the VivaDiag ™ COVID-19 lgM / IgG Rapid Test in Early Detecting the Infection of COVID-19	Not yet recruiting	No Results Available	Coronavirus Infections	Device: VivaDiag™ COVID-19 lgM/IgG Rapid Test	Not Applicable	Interventional	"Unità' Complesse di cure primarie (UCCP), ASP Catanzaro, Catanzaro, Italy"	https://ClinicalTrials.gov/show/NCT04316728
952	NCT04393727	Transfusion of Convalescent Plasma for the Early Treatment of Patients With COVID-19	Recruiting	No Results Available	COVID|SARS-CoV 2	Biological: CONVALESCENT PLASMA	Phase 2	Interventional	"Azienda Ospedaliero Universitaria Pisana, Pisa, Italy"	https://ClinicalTrials.gov/show/NCT04393727
953	NCT04424134	BromhexIne And Spironolactone For CoronаVirUs Infection Requiring HospiTalization	Recruiting	No Results Available	COVID 19	Drug: Bromhexine and Spironolactone|Drug: Base therapy	Phase 3	Interventional	"Lomonosov Moscow State University Medical Research and Educational Center, Moscow, Moscow Region, Russian Federation"	https://ClinicalTrials.gov/show/NCT04424134
954	NCT04327349	Investigating Effect of Convalescent Plasma on COVID-19 Patients Outcome: A Clinical Trial	Enrolling by invitation	No Results Available	Coronavirus Infections	Biological: Convalescent Plasma	Not Applicable	Interventional	"Imam Khomeini Hospital, Mazandaran University of Medical Sciences, Sari, Mazandaran, Iran, Islamic Republic of"	https://ClinicalTrials.gov/show/NCT04327349
955	NCT04365101	Natural Killer Cell (CYNK-001) Infusions in Adults With COVID-19 (CYNK-001-COVID-19)	Recruiting	No Results Available	"Coronavirus|Coronavirus Infection|Severe Acute Respiratory Syndrome Coronavirus 2|Pneumonia|Pneumonia, Viral|Lung Diseases|Respiratory Tract Disease|Respiratory Tract Infections|Coronaviridae Infections|Nidovirales Infections|RNA Virus Infections|Virus Disease|Immunologic Disease|ARDS|Immunologic Factors|Physiological Effects of Drugs|Antiviral Agents|Anti-infective Agents|Analgesics|Antimetabolites, Antineoplastic"	Biological: CYNK-001	Phase 1|Phase 2	Interventional	"Hackensack University Medical Center, Hackensack, New Jersey, United States|Atlantic Health, Morristown, New Jersey, United States|Atlantic Health, Summit, New Jersey, United States|Multicare Health System, Tacoma, Washington, United States"	https://ClinicalTrials.gov/show/NCT04365101
956	NCT04357730	Fibrinolytic Therapy to Treat ARDS in the Setting of COVID-19 Infection	Recruiting	No Results Available	Severe Acute Respiratory Syndrome|Respiratory Failure|Acute Respiratory Distress Syndrome	Drug: Alteplase 50 MG [Activase]|Drug: Alteplase 100 MG [Activase]	Phase 2	Interventional	"Denver Health Medical Center, Denver, Colorado, United States"	https://ClinicalTrials.gov/show/NCT04357730
957	NCT04328129	Household Transmission Investigation Study for COVID-19 in French Guiana	Recruiting	No Results Available	Coronavirus Infections|Severe Acute Respiratory Syndrome|SARS-CoV Infection	Procedure: Human biological samples	Not Applicable	Interventional	"Centre Hospitalier Andrée Rosemon, Cayenne, French Guiana|Institut Pasteur de la Guyane, Cayenne, French Guiana"	https://ClinicalTrials.gov/show/NCT04328129
958	NCT04407208	Convalescent Plasma Therapy in Patients With COVID-19	Completed	No Results Available	Convalescence|Corona Virus Infection|Plaque	Biological: Convalescent plasma	Phase 1	Interventional	"Gatot Soebroto central army presidential hospital, Jakarta Pusat, Indonesia"	https://ClinicalTrials.gov/show/NCT04407208
959	NCT04453371	Impact of Tissue Plasminogen Activator (tPA) Treatment for an Atypical Acute Respiratory Distress Syndrome (COVID-19)	Not yet recruiting	No Results Available	Acute Respiratory Distress Syndrome	Drug: Tissue plasminogen activator|Drug: Ringer solution	Phase 3	Interventional		https://ClinicalTrials.gov/show/NCT04453371
960	NCT04366817	Psychological Impact of the Lockdown on Patients Giving Birth During the COVID-19 Epidemic Short Title : Isolement and Childbirth: Psychological Impact	Not yet recruiting	No Results Available	Post Partum Depression	Behavioral: psychological assessment	Not Applicable	Interventional	"Service médecine foetale-Hôpital Trousseau, Paris, France"	https://ClinicalTrials.gov/show/NCT04366817
961	NCT04447469	Study of Mavrilimumab (KPL-301) in Participants Hospitalized With Severe Corona Virus Disease 2019 (COVID-19) Pneumonia and Hyper-inflammation	Not yet recruiting	No Results Available	COVID	Drug: mavrilimumab|Other: Placebo	Phase 2|Phase 3	Interventional	"Tulane Medical Center, New Orleans, Louisiana, United States"	https://ClinicalTrials.gov/show/NCT04447469
962	NCT04429555	"Efficacy, Safety, Tolerability, and Biomarkers of MN-166 (Ibudilast) in Patients Hospitalized With COVID-19 and at Risk for ARDS"	Not yet recruiting	No Results Available	"Pneumonia, Viral"	Drug: Ibudilast|Drug: Placebo	Phase 2	Interventional		https://ClinicalTrials.gov/show/NCT04429555
963	NCT04400838	Investigating a Vaccine Against COVID-19	Recruiting	No Results Available	Coronavirus	Biological: ChAdOx1 nCoV-19 (Abs 260)|Biological: MenACWY vaccine|Biological: ChAdOx1 nCoV-19 (Abs 260) + 2.2x10^10vp (qPCR) boost|Biological: Two dose MenACWY vaccine|Biological: ChAdox1 n-CoV-19 (Abs 260) vaccine low dose|Biological: ChAdOx1 nCoV-19 (qPCR)|Biological: ChAdOx1 nCoV-19 plus 5x10^10vp boost (qPCR)	Phase 2|Phase 3	Interventional	"University Hospital Southampton NHS Foundation Trust, Southampton, Hampshire, United Kingdom|Castle Hill Hospital, Cottingham, Hull, United Kingdom|St Georges University Hospital NHS Foundation Trust, London, Tooting, United Kingdom|University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom|University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, United Kingdom|North Bristol NHS Trust, Bristol, United Kingdom|NIHR Cambridge Clinical Research Facility, Cambridge, United Kingdom|NHS Lothian, Western General Hospital, Edinburgh, United Kingdom|Glasgow University and NHS Greater Glasgow & Clyde, New Lister Building, Glasgow Royal Infirmary & Queen Elizabeth University Hospital, Glasgow, United Kingdom|Liverpool School of Tropical Medicine (LSTM), Accelerator Research Clinic. Clinical Sciences Accelerator, LIverpool, United Kingdom|London North West University Healthcare Trust (LNWUH), Northwick Park Hospital, London, United Kingdom|University College London Hospitals NHS Foundation Trust, London, United Kingdom|Guy's and St Thomas' NHS Foundation Trust, Department of Infection, St Thomas Hospital, London, United Kingdom|Imperial College Healthcare NHS Trust, London, United Kingdom|The Newcastle upon Tyne Hospitals NHS Foundation Trust, Royal Victoria Infirmary, Newcastle upon Tyne, United Kingdom|Public Health Wales, Newport, United Kingdom|University of Nottingham Health Service, Cripps Health Centre, University Park, Nottingham, United Kingdom|CCVTM, University of Oxford, Churchill Hospital, Oxford, United Kingdom|John Radcliffe Hospital, Oxford, United Kingdom|Sheffield Teaching Hospitals, Royal Hallamshire Hospital, Sheffield, United Kingdom"	https://ClinicalTrials.gov/show/NCT04400838
964	NCT04379453	Robot Assisted Percutaneous Cardiovascular Intervention as a Strategy to Reduce or Risk of Intra-Procedure Contamination by COVID-19 and Other Respiratory Viruses	Recruiting	No Results Available	Coronary Artery Disease	Procedure: Robot Assisted Percutaneous Cardiovascular Intervention	Not Applicable	Interventional	"Hospital Israelita Albert Einstein, São Paulo, Brazil"	https://ClinicalTrials.gov/show/NCT04379453
965	NCT04343261	Convalescent Plasma in the Treatment of COVID 19	Enrolling by invitation	No Results Available	SARS-CoV-2|COVID|Coronavirus	Biological: Convalescent Plasma	Phase 2	Interventional	"Trinity Health Of New England, Hartford, Connecticut, United States"	https://ClinicalTrials.gov/show/NCT04343261
966	NCT04367077	MultiStem Administration for COVID-19 Induced ARDS (MACoVIA)	Recruiting	No Results Available	ARDS	Biological: MultiStem|Biological: Placebo	Phase 2|Phase 3	Interventional	"Athersys Investigational Site 101, Cleveland, Ohio, United States|Athersys Investigational Site 102, Cleveland, Ohio, United States"	https://ClinicalTrials.gov/show/NCT04367077
967	NCT04333368	Cell Therapy Using Umbilical Cord-derived Mesenchymal Stromal Cells in SARS-CoV-2-related ARDS	Recruiting	No Results Available	Severe Acute Respiratory Syndrome Coronavirus 2|Severe Acute Respiratory Distress Syndrome	Biological: Umbilical cord Wharton's jelly-derived human|Other: NaCl 0.9%	Phase 1|Phase 2	Interventional	"Hôpital Pitié-Salpêtrière - APHP, Paris, France|Hôpital Européen Georges Pompidou - APHP, Paris, France"	https://ClinicalTrials.gov/show/NCT04333368
968	NCT04439006	Ibrutinib for the Treatment of COVID-19 in Patients Requiring Hospitalization	Not yet recruiting	No Results Available	Aplastic Anemia|Hematopoietic and Lymphoid Cell Neoplasm|Malignant Solid Neoplasm|Monoclonal B-Cell Lymphocytosis|Monoclonal Gammopathy of Undetermined Significance|Myelodysplastic Syndrome|Symptomatic COVID-19 Infection Laboratory-Confirmed	Other: Best Practice|Drug: Ibrutinib	Phase 2	Interventional	"Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States"	https://ClinicalTrials.gov/show/NCT04439006
969	NCT04394377	Full Anticoagulation Versus Prophylaxis in COVID-19: COALIZAO ACTION Trial	Recruiting	No Results Available	Coronavirus Infection	Drug: Group 1: Rivaroxaban 20mg/d followed by enoxaparin/unfractionated heparin when needed|Drug: Group 2: control group with enoxaparin 40mg/d	Phase 4	Interventional	"Hospital Vera Cruz, Belo Horizonte, Minas Gerais, Brazil|Núcleo de Ciências de Saúde - Unidade de Pesquisa - Hospital Felício Rocho, Belo Horizonte, Minas Gerais, Brazil|Unidade de Pesquisa Clínica da Faculdade de Medicina de Botucatu - Unesp, Botucatu, São Paulo, Brazil|Hospital Israelita Albert Einstein, São Paulo, Brazil"	https://ClinicalTrials.gov/show/NCT04394377
970	NCT04360096	Inhaled Aviptadil for the Treatment of Moderate and Severe COVID-19	Not yet recruiting	No Results Available	SARS-CoV 2|COVID|ARDS|ALI|Acute Lung Injury/Acute Respiratory Distress Syndrome (ARDS)|Dyspnea	Drug: RLF-100 (aviptadil)|Drug: Placebo|Device: Nebulized administration of RLF-100 or Placebo	Phase 2|Phase 3	Interventional		https://ClinicalTrials.gov/show/NCT04360096
971	NCT04433078	RepurpoSing Old Drugs TO SuppRess a Modern Threat: COVID-19 STORM	Recruiting	No Results Available	Cytokine Storm|SARS-CoV-2	Drug: Doxycycline|Drug: Placebo	Phase 2	Interventional	"Temple University Hospital, Philadelphia, Pennsylvania, United States"	https://ClinicalTrials.gov/show/NCT04433078
972	NCT03042143	Repair of Acute Respiratory Distress Syndrome by Stromal Cell Administration (REALIST) (COVID-19)	Recruiting	No Results Available	Acute Respiratory Distress Syndrome	Biological: Human umbilical cord derived CD362 enriched MSCs|Biological: Placebo (Plasma-Lyte 148)	Phase 1|Phase 2	Interventional	"Belfast Health and Social Care Trust, Royal Hospitals, Belfast, Northern Ireland, United Kingdom"	https://ClinicalTrials.gov/show/NCT03042143
973	NCT04380818	Low Dose Anti-inflammatory Radiotherapy for the Treatment of Pneumonia by COVID-19	Recruiting	No Results Available	"Pneumonia, Viral"	Radiation: Low-dose radiotherapy|Drug: Hydroxychloroquine Sulfate|Drug: Ritonavir/lopinavir|Drug: Tocilizumab Injection [Actemra]|Drug: Azithromycin|Drug: Corticosteroid|Drug: Low molecular weight heparin|Device: Oxygen supply	Not Applicable	Interventional	"Hospital Sant Joan de Reus, Reus, Tarragona, Spain|Hospital Del Mar, Barcelona, Spain|Hospital Universitario Madrid Sanchinarro, Madrid, Spain"	https://ClinicalTrials.gov/show/NCT04380818
974	NCT04359810	Plasma Therapy of COVID-19 in Critically Ill Patients	Recruiting	No Results Available	SARS-CoV Infection	Biological: Convalescent Plasma (anti-SARS-CoV-2 plasma)|Biological: Non-convalescent Plasma (control plasma)	Phase 2	Interventional	"Columbia University Irving Medical Center/NYP, New York, New York, United States"	https://ClinicalTrials.gov/show/NCT04359810
975	NCT04382547	Treatment of Covid-19 Associated Pneumonia With Allogenic Pooled Olfactory Mucosa-derived Mesenchymal Stem Cells	Enrolling by invitation	No Results Available	"COVID|Covid-19|Coronavirus|Pneumonia|Pneumonia, Viral|Pneumonia, Interstitial|Sars-CoV2"	Biological: Allogenic pooled olfactory mucosa-derived mesenchymal stem cells|Other: Standard treatment according to the Clinical protocols	Phase 1|Phase 2	Interventional	"Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus, Minsk, Belarus"	https://ClinicalTrials.gov/show/NCT04382547
976	NCT04340349	Low-dose Hydroxychloroquine and Bromhexine: a Novel Regimen for COVID-19 Prophylaxis in Healthcare Professionals	Enrolling by invitation	No Results Available	Hydroxychloroquine|Antimalarials|Enzyme Inhibitors|Antirheumatic Agents	Drug: Hydroxychloroquine Sulfate|Drug: Bromhexine 8 MG	Early Phase 1	Interventional	"National Institute of Rehabilitation, Mexico City, Cdmx, Mexico"	https://ClinicalTrials.gov/show/NCT04340349
977	NCT04252274	Efficacy and Safety of Darunavir and Cobicistat for Treatment of COVID-19	Recruiting	No Results Available	"Pneumonia, Pneumocystis|Coronavirus"	Drug: Darunavir and Cobicistat	Phase 3	Interventional	"Shanghai Public Health Clinical Center, Shanghai, Shanghai, China|Shanghai Public Health Clinical Center, Shanghai, Shanghai, China"	https://ClinicalTrials.gov/show/NCT04252274
978	NCT04432051	The Use of Lung Ultrasonography in COVID-19 Patients	Recruiting	No Results Available	Ultrasonography	Behavioral: mechanical ventilator settings and position	Not Applicable	Interventional	"Gazoosmanpasa Education and Research Hospital, Istanbul, Turkey"	https://ClinicalTrials.gov/show/NCT04432051
979	NCT04305457	Nitric Oxide Gas Inhalation Therapy for Mild/Moderate COVID-19	Recruiting	No Results Available	"Coronavirus Infections|Pneumonia, Viral|Acute Respiratory Distress Syndrome"	Drug: Nitric Oxide	Phase 2	Interventional	"Louisiana State University Health Shreveport, Shreveport, Louisiana, United States|Massachusetts General Hospital, Boston, Massachusetts, United States"	https://ClinicalTrials.gov/show/NCT04305457
980	NCT02735707	"Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia"	Recruiting	No Results Available	"Community-acquired Pneumonia, Influenza, COVID-19"	Drug: Fixed-duration Hydrocortisone|Drug: Shock-dependent hydrocortisone|Drug: Ceftriaxone|Drug: Moxifloxacin or Levofloxacin|Drug: Piperacillin-tazobactam|Drug: Ceftaroline|Drug: Amoxicillin-clavulanate|Drug: Macrolide administered for 3-5 days|Drug: Macrolide administered for up to 14 days|Drug: Five-days oseltamivir|Drug: Ten-days oseltamivir|Drug: Lopinavir/ritonavir|Drug: Hydroxychloroquine|Drug: Hydroxychloroquine + lopinavir/ritonavir|Drug: Interferon-β1a|Drug: Anakinra|Drug: Fixed-duration higher dose Hydrocortisone|Drug: Tocilizumab|Drug: Sarilumab	Phase 4	Interventional	"St Vincent's Hospital Sydney, Sydney, New South Wales, Australia|Royal Prince Alfred Hospital, Sydney, New South Wales, Australia|Royal North Shore Hospital, Sydney, New South Wales, Australia|Nepean Hospital, Sydney, New South Wales, Australia|Wollongong Hospital, Sydney, New South Wales, Australia|Royal Darwin Hospital,, Darwin, Northern Territory, Australia|Sunshine Coast University Hospital, Birtinya, Queensland, Australia|Princess Alexandra Hospital, Brisbane, Queensland, Australia|Logan Hospital, Brisbane, Queensland, Australia|Toowoomba Hospital, Toowoomba, Queensland, Australia|The Queen Elizabeth Hospital, Adelaide, South Australia, Australia|Bendigo Hospital, Bendigo, Victoria, Australia|University Hosptial Geelong, Geelong, Victoria, Australia|The Alfred Hospital, Melbourne, Victoria, Australia|Royal Melbourne Hospital, Melbourne, Victoria, Australia|St Vincent's Hospital Melbourne, Melbourne, Victoria, Australia|Royal Perth Hospital, Perth, Western Australia, Australia|Sir Charles Gairdner Hospital, Perth, Western Australia, Australia|St John of God Hospital Midland, Perth, Western Australia, Australia|Fiona Stanley Hospital, Perth, Western Australia, Australia|St John of God Hospital Murdoch, Perth, Western Australia, Australia|AZ Sint-Jan, Brugge, Belgium|CHU de Charleroi - Hôpital Civil Marie Curie, Charleroi, Belgium|Universitair Ziekenhuis Antwerp, Edegem, Belgium|Universitair Ziekenhuis Gent, Gent, Belgium|St. Joseph's Healthcare Hamilton, Hamilton, Canada|Centre Hospitalier de l'Université de Sherbrooke, Sherbrooke, Canada|St. Michael's Hospital Unity Health Toronto, Toronto, Canada|General County Hospital Požega, Požega, Croatia|University Hospital Centre Zagreb, Zagreb, Croatia|University Hospital for Infectious Diseases, Zagreb, Croatia|Charité - Universitätsmedizin Berlin - Infektiologie und Pneumologie, Berlin, Germany|Charité - Universitätsmedizin Berlin - Nephrologie, Berlin, Germany|Vivantes Klinikum Neukölln, Berlin, Germany|Universitätsklinikum Köln, Cologne, Germany|Universitätsklinikum Frankfurt, Frankfurt, Germany|University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany|Medizinische Hochschule Hannover, Hannover, Germany|Universitätsklinikum Jena, Jena, Germany|Universitätsklinikum Leipzig, Leipzig, Germany|Universitäts Klinikum Tübingen, Tübingen, Germany|Universitätsklinikum Würzburg, Würzburg, Germany|Jósa András County Hospital, Nyíregyháza, Hungary|Csolnoky Ferenc Kórház - Veszprem County Hospital, Veszprém, Hungary|Almási Balogh Pál Kórház, Ózd, Hungary|Beaumont Hospital, Dublin, Ireland|St. Vincent's University Hospital, Dublin, Ireland|University Hospital Galway, Galway, Ireland|Meander Medisch Centrum, Amersfoort, Netherlands|Jeroen Bosch Ziekenhuis, Den Bosch, Netherlands|Martini Hospital Groningen, Groningen, Netherlands|University Medical Center Groningen, Groningen, Netherlands|Leiden University Medical Center, Leiden, Netherlands|Canisius Wilhelmina Ziekenhuis, Nijmegen, Netherlands|Radboud University Medical Center, Nijmegen, Netherlands|University Medical Center Utrecht, Utrecht, Netherlands|North Shore Hospital, Auckland, New Zealand|CVICU, Auckland City Hospital, Auckland, New Zealand|DCCM, Auckland City Hospital, Auckland, New Zealand|Middlemore Hospital, Auckland, New Zealand|Christchurch Hospital, Christchurch, New Zealand|Waikato Hospital, Hamilton, New Zealand|Rotorua Hospital, Rotorua, New Zealand|Tauranga Hospital, Tauranga, New Zealand|Wellington Regional Hospital, Wellington, New Zealand|Whangarei Hospital, Whangarei, New Zealand|Centro Hospitalar do Medio Tejo, Abrantes, Portugal|Hospital Lusíadas Lisbon, Lisboa, Portugal|Clinical Hospital of Infectious and Tropical Diseases ""Dr. Victor Babes"", Bucharest, Romania|Institut Hospital del Mar d'Investigacions Mèdiques, Barcelona, Spain|Hospital Universitario Reina Sofia, Córdoba, Spain|Basingstoke and North Hampshire Hospital, Basingstoke, United Kingdom|Southmead Hospital, Bristol, United Kingdom|University Hospital Coventry, Coventry, United Kingdom|Darlington Memorial Hospital, Darlington, United Kingdom|University Hospital of North Durham, Durham, United Kingdom|Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom|Maidstone Hospital - Maidstone and Tunbridge Wells NHS Trust, Maidstone, United Kingdom|The James Cook University Hospital, Middlesbrough, United Kingdom|Milton Keynes University Hospital, Milton Keynes, United Kingdom|Northampton General Hospital, Northampton, United Kingdom|Queen's Medical Centre - Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom|Poole Hospital NHS Foundation Trust, Poole, United Kingdom|Queen Alexandra Hospital - Portsmouth Hospitals NHS Trust, Portsmouth, United Kingdom|Royal Berkshire Hospital, Reading, United Kingdom|University Hospital of North Tees, Stockton-on-Tees, United Kingdom|Royal Cornwall Hospital, Truro, United Kingdom|Tunbridge Wells Hospital - Maidstone and Tunbridge Wells NHS Trust, Tunbridge Wells, United Kingdom|York Hospital, York, United Kingdom"	https://ClinicalTrials.gov/show/NCT02735707
981	NCT04401046	COVID-19 and Reorganisation of Cancer Patient Care: Self- Evaluation of Potential Post-traumatic Stress Disorder	Not yet recruiting	No Results Available	Cancer	Other: Survey to assess Post traumatic stress and anxiety at inclusion and 6 months later	Not Applicable	Interventional		https://ClinicalTrials.gov/show/NCT04401046
982	NCT04348695	Study of Ruxolitinib Plus Simvastatin in the Prevention and Treatment of Respiratory Failure of COVID-19.	Recruiting	No Results Available	Coronavirus Infection	Drug: Ruxolitinib plus simvastatin|Other: Standard of Care	Phase 2	Interventional	"Hospital Universitario Madrid Sanchinarro, Madrid, Spain"	https://ClinicalTrials.gov/show/NCT04348695
983	NCT04320277	"Baricitinib in Symptomatic Patients Infected by COVID-19: an Open-label, Pilot Study."	Not yet recruiting	No Results Available	Pharmacological Action	Drug: Baricitinib	Phase 2|Phase 3	Interventional	"Fabrizio Cantini, Prato, Tuscany, Italy"	https://ClinicalTrials.gov/show/NCT04320277
984	NCT04433546	"PB1046, a Long-acting, Sustained Release Human VIP Analogue, Intended to Provide Clinical Improvement to Hospitalized COVID-19 Patients at High Risk for Rapid Clinical Deterioration and Acute Respiratory Distress Syndrome (ARDS)."	Not yet recruiting	No Results Available	Acute Respiratory Distress Syndrome|Coronavirus|Hypoxic Respiratory Failure|Hypoxemic Respiratory Failure|Respiratory Complication|Respiratory Insufficiency|Cardiac Dysfunction|Pneumonia|Pulmonary Edema|Pulmonary Inflammation|Respiratory Failure|Cytokine Storm|COVID 19|SARS-CoV-2|Cardiac Event|Cardiac Complication|Cardiac Failure|Cardiac Infarct	Drug: PB1046|Drug: Low Dose (10 mg) Control	Phase 2	Interventional		https://ClinicalTrials.gov/show/NCT04433546
985	NCT04409743	Brief Telehealth CBT-I Intervention in the Context of the COVID-19 Pandemic	Recruiting	No Results Available	Sleep Disturbance|Insomnia	Behavioral: Remote Cognitive Behavioral Therapy for Insomnia	Not Applicable	Interventional	"Stanford University, Palo Alto, California, United States"	https://ClinicalTrials.gov/show/NCT04409743
986	NCT04349228	Assessment of the Efficacy and Safety of (HCQ) as a Prophylaxis for COVID19 for Health Professionals	Recruiting	No Results Available	COVID19|Sars-CoV2|Hydroxychloroquine|Prophylaxis|Healthcare Worker	Drug: Hydroxychloroquine (HCQ)|Drug: Placebo oral tablet	Phase 3	Interventional	"Eshmoun Clinical Research Centre/ Hôpital Abderrahmane Mami-Ariana, Tunis, Tunisia"	https://ClinicalTrials.gov/show/NCT04349228
987	NCT04406181	Psychological Well-being of Patients Awaiting for Cardiac Surgery During the COVID-19 Pandemic	Recruiting	No Results Available	Anxiety and Fear|Anxiety Depression|Anxiety Postoperative|Psychological Stress	Behavioral: HADS|Behavioral: a survey	Not Applicable	Interventional	"universitair Ziekenhuis Brussel, Jette, Vlaams Brabant, Belgium"	https://ClinicalTrials.gov/show/NCT04406181
988	NCT04403243	COLchicine Versus Ruxolitinib and Secukinumab In Open Prospective Randomized Trial	Recruiting	No Results Available	COVID 19	Drug: Colchicine|Drug: Ruxolitinib 5 MG|Drug: Secukinumab 150 MG/ML Subcutaneous Solution [COSENTYX]|Other: standard therapy	Phase 2	Interventional	"Lomonosov Moscow State University Medical Research and Educational Center, Moscow, Moscow Region, Russian Federation"	https://ClinicalTrials.gov/show/NCT04403243
989	NCT04342650	Chloroquine Diphosphate in the Prevention of SARS in Covid-19 Infection	Recruiting	No Results Available	COVID-19|SARS-CoV Infection|Severe Acute Respiratory Syndrome (SARS) Pneumonia|Clinical Trial	Drug: Chloroquine Diphosphate|Drug: Placebo oral tablet	Phase 2	Interventional	"Hospital e Pronto Socorro Delphina Rinaldi Abdel Aziz, Manaus, Amazonas, Brazil"	https://ClinicalTrials.gov/show/NCT04342650
990	NCT04412356	Timing of Tracheotomy in Covid-19 Patients	Recruiting	No Results Available	Covid-19|ARDS|Tracheostomy Complication|Respiratory Insufficiency|Corona Virus Infection	Procedure: Tracheotomy	Not Applicable	Interventional	"Sahlgrenska University Hospital, Gothenburg, Sweden"	https://ClinicalTrials.gov/show/NCT04412356
991	NCT04358081	Hydroxychloroquine Monotherapy and in Combination With Azithromycin in Patients With Moderate and Severe COVID-19 Disease	Recruiting	No Results Available	Pneumonia	Drug: HCQ|Drug: HCQ+AZT|Drug: Placebo	Phase 3	Interventional	"Novartis Investigative Site, Los Angeles, California, United States|Novartis Investigative Site, San Francisco, California, United States|Novartis Investigative Site, Gainesville, Florida, United States|Novartis Investigative Site, Chicago, Illinois, United States|Novartis Investigative Site, Baton Rouge, Louisiana, United States|Novartis Investigative Site, Baltimore, Maryland, United States|Novartis Investigative Site, Baltimore, Maryland, United States|Novartis Investigative Site, Columbia, Missouri, United States|Novartis Investigative Site, Chapel Hill, North Carolina, United States|Novartis Investigative Site, Seattle, Washington, United States"	https://ClinicalTrials.gov/show/NCT04358081
992	NCT04325867	Integrated Distance Management Strategy for Patients With Cardiovascular Diseases in the Context of COVID-19	Recruiting	No Results Available	"Angina Pectoris|Acute Coronary Syndrome|Coronary Syndrome|Coronary Artery Disease|Angioplasty|Stent Restenosis|Hypertension|Heart Failure, Systolic|Depression, Anxiety|Covid-19|Isolation, Social"	Other: Tele-medicine platform	Not Applicable	Interventional	"Medical Sciences Academy, Bucharest, Romania|University of Medicine and Pharmacy Gr T Popa, Iasi, Romania"	https://ClinicalTrials.gov/show/NCT04325867
993	NCT04342156	Safety And Efficacy Of Hydroxychloroquine For At Risk Population (SHARP) Against COVID-19	Not yet recruiting	No Results Available	Coronavirus Infection|Hydroxychloroquine Adverse Reaction	Drug: Hydroxychloroquine Sulfate 200 milligram (mg) Tab	Phase 3	Interventional		https://ClinicalTrials.gov/show/NCT04342156
994	NCT04279197	Treatment of Pulmonary Fibrosis Due to 2019-nCoV Pneumonia With Fuzheng Huayu	Recruiting	No Results Available	Pulmonary Fibrosis Due to 2019-nCoV	Drug: N-acetylcysteine+ Fuzheng Huayu Tablet|Drug: N-acetylcysteine+Placebo	Phase 2	Interventional	"Shuguang Hospital, Shanghai, Shanghai, China"	https://ClinicalTrials.gov/show/NCT04279197
995	NCT04412330	Optimizing Outcomes With Physical Therapy Treatment for IndividuALs Surviving an ICU Admission for Covid-19	Recruiting	No Results Available	Covid-19|Critical Illness|Post Intensive Care Unit Syndrome|Muscle Weakness	Other: ICU Recovery + Physical Therapy	Not Applicable	Interventional	"University of Kentucky, Lexington, Kentucky, United States"	https://ClinicalTrials.gov/show/NCT04412330
996	NCT03963622	Careful Ventilation in COVID-19 -Induced Acute Respiratory Distress Syndrome	Not yet recruiting	No Results Available	ARDS	Other: Respiratory Mechanics|Other: Standard Ventilation Strategy	Not Applicable	Interventional		https://ClinicalTrials.gov/show/NCT03963622
997	NCT04358003	Plasma Adsorption in Patients With Confirmed COVID-19	Recruiting	No Results Available	Respiratory Failure|ARDS	Device: Marker Therapeutics D2000 Cartridge (D2000) for use with the Spectra Optia® Apheresis System (Optia SPD Protocol)	Not Applicable	Interventional	"UNM Health Science Center, Albuquerque, New Mexico, United States|Providence Portland Medical Center, Portland, Oregon, United States|UT Southwestern/Clements Hospital, Dallas, Texas, United States|UTMB, Galveston, Texas, United States"	https://ClinicalTrials.gov/show/NCT04358003
998	NCT04366297	Intravascular Access of COVID-19 Patient Under Personal Protective Equipment	Completed	No Results Available	Cardiac Arrest|Emergencies	Device: Intravenous access|Device: Intraosseous access	Not Applicable	Interventional	"Lazarski Univeristy, Warsaw, Poland"	https://ClinicalTrials.gov/show/NCT04366297
999	NCT04389385	COVID-19 Specific T Cell Derived Exosomes (CSTC-Exo)	"Active, not recruiting"	No Results Available	Corona Virus Infection|Pneumonia	Biological: COVID-19 Specific T Cell derived exosomes (CSTC-Exo)	Phase 1	Interventional	"GENKOK, Kayseri, Melikgazi, Turkey"	https://ClinicalTrials.gov/show/NCT04389385
1000	NCT04394182	Ultra Low Doses of Therapy With Radiation Applicated to COVID-19	Recruiting	No Results Available	"Pneumonia, Viral|Cytokine Storm"	Radiation: Ultra-Low-dose radiotherapy|Device: ventilatory support with oxygen therapy|Drug: Lopinavir/ritonavir|Drug: Hydroxychloroquine|Drug: Azithromycin|Drug: Piperacillin/tazobactam|Drug: Low molecular weight heparin|Drug: Corticosteroid injection|Drug: Tocilizumab	Not Applicable	Interventional	"Hospital La Milagrosa, GenesisCare, Madrid, Spain|Hospital Vithas Valencia Consuelo, Valencia, Spain"	https://ClinicalTrials.gov/show/NCT04394182
1001	NCT04422613	Characterization of Persistent Pulmonary Abnormalities Following COVID-19 Pneumonia	Recruiting	No Results Available	"Pneumonia, Viral"	Diagnostic Test: pulmonary anomalies 4 months after documented COVID-19 pneumonia	Not Applicable	Interventional	"University Hospital of Toulouse, Toulouse, France"	https://ClinicalTrials.gov/show/NCT04422613
1002	NCT04327401	COVID-19-associated ARDS Treated With Dexamethasone: Alliance Covid-19 Brasil III	"Active, not recruiting"	No Results Available	"Coronavirus Infection|Pneumonia, Viral|Acute Respiratory Distress Syndrome"	Drug: Dexamethasone	Phase 3	Interventional	"Hospital Ana Nery, Salvador, Bahia, Brazil|Instituto de Cardiologia do Distrito Federal, Brasília, Distrito Federal, Brazil|Fundação Social Rural de Colatina, Colatina, Esoírito Santo, Brazil|Hospital Vera Cruz AS, Belo Horizonte, Minas Gerais, Brazil|Hospital Maternidade E Pronto Socorro Santa Lucia Ltda, Poços De Caldas, Minas Gerais, Brazil|Universidade Estadual de Londrina, Londrina, Paraná, Brazil|Eurolatino Natal Pesquisas Médicas Ltda, Natal, Rio Grande Do Norte, Brazil|Irmandade da Santa Casa de Misericordia de Porto Alegre, Porto Alegre, Rio Grande Do Sul, Brazil|Maestri E Kormann Consultoria Medico-Cientifica, Blumenau, Santa Catarina, Brazil|Sociedade Literaria e Caritativa Santo Agostinho, Criciúma, Santa Catarina, Brazil|Fundação Pio XII, Barretos, São Paulo, Brazil|Santa Casa de Misericordia de Votuporanga, Votuporanga, São Paulo, Brazil|Associacao Beneficente Siria, São Paulo, Brazil|Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto da USP - HCFMRP, São Paulo, Brazil|Hospital Israelita Albert Einstein, São Paulo, Brazil|Prevent Senior Private Operadora de Saude Ltda, São Paulo, Brazil|Real e Benemérita Associação Portuguesa de Beneficência/SP, São Paulo, Brazil|Santa Casa de Misericórdia, São Paulo, Brazil|Secretaria de Saúde do Estado de São Paulo, São Paulo, Brazil|Sociedade Beneficente de Senhoras Hospital Sírio-Libanês, São Paulo, Brazil|Universidade Federal de São Paulo, São Paulo, Brazil"	https://ClinicalTrials.gov/show/NCT04327401
1003	NCT04373382	Peer Champion Support for Hospital Staff During and After the COVID-19 Pandemic	Not yet recruiting	No Results Available	Burnout	Behavioral: Peer Resilience Champion|Behavioral: Enriched Survey Feedback	Not Applicable	Interventional	"Sinai Health, Toronto, Ontario, Canada"	https://ClinicalTrials.gov/show/NCT04373382
1004	NCT04361396	Assessment of the Presence of the SARS-COV-2 Virus in the Peritoneum of COVID-19 Patients	Recruiting	No Results Available	Coronavirus Infection	Other: Collection of samples	Not Applicable	Interventional	"CH Victor Dupouy, Argenteuil, France|CH Intercommunal, Créteil, France|Department of General and Digestive Surgery, Hospital René Dubos, Pontoise, France|Department of Gynecology-Obstetrics, Hospital René Dubos, Pontoise, France|CH Delafontaine, Saint-Denis, France"	https://ClinicalTrials.gov/show/NCT04361396
1005	NCT04345861	Hydroxychloroquine Plus Azithromycin Versus Hydroxychloroquine for COVID-19 Pneumonia (COVIDOC Trial)	Terminated	No Results Available	"Coronavirus Infection|Pneumonia, Viral"	Drug: Hydroxychloroquine + placebo|Drug: hydroxychloroquine + azithromycin	Phase 2|Phase 3	Interventional	"Montpellier University hospital, Montpellier, France"	https://ClinicalTrials.gov/show/NCT04345861
1006	NCT04453384	Study to Evaluate the Safety and Efficacy of XAV-19 in Patients With COVID-19 Induced Moderate Pneumonia	Not yet recruiting	No Results Available	SARS Virus	Drug: XAV-19|Drug: Placebo	Phase 2	Interventional	"CHD Vendée, La Roche-sur-Yon, France|Hospices Civils Lyon, Lyon, France|CHU Nantes, Nantes, France|Hôpital Saint Antoine, Paris, France"	https://ClinicalTrials.gov/show/NCT04453384
1007	NCT04345614	A Study of CM4620-Injectable Emulsion (IE) in Patients With Severe COVID-19 Pneumonia	Recruiting	No Results Available	Pneumonia	Drug: CM4620-Injectable Emulsion	Phase 2	Interventional	"Henry Ford Hospital, Detroit, Michigan, United States|Methodist Hospital, Saint Louis Park, Minnesota, United States|Regions Hospital, Saint Paul, Minnesota, United States"	https://ClinicalTrials.gov/show/NCT04345614
1008	NCT04447235	Early Treatment With Ivermectin and LosarTAN for Cancer Patients With COVID-19 Infection	Not yet recruiting	No Results Available	Cancer|COVID|Coronavirus Infection	Drug: Placebo|Drug: Ivermectin|Drug: Losartan	Phase 2	Interventional		https://ClinicalTrials.gov/show/NCT04447235
1009	NCT04360811	"Assessment of Obstetric, Fetal and Neonatal Risks and Vertical SARS-CoV-2 Transmission During COVID-19 Pandemic"	Recruiting	No Results Available	Pregnancy	Diagnostic Test: COVID 19 diagnostic test by PCR	Not Applicable	Interventional	"University Hospital of Toulouse, Toulouse, France"	https://ClinicalTrials.gov/show/NCT04360811
1010	NCT04376684	Investigating Otilimab in Patients With Severe Pulmonary COVID-19 Related Disease	Recruiting	No Results Available	Severe Acute Respiratory Syndrome	Biological: Otilimab|Biological: Placebo|Drug: Standard of care	Phase 2	Interventional	"GSK Investigational Site, Torrance, California, United States|GSK Investigational Site, Saint Louis Park, Minnesota, United States|GSK Investigational Site, Saint Paul, Minnesota, United States|GSK Investigational Site, Charlotte, North Carolina, United States|GSK Investigational Site, Toledo, Ohio, United States|GSK Investigational Site, Logroño, Spain|GSK Investigational Site, Madrid, Spain|GSK Investigational Site, Madrid, Spain|GSK Investigational Site, San Sebastián De Los Reyes/Madrid, Spain|GSK Investigational Site, Liverpool, United Kingdom"	https://ClinicalTrials.gov/show/NCT04376684
1011	NCT04371419	COVID-19 Health Messaging to Underserved Communities	Completed	No Results Available	Coronavirus	Behavioral: Messaging	Not Applicable	Interventional	"JPAL North America, Cambridge, Massachusetts, United States"	https://ClinicalTrials.gov/show/NCT04371419
1012	NCT04394169	Early Care Program for the Management of Post-ICU Syndrome and Chronic Pain After COVID-19 Infection.	Not yet recruiting	No Results Available	Post ICU Syndrome|Chronic Pain|Covid-19	Behavioral: Intervention program	Not Applicable	Interventional		https://ClinicalTrials.gov/show/NCT04394169
1013	NCT04359875	A Phone-call With a Student/General Practitioner Team to Impact Morbidity of Chronic Patients During COVID-19 Containment	Not yet recruiting	No Results Available	Cardiovascular Diseases|Mental Disorder	Behavioral: Phone-call screening and management by a medical student/general practitioner tandem	Not Applicable	Interventional	"Dibao-Dina, Tours, France"	https://ClinicalTrials.gov/show/NCT04359875
1014	NCT04344210	Impact of Tele-interventions During the COVID-19 Pandemic in Patients With Diabetes Mellitus	Enrolling by invitation	No Results Available	"COVID|Diabetes Mellitus, Type 2|Diabetes Mellitus, Type 1"	Behavioral: Tele-interventions related to diabetes management and mental well-being	Not Applicable	Interventional	"Hospital de Clínicas de Porto Alegre, Porto Alegre, Rio Grande Do Sul, Brazil"	https://ClinicalTrials.gov/show/NCT04344210
1015	NCT04386070	Preventing Pulmonary Complications in Surgical Patients at Risk of COVID-19	Not yet recruiting	No Results Available	Pulmonary Complications in Surgical Patients|COVID|Severe Acute Respiratory Syndrome	Drug: Lopinavir-Ritonavir|Drug: Hydroxychloroquine	Phase 3	Interventional		https://ClinicalTrials.gov/show/NCT04386070
1016	NCT04349592	Qatar Prospective RCT Of Therapy Eliminating Covid Transmission	Not yet recruiting	No Results Available	Covid19	Drug: Hydroxychloroquine + Azithromycin|Drug: Hydroxychloroquine + Placebo|Other: Placebo + Placebo	Not Applicable	Interventional		https://ClinicalTrials.gov/show/NCT04349592
1017	NCT04426318	COVID-19 and the Healthy Minds Program for Educators	Recruiting	No Results Available	Anxiety|Depression|Psychological Stress|Psychological Distress|Well-being	Behavioral: Healthy Minds Program Foundations Training	Not Applicable	Interventional	"University of Wisconsin, Madison, Wisconsin, United States"	https://ClinicalTrials.gov/show/NCT04426318
1018	NCT04393792	SINUS WASH Pilot Study in Adults Testing Positive for COVID-19	Recruiting	No Results Available	Coronavirus Infection	Drug: Povidone-Iodine|Drug: Normal saline	Phase 1	Interventional	"Hampshire Hospitals NHS Foundation Trust, Basingstoke, Hampshire, United Kingdom"	https://ClinicalTrials.gov/show/NCT04393792
1019	NCT04402970	Dornase Alfa for ARDS in Patients With SARS-CoV-2	Recruiting	No Results Available	SARS-CoV 2|ARDS	Drug: Dornase Alfa Inhalation Solution	Phase 3	Interventional	"University of Missouri Hospital and Clinics, Columbia, Missouri, United States"	https://ClinicalTrials.gov/show/NCT04402970
1020	NCT04408235	High Versus Low LMWH Dosages in Hospitalized Patients With Severe COVID-19 Pneumonia and Coagulopathy	Not yet recruiting	No Results Available	"COVID|Pneumonia, Viral|Coagulation Disorder"	Drug: Enoxaparin	Phase 3	Interventional	"Azienda Ospedaliero-Universitaria, Modena, Italy"	https://ClinicalTrials.gov/show/NCT04408235
1021	NCT04355234	"Prevalence and Impact of COVID-19 Infection in Pregnant Women, Fetuses and Newborns"	Not yet recruiting	No Results Available	Pregnancy	Diagnostic Test: identify SARS-CoV-2 infection by serology|Biological: collection of biological samples	Not Applicable	Interventional		https://ClinicalTrials.gov/show/NCT04355234
1022	NCT04321174	COVID-19 Ring-based Prevention Trial With Lopinavir/Ritonavir	Recruiting	No Results Available	Coronavirus Infections|Post-exposure Prophylaxis	Drug: Lopinavir/ritonavir	Phase 3	Interventional	"St. Paul's Hospital, Vancouver, British Columbia, Canada|Sunnybrook Hospital, Toronto, Ontario, Canada|St. Michael's Hospital, Toronto, Ontario, Canada|Toronto General Hospital, Toronto, Ontario, Canada"	https://ClinicalTrials.gov/show/NCT04321174
1023	NCT04365608	Prehospital Intubation of COVID-19 Patient With Personal Protective Equipment	Recruiting	No Results Available	Intubation Complication|Intubation; Difficult or Failed|Cardiac Arrest|Influenza|Safety Issues	Procedure: Direct laryngoscopy|Procedure: Vie Scope laryngoscopy	Not Applicable	Interventional	"Emergency Medical Service, Poznan, Poland|Emergency Medical Service, Warsaw, Poland"	https://ClinicalTrials.gov/show/NCT04365608
1024	NCT04363593	Serology COVID-19 From the Cornwall Hospital Union	Recruiting	No Results Available	Corona Virus Infection	Biological: Serological test|Biological: Serum test	Not Applicable	Interventional	"CH de Cornouaille, Quimper, France"	https://ClinicalTrials.gov/show/NCT04363593
1025	NCT04397796	Study of the Safety of Therapeutic Tx With Immunomodulatory MSC in Adults With COVID-19 Infection Requiring Mechanical Ventilation	Not yet recruiting	No Results Available	COVID	Biological: BM-Allo.MSC|Biological: Placebo	Phase 1	Interventional		https://ClinicalTrials.gov/show/NCT04397796
1026	NCT04370938	Provider Burnout During COVID-19	Recruiting	No Results Available	"Perceived Organizational Support, Anxiety, Burnout"	Behavioral: Coping strategies video	Not Applicable	Interventional	"UPMC, Pittsburgh, Pennsylvania, United States"	https://ClinicalTrials.gov/show/NCT04370938
1027	NCT04264858	Treatment of Acute Severe 2019-nCoV Pneumonia With Immunoglobulin From Cured Patients	Not yet recruiting	No Results Available	2019-nCoV|Immunoglobulin of Cured Patients	Drug: Immunoglobulin of cured patients|Drug: γ-Globulin	Not Applicable	Interventional	"Department of Cardiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China"	https://ClinicalTrials.gov/show/NCT04264858
1028	NCT04354155	COVID-19 Anticoagulation in Children - Thromboprophlaxis (COVAC-TP) Trial	Not yet recruiting	No Results Available	"Infection Viral|Thromboses, Venous"	Drug: Enoxaparin Prefilled Syringe [Lovenox]	Phase 2	Interventional	"Johns Hopkins All Children's Hospital, Saint Petersburg, Florida, United States"	https://ClinicalTrials.gov/show/NCT04354155
1029	NCT04324463	Anti-Coronavirus Therapies to Prevent Progression of Coronavirus Disease 2019 (COVID-19) Trial	Recruiting	No Results Available	Coronavirus|Severe Acute Respiratory Syndrome	Drug: Colchicine|Drug: Interferon-Beta|Drug: Aspirin|Drug: Rivaroxaban	Phase 3	Interventional	"Hamilton Health Sciences, Hamilton, Ontario, Canada"	https://ClinicalTrials.gov/show/NCT04324463
1030	NCT04416919	Assessment of N-95 Facemask for Use in COVID-19 Pandemic in Case of Shortage of Personal Protective Equipment	Recruiting	No Results Available	Coronavirus Infection|Disease Prevention	Other: Assembled mask	Not Applicable	Interventional	"Oklahoma City VA Health Care System, Oklahoma City, Oklahoma, United States"	https://ClinicalTrials.gov/show/NCT04416919
1031	NCT04402944	Pulmozyme to Improve COVID-19 ARDS Outcomes	Not yet recruiting	No Results Available	COVID	Drug: Pulmozyme|Drug: Placebo	Phase 2	Interventional		https://ClinicalTrials.gov/show/NCT04402944
1032	NCT04382846	Novel Regimens in COVID-19 Treatment	Not yet recruiting	No Results Available	COVID|Corona Virus Infection	Drug: Nitazoxanide|Drug: Ivermectin|Drug: Chloroquine|Drug: Azithromycin	Phase 3	Interventional		https://ClinicalTrials.gov/show/NCT04382846
1033	NCT04381000	Quarantine and Telerehabilitation in Chronic Pain Patients During COVID-19 Pandemic.	Completed	No Results Available	Chronic Pain	Other: Exercise Group	Not Applicable	Interventional	"Clinical Exercise Physiology and Rehabilitation Laboratory, Lamia, Sterea Ellada, Greece"	https://ClinicalTrials.gov/show/NCT04381000
1034	NCT04365439	Convalescent Plasma for COVID-19	Not yet recruiting	No Results Available	Blood Plasma Therapy|COVID	Biological: Blood plasma	Not Applicable	Interventional		https://ClinicalTrials.gov/show/NCT04365439
1035	NCT04392713	Efficacy of Ivermectin in COVID-19	Recruiting	No Results Available	COVID	Drug: Ivermectin 6 MG Oral Tablet (2 tablets)	Not Applicable	Interventional	"Combined Military Hospital Lahore, Lahore, Punjab, Pakistan"	https://ClinicalTrials.gov/show/NCT04392713
1036	NCT04376515	Harnessing Online Peer Education Online Support Intervention for COVID-19 (HOPE COVID-19)	"Active, not recruiting"	No Results Available	Anxiety	Behavioral: HOPE intervention	Not Applicable	Interventional	"UC Irvine, Irvine, California, United States"	https://ClinicalTrials.gov/show/NCT04376515
1037	NCT04400019	Prevention of COVID19 Infection in Nursing Homes by Chemoprophylaxis With Hydroxychloroquine (PREVICHARM)	Not yet recruiting	No Results Available	Sars-CoV2|Coronavirus Infection|Prevention & Control|Nursing Home|Hydroxychloroquine	Drug: Hydroxychloroquine Only Product in Oral Dose Form	Phase 2|Phase 3	Interventional		https://ClinicalTrials.gov/show/NCT04400019
1038	NCT04334629	LIBERATE Trial in COVID-19	Recruiting	No Results Available	Coronavirus|Respiratory Distress Syndrome|SARS-CoV Infection	Drug: Ibuprofen	Phase 4	Interventional	"Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom"	https://ClinicalTrials.gov/show/NCT04334629
1039	NCT04408027	Mental Health Support for SickKids Children and Families During COVID-19 Using Established eHealth Interventions	Not yet recruiting	No Results Available	Anxiety Disorder of Childhood or Adolescence	Behavioral: Virtual-Care Cognitive Behavioural Therapy	Not Applicable	Interventional	"The Hospital for Sick Children (SickKids), Toronto, Ontario, Canada"	https://ClinicalTrials.gov/show/NCT04408027
1040	NCT04411446	Cholecalciferol to Improve the Outcomes of COVID-19 Patients	Not yet recruiting	No Results Available	COVID	Drug: Vitamin D|Drug: Placebo	Phase 4	Interventional	"Hospital de Alta Complejidad en Red El Cruce, Florencio Varela, Buenos Aires, Argentina"	https://ClinicalTrials.gov/show/NCT04411446
1041	NCT04445311	Ivermectin in Treatment of COVID-19	Recruiting	No Results Available	COVID	Drug: Ivermectin	Phase 2|Phase 3	Interventional	"Waheed Shouman, Zagazig, Sharkia, Egypt"	https://ClinicalTrials.gov/show/NCT04445311
1042	NCT04436458	Niclosamide In Moderate COVID-19	Not yet recruiting	No Results Available	COVID	Drug: Niclosamide Oral Tablet|Drug: Placebo	Phase 2	Interventional		https://ClinicalTrials.gov/show/NCT04436458
1043	NCT04429828	COVID-19 Psychological Wellbeing for Healthcare Students	Not yet recruiting	No Results Available	Psychological Wellbeing	Other: COVID-19 e-package: Psychological wellbeing for healthcare workers	Not Applicable	Interventional		https://ClinicalTrials.gov/show/NCT04429828
1044	NCT04384458	COVID-19 Prophylaxis With Hydroxychloroquine Associated With Zinc For High-Risk Healthcare Workers	Not yet recruiting	No Results Available	Coronavirus Infections	Drug: Hydroxychloroquine	Not Applicable	Interventional	"Drug Research and Development Center (NPDM), Federal University of Ceará (UFC), Fortaleza, Ceará, Brazil"	https://ClinicalTrials.gov/show/NCT04384458
1045	NCT04414631	Conestat Alfa in the Prevention of Severe SARS-CoV-2 Infection in Hospitalized Patients With COVID-19	Not yet recruiting	No Results Available	Coronavirus Infections	Drug: Conestat alfa	Phase 2	Interventional	"University Hospital Basel, Division of Internal Medicine, Basel, Switzerland"	https://ClinicalTrials.gov/show/NCT04414631
1046	NCT04387409	Study to Assess VPM1002 in Reducing Healthcare Professionals' Absenteeism in COVID-19 Pandemic	Recruiting	No Results Available	"Infection, Respiratory Tract"	Biological: VPM1002|Biological: Placebo	Phase 3	Interventional	"Medizinische Hochschule Hannover, Hannover, Niedersachsen, Germany|SocraTec R&D GmbH, Erfurt, Thüringen, Germany"	https://ClinicalTrials.gov/show/NCT04387409
1047	NCT04320238	Experimental Trial of rhIFNα Nasal Drops to Prevent 2019-nCOV in Medical Staff	Recruiting	No Results Available	2019 Novel Coronavirus Infection	Drug: recombinant human interferon Alpha-1b|Drug: thymosin alpha 1	Phase 3	Interventional	"Taihe Hospital, Shiyan, Hubei, China"	https://ClinicalTrials.gov/show/NCT04320238
1048	NCT04422561	Prophylactic Ivermectin in COVID-19 Contacts	Recruiting	No Results Available	COVID	Drug: Ivermectin Tablets	Phase 2|Phase 3	Interventional	"Zagazig University, Zagazig, Sharkia, Egypt"	https://ClinicalTrials.gov/show/NCT04422561
1049	NCT04365309	Protective Effect of Aspirin on COVID-19 Patients	Enrolling by invitation	No Results Available	Novel Coronavirus Pneumonia|Aspirin|Treatment	Drug: Aspirin 100mg	Phase 2|Phase 3	Interventional	"Cai Yue, Xi'an, Shaanxi, China"	https://ClinicalTrials.gov/show/NCT04365309
1050	NCT04403555	Ivermectin and Doxycycine in COVID-19 Treatment	Not yet recruiting	No Results Available	COVID	Drug: Ivermectin|Drug: Doxycycline|Drug: Chloroquine	Phase 2|Phase 3	Interventional	"Sherief Abd-Elsalam, Tanta, Egypt"	https://ClinicalTrials.gov/show/NCT04403555
1051	NCT04379531	LDCT in COVID-19 Pneumonia: a Prospective Moscow Study	Completed	No Results Available	Pneumonia|Coronavirus Infection	Diagnostic Test: Low-dose Chest CT	Not Applicable	Interventional	"Victor Gombolevskiy, Moscow, Russian Federation"	https://ClinicalTrials.gov/show/NCT04379531
1052	NCT04351295	Efficacy of Faviprevir in COVID-19 Treatment	Not yet recruiting	No Results Available	COVID	Drug: Favipiravir|Drug: Placebos	Phase 2|Phase 3	Interventional	"Tanta University, Tanta, Egypt"	https://ClinicalTrials.gov/show/NCT04351295
1053	NCT04335279	Evaluation of the Scleroderma Patient-centered Intervention Network COVID-19 Home-isolation Activities Together Program	"Active, not recruiting"	No Results Available	"Scleroderma|Scleroderma, Systemic|Systemic Sclerosis"	Other: SPIN-CHAT Program	Not Applicable	Interventional	"Sir Mortimer B. Davis Jewish General Hospital, Montreal, Quebec, Canada"	https://ClinicalTrials.gov/show/NCT04335279
1054	NCT04414371	Tools for Wellbeing COVID-19 National Study of Undergraduate Students	Recruiting	No Results Available	Stress|Anxiety|Depression|Resilience|Wellbeing|Mood	Other: Yoga	Not Applicable	Interventional	"Rutgers University, New Brunswick, New Jersey, United States"	https://ClinicalTrials.gov/show/NCT04414371
1055	NCT04406493	Monitoring COVID-19 Patients' Lung Fluid Using Impedance Technique	Recruiting	No Results Available	ARDS|COVID	Diagnostic Test: Lung impedance technique	Not Applicable	Interventional	"Hillel Yaffe MC,, Hadera, Israel"	https://ClinicalTrials.gov/show/NCT04406493
1056	NCT04326452	Treating COVID-19 With a Bidirectional Oxygenation Valve	Recruiting	No Results Available	Coronavirus Infection	Device: bidirectional oxygenation mouthpiece	Not Applicable	Interventional	"TMC HealthCare, Tucson, Arizona, United States|Stanford University, Stanford, California, United States|Emory Saint Joseph's Hospital, Atlanta, Georgia, United States"	https://ClinicalTrials.gov/show/NCT04326452
1057	NCT04382768	Inhaled Ibuprofen to Treat COVID-19	Recruiting	No Results Available	Coronavirus Infection|Respiratory Disease|SARS (Disease)	Drug: Inhaled Hypertonic ibuprofen	Not Applicable	Interventional	"Centro de Excelencia en Productos y Procesos Córdoba, Córdoba, Argentina"	https://ClinicalTrials.gov/show/NCT04382768
1058	NCT04403685	Safety and Efficacy of Tocilizumab in Moderate to Severe COVID-19 With Inflammatory Markers	Recruiting	No Results Available	COVID|SARS Pneumonia|Cytokine Release Syndrome	Drug: Tocilizumab	Phase 3	Interventional	"UNIFESP, São Paulo, Sao Paulo, Brazil|HCOR -Hospital do Coracao, Sao Paulo, SP, Brazil|HAOC - Hospital Alemao Oswaldo Cruz, Sao Paulo, Brazil|Beneficência Portuguesa de Sao Paulo, Sao Paulo, Brazil|HAOC - Hospital Alemao Oswaldo Cruz - unidade Vergueiro, Sao Paulo, Brazil|HIAE - Hospital Israelita Albert Einstein, Sao Paulo, Brazil|HSL - Hospital Sírio Libanês, Sao Paulo, Brazil"	https://ClinicalTrials.gov/show/NCT04403685
1059	NCT04312243	NO Prevention of COVID-19 for Healthcare Providers	Recruiting	No Results Available	Coronavirus Infections|Healthcare Associated Infection	Drug: Inhaled nitric oxide gas	Phase 2	Interventional	"Massachusetts General Hospital, Boston, Massachusetts, United States"	https://ClinicalTrials.gov/show/NCT04312243
1060	NCT04425720	Use of Remote Monitoring for COVID-19 Patient	Not yet recruiting	No Results Available	COVID	Device: LifeSignals Biosensor 1AX*|Other: Standard of Care	Not Applicable	Interventional	"Montefiore Medical Center, Bronx, New York, United States"	https://ClinicalTrials.gov/show/NCT04425720
1061	NCT04406064	Viral Specific T-cells for Treatment of COVID-19	Not yet recruiting	No Results Available	Viral Infection	Biological: Viral Specific T-cells (VSTs)	Phase 2	Interventional	"Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States"	https://ClinicalTrials.gov/show/NCT04406064
1062	NCT04408131	Morbi-mortality by COVID-19 Among Homeless People in Marseille: a Cohort Study	Recruiting	No Results Available	Homeless	Biological: Blood sample	Not Applicable	Interventional	"Assistance Publique Hôpitaux de Marseille, Marseille, Paca, France"	https://ClinicalTrials.gov/show/NCT04408131
1063	NCT04368377	Enhanced Platelet Inhibition in Critically Ill Patients With COVID-19	Completed	No Results Available	"Pneumonia, Viral|Corona Virus Infection|Respiratory Failure|Embolism and Thrombosis"	Drug: Tirofiban Injection|Drug: Clopidogrel|Drug: Acetylsalicylic acid|Drug: Fondaparinux	Phase 2	Interventional	"L. Sacco Hospital, Milano, Lombardia, Italy"	https://ClinicalTrials.gov/show/NCT04368377
1064	NCT04410692	Can the Prediction Market Improve Predictions of COVID-19?	Completed	No Results Available	"Health Knowledge, Attitudes, Practice"	Other: Prediction Market	Not Applicable	Interventional	"National University of Singapore, Singapore, Singapore"	https://ClinicalTrials.gov/show/NCT04410692
1065	NCT04361526	Pilot Study on Cytokine Filtration in COVID-19 ARDS	Recruiting	No Results Available	Coronavirus Infection|Acute Respiratory Distress Syndrome|COVID	Device: Cytokine Adsorption	Not Applicable	Interventional	"Hospital Clínic de Barcelona, Barcelona, Spain"	https://ClinicalTrials.gov/show/NCT04361526
1066	NCT04395807	Helmet CPAP Versus HFNC in COVID-19	Recruiting	No Results Available	COVID|Acute Hypoxemic Respiratory Failure	Device: Helmet CPAP|Device: HFNC	Not Applicable	Interventional	"Helsingborg's Hospital, Helsingborg, Region Skane, Sweden"	https://ClinicalTrials.gov/show/NCT04395807
1067	NCT04363840	"The LEAD COVID-19 Trial: Low-risk, Early Aspirin and Vitamin D to Reduce COVID-19 Hospitalizations"	Not yet recruiting	No Results Available	COVID|Vitamin D Deficiency|Coagulopathy|Disseminated Intravascular Coagulation	Drug: Aspirin 81 mg|Dietary Supplement: Vitamin D	Phase 2	Interventional		https://ClinicalTrials.gov/show/NCT04363840
1068	NCT04404218	The Açaí Berry COVID-19 Anti-Inflammation Trial	Not yet recruiting	No Results Available	COVID	Dietary Supplement: Açaí palm berry extract - natural product|Other: Placebo	Phase 2	Interventional		https://ClinicalTrials.gov/show/NCT04404218
1069	NCT04425031	Handling Oxygenation Targets in COVID-19	Not yet recruiting	No Results Available	Hypoxemic Respiratory Failure|Oxygen Toxicity	Drug: Oxygen	Phase 4	Interventional	"Dept. of Intensive Care, Aalborg University Hospital, Aalborg, Denmark"	https://ClinicalTrials.gov/show/NCT04425031
1070	NCT04306055	Blood Donor Recruitment During Epidemic of COVID-19	Completed	No Results Available	Blood Donation	Other: Questionnaire with precaution information|Other: Experimental: Questionnaire without precaution information	Not Applicable	Interventional	"Guangzhou Blood Center, Guangzhou, Guangdong, China"	https://ClinicalTrials.gov/show/NCT04306055
1071	NCT03808922	Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study	Recruiting	No Results Available	Lower Respiratory Tract Infection|Parainfluenza|Immunocompromised|COVID-19	Drug: DAS181|Drug: Placebo|Drug: DAS181 COVID-19|Drug: DAS181 OL	Phase 3	Interventional	"City of Hope cancer Center, Duarte, California, United States|UCLA, Los Angeles, California, United States|Children's Hospital Colorado, Aurora, Colorado, United States|Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, United States|University of Chicago, Chicago, Illinois, United States|Loyola University Medical Center, Maywood, Illinois, United States|University of Kansas Medical Center, Fairway, Kansas, United States|Brigham and Women's Hospital, Boston, Massachusetts, United States|Washington University, Saint Louis, Missouri, United States|University of Nebraska Medical Center, Omaha, Nebraska, United States|Duke University, Durham, North Carolina, United States|Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States|Oregon Health & Science University, Portland, Oregon, United States|University of Pennsylvania, Philadelphia, Pennsylvania, United States|University of Pittsburgh Medical Center Health System, Pittsburgh, Pennsylvania, United States|Vanderbilt University Medical Center, Nashville, Tennessee, United States|Cook Children's, Fort Worth, Texas, United States|MD Anderson, Houston, Texas, United States|VCU Health System, Richmond, Virginia, United States|Seattle Children's Hospital, Seattle, Washington, United States|Fred Hutchinson Cancer Research Center, Seattle, Washington, United States|Medical College of Wisconsin, Milwaukee, Wisconsin, United States|Westmead Hospital, Sydney, New South Wales, Australia|The Wesley Hospital, Brisbane, Queensland, Australia|Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia|Royal Melbourne Hospital, Melbourne, Victoria, Australia|Seoul National University Bundang Hospital, Seongnam-si, Guenoggi-do, Korea, Republic of|Samsung Medical Center, Gangnam-gu, Seoul, Korea, Republic of|Seoul National University Hospital, Jongno-gu, Seoul, Korea, Republic of|The Catholic University of Korea, Seoul St. Mary's Hospital, Seocho-gu, Seoul, Korea, Republic of|Asan Medical Center, Songpa-gu, Seoul, Korea, Republic of|National Taiwan University Hospital, Zhongzheng Dist., Taipei City, Taiwan"	https://ClinicalTrials.gov/show/NCT03808922
1072	NCT04357613	IMATINIB IN COVID-19 DISEASE IN AGED PATIENTS.	Not yet recruiting	No Results Available	SARS Virus	Drug: Experimental drug	Phase 2	Interventional	"CHU Bordeaux, Bordeaux, France|CH de Versailles, Le Chesnay, France"	https://ClinicalTrials.gov/show/NCT04357613
1073	NCT04340414	Safety and Effectiveness of Low-flow ECMO Driving by CVVH Machine in Severe NCP	Recruiting	No Results Available	COVID-19|ECMO	Device: Low flow ECMO driving by CVVH machine	Not Applicable	Interventional	"Yun Long, Beijing, Beijing, China"	https://ClinicalTrials.gov/show/NCT04340414
1074	NCT04337008	Renin Angiotensin System - CoronaVirus	Recruiting	No Results Available	COVID 19	Other: blood draw	Not Applicable	Interventional	"ASSISTANCE PUBLIQUE HÖPITAUX de MARSEILLE, Marseille, France"	https://ClinicalTrials.gov/show/NCT04337008
1075	NCT04293887	Efficacy and Safety of IFN-α2β in the Treatment of Novel Coronavirus Patients	Not yet recruiting	No Results Available	COVID-19|Recombinant Human Interferon α1β	Drug: Recombinant human interferon α1β	Early Phase 1	Interventional		https://ClinicalTrials.gov/show/NCT04293887
1076	NCT04370886	Recruit Blood Donors Via SMS During Epidemic of COVID-19	Completed	No Results Available	Blood Donation	Behavioral: blood donation SMS	Not Applicable	Interventional	"Guangzhou Blood Center, Guangzhou, Guangdong, China"	https://ClinicalTrials.gov/show/NCT04370886
1077	NCT04386291	Meditation and Kundalini Yoga for Heightened Anxiety Related to COVID-19	Recruiting	No Results Available	Generalized Anxiety|Health Anxiety	Behavioral: Anxiety Reduction Training|Behavioral: Kundalini Yoga and Anxiety Reduction Training|Behavioral: Meditation and Anxiety Reduction Training	Not Applicable	Interventional	"ProofPilot (Virtual Study: https://proofpilot.com/covid-anxiety/), New York, New York, United States|Columbia University Department of Psychiatry, New York, New York, United States"	https://ClinicalTrials.gov/show/NCT04386291
1078	NCT04408287	Improving Activity Engagement Among Persons With SCI During COVID-19	Not yet recruiting	No Results Available	Spinal Cord Injuries	Other: WebEx Physical Activity Program	Not Applicable	Interventional	"St. Josephs Parkwood Institute, London, Ontario, Canada"	https://ClinicalTrials.gov/show/NCT04408287
1079	NCT04371523	Hydroxychloroquine to Prevent COVID-19 Disease Amongst Healthcare Workers	Not yet recruiting	No Results Available	Corona Virus Infection	Drug: Apo-Hydroxychloroquine|Drug: Matched Placebo	Phase 3	Interventional	"St. Joseph's Healthcare Hamilton, Hamilton, Ontario, Canada"	https://ClinicalTrials.gov/show/NCT04371523
1080	NCT04333654	Hydroxychloroquine in Outpatient Adults With COVID-19	Suspended	No Results Available	Coronavirus Infection	Drug: Hydroxychloroquine SAR321068|Drug: Placebo	Phase 1	Interventional	"Investigational Site Number 8400001, Boston, Massachusetts, United States|Investigational Site Number 0561001, Bruxelles, Belgium|Investigational Site Number 0561002, Lodelinsart, Belgium|Investigational Site Number 2501001, Bordeaux Cedex, France|Investigational Site Number 2501002, Paris, France|Investigational Site Number 5281001, Groningen, Netherlands|Investigational Site Number 5281002, Harderwijk, Netherlands"	https://ClinicalTrials.gov/show/NCT04333654
1081	NCT04359901	Sarilumab for Patients With Moderate COVID-19 Disease	Recruiting	No Results Available	COVID	Biological: SARILUMAB	Phase 2	Interventional	"VA Boston Healthcare System, Boston, Massachusetts, United States"	https://ClinicalTrials.gov/show/NCT04359901
1082	NCT04408040	Use of Convalescent Plasma for COVID-19	Not yet recruiting	No Results Available	COVID	Biological: Convalescent Plasma	Phase 2	Interventional	"Northside Hospital, Atlanta, Georgia, United States"	https://ClinicalTrials.gov/show/NCT04408040
1083	NCT04431297	Virtual Mindfulness Rounds in the Time of COVID-19 Pandemic	Not yet recruiting	No Results Available	Chronic Stress	Other: Mindfulness Rounds	Not Applicable	Interventional	"Icahn School of Medicine at Mount Sinai, New York, New York, United States"	https://ClinicalTrials.gov/show/NCT04431297
1084	NCT04420806	Effects of COVID-19 Lockdown in Exercising Early Postmenopausal Women	"Active, not recruiting"	No Results Available	Exercise|Detraining|Muscle Weakness|Muscle Atrophy	Other: HIT-exercise|Other: Sham intervention	Not Applicable	Interventional	"Institute of Medical Physics, Friedrich-Alexanden University Erlangen-Nürnberg, Erlangen, Germany"	https://ClinicalTrials.gov/show/NCT04420806
1085	NCT04405544	Determination of Acute Encephalopathy Predictors in Patients With COVID-19	Recruiting	No Results Available	Encephalopathy|COVID	Diagnostic Test: CT-scan|Diagnostic Test: EEG|Diagnostic Test: EP|Diagnostic Test: Pulse oximetry|Diagnostic Test: Blood tests	Not Applicable	Interventional	"N.I. Pirogov National Medical and Surgical Center, Moscow, Russian Federation"	https://ClinicalTrials.gov/show/NCT04405544
1086	NCT04424082	External Dead Space in Ventilated COVID-19 Patients	Recruiting	No Results Available	"Coronavirus|ARDS, Human"	Other: Removal of dead space filter	Not Applicable	Interventional	"Karolinska University Hospital, Stockholm, Sweden"	https://ClinicalTrials.gov/show/NCT04424082
1087	NCT04346420	Impact of the Double-Trunk Mask on Oxygenation Titration in COVID-19	Completed	No Results Available	COVID|Hypoxemia	Other: Standard interface|Device: Double-Trunk Mask	Not Applicable	Interventional	"Cliniques universitaires Saint-Luc, Brussels, Brussels Capital, Belgium"	https://ClinicalTrials.gov/show/NCT04346420
1088	NCT04296643	Medical Masks vs N95 Respirators for COVID-19	Not yet recruiting	No Results Available	Coronavirus|N95|Medical Mask	Device: Medical Mask|Device: N95 respirator	Not Applicable	Interventional		https://ClinicalTrials.gov/show/NCT04296643
1089	NCT04425915	Efficacy of Convalescent Plasma Therapy in Patients With COVID-19	Recruiting	No Results Available	COVID	Biological: Convalescent Plasma|Other: Standard of Care	Phase 3	Interventional	"Maulana Azad Medical College, New Delhi, Delhi, India|Institute of Liver & Biliary Sciences, New Delhi, Delhi, India|Rajiv Gandhi Super Speciality Hospital, New Delhi, Delhi, India"	https://ClinicalTrials.gov/show/NCT04425915
1090	NCT04351347	The Efficacy of Ivermectin and Nitazoxanide in COVID-19 Treatment	Recruiting	No Results Available	COVID	Drug: Ivermectin|Drug: Nitazoxanide with ivermectin|Drug: Ivermectin wth chloroquine	Phase 2|Phase 3	Interventional	"Tanta University, Tanta, Egypt"	https://ClinicalTrials.gov/show/NCT04351347
1091	NCT04344561	Incline Positioning in COVID-19 Patients for Improvement in Oxygen Saturation	Recruiting	No Results Available	COVID|Hypoxic Respiratory Failure	Other: Postural Positioning	Not Applicable	Interventional	"Johns Hopkins Bayview Hospital, Baltimore, Maryland, United States|Johns Hopkins Hospital, Baltimore, Maryland, United States"	https://ClinicalTrials.gov/show/NCT04344561
1092	NCT04399681	The Utility of Bedside Lung Ultrasonography on Diagnosis of COVID-19	Recruiting	No Results Available	"COVID|Pneumonia, Viral"	Device: Bedside lung ultrasound	Not Applicable	Interventional	"Istanbul Kanuni Sultan Suleyman Training and Research Hospital, Istanbul, Turkey"	https://ClinicalTrials.gov/show/NCT04399681
1093	NCT04406246	Prevention of Coronavirus Disease (COVID-19) Outbreaks With Nitazoxanide	Recruiting	No Results Available	Coronavirus Infection	Drug: Nitazoxanide 500Mg Oral Tablet	Phase 4	Interventional	"Materno-Perinatal Hospital ""Mónica Pretelini"", Toluca, Mexico"	https://ClinicalTrials.gov/show/NCT04406246
1094	NCT04409886	Hyperbaric Oxygen Therapy in Non-ventilated COVID-19 Patients	Not yet recruiting	No Results Available	"COVID, Coronavirus"	Device: Hyperbaric Chamber	Not Applicable	Interventional		https://ClinicalTrials.gov/show/NCT04409886
1095	NCT04452799	Hesperidin and Diosmin for Treatment of COVID-19	Not yet recruiting	No Results Available	Coronavirus Infection	Drug: Hesperidin and Diosmin mixture	Early Phase 1	Interventional		https://ClinicalTrials.gov/show/NCT04452799
1096	NCT04428073	Therapeutic Vaccine Trial of COVID-19 for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection	Not yet recruiting	No Results Available	COVID	Biological: Covax-19™	Phase 1	Interventional		https://ClinicalTrials.gov/show/NCT04428073
1097	NCT04366947	Intravascular Access in Suspected/Confirmed COVID-19 Patient	"Active, not recruiting"	No Results Available	Emergency Medicine|Cardiopulmonary Arrest|Shock	Device: NIO® (Intraosseous access)|Device: Standard of Care (Intravenous access)	Not Applicable	Interventional	"Lazarsku University, Warsaw, Masovian, Poland"	https://ClinicalTrials.gov/show/NCT04366947
1098	NCT04348461	BAttLe Against COVID-19 Using MesenchYmal Stromal Cells	Not yet recruiting	No Results Available	COVID|Respiratory Distress Syndrome	Drug: Allogeneic and expanded adipose tissue-derived mesenchymal stromal cells	Phase 2	Interventional		https://ClinicalTrials.gov/show/NCT04348461
1099	NCT04377100	Impact on Anxiety and Motivation of COVID-19 and Predictors of Individual Responses	Not yet recruiting	No Results Available	Anxiety|Healthy Volunteers	Behavioral: Computer task questionnaires	Not Applicable	Interventional	"National Institute of Mental Health (NIMH), Bethesda, Maryland, United States"	https://ClinicalTrials.gov/show/NCT04377100
1100	NCT04447534	Zinc With Chloroquine/Hydroxychloroquine in Treatment of COVID-19	Recruiting	No Results Available	COVID	Drug: Chloroquine|Drug: zinc	Phase 3	Interventional	"Tanta university hospital, Tanta, Egypt"	https://ClinicalTrials.gov/show/NCT04447534
1101	NCT04410458	Recruit Blood Donors Via SMS During Epidemic of COVID-19 （Repeat Trial）	Enrolling by invitation	No Results Available	Blood Donation	Behavioral: blood donation SMS	Not Applicable	Interventional	"Guangzhou Blood Center, Guangzhou, Guangdong, China"	https://ClinicalTrials.gov/show/NCT04410458
1102	NCT04290871	Nitric Oxide Gas Inhalation for Severe Acute Respiratory Syndrome in COVID-19.	Withdrawn	No Results Available	Coronavirus|SARS (Severe Acute Respiratory Syndrome)	Drug: Nitric Oxide Gas	Phase 2	Interventional		https://ClinicalTrials.gov/show/NCT04290871
1103	NCT04391140	Prone Positioning and High-flow Nasal Cannula in COVID-19 Induced ARDS	Recruiting	No Results Available	COVID|ARDS|Acute Respiratory Distress Syndrome|Acute Respiratory Failure|Corona Virus Infection	Other: Prone position	Not Applicable	Interventional	"Hospital Universitari Vall d'Hebron, Barcelona, Spain"	https://ClinicalTrials.gov/show/NCT04391140
1104	NCT04341493	Hydroxychloroquine vs Nitazoxanide in Patients With COVID-19	Recruiting	No Results Available	Coronavirus Infection	Drug: Nitazoxanide 500 MG|Drug: Hydroxychloroquine	Phase 4	Interventional	"Materno-Perinatal Hospital ""Mónica Pretelini"", Toluca, Mexico"	https://ClinicalTrials.gov/show/NCT04341493
1105	NCT04315480	Tocilizumab for SARS-CoV2 (COVID-19) Severe Pneumonitis	"Active, not recruiting"	No Results Available	SARS Pneumonia	Drug: Tocilizumab	Phase 2	Interventional	"Università Politecnica delle Marche, Ancona, AN, Italy"	https://ClinicalTrials.gov/show/NCT04315480
1106	NCT04431180	Recruit Blood Donors Via SMS During Epidemic of COVID-19 #Second Repeat Trial#	Enrolling by invitation	No Results Available	Blood Donation	Behavioral: blood donation SMS	Not Applicable	Interventional	"Guangzhou Blood Center, Guangzhou, Guangdong, China"	https://ClinicalTrials.gov/show/NCT04431180
1107	NCT04425499	A Gamified Network for Surgical Education During COVID-19: A Randomized Controlled Trial	Not yet recruiting	No Results Available	Advanced Suturing Skills|Surgical Education	Other: Learning running subcuticular sutures on the Gamified Educational Network	Not Applicable	Interventional		https://ClinicalTrials.gov/show/NCT04425499
1108	NCT04399746	Ivermectin-Azithromycin-Cholecalciferol (IvAzCol) Combination Therapy for COVID-19	Recruiting	No Results Available	COVID	Drug: Ivermectin|Drug: Azithromycin|Drug: Cholecalciferol	Not Applicable	Interventional	"Outpatient treatment, Mexico City, Mexico"	https://ClinicalTrials.gov/show/NCT04399746
1109	NCT04451239	Topical Steroids and Cyclosporin-A for COVID-19 Keratoconjunctivitis	Not yet recruiting	No Results Available	Keratonjunctivitis	Drug: topical steroids and cyclosporin-A	Not Applicable	Interventional	"Farawanyia hospital, Kuwait, Farawanyia, Kuwait"	https://ClinicalTrials.gov/show/NCT04451239
1110	NCT04417270	Reliability of the Freestyle Libre CGM in the Inpatient Setting During the COVID-19 Surge	Not yet recruiting	No Results Available	Diabetes Mellitus	Device: Freestyle Libre 14 day CGM system|Device: Accuchek Inform II platform	Not Applicable	Interventional		https://ClinicalTrials.gov/show/NCT04417270
1111	NCT04453514	Feasibility of a Brief Trauma-informed Yoga Intervention for Anxiety During the Coronavirus Disease (COVID-19) Pandemic	Not yet recruiting	No Results Available	Anxiety	Behavioral: Trauma-informed yoga video recording	Not Applicable	Interventional	"National University of Natural Medicine, Portland, Oregon, United States"	https://ClinicalTrials.gov/show/NCT04453514
1112	NCT04362059	A Clinical Trial of Nebulized Surfactant for the Treatment of Moderate to Severe COVID-19	Not yet recruiting	No Results Available	Respiratory Infections	Device: COVSurf Drug Delivery System|Other: Standard of Care	Not Applicable	Interventional		https://ClinicalTrials.gov/show/NCT04362059
1113	NCT04401644	COVID-19: Laser Interferometry for Rapid Single Coronavirus Detection	Not yet recruiting	No Results Available	Diagnoses Disease|Coronavirus	Diagnostic Test: Novel laser inferometry test for CORONA virus	Not Applicable	Interventional	"Somerset NHS Foundation Trust, Taunton, Somerset, United Kingdom"	https://ClinicalTrials.gov/show/NCT04401644
1114	NCT04346446	Efficacy of Convalescent Plasma Therapy in Severely Sick COVID-19 Patients	Completed	No Results Available	COVID	Drug: Convalescent Plasma Transfusion|Other: Supportive Care|Drug: Random Donor Plasma	Phase 2	Interventional	"Maulana Azad medical College, New Delhi, Delhi, India|Institute of Liver and Biliary Sciences, New Delhi, Delhi, India"	https://ClinicalTrials.gov/show/NCT04346446
1115	NCT04445467	An Adaptive Randomised Placebo Controlled Phase II Trial of Antivirals for COVID-19 Infection	Not yet recruiting	No Results Available	COVID	Drug: Favipiravir	Phase 2	Interventional		https://ClinicalTrials.gov/show/NCT04445467
1116	NCT04420260	Primary Prevention of Infection by COVID-19 in Health Providers	Not yet recruiting	No Results Available	COVID	Dietary Supplement: Group A: oropharygeal spray and immunostimulant|Dietary Supplement: Group B: Placebo oropharyngeal spray + Active principle immunostimulant|Dietary Supplement: Group C:Active principle oropharyngeal spray + Placebo taken PO|Dietary Supplement: Group D:Placebo oropharyngeal spray + Placebo taken PO	Not Applicable	Interventional		https://ClinicalTrials.gov/show/NCT04420260
1117	NCT04399798	Baricitinib for coRona Virus pnEumonia (COVID-19): a THerapeutic Trial	Not yet recruiting	No Results Available	Corona Virus Infection	Drug: Baricitinib	Phase 2	Interventional		https://ClinicalTrials.gov/show/NCT04399798
1118	NCT04423289	Telematic Monitoring Through a Mobile Application of Patients With COVID-19	Completed	No Results Available	Face-to-face Reconsultation to Emergency Room	Other: Farmalarm	Not Applicable	Interventional	"Vall d'Hebron Hospital Universitari, Barcelona, Spain"	https://ClinicalTrials.gov/show/NCT04423289
1119	NCT04416308	COVID 19 : Seroprevalence Study of Anti SRAS-CoV-2 Antibodies in GHT Employees in Haute Bretagne (AntiCoV-HB)	Recruiting	No Results Available	Coronavirus	Diagnostic Test: NG test|Diagnostic Test: Blood test|Behavioral: Self-questionnary	Not Applicable	Interventional	"Chu Rennes, Rennes, France"	https://ClinicalTrials.gov/show/NCT04416308
1120	NCT04363437	COlchicine in Moderate-severe Hospitalized Patients Before ARDS to Treat COVID-19	Recruiting	No Results Available	Coronavirus Infection	Drug: Colchicine|Drug: Usual Care	Phase 2	Interventional	"Maimonides Medical Center, Brooklyn, New York, United States"	https://ClinicalTrials.gov/show/NCT04363437
1121	NCT04365582	OUTpatient Treatment of COVID-19 in Patients With Risk Factor for Poor Outcome	Recruiting	No Results Available	COVID	Drug: Azithromycin|Drug: Hydroxychloroquine|Drug: Lopinavir 200Mg/Ritonavir 50Mg Tab	Phase 3	Interventional	"Hôpital Privé d'Antony, Antony, France|Hôpital Avicenne, Bobigny, France|Centre Hospitalier Intercommunal de Créteil, Créteil, France|Groupe Hospitalier Paris Saint-Joseph, Paris, France|Institut Mutualiste Montsouris, Paris, France"	https://ClinicalTrials.gov/show/NCT04365582
1122	NCT04325906	Early PP With HFNC Versus HFNC in COVID-19 Induced Moderate to Severe ARDS	Recruiting	No Results Available	Prone Positioning|High Flow Nasal Cannula|Acute Respiratory Distress Syndrome|Corona Virus Infection	Device: high flow nasal cannula (HFNC)|Procedure: Prone positioning (PP)	Not Applicable	Interventional	"Rush University Medical Center, Chicago, Illinois, United States"	https://ClinicalTrials.gov/show/NCT04325906
1123	NCT04346589	Convalescent Antibodies Infusion in Critically Ill COVID 19 Patients	Recruiting	No Results Available	"Pneumonia, Ventilator-Associated|Coronavirus Infection"	Biological: Anti-coronavirus antibodies (immunoglobulins)obtained with DFPP from convalescent patients	Not Applicable	Interventional	"IRFMN - Clinical Research Center for Rare Diseases, Ranica, BG, Italy|ASST HPG23 - Unit of Nephrology, Bergamo, Italy|ASST Papa Giovanni XXIII - Microbiology and Virology Unit, Bergamo, Italy|Asst Pg23 - S.I.M.T, Bergamo, Italy|ASST-PG23 - Intensive Care Unit, Bergamo, Italy"	https://ClinicalTrials.gov/show/NCT04346589
1124	NCT04448769	Epidemiological Study of Seroprevalence Against the SARS-CoV-2 Virus (COVID-19)	Not yet recruiting	No Results Available	Coronavirus Infection|Prevalence	Biological: Anti-SARS-CoV-2 IgT seropositivity	Not Applicable	Interventional		https://ClinicalTrials.gov/show/NCT04448769
1125	NCT04384965	Accelerated iTBS for Depressed Patients During the COVID-19 Pandemic	Recruiting	No Results Available	Major Depressive Disorder	"Device: MagPro X100 Stimulator, B70 Fluid-Cooled Coil"	Not Applicable	Interventional	"CAMH, Toronto, Ontario, Canada"	https://ClinicalTrials.gov/show/NCT04384965
1126	NCT04410016	Evaluation of Staff COVID-19 Wellbeing Centres in a Healthcare Workplace: COVID-WELL Study	Recruiting	No Results Available	Mental Health Wellness 1	Other: Staff Wellbeing Centres	Not Applicable	Interventional	"Nottingham University Hospitals NHS Trust, Nottingham, Nottinghamshire, United Kingdom"	https://ClinicalTrials.gov/show/NCT04410016
1127	NCT04327388	Sarilumab COVID-19	Recruiting	No Results Available	Corona Virus Infection	Drug: Sarilumab SAR153191|Drug: Placebo	Phase 3	Interventional	"Investigational Site Number 0320001, Caba, Argentina|Investigational Site Number 0320003, Caba, Argentina|Investigational Site Number 0760003, Porto Alegre, Brazil|Investigational Site Number 0760001, Sao Paulo, Brazil|Investigational Site Number 0760002, Sao Paulo, Brazil|Investigational Site Number 0760004, São José Do Rio Preto, Brazil|Investigational Site Number 0760005, São Paulo, Brazil|Investigational Site Number 1240001, Montreal, Canada|Investigational Site Number 1240005, Montreal, Canada|Investigational Site Number 1240004, Toronto, Canada|Investigational Site Number 1240002, Toronto, Canada|Investigational Site Number 1240003, Vancouver, Canada|Investigational Site Number 1520003, Santiago, Chile|Investigational Site Number 1520002, Santiago, Chile|Investigational Site Number 1520004, Santiago, Chile|Investigational Site Number 1520001, Talca, Chile|Investigational Site Number 2500001, Bordeaux Cedex, France|Investigational Site Number 2500007, Clamart, France|Investigational Site Number 2500006, La Roche Sur Yon Cedex 9, France|Investigational Site Number 2500002, Nantes, France|Investigational Site Number 2500005, Paris Cedex 18, France|Investigational Site Number 2500003, Strasbourg, France|Investigational Site Number 2500004, Suresnes, France|Investigational Site Number 2760003, Bonn, Germany|Investigational Site Number 2760006, Braunschweig, Germany|Investigational Site Number 2760002, Essen, Germany|Investigational Site Number 2760004, Köln, Germany|Investigational Site Number 2760001, Münster, Germany|Investigational Site Number 3760003, Ashdod, Israel|Investigational Site Number 3760002, Jerusalem, Israel|Investigational Site Number 3760001, Ramat Gan, Israel|Investigational Site Number 3800005, Milano, Italy|Investigational Site Number 3800001, Milano, Italy|Investigational Site Number 3800002, Milano, Italy|Investigational Site Number 3800003, Modena, Italy|Investigational Site Number 3800004, Parma, Italy|Investigational Site Number 3800006, Rozzano, Italy|Investigational Site Number 3920002, Fuchu-Shi, Japan|Investigational Site Number 3920003, Iruma-Gun, Japan|Investigational Site Number 3920001, Kamakura-Shi, Japan|Investigational Site Number 6430003, Moscow, Russian Federation|Investigational Site Number 6430002, Moscow, Russian Federation|Investigational Site Number 6430001, Moscow, Russian Federation|Investigational Site Number 7240003, Barcelona, Spain|Investigational Site Number 7240004, Barcelona, Spain|Investigational Site Number 7240002, Madrid / Madrid, Spain|Investigational Site Number 7240005, Madrid, Spain|Investigational Site Number 7240001, Madrid, Spain"	https://ClinicalTrials.gov/show/NCT04327388
1128	NCT04456062	Using Caring Contacts to Reduce Psychiatric Morbidity Following Hospitalization During the COVID-19 Pandemic	Not yet recruiting	No Results Available	Psychiatric Hospitalization	Other: Caring Contacts	Not Applicable	Interventional		https://ClinicalTrials.gov/show/NCT04456062
1129	NCT04344535	Convalescent Plasma vs. Standard Plasma for COVID-19	Enrolling by invitation	No Results Available	COVID	Biological: Convalescent Plasma|Biological: Standard Donor Plasma	Phase 1|Phase 2	Interventional	"Stony Brook University Hospital, Stony Brook, New York, United States"	https://ClinicalTrials.gov/show/NCT04344535
1130	NCT04338906	Combination Therapy With Camostat Mesilate + Hydroxychloroquine for COVID-19	Not yet recruiting	No Results Available	COVID	Drug: Camostat Mesilate|Drug: Placebo|Drug: Hydroxychloroquine	Phase 4	Interventional		https://ClinicalTrials.gov/show/NCT04338906
1131	NCT04325893	Hydroxychloroquine Versus Placebo in COVID-19 Patients at Risk for Severe Disease	Recruiting	No Results Available	Coronavirus	Drug: Hydroxychloroquine|Drug: Placebo	Phase 3	Interventional	"CH Agen, Agen, France|CHU Amiens, Amiens, France|CHU Angers, Angers, France|CH Auxerre, Auxerre, France|APHP Avicenne, Bobigny, France|CHU Brest, Brest, France|CHU Caen, Caen, France|CH Chalon Sur Saône, Chalon Sur Saône, France|CH Cherbroug, Cherbourg, France|CH Cholet, Cholet, France|CH Colmar, Colmar, France|CH Compiègne, Compiègne, France|APHP Henri Mondor, Créteil, France|CH Intercommunal Créteil, Créteil, France|CHU Dijon, Dijon, France|APHP Joffre Dupuytren, Draveil, France|CHD Vendée, La Roche-sur-Yon, France|CH Laval, Laval, France|CH Le Mans, Le Mans, France|CH Emile Roux, Le Puy-en-Velay, France|APHP Emile ROUX, Limeil-Brevannes, France|CHU Limoges, Limoges, France|CH Lorient, Lorient, France|Hôpital Européen - Marseille, Marseille, France|Hôpital Saint-Joseph, Marseille, France|CH Melun, Melun, France|CHU Nantes, Nantes, France|Hôpital Privé du Confluent, Nantes, France|CH Niort, Niort, France|CHR Orléans, Orléans, France|APHP Saint-Antoine, Paris, France|GH Croix Saint Simon, Paris, France|La Pitié-Salpétrière, Paris, France|CHU Poitiers, Poitiers, France|CH Pointoise, Pontoise, France|CH Quimper, Quimper, France|CH Saint-Brieuc, Saint-Brieuc, France|CH Saint-Nazaire, Saint-Nazaire, France|CHU Saint-Etienne, Saint-Étienne, France|CHU Toulouse, Toulouse, France|CH Tourcoing, Tourcoing, France|CHU Tours, Tours, France|CH Valenciennes, Valenciennes, France|Clinique Tessier Valenciennes, Valenciennes, France|CH Vannes, Vannes, France|CH Versailles, Versailles, France|CH Princesse Grace, Monaco, Monaco"	https://ClinicalTrials.gov/show/NCT04325893
1132	NCT04371367	"Avdoralimab an Anti-C5aR Antibody, in Patients With COVID-19 Severe Pneumonia ( FORCE )"	Recruiting	No Results Available	COVID	Biological: avdoralimab|Other: Placebo	Phase 2	Interventional	"Assistance Publique Hôpitaux de Marseille, Marseille, France"	https://ClinicalTrials.gov/show/NCT04371367
1133	NCT04427137	Accelerated LFR for Bipolar Patients During the COVID-19 Pandemic	Recruiting	No Results Available	Bipolar Depression	"Device: MagPro X100 Stimulator, B70 Fluid-Cooled Coil"	Not Applicable	Interventional	"CAMH, Toronto, Ontario, Canada"	https://ClinicalTrials.gov/show/NCT04427137
1134	NCT04379518	Rintatolimod and IFN Alpha-2b for the Treatment of Mild or Moderate COVID-19 Infection in Cancer Patients	Not yet recruiting	No Results Available	Malignant Neoplasm|SARS Coronavirus 2 Infection	Biological: Recombinant Interferon Alfa-2b|Drug: Rintatolimod	Phase 1|Phase 2	Interventional	"Roswell Park Cancer Institute, Buffalo, New York, United States"	https://ClinicalTrials.gov/show/NCT04379518
1135	NCT04369456	Blood Biomarkers as Predictors of COVID-19 Disease Progression in Recently Infected Kidney Transplant Patients	Recruiting	No Results Available	Kidney Transplant; Complications|Coronavirus Infection	Other: blood sample	Not Applicable	Interventional	"Lyon Univerity Hospital, Lyon, France|APHM, Marseille, France|Montpellier University Hospital, Montpellier, France|University Nice Hospital, Nice, France|APHP, Paris, France|Saint Etienne University Hospital, Saint-Étienne, France|Strasbourg Univeristy Hospital, Strasbourg, France"	https://ClinicalTrials.gov/show/NCT04369456
1136	NCT04374539	Plasma Exchange in Patients With COVID-19 Disease and Invasive Mechanical Ventilation: a Randomized Controlled Trial	Recruiting	No Results Available	Coronavirus	Biological: Plasma exchange|Drug: Standar medical treatmen	Phase 2	Interventional	"Hospital Clinic i Provincial de Barcelona, Barcelona, Spain"	https://ClinicalTrials.gov/show/NCT04374539
1137	NCT04251871	Treatment and Prevention of Traditional Chinese Medicines (TCMs) on COVID-19 Infection	Recruiting	No Results Available	Pneumonia Caused by Human Coronavirus (Disorder)	"Drug: Conventional medicines (Oxygen therapy, alfa interferon via aerosol inhalation, and lopinavir/ritonavir) and Traditional Chinese Medicines (TCMs) granules|Drug: Conventional medicines (Oxygen therapy, alfa interferon via aerosol inhalation, and lopinavir/ritonavir)"	Not Applicable	Interventional	"The Fifth Medical Center, General Hospital of PLA, Beijing, Beijing, China"	https://ClinicalTrials.gov/show/NCT04251871
1138	NCT04346082	Feasibility of Online Based Mindfulness Interventions During COVID-19 Outbreak	Not yet recruiting	No Results Available	Stress	Behavioral: online mindfulness group	Not Applicable	Interventional	"School of public health and primary care, Hong Kong, Hong Kong"	https://ClinicalTrials.gov/show/NCT04346082
1139	NCT04326114	Effectiveness and Safety of Respiratory Training in the Prevention and Severity of COVID-19	Not yet recruiting	No Results Available	"Disease, Infectious|Respiratory Disease|Safety Issues|Effectiveness"	Device: Inspiratory training device|Device: Expiratory training device	Not Applicable	Interventional		https://ClinicalTrials.gov/show/NCT04326114
1140	NCT04420364	Maintenance Versus Reduction of Immunosuppression for Renal Transplant Patients Hospitalized With COVID-19 Disease	Not yet recruiting	No Results Available	COVID|Kidney Transplant; Complications|Immunosuppression	Other: Maintenance or reduction of immunosuppression	Phase 2|Phase 3	Interventional		https://ClinicalTrials.gov/show/NCT04420364
1141	NCT04361253	Evaluation of SARS-CoV-2 (COVID-19) Antibody-containing Plasma thErapy	Recruiting	No Results Available	COVID|Infectious Disease	Biological: High-Titer COVID-19 Convalescent Plasma (HT-CCP)|Biological: Standard Plasma (FFP)	Phase 3	Interventional	"Brigham and Women's Hospital, Boston, Massachusetts, United States"	https://ClinicalTrials.gov/show/NCT04361253
1142	NCT04441424	Convalescent Plasma Therapy on Critically-ill Novel Coronavirus (COVID-19) Patients	Completed	No Results Available	IMMUNOTHERAPY	Biological: Convalescent plasma|Drug: Hydroxychloroquin with Azithromycin	Not Applicable	Interventional	"Akarkh Healt hdirectorate, Baghdad, Iraq"	https://ClinicalTrials.gov/show/NCT04441424
1143	NCT04389333	Feasibility of Non-contact Magnetically-controlled Capsule Endoscopy During COVID-19 Pandemic	Recruiting	No Results Available	Gastrointestinal Disease|Infectious Disease|Capsule Endoscopy	Device: non-contact magnetically-controlled capsule endoscopy	Not Applicable	Interventional	"Changhai Hospital, Shanghai, Shanghai, China"	https://ClinicalTrials.gov/show/NCT04389333
1144	NCT04367545	Development of a Molecular Diagnostic Strategy for SARS-CoV2 Based on Saliva in the Context of the COVID-19 Pandemic	Recruiting	No Results Available	COVID|RT-ddPCR Multiplex	Diagnostic Test: Saliva collection	Not Applicable	Interventional	"Rouen University Hospital, Rouen, France"	https://ClinicalTrials.gov/show/NCT04367545
1145	NCT04382131	Hypertonic Saline Nasal Irrigation and Gargling in Suspected or Confirmed COVID-19	Not yet recruiting	No Results Available	Upper Respiratory Tract Infections|Virus|COVID|Virus Shedding|Virus Diseases	Other: NaCl Solution	Not Applicable	Interventional	"NHS Lothian, Edinburgh, United Kingdom"	https://ClinicalTrials.gov/show/NCT04382131
1146	NCT04425317	Detection of SARS-CoV-2 in Follicular Fluid and Cumulus-oocyte-complexes in COVID-19 Patients	Not yet recruiting	No Results Available	Infertility|COVID|IVF	Diagnostic Test: Blood sample	Not Applicable	Interventional		https://ClinicalTrials.gov/show/NCT04425317
1147	NCT04367636	The Effects of Attention Training on Emotion Regulation and Stress Related Complaints During COVID-19	Not yet recruiting	No Results Available	Rumination|Anxiety|Stress|Depressive Symptoms	Behavioral: Behavioral: OCAT-sham|Behavioral: Behavioral: OCAT|Other: psycho-education video	Not Applicable	Interventional	"Ghent University, Gent, Oost-Vlaanderen, Belgium"	https://ClinicalTrials.gov/show/NCT04367636
1148	NCT04394013	A Web-Based Gentle Body Stretching to Alleviate Loneliness and Improve Mental Fitness During COVID-19 Isolation Period	Not yet recruiting	No Results Available	Mental Health Issue	Behavioral: Mindfulness intervention|Behavioral: Non-Mindfulness intervention	Not Applicable	Interventional	"Monash University Malaysia, Bandar Sunway, Selangor, Malaysia"	https://ClinicalTrials.gov/show/NCT04394013
1149	NCT04322123	Safety and Efficacy of Hydroxychloroquine Associated With Azithromycin in SARS-Cov-2 Virus (COVID-19)	"Active, not recruiting"	No Results Available	Coronavirus Infections	Drug: Hydroxychloroquine Oral Product|Drug: Hydroxychloroquine + azithromycin	Phase 3	Interventional	"Hospital Geral Clériston Andrade, Feira De Santana, BA, Brazil|Hospital Ana Nery - HAN/SESAB, Salvador, BA, Brazil|HHospital SAMUR, Vitória Da Conquista, BA, Brazil|Hospital Geral de Vitória da Conquista, Vitória Da Conquista, BA, Brazil|Hospital de Brasília, Brasilia, DF, Brazil|Instituto de Cardiologia do Distrito Federal, Brasília, DF, Brazil|Hospital Maternidade São José - UNESC - Fundação Social Rural de Colatina, Colatina, ES, Brazil|Hospital Vila da Serra, Nova Lima, MG, Brazil|Santa Casa de Misericórdia de São João Del Rei, São João Del Rei, MG, Brazil|Associação Evangélica Beneficente de Londrina - Hospital Evangélico de Londrina, Londrina, PR, Brazil|Instituto Estadual do Cérebro Paulo Niemeyer, Rio De Janeiro, RJ, Brazil|Hospital Geral de Caxias do Sul, Caxias do Sul, RS, Brazil|Hospital Santa Rita - Irmandade Santa Casa de Porto Alegre, Porto Alegre, RS, Brazil|Hospital São Francisco - Irmandade Santa Casa de Porto Alegre, Porto Alegre, RS, Brazil|Hospital São José, Criciuma, SC, Brazil|Hospital Baía Sul - Baía Sul Medical Center, Florianópolis, SC, Brazil|Hospital Nereu Ramos, Florianópolis, Sc, Brazil|Centro Hospitalar Unimed, Joinville, SC, Brazil|Hospital de Amor - Unidade Barretos (Fundação PIO XII), Barretos, SP, Brazil|Casa de Saúde Santa Marcelina, São Paulo, SP, Brazil|Hospital Albert Einstein, São Paulo, SP, Brazil|Hospital Beneficência Portuguesa - Real e Benemérita Associação Portuguesa de Beneficência, São Paulo, SP, Brazil|Hospital BP Mirante - Real e Benemérita, São Paulo, SP, Brazil|Hospital das Clínicas da FMUSP, São Paulo, SP, Brazil|Hospital do Servidor Público Estadual - HSPE - IAMSPE, São Paulo, SP, Brazil|Hospital São Paulo - UNIFESP, São Paulo, SP, Brazil|Hospital Sírio-Libanês, São Paulo, SP, Brazil|Hospital SEPACO, São Paulo, S, Brazil"	https://ClinicalTrials.gov/show/NCT04322123
1150	NCT04384549	Efficacy of BCG Vaccination in the Prevention of COVID19 Via the Strengthening of Innate Immunity in Health Care Workers	Not yet recruiting	No Results Available	"Infection|Viral, Agent as Cause of Disease Classified Elsewhere"	Biological: BCG GROUP|Other: PLACEBO GROUP	Phase 3	Interventional	"I-REIVAC/CIC 1417 Cochin Hospital, APHP, Paris, France"	https://ClinicalTrials.gov/show/NCT04384549
1151	NCT04346953	Video-Based Exercise for Individuals With Social Isolation Due to Coronavirus (COVID-19)	Not yet recruiting	No Results Available	Healthy Lifestyle	Behavioral: Video based exercise	Not Applicable	Interventional		https://ClinicalTrials.gov/show/NCT04346953
1152	NCT04363502	Use of the Interleukin-6 Inhibitor Clazakizumab in Patients With Life-threatening COVID-19 Infection	Recruiting	No Results Available	COVID	Drug: Clazakizumab|Drug: Placebo	Phase 2	Interventional	"Johns Hopkins Hospital, Baltimore, Maryland, United States"	https://ClinicalTrials.gov/show/NCT04363502
1153	NCT04392453	Upper Limb Robotic Rehabilitation During COVID-19 Outbreak	Not yet recruiting	No Results Available	Stroke	Device: Robotic therapy	Not Applicable	Interventional		https://ClinicalTrials.gov/show/NCT04392453
1154	NCT04404361	PRE-VENT Study in Hospitalized Patients With Severe COVID-19 With or Without Cancer	Recruiting	No Results Available	COVID	Drug: Pacritinib|Drug: Placebo	Phase 3	Interventional	"Grady Memorial Hospital, Atlanta, Georgia, United States|St. Agnes Healthcare, Baltimore, Maryland, United States|Brigham and Women's Hospital, Boston, Massachusetts, United States|University of Michigan, Ann Arbor, Michigan, United States|Ascension St. John Hospital, Grosse Pointe Woods, Michigan, United States|Ascension Providence Hospital- Novi Campus, Southfield, Michigan, United States|Providence Cancer Institute, Southfield, Michigan, United States|Atlantic Melanoma Center, Morristown, New Jersey, United States|Chilton Medical Center, Morristown, New Jersey, United States|Overlook Medical Center, Morristown, New Jersey, United States|Mount Sinai Medical Center, New York, New York, United States|The Carl and Edyth Lindner Center for Research and Education at The Christ Hospital, Cincinnati, Ohio, United States|St. John Medical Center, Tulsa, Oklahoma, United States|Rhode Island Hospital, Providence, Rhode Island, United States|The Miriam Hospital, Providence, Rhode Island, United States|Ascension All Saints, Racine, Wisconsin, United States|Ascension St. Francis Hospital, Racine, Wisconsin, United States"	https://ClinicalTrials.gov/show/NCT04404361
1155	NCT04445324	Effects of Online and Recovery-oriented Peer Support Groups Facilitated by Peer Support Workers in Times of COVID-19	Not yet recruiting	No Results Available	Psychotic Disorders|Anxiety Depression	"Behavioral: Transitional Online Peer Support Group (n=24)|Other: Control Group (pharmacotherapy and/or psychotherapy, n=24)"	Not Applicable	Interventional	"CR-IUSMM, Montreal, Quebec, Canada"	https://ClinicalTrials.gov/show/NCT04445324
1156	NCT04443868	Nitric Oxide Releasing Solution to Treat and Prevent Exacerbation of Mild COVID-19 Infection	Not yet recruiting	No Results Available	SARS-CoV Infection	Drug: Nitric Oxide-Releasing Drug	Phase 2	Interventional		https://ClinicalTrials.gov/show/NCT04443868
1157	NCT04444700	A Pragmatic Randomized Controlled Trial of Therapeutic Anticoagulation Versus Standard Care as a Rapid Response to COVID-19 Pandemic	Recruiting	No Results Available	"COVID|Coronavirus Infection|Severe Acute Respiratory Syndrome|Thromboembolism, Venous|Anticoagulants and Bleeding Disorders"	Drug: Therapeutic anticoagulation	Phase 3	Interventional	"Hospital das Clínicas da FMUSP, São Paulo, SP, Brazil"	https://ClinicalTrials.gov/show/NCT04444700
1158	NCT04380935	Effectiveness and Safety of Convalescent Plasma Therapy on COVID-19 Patients With Acute Respiratory Distress Syndrome	Not yet recruiting	No Results Available	COVID|Acute Respiratory Distress Syndrome	Biological: Convalescent plasma|Drug: Standard of care	Phase 2|Phase 3	Interventional	"Dr. Cipto Mangunkusumo General Hospital, Jakarta, DKI Jakarta, Indonesia|St. Carolus Hospital, Jakarta, DKI Jakarta, Indonesia|PELNI Hospital, Jakarta, DKI Jakarta, Indonesia"	https://ClinicalTrials.gov/show/NCT04380935
1159	NCT04382924	Safety and Efficacy of NP-120 (Ifenprodil) for the Treatment of Confirmed COVID-19 Infected Hospitalized Patients	Not yet recruiting	No Results Available	COVID	Drug: NP-120 (Ifenprodil)	Phase 2|Phase 3	Interventional		https://ClinicalTrials.gov/show/NCT04382924
1160	NCT04351906	Low-flow Extracorporeal Carbon Dioxide Removal in COVID-19-associated Acute Respiratory Distress Syndrome	Recruiting	No Results Available	ARDS|Hypercapnic Respiratory Failure|AKI	Device: ECCO2R	Not Applicable	Interventional	"University Hospital Giessen and Marburg, Giessen, Giessen, Hessen, Germany"	https://ClinicalTrials.gov/show/NCT04351906
1161	NCT04411602	Feasibility Study of Anti-SARS-CoV-2 Plasma Transfusions in COVID-19 Patients With SRD	Recruiting	No Results Available	Severe Acute Respiratory Syndrome|COVID	Drug: SARS-CoV-2 plasma	Phase 1	Interventional	"Ascension Providence Hospital, Novi Campus, Novi, Michigan, United States|Ascension Providence Hospital, Southfield Campus, Southfield, Michigan, United States|Ascension Macomb-Oakland Hospital, Warren Campus, Warren, Michigan, United States"	https://ClinicalTrials.gov/show/NCT04411602
1162	NCT04395911	Safety and Efficacy of SCD in AKI or ARDS Patients Associated With COVID-19 Infections	Not yet recruiting	No Results Available	AKI|ARDS|COVID	Device: SCD	Not Applicable	Interventional		https://ClinicalTrials.gov/show/NCT04395911
1163	NCT04337918	Nitric Oxide Releasing Solutions to Prevent and Treat Mild/Moderate COVID-19 Infection	Recruiting	No Results Available	Corona Virus Infection	Drug: NORS (Nitric Oxide Releasing Solution)	Phase 2	Interventional	"BC Diabetes, Vancouver, British Columbia, Canada|LMC Manna, Pointe-Claire, Quebec, Canada|Diex Recherche Québec, Québec, Quebec, Canada|Diex Recherche Joliette, Saint-Charles-Borromée, Quebec, Canada|Diex Recherche Sherbrooke, Sherbrooke, Quebec, Canada"	https://ClinicalTrials.gov/show/NCT04337918
1164	NCT04326036	Use of cSVF Via IV Deployment for Residual Lung Damage After Symptomatic COVID-19 Infection	Enrolling by invitation	No Results Available	Pulmonary Alveolar Proteinosis|COPD|Idiopathic Pulmonary Fibrosis|Viral Pneumonia|Coronavirus Infection|Interstitial Lung Disease	Procedure: Microcannula Harvest Adipose Derived tissue stromal vascular fraction (tSVF)|Device: Centricyte 1000|Procedure: IV Deployment Of cSVF In Sterile Normal Saline IV Solution|Drug: Liberase Enzyme (Roche)|Drug: Sterile Normal Saline for Intravenous Use	Early Phase 1	Interventional	"Robert W. Alexander, MD, FICS, LLC, Stevensville, Montana, United States"	https://ClinicalTrials.gov/show/NCT04326036
1165	NCT04389450	"Double-Blind, Multicenter, Study to Evaluate the Efficacy of PLX PAD for the Treatment of COVID-19"	Recruiting	No Results Available	COVID|ARDS	Biological: PLX-PAD|Biological: Placebo	Phase 2	Interventional	"Holy Medical Center, Teaneck, New Jersey, United States|Maimonides Medical Center, New York, New York, United States|Thomas Jefferson University, Philadelphia, Pennsylvania, United States"	https://ClinicalTrials.gov/show/NCT04389450
1166	NCT04399109	Evaluation of a Remote Monitoring Smartphone Application and Care Model of COVID-19 Patients in the Community (ReCOVER)	Recruiting	No Results Available	COVID	Device: TCC-COVID mHealth solution	Not Applicable	Interventional	"The Sutherland Hospital, Caringbah, New South Wales, Australia|St George Hospital, Kogarah, New South Wales, Australia|Prince of Wales Hospital, Randwick, New South Wales, Australia"	https://ClinicalTrials.gov/show/NCT04399109
1167	NCT04344548	Phase I / II Clinical Study of Immunotherapy Based on Adoptive Cell Transfer as a Therapeutic Alternative for Patients With COVID-19 in Colombia	Not yet recruiting	No Results Available	COVID	Biological: Allogeneic NK transfer	Phase 1|Phase 2	Interventional	"Fundacion Salud De Los Andes, Bogotá, Bogotá Distrito Capital, Colombia|Universidad Nacional de Colombia, Bogota, Cundinamarca, Colombia"	https://ClinicalTrials.gov/show/NCT04344548
1168	NCT04346693	An Open Randomized Study of Dalargin Effectiveness in Patients With Severe and Critical Manifestations of SARS-COVID-19	"Active, not recruiting"	No Results Available	Acute Respiratory Tract Infection|Acute Respiratory Insufficiency|Pneumonia|Septic Shock|Hypoxemia	Procedure: Standard therapy recommended by the Ministry of Health of the Russian Federation.|Procedure: Standard therapy recommended by the Ministry of Health of the Russian Federation and Dalargin intramuscular injection|Procedure: Standard therapy recommended by the Ministry of Health of the Russian Federation and Dalargin inhalation|Procedure: Standard therapy recommended by the Ministry of Health of the Russian Federation and Dalargin intramuscular injection combined with Dalargin inhalation	Phase 3	Interventional	"Burnasyan Federal Medical Biophysical Center FMBA of Russia, Moscow, Russian Federation"	https://ClinicalTrials.gov/show/NCT04346693
1169	NCT04377672	Human Convalescent Plasma for High Risk Children Exposed or Infected With SARS-CoV-2 (COVID-19)	Recruiting	No Results Available	Corona Virus Infection	Biological: Anti-SARS-CoV-2 Human Convalescent Plasma	Phase 1	Interventional	"Johns Hopkins Hospitals, Baltimore, Maryland, United States"	https://ClinicalTrials.gov/show/NCT04377672
1170	NCT04341610	ASC Therapy for Patients With Severe Respiratory COVID-19	Withdrawn	No Results Available	Respiratory Tract Diseases	Drug: Stem Cell Product	Phase 1|Phase 2	Interventional	"2014 Department of Cardiology, The Heart Centre, University Hospital Rigshospitalet, Copenhagen, Denmark"	https://ClinicalTrials.gov/show/NCT04341610
1171	NCT04322396	Proactive Prophylaxis With Azithromycin and hydroxyChloroquine in Hospitalized Patients With COVID-19	Recruiting	No Results Available	Virus Diseases|Infection Viral|Corona Virus Infection	Drug: Azithromycin|Drug: Hydroxychloroquine|Drug: Placebo oral tablet	Phase 2	Interventional	"Aalborg Sygehus, Aalborg, Denmark|Bispebjerg Hospital, Copenhagen, Denmark|Herlev-Gentofte Hospital, Copenhagen, Denmark|Hvidovre Hospital, Copenhagen, Denmark|Nordsjællands Hospital, Hillerød, Denmark|Odense Universitetshospital, Odense, Denmark|Roskilde Sygehus, Roskilde, Denmark|Slagelse Sygehus, Slagelse, Denmark"	https://ClinicalTrials.gov/show/NCT04322396
1172	NCT04452669	VentaProst (Inhaled Epoprostenol Delivered Via Dedicated Delivery System) in Subjects With COVID-19 Requiring Mechanical Ventilation	Not yet recruiting	No Results Available	Acute Respiratory Distress Syndrome	Drug: VentaProst (inhaled Flolan delivered via a dedicated delivery system)	Phase 2	Interventional	"Ohio State University, Columbus, Ohio, United States"	https://ClinicalTrials.gov/show/NCT04452669
1173	NCT04395144	COVid-19: Awake Proning and High-flow Nasal Cannula in respiratorY DistrEss	Recruiting	No Results Available	Coronavirus Infection|COVID|Severe Acute Respiratory Syndrome|Respiratory Failure|Respiratory Insufficiency|Respiratory Distress Syndrome|ARDS|Lung Diseases	Procedure: Awake Prone Positioning|Procedure: Standard care	Not Applicable	Interventional	"Hôpital de Verdun, Montréal, Quebec, Canada"	https://ClinicalTrials.gov/show/NCT04395144
1174	NCT04418531	Convalescent Antibodies Infusion in COVID 19 Patients	Not yet recruiting	No Results Available	"Pneumonia, Viral|Corona Virus Infection"	Biological: Anti-coronavirus antibodies (immunoglobulins) obtained with DFPP form convalescent patients	Not Applicable	Interventional	"ASST - Papa Giovanni XXIII - Unit of Nephrology, Bergamo, BG, Italy|Asst Hpg23 - Eas, Bergamo, BG, Italy|ASST HPG23 - Intensive Care Unit, Bergamo, BG, Italy|ASST HPG23 - Microbioly and Virology Unit, Bergamo, BG, Italy|Sst Hpg23 - S.I.M.T., Bergamo, BG, Italy|IRFMN - Clinical Research Center for Rare Diseases, Ranica, BG, Italy"	https://ClinicalTrials.gov/show/NCT04418531
1175	NCT04321278	Safety and Efficacy of Hydroxychloroquine Associated With Azithromycin in SARS-CoV2 Virus (Coalition Covid-19 Brasil II)	Completed	No Results Available	"Coronavirus Infections|Pneumonia, Viral"	Drug: Hydroxychloroquine + azithromycin|Drug: Hydroxychloroquine	Phase 3	Interventional	"Hospital de Urgência e Emergência de Rio Branco, Rio Branco, AC, Brazil|Hospital e Clínica São Roque, Ipiaú, BA, Brazil|Hospital da Cidade, Salvador, BA, Brazil|Hospital Maternidade São Vicente de Paulo, Barbalha, CE, Brazil|Hospital de Messejana Dr. Carlos Alberto Studart Gomes, Fortaleza, CE, Brazil|Hospital Unimed Cariri, Juazeiro Do Norte, CE, Brazil|Hospital Brasilia, Brasilia, DF, Brazil|Instituto de Cardiologia do Distrito Federal, Brasília, Distrito Federal, Brazil|Fundação Social Rural de Colatina, Colatina, Espirito Santo, Brazil|Hospital Estadual Jayme dos Santos Neves, Serra, ES, Brazil|Hospital Evangélico de Vila Velha, Vila Velha, ES, Brazil|Secretaria de Estado de Saúde de Goias, Goiânia, GO, Brazil|Santa Casa de Misericórdia de Belo Horizonte Santa Casa de BH, Belo Horizonte, MG, Brazil|Hospital Santa Paula, Passos, MG, Brazil|Santa Casa da Misericordia - UTI (São João Del Rey), São João Del Rei, MG, Brazil|Hospital Maternidade E Pronto Socorro Santa Lucia Ltda, Poços De Caldas, Minas Gerais, Brazil|Universidade Estadual de Londrina, Londrina, Paraná, Brazil|Hospital Adventista de Belém, Belém, Pará, Brazil|Hospital Adventista de Belem, Belem, PA, Brazil|Procape - Pronto S.Cardiologico de Pe.Prof.Luiz Tavares-, Recife, PE, Brazil|Liga Paranaense de Combate ao Câncer, Curitiba, PR, Brazil|Hospital Giselda Trigueiro, Natal, Rio Grande Do Norte, Brazil|Hospital Moinhos de Vento, Porto Alegre, Rio Grande Do Sul, Brazil|Irmandade da Santa Casa de Misericordia de Porto Alegre, Porto Alegre, Rio Grande Do Sul, Brazil|Hospital Naval Marcílio Dias, Rio de Janeiro, RJ, Brazil|Hospital São Lucas, Rio De Janeiro, RJ, Brazil|Hospital Maternidade PROMATER, Natal, RN, Brazil|Associação Dr. Bartholomeu Tacchini, Bento Gonçalves, RS, Brazil|Hospital Geral de Caxias do Sul, Caxias Do Sul, RS, Brazil|Hospital Bruno Born, Lajeado, RS, Brazil|Hospital São Vicente de Paulo, Passo Fundo, RS, Brazil|Maestri E Kormann Consultoria Medico-Cientifica, Blumenau, Santa Catarina, Brazil|Sociedade Literaria e Caritativa Santo Agostinho, Criciúma, Santa Catarina, Brazil|Hospital Nereu Ramos, Florianópolis, SC, Brazil|Hospital Universitário Polydoro Ernani de São Thiago/HU - UFSC, Florianópolis, SC, Brazil|Centro Hospitalar Unimed, Joinville, SC, Brazil|Hospital Dona Helena, Joinville, SC, Brazil|Hospital Municipal Sao Jose, Joinville, SC, Brazil|Hospital Regional Hans Dieter Schmidt, Joinville, SC, Brazil|Faculdade de Medicina de Botucatu, Botucatu, SP, Brazil|nstituto de Pesquisa Clínica de Campinas, Campinas, SP, Brazil|Fundação do ABC (Hospital Estadual Mário Covas), Santo André, SP, Brazil|AC Camargo Cancer Center - Fundação Antonio Prudente, São Paulo, SP, Brazil|Casa de Saude Santa Marcelina, São Paulo, SP, Brazil|Hospital Alemão Oswaldo Cruz, São Paulo, SP, Brazil|Hospital Moriah, São Paulo, SP, Brazil|Hospital Nove de Julho, São Paulo, SP, Brazil|Hospital Santa Paula, São Paulo, SP, Brazil|Hospital São Camilo Pompeia, São Paulo, SP, Brazil|Fundação Pio XII, Barretos, São Paulo, Brazil|Santa Casa de Misericordia de Votuporanga, Votuporanga, São Paulo, Brazil|Hospital Israelita Albert Einstein, São Paulo, Brazil|Associacao Beneficente Siria, São Paulo, Brazil|Hospital Vila Santa Catarina, São Paulo, Brazil|Real e Benemérita Associação Portuguesa de Beneficência/SP, São Paulo, Brazil|Secretaria de Saúde do Estado de São Paulo, São Paulo, Brazil|Serv Social da Industria do papel, papelão e cortiça do estado de SP, São Paulo, Brazil|Sociedade Beneficente de Senhoras Hospital Sírio-Libanês, São Paulo, Brazil|Universidade Federal de São Paulo, São Paulo, Brazil"	https://ClinicalTrials.gov/show/NCT04321278
1176	NCT04415073	A Phase 2 Study to Evaluate Axatilimab for Hospitalized Patients With Respiratory Involvement Secondary to COVID-19	Recruiting	No Results Available	Coronavirus|COVID|ARDS|Cytokine Storm|Cytokine Release Syndrome	Drug: SNDX-6352|Drug: Placebo	Phase 2	Interventional	"HonorHealth, Scottsdale, Arizona, United States|Montefiore Medical Center, Bronx, New York, United States"	https://ClinicalTrials.gov/show/NCT04415073
1177	NCT04400305	Increasing Physical Activity in Canadian Adults Who Have Been Affected by COVID-19 Social Distancing Restrictions: A Feasibility Trial of an Online Intervention	Recruiting	No Results Available	"Physical Activity, Healthy Promotion"	Behavioral: Digital Health Online Platform	Not Applicable	Interventional	"University of Victoria, Victoria, British Columbia, Canada"	https://ClinicalTrials.gov/show/NCT04400305
1178	NCT04412239	To Assess the Efficiency and Satisfaction of Pharmacist Giving Patient-centred Advice on Telephone Consultation in TB Patients: Experience of the COVID-19 Pandemic	Recruiting	No Results Available	TB - Tuberculosis|Patient Satisfaction	Behavioral: Patient-centred advice on Telephone Consultation in TB Patients:	Not Applicable	Interventional	"Dhq Bannu Kpk, Bannu, KPK, Pakistan|District Bannu TB Control Center, Bannu, KPK, Pakistan"	https://ClinicalTrials.gov/show/NCT04412239
1179	NCT04378257	Efficacy of Therapist Guided e-Therapy Versus Self-Help Therapy on Psychological Distress Among Individuals in Oman During COVID-19 Pandemic	Not yet recruiting	No Results Available	Depressive Symptoms|Generalized Anxiety	Behavioral: Therapist Guided E-Therapy|Behavioral: Self-Help Therapy	Phase 3	Interventional		https://ClinicalTrials.gov/show/NCT04378257
1180	NCT04324073	Cohort Multiple Randomized Controlled Trials Open-label of Immune Modulatory Drugs and Other Treatments in COVID-19 Patients - Sarilumab Trial - CORIMUNO-19 - SARI	"Active, not recruiting"	No Results Available	Corona Virus Infection	Drug: Sarilumab	Phase 2|Phase 3	Interventional	"Kremlin Bicetre hospital APHP, Le Kremlin-Bicêtre, Ile De France, France|Cochin Aphp, Paris, Ile De France, France|HEGP, Paris, Ile De France, France|NECKER Hospital, Paris, France"	https://ClinicalTrials.gov/show/NCT04324073
1181	NCT04344041	COvid-19 and Vitamin D Supplementation: a Multicenter Randomized Controlled Trial of High Dose Versus Standard Dose Vitamin D3 in High-risk COVID-19 Patients (CoVitTrial)	Recruiting	No Results Available	Coronavirus	"Drug: cholecalciferol 200,000 IU|Drug: cholecalciferol 50,000 IU"	Phase 3	Interventional	"CHU Angers, Angers, France|CHU Bordeaux, Bordeaux, France|CH Le Mans, Le Mans, France|CHU Lille, Lille, France|CHU Limoges, Limoges, France|CHU Nantes, Nantes, France|CHU Nice, Nice, France|CHU Saint Etienne, Saint Etienne, France|CH Saumur, Saumur, France|CHU Tours, Tours, France"	https://ClinicalTrials.gov/show/NCT04344041
1182	NCT04345289	Efficacy and Safety of Novel Treatment Options for Adults With COVID-19 Pneumonia	Recruiting	No Results Available	COVID|Corona Virus Infection|Viral Pneumonia	Biological: Convalescent anti-SARS-CoV-2 plasma|Drug: Sarilumab|Drug: Baricitinib|Drug: Hydroxychloroquine|Other: Injective placebo|Other: Oral placebo	Phase 3	Interventional	"Aalborg University Hospital, Aalborg, Denmark|Aarhus University Hospital, Arhus, Denmark|Bispebjerg Hospital, Copenhagen, Denmark|Rigshospitalet, Copenhagen, Denmark|Herlev Gentofte Hospital, Herlev, Denmark|Herning Hospital, Herning, Denmark|Nordsjællands Hospital, Hillerød, Denmark|Hvidovre Hospital, Hvidovre, Denmark|Kolding Hospital, Kolding, Denmark|Odense University Hospital, Odense, Denmark|Roskilde Hospital, Roskilde, Denmark|Vejle Hospital, Vejle, Denmark"	https://ClinicalTrials.gov/show/NCT04345289
1183	NCT04382950	Combination of Recombinant Bacterial ACE2 Receptors -Like Enzyme of B38-CAP and Isotretinoin Could be Promising COVID-19 Infection- and Lung Injury Preventing Drug Better Than Recombinant Human ACE2	Not yet recruiting	No Results Available	COVID	Combination Product: Recombinant Bacterial ACE2 receptors -like enzyme of B38-CAP (rbACE2) plus Aerosolized 13 cis retinoic acid	Phase 1	Interventional		https://ClinicalTrials.gov/show/NCT04382950
1184	NCT04396067	Combination With Inhibitor of Neutrophil Elastase (All-trans Retinoic Acid ) and Isotretinoin May Enhances Neutralizing Antibodies in COVID -19 Infected Patients Better Than COVID-19 Inactivated Vaccines	Not yet recruiting	No Results Available	COVID -19	Drug: Aerosolized 13 cis retinoic acid|Drug: Aerosolized All trans retinoic acid|Other: Placebo	Phase 2	Interventional		https://ClinicalTrials.gov/show/NCT04396067
1185	NCT04358783	Convalescent Plasma Compared to the Best Available Therapy for the Treatment of SARS-CoV-2 Pneumonia	Recruiting	No Results Available	Coronavirus Infection	Biological: Plasma|Other: Best Available Therapy	Phase 2	Interventional	"Hospital Universitario José E. Gonzalez, Monterrey, Nuevo Leon, Mexico"	https://ClinicalTrials.gov/show/NCT04358783
1186	NCT04359303	Indirect Endovenous Systemic Ozone for New Coronavirus Disease (COVID19) in Non-intubated Patients	Not yet recruiting	No Results Available	COVID	Other: Systemic indirect endovenous ozone therapy	Phase 3	Interventional	"SEOT, Valencia, Spain"	https://ClinicalTrials.gov/show/NCT04359303
1187	NCT04453657	"Tele-Wellness Supported App for Family Child Care Home Providers and Families to Promote Health, Family Engagement, and School Readiness Amid Coronavirus Disease of 2019 (COVID-19)"	Not yet recruiting	No Results Available	"Stress, Psychological|Child Behavior|Social Competence"	Device: FamilyChildCare (provisional name of app)	Not Applicable	Interventional		https://ClinicalTrials.gov/show/NCT04453657
1188	NCT04369365	"A Single-blinded, Randomized, Placebo Controlled Phase II Trial of Prophylactic Treatment With Oral Azithromycin Versus Placebo in Cancer Patients Undergoing Antineoplastic Treatment During the Corona Virus Disease 19 (COVID-19) Pandemic"	Recruiting	No Results Available	COVID	Drug: Azithromycin 500 milligram (mg) oral Tablet|Drug: Placebo	Phase 2	Interventional	"AKH Vienna, Department for Internal Medicine I, Oncology, Vienna, Austria"	https://ClinicalTrials.gov/show/NCT04369365
1189	NCT04400279	The COVID-19 Pandemic and Exercise Study	Not yet recruiting	No Results Available	Depressive Symptomatology|Psychological Distress|Health Behavior	Behavioral: Yoga group|Behavioral: High Intensity Interval Training group|Behavioral: Combination	Not Applicable	Interventional		https://ClinicalTrials.gov/show/NCT04400279
1190	NCT04353037	PATCH 2&3:Prevention & Treatment of COVID-19 (Severe Acute Respiratory Syndrome Coronavirus 2) With Hydroxychloroquine	Recruiting	No Results Available	Coronavirus|Corona Virus Infection	Drug: Group A HCQ|Drug: Group B Control	Phase 2	Interventional	"ProHealth New York, New York, New York, United States"	https://ClinicalTrials.gov/show/NCT04353037
1191	NCT04260594	Clinical Study of Arbidol Hydrochloride Tablets in the Treatment of Pneumonia Caused by Novel Coronavirus	Not yet recruiting	No Results Available	2019-nCoV	Drug: Arbidol|Other: basic treatment	Phase 4	Interventional		https://ClinicalTrials.gov/show/NCT04260594
1192	NCT04320056	Closed-Loop Oxygen to Verify That Healthcare Workers Interventions Decrease During SARS-CoV-2 Pneumonia (COVID-19)	Recruiting	No Results Available	Coronavirus|Pneumonia|Oxygen Toxicity	Other: Standard administration of oxygen flow|Device: Automated oxygen administration - FreeO2	Not Applicable	Interventional	"Institut universitaire de cardiologie et de pneumologie de Québec - Université Laval, Quebec, Canada"	https://ClinicalTrials.gov/show/NCT04320056
1193	NCT04336748	HCQ for Primary Prophylaxis Against COVID19 in Health-care Workers	Not yet recruiting	No Results Available	Sars-CoV2|Infection Viral|Healthcare Worker|Prophylaxis	Drug: Hydroxychloroquine	Phase 3	Interventional		https://ClinicalTrials.gov/show/NCT04336748
1194	NCT04359329	Estrogen Patch for COVID-19 Symptoms	Recruiting	No Results Available	COVID	Drug: Estradiol patch	Phase 2	Interventional	"Stony Brook University Hospital, Stony Brook, New York, United States"	https://ClinicalTrials.gov/show/NCT04359329
1195	NCT04383717	Levamisole and Isoprinosine in the Treatment of COVID19: A Proposed Therapeutic Trial	Not yet recruiting	No Results Available	Respiratory Tract Infections	Drug: Levamisole and isoprinosine|Drug: Azithromycin and hydroxychloroquine	Phase 3	Interventional		https://ClinicalTrials.gov/show/NCT04383717
1196	NCT04435353	Assessment of the Effectiveness of Vibroacoustic Therapy for Respiratory Failure Caused by COVID 19	Recruiting	No Results Available	Respiratory Distress Syndrome|Hypoxemia	Device: VibroLUNG	Not Applicable	Interventional	"Mukatova Irina, Astana, Nur-Sultan, Kazakhstan|Center of pulmonology Astana, Astana, Kazakhstan"	https://ClinicalTrials.gov/show/NCT04435353
1197	NCT04326426	ODYSSEY: A Study to Investigate the Efficacy of Tradipitant in Treating Severe or Critical COVID-19 Infection	Enrolling by invitation	No Results Available	Coronavirus Infection	Drug: Tradipitant|Drug: Placebo	Phase 3	Interventional	"Lenox Hill Hospital Northwell Health, New York, New York, United States"	https://ClinicalTrials.gov/show/NCT04326426
1198	NCT04341922	A Online-delivered Cognitive-behavioral Intervention for Dysfunctional Worry Related to the Covid-19 Pandemic	"Active, not recruiting"	No Results Available	Dysfunctional Worry	Behavioral: Internet-delivered cognitive behavior therapy (ICBT) for dysfunctional worry related to the Covid-19 pandemic	Not Applicable	Interventional	"Karolinska Institutet, Stockholm, Sweden"	https://ClinicalTrials.gov/show/NCT04341922
1199	NCT04334434	Telerehabilitation in Individuals Over 65 Years of Age Having Social Isolation Due to Coronavirus (Covid-19)	Not yet recruiting	No Results Available	Telerehabilitation	Other: Telerehabilitation	Not Applicable	Interventional	"Istanbul university Cerrahpasa, Istanbul, Turkey"	https://ClinicalTrials.gov/show/NCT04334434
1200	NCT04419610	RAS and Coagulopathy in COVID19	Not yet recruiting	No Results Available	COVID	Biological: TRV027|Other: sodium chloride 0.9%	Early Phase 1	Interventional		https://ClinicalTrials.gov/show/NCT04419610
1201	NCT04389294	HSS Covid-19 Antibody Serology Among Surgeons & Anesthesiologists	Recruiting	No Results Available	COVID	Diagnostic Test: SARS-CoV2 serum antibody testing	Not Applicable	Interventional	"Hospital for Special Surgery, New York, New York, United States"	https://ClinicalTrials.gov/show/NCT04389294
1202	NCT04431466	A Study to Compare the Efficacy and Safety of Different Doses of Ivermectin for COVID-19	Not yet recruiting	No Results Available	Coronavirus Infection	Drug: Ivermectin|Other: Standard treatment for COVID-19	Phase 2	Interventional	"Hospital Univeristário da Universidade Federal de São Carlos (HU-UFSCar), São Carlos, São Paulo, Brazil"	https://ClinicalTrials.gov/show/NCT04431466
1203	NCT04374942	Does Hydroxychloroquine Before & During Patient Exposure Protect Healthcare Workers From Coronavirus?	Enrolling by invitation	No Results Available	Pre-Exposure Prophylaxis|Coronavirus|SARS-CoV 2	Drug: Hydroxychloroquine|Drug: Placebo oral tablet	Phase 3	Interventional	"University Health Network, Toronto, Ontario, Canada"	https://ClinicalTrials.gov/show/NCT04374942
1204	NCT04345406	Angiotensin Converting Enzyme Inhibitors in Treatment of Covid 19	Not yet recruiting	No Results Available	COVID	Drug: ACEIs|Drug: Conventional treatment	Phase 3	Interventional	"Tanta University, Tanta, Egypt"	https://ClinicalTrials.gov/show/NCT04345406
1205	NCT04372030	Health Care Use During the Covid19 Crisis	Not yet recruiting	No Results Available	Health Care Utilization	Other: Online questionnaire	Not Applicable	Interventional		https://ClinicalTrials.gov/show/NCT04372030
1206	NCT04377737	Incidence of Covid-19 in School Children	Withdrawn	No Results Available	"Infection; Viral, Coronavirus"	Diagnostic Test: RT-PCR Covid-19	Not Applicable	Interventional	"Hôpitaux Pédiatrique de Nice CHU Lenval, Nice, France"	https://ClinicalTrials.gov/show/NCT04377737
1207	NCT04385186	Inactivated Convalescent Plasma as a Therapeutic Alternative in Patients CoViD-19	Not yet recruiting	No Results Available	"Infections, Coronavirus"	Drug: Inactivated convalescent plasma|Drug: Support treatment	Phase 2	Interventional	"Clínica Antioquía, Medellín, Antioquía, Colombia|Clínica Sagrado Corazón, Medellín, Antioquía, Colombia|IPS Universitaria, Medellín, Antioquía, Colombia|Universidad de Antioquía, Medellín, Antioquía, Colombia|National Blood Center Foundation, Hemolife/Fundación Banco Nacional de Sangre Hemolife, Bogotá, Cundinamarca, Colombia|Clínica Rosales, Pereira, Risaralda, Colombia|Clinica Nuestra, Cali, Valle, Colombia|Clínica Corpas, Bogotá, Colombia|E.S.E Hospital San Rafael Facatativa, Facatativa, Colombia|Clínica la Estancia, Popayán, Colombia"	https://ClinicalTrials.gov/show/NCT04385186
1208	NCT04345549	Ayurveda Self-Management for Flu Like Symptoms During the Covid-19 Outbreak	Completed	No Results Available	Flu Like Symptom|Flu Like Illness	Other: Individualised Ayurveda	Not Applicable	Interventional	"Aarogyam, Leicester, United Kingdom"	https://ClinicalTrials.gov/show/NCT04345549
1209	NCT04290858	Nitric Oxide Gas Inhalation Therapy for Mild/Moderate COVID19 Infection	Withdrawn	No Results Available	"Coronavirus Infections|Pneumonia, Viral|Dyspnea"	Drug: Nitric Oxide	Phase 2	Interventional		https://ClinicalTrials.gov/show/NCT04290858
1210	NCT04393818	Mobile Phone Based Intervention to Protect Mental Health in Healthcare Workers at Frontline Against COVID19	Not yet recruiting	No Results Available	Mental Health Disorder|Depression|Posttraumatic Stress Disorder|Burnout|Anxiety Disorders	Behavioral: Intervention App	Phase 3	Interventional		https://ClinicalTrials.gov/show/NCT04393818
1211	NCT04359290	Ruxolitinib for Treatment of Covid-19 Induced Lung Injury ARDS	Not yet recruiting	No Results Available	"ARDS, Human|COVID"	Drug: Ruxolitinib administration	Phase 2	Interventional		https://ClinicalTrials.gov/show/NCT04359290
1212	NCT04416360	Autism Spectrum Disorder or Attention Deficit Hyperactivity Disorder in Covid-19 Outbreak	Recruiting	No Results Available	Autism Spectrum Disorder|Attention-deficit Hyperactivity Disorder	Other: Interview by psychologists	Not Applicable	Interventional	"University hospital of Toulouse, Toulouse, Occitanie, France|Centre Hospitalier de Versailles, Le Chesnay, France|Centre Hospitalier Esquirol, Limoges, France|Hôpital Robert-Debré (AP-HP), Paris, France|Maison de Solenn (Hôpital Cochin AP-HP), Paris, France"	https://ClinicalTrials.gov/show/NCT04416360
1213	NCT04366856	PROne Positioning in coVID-19 Oxygeno-dependent Patients in Spontaneous Ventilation (PROVID Study)	Not yet recruiting	No Results Available	COVID|ARDS	Behavioral: 1: Prone positioning|Behavioral: 2: No instruction regarding positioning	Not Applicable	Interventional	"Département d'Anesthésie Réanimation - Kremlin Bicêtre, Le Kremlin-Bicêtre, France"	https://ClinicalTrials.gov/show/NCT04366856
1214	NCT04280224	NK Cells Treatment for COVID-19	Recruiting	No Results Available	Novel Coronavirus Pneumonia	Biological: NK Cells	Phase 1	Interventional	"The First Affiliated Hospital of Xinxiang Medical University, Xinxiang, Henan, China"	https://ClinicalTrials.gov/show/NCT04280224
1215	NCT04388826	COVID-19 Treatment of Severe Acute Respiratory Syndrome With Veru-111	Recruiting	No Results Available	"Respiratory Distress Syndrome, Adult"	Drug: Veru-111	Phase 2	Interventional	"HonorHealth, Scottsdale, Arizona, United States|Methodist Hospital, Saint Louis Park, Minnesota, United States|Regions Hospital, Saint Paul, Minnesota, United States|WC-CRCN at North Vista Hospital, Las Vegas, Nevada, United States|Inspira Medical Center, Vineland, New Jersey, United States"	https://ClinicalTrials.gov/show/NCT04388826
1216	NCT04338802	Efficacy and Safety of Nintedanib in the Treatment of Pulmonary Fibrosis in Patients With Moderate to Severe COVID -19	Not yet recruiting	No Results Available	COVID-19|Nintedanib|Safety|Effect of Drugs	Drug: Nintedanib 150 MG|Other: Placebo	Phase 2	Interventional		https://ClinicalTrials.gov/show/NCT04338802
1217	NCT04453852	Monovalent Recombinant COVID19 Vaccine	Recruiting	No Results Available	Coronavirus Infection|COVID	Biological: COVID19 vaccine|Biological: Saline	Phase 1	Interventional	"PARC,, Adelaide, South Australia, Australia"	https://ClinicalTrials.gov/show/NCT04453852
1218	NCT04407390	Effects of Nicotinamide Riboside on the Clinical Outcome of Covid-19 in the Elderly	Recruiting	No Results Available	COVID	Dietary Supplement: Nicotinamide riboside|Dietary Supplement: Placebo	Phase 2	Interventional	"Bispebjerg Hospital, Copenhagen NV, Denmark"	https://ClinicalTrials.gov/show/NCT04407390
1219	NCT04374474	Anosmia Rehabilitation in Patients Post Coronavirus Disease (COVID 19)	Not yet recruiting	No Results Available	Olfactory Disorder	Other: Olfactory retraining|Drug: corticosteroid nasal irrigation|Other: smell household Items|Other: Nasal Irrigation	Phase 4	Interventional	"St. Joseph's Health Care, London, Ontario, Canada"	https://ClinicalTrials.gov/show/NCT04374474
1220	NCT04345887	Spironolactone in Covid-19 Induced ARDS	Not yet recruiting	No Results Available	"Respiratory Distress Syndrome, Adult"	Drug: Spironolactone 100mg|Drug: Placebo oral tablet	Phase 4	Interventional	"Istanbul University-Cerrahpaşa, Istanbul, Turkey"	https://ClinicalTrials.gov/show/NCT04345887
1221	NCT04320953	Non-contact Endoscopy at Covid-19 Outbreak	Completed	No Results Available	Gastrointestinal Disease|Infectious Disease	Device: Non-contact MCE system	Not Applicable	Interventional	"Changhai Hospital, Shanghai, China"	https://ClinicalTrials.gov/show/NCT04320953
1222	NCT04378738	Social Media and Covid19 Pandemic	Enrolling by invitation	No Results Available	Social Media|Corona Virus Infection	Behavioral: survey	Not Applicable	Interventional	"Bahar Yuksel, Istanbul, Turkey|Haseki Training and Research Hospital, Istanbul, Turkey"	https://ClinicalTrials.gov/show/NCT04378738
1223	NCT04444674	COVID-19 Vaccine (ChAdOx1 nCoV-19) Trial in South African Adults With and Without HIV-infection	Not yet recruiting	No Results Available	Coronavirus	Biological: ChAdOx1 nCoV-19|Biological: Normal saline 0.9%	Phase 1|Phase 2	Interventional	"PHRU Kliptown, Johannesburg, Gauteng, South Africa|Wits RHI Shandukani Research Centre, Johannesburg, Gauteng, South Africa|Setshaba Research Centre (SRC), Soshanguve, Gauteng, South Africa|Chris Hani Baragwanath Academic Hospital - DST/NRF VPD RMPRU, Soweto, Gauteng, South Africa|FAMCRU, Cape Town, Western Cape, South Africa|Groote Schuur hospital, Lung infection and immunity unit, UCT, Cape Town, Western Cape, South Africa"	https://ClinicalTrials.gov/show/NCT04444674
1224	NCT04412343	The Seniors COvid-19 Pandemic and Exercise Study	Recruiting	No Results Available	Well-Being (Psychological Flourishing)|Depression|Quality of Life|Loneliness|Physical Activity|Social Identification|Physical Health	Behavioral: Virtual Group Intervention|Behavioral: Personal Exercise Intervention	Not Applicable	Interventional	"University of British Columbia, Vancouver, British Columbia, Canada"	https://ClinicalTrials.gov/show/NCT04412343
1225	NCT04299152	Stem Cell Educator Therapy Treat the Viral Inflammation in COVID-19	Not yet recruiting	No Results Available	Severe Acute Respiratory Syndrome (SARS) Pneumonia	Combination Product: Stem Cell Educator-Treated Mononuclear Cells Apheresis	Phase 2	Interventional		https://ClinicalTrials.gov/show/NCT04299152
1226	NCT04322344	Escin in Patients With Covid-19 Infection	Recruiting	No Results Available	Coronavirus Infections	Drug: Escin|Drug: standard therapy	Phase 2|Phase 3	Interventional	"Luca Gallelli, Catanzaro, Italy"	https://ClinicalTrials.gov/show/NCT04322344
1227	NCT04449276	"A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of Vaccine CVnCoV in Healthy Adults"	Recruiting	No Results Available	Severe Acute Respiratory Syndrome|Coronavirus|SARS-CoV-2|COVID-19	Biological: CVnCoV Vaccine|Drug: Placebo	Phase 1	Interventional	"Universitair Ziekenhuis Ghent, Ghent, Belgium|Ludwig-Maximilians-Universität München, München, Bavaria, Germany|Medical University Hannover (MHH), Hannover, Germany|University Hospital Tübingen Institut für Tropenmedizin, Tübingen, Germany"	https://ClinicalTrials.gov/show/NCT04449276
1228	NCT04306393	Nitric Oxide Gas Inhalation in Severe Acute Respiratory Syndrome in COVID-19	Recruiting	No Results Available	SARS (Severe Acute Respiratory Syndrome)|Coronavirus	Drug: Nitric Oxide Gas	Phase 2	Interventional	"University of Alabama, Birmingham, Alabama, United States|Louisiana State University Health Shreveport, Shreveport, Louisiana, United States|Massachusetts General Hospital, Boston, Massachusetts, United States|Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States"	https://ClinicalTrials.gov/show/NCT04306393
1229	NCT04361552	Tocilizumab for the Treatment of Cytokine Release Syndrome in Patients With COVID-19 (SARS-CoV-2 Infection)	Withdrawn	No Results Available	Cerebrovascular Accident|Chronic Obstructive Pulmonary Disease|Chronic Renal Failure|Coronary Artery Disease|Diabetes Mellitus|Malignant Neoplasm|SARS Coronavirus 2 Infection	Other: Best Practice|Biological: Tocilizumab	Phase 3	Interventional	"Emory University Hospital/Winship Cancer Institute, Atlanta, Georgia, United States"	https://ClinicalTrials.gov/show/NCT04361552
1230	NCT04323800	Convalescent Plasma to Stem Coronavirus (CSSC-001)	Recruiting	No Results Available	Coronavirus|Convalescence	Biological: Anti- SARS-CoV-2 Plasma|Biological: SARS-CoV-2 non-immune Plasma	Phase 2	Interventional	"University of Alabama at Birmingham, Birmingham, Alabama, United States|University of California, San Diego, La Jolla, California, United States|University of California, Los Angeles, Los Angeles, California, United States|University of California, Irvine Health, Orange, California, United States|MedStar Georgetown University Hospital, Washington, District of Columbia, United States|Lee Memorial Health System, Fort Myers, Florida, United States|NorthShore University HealthSystem, Evanston, Illinois, United States|Anne Arundel Medical Center, Annapolis, Maryland, United States|JHSPH Center for American Indian Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States|The Johns Hopkins University, Baltimore, Maryland, United States|University of Massachusetts Worcester, Worcester, Massachusetts, United States|University of Rochester, Rochester, New York, United States|University of Cincinnati Medical Center, Cincinnati, Ohio, United States|Lifespan/BrownUniversity (Rhode Island Hospital), Providence, Rhode Island, United States|University of Texas Health Science Center at Houston, Houston, Texas, United States"	https://ClinicalTrials.gov/show/NCT04323800
1231	NCT04322773	Anti-il6 Treatment of Serious COVID-19 Disease With Threatening Respiratory Failure	Recruiting	No Results Available	Corona Virus Disease	Drug: RoActemra iv|Drug: RoActemra sc|Drug: Kevzara sc|Other: Standard medical care	Phase 2	Interventional	"Bispebjerg-Frederiksberg Hospital, Copenhagen, Denmark|Hillerød Hospital, Hillerød, Denmark"	https://ClinicalTrials.gov/show/NCT04322773
1232	NCT04453774	At Home Monitoring for Patients With Covid19	Not yet recruiting	No Results Available	Coronavirus	Device: Covidfree@home	Not Applicable	Interventional	"Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada|University Health Network, Toronto, Ontario, Canada"	https://ClinicalTrials.gov/show/NCT04453774
1233	NCT04359225	A Comparison of 3D and 2D Telemedicine During Covid 19	Not yet recruiting	No Results Available	Telehealth	Other: 3D Telemedicine|Other: 2D Telemedicine	Not Applicable	Interventional	"Canniesburn Regional Plastic Surgery and Burns Unit, Glasgow, Scotland, United Kingdom"	https://ClinicalTrials.gov/show/NCT04359225
1234	NCT04345419	A Real-life Experience on Treatment of Patients With COVID 19	Recruiting	No Results Available	COVID	Drug: Chloroquine|Drug: Favipiravir|Drug: Nitazoxanide|Drug: Ivermectin|Drug: Niclosamide|Drug: Other drugs	Phase 2|Phase 3	Interventional	"Tanta university hospital, Tanta, Egypt"	https://ClinicalTrials.gov/show/NCT04345419
1235	NCT04445454	Mesenchymal Stromal Cell Therapy for Severe Covid-19 Infection	Recruiting	No Results Available	Coronavirus Infection	Biological: Mesenchymal stromal cells	Phase 1|Phase 2	Interventional	"CHU de Liège, Liège, Belgium"	https://ClinicalTrials.gov/show/NCT04445454
1236	NCT04346329	Immune Monitoring of Prophylactic Effect of Hydroxychloroquine in Healthcare Providers Highly Exposed to COVID-19	Not yet recruiting	No Results Available	COVID	Drug: Hydroxychloroquine|Drug: Placebo oral tablet	Phase 3	Interventional	"Facultad de Medicina - Universidad Nacional de Colombia, Bogota, Cundinamarca, Colombia|Universidad Nacional de Colombia, Bogota, Cundinamarca, Colombia"	https://ClinicalTrials.gov/show/NCT04346329
1237	NCT04336410	"Safety, Tolerability and Immunogenicity of INO-4800 for COVID-19 in Healthy Volunteers"	Recruiting	No Results Available	Coronavirus Infection	Drug: INO-4800|Device: CELLECTRA® 2000	Phase 1	Interventional	"Central Kentucky Research Associates, Lexington, Kentucky, United States|Center for Pharmaceutical Research, Kansas City, Missouri, United States|University of Pennsylvania, Philadelphia, Pennsylvania, United States"	https://ClinicalTrials.gov/show/NCT04336410
1238	NCT04433988	Efficacy of Pentoxifylline as Add on Therapy in COVID19 Patients	Not yet recruiting	No Results Available	COVID	Drug: Pentoxifylline|Drug: Placebo	Phase 1|Phase 2	Interventional	"Faculty of Medicine, Shibīn Al Kawm, Egypt"	https://ClinicalTrials.gov/show/NCT04433988
1239	NCT04420338	"SeroCOVIDial Study: Assessment of COVID-19 Seroconversion in Patients on Chronic Hemodialysis and in Their Caregivers, a Cohort Study"	Recruiting	No Results Available	Chronic Hemodialysis Patients|Caregivers of Chronic Hemodialysis Patients	Biological: Blood sample|Biological: Serum tube collection	Not Applicable	Interventional	"Assistance Publique Hôpitaux de Marseille, Marseille, Paca, France"	https://ClinicalTrials.gov/show/NCT04420338
1240	NCT04432272	ANTIBODY-LEVEL BASED ANALYSIS OF COVID CONVALESCENT SERUM (ABACCuS)	Not yet recruiting	No Results Available	COVID-19|Severe Acute Respiratory Syndrome (SARS)|Coronavirus Infections	Biological: COVID-19 convalescent plasma	Phase 2	Interventional	"William Beaumont Hospital, Royal Oak, Michigan, United States"	https://ClinicalTrials.gov/show/NCT04432272
1241	NCT04355637	Inhaled Corticosteroid Treatment of COVID19 Patients With Pneumonia	Recruiting	No Results Available	Coronavirus Infection	Drug: Inhaled budesonide	Phase 4	Interventional	"Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, Spain|Hospital Universitari de Bellvitge, Hospitalet de Llobregat, Barcelona, Spain|Hospital de Sabadell-Parc Tauli, Sabadell, Barcelona, Spain|Hospital del Mar, Barcelona, Spain|Hospital Universitari Vall d'Hebron, Barcelona, Spain|Hospital Clinic of Barcelona, Barcelona, Spain|Hospital de la Santa Creu i Sant Pau, Barcelona, Spain"	https://ClinicalTrials.gov/show/NCT04355637
1242	NCT04351542	Ayurveda for Flu Like Illness During Covid-19 Outbreak	Completed	No Results Available	Flu Like Illness	Dietary Supplement: Ayurveda|Other: Usual Care	Not Applicable	Interventional	"Aarogyam, Leicester, United Kingdom"	https://ClinicalTrials.gov/show/NCT04351542
1243	NCT04397705	Remote Monitoring of Cancer Patients With Suspected Covid-19	Not yet recruiting	No Results Available	COVID|Oncology|Haematological Malignancy	Device: Patient Status Engine	Phase 1	Interventional	"The Christie NHS Foundation Trust, Manchester, Greater Manchester, United Kingdom"	https://ClinicalTrials.gov/show/NCT04397705
1244	NCT04427631	Exploring Interventions for Glue Ear During Covid-19	Not yet recruiting	No Results Available	"Hearing Impaired Children|Glue Ear|Hearing Loss, Conductive"	Device: Bone conduction headphones	Not Applicable	Interventional	"Peacock Children's centre. Brookfields Hospital, Cambridge, Cambridgeshire, United Kingdom"	https://ClinicalTrials.gov/show/NCT04427631
1245	NCT04382391	Study Assessing Vagus Nerve Stimulation in CoViD-19 Respiratory Symptoms	Recruiting	No Results Available	"COVID|Corona Virus Infection|Respiratory Failure|Respiratory Distress Syndrome, Adult|ARDS, Human|SARS (Severe Acute Respiratory Syndrome)"	Device: gammaCore® Sapphire (non-invasive vagus nerve stimulator)|Other: Standard of care therapies	Not Applicable	Interventional	"AHN Allegheny General Hospital, Pittsburgh, Pennsylvania, United States"	https://ClinicalTrials.gov/show/NCT04382391
1246	NCT04425005	Home-based Exercise Training During Covid-19 Pandemic in Post-bariatric	Recruiting	No Results Available	Bariatric Surgery|Obesity	Other: Home-based exercise	Not Applicable	Interventional	"Univsersity of Sao Paulo, Sao Paulo, Brazil"	https://ClinicalTrials.gov/show/NCT04425005
1247	NCT04344106	Prone Positioning in Spontaneously Breathing Nonintubated Covid-19 Patient: a Pilot Study	Recruiting	No Results Available	Coronavirus Infection|Oxygen Deficiency	Procedure: Prone positioning	Not Applicable	Interventional	"CHI Aix-Pertuis, Aix-en-Provence, France"	https://ClinicalTrials.gov/show/NCT04344106
1248	NCT04435379	Study to Assess VPM1002 in Reducing Hospital Admissions and/or Severe Respiratory Infectious Diseases in Elderly in COVID-19 Pandemic	Recruiting	No Results Available	"Infection, Respiratory Tract"	Biological: VPM1002|Biological: Placebo	Phase 3	Interventional	"Medizinische Hochschule Hannover, Hannover, Niedersachsen, Germany|SocraTec R&D GmbH, Erfurt, Thüringen, Germany|emovis GmbH, Berlin, Germany|Klinische Forschung Berlin GbR, Berlin, Germany"	https://ClinicalTrials.gov/show/NCT04435379
1249	NCT04403906	Somerset and South Essex Coronavirus Antigen Testing	Not yet recruiting	No Results Available	COVID|SARS-CoV 2	Diagnostic Test: PCL COV05 - COVID 19 Ag Rapid FIA test (Rapid Antigen Test)	Not Applicable	Interventional	"Musgrove Park Hospital, Taunton, Somerset, United Kingdom"	https://ClinicalTrials.gov/show/NCT04403906
1250	NCT04363606	Chronic Fatigue Etiology and Recovery in Covid-19 Patients: the Role of Fatigability	Recruiting	No Results Available	Chronic Fatigue Syndrome|Intensive Care Unit|Muscle	Other: Questionnaires|Biological: blood test|Other: Maximal effort test|Device: actigraphy|Device: Neuromuscular evaluation	Not Applicable	Interventional	"CHU de Grenoble, Grenoble, France|Clinique de la Sauvegarde - Lyon, Lyon, France|Hôpital Croix Rousse - HCL, Lyon, France|Chu Saint-Etienne, Saint Etienne, France|Clinique Mutualiste Saint Etienne, Saint Etienne, France|Hôpital privé de la Loire, Saint-Étienne, France"	https://ClinicalTrials.gov/show/NCT04363606
1251	NCT04420676	Synbiotic Therapy of Gastrointestinal Symptoms During Covid-19 Infection	Not yet recruiting	No Results Available	COVID	Dietary Supplement: Omnibiotic AAD|Dietary Supplement: Placebo	Not Applicable	Interventional	"Department of Internal Medicine, Medical University of Graz, Graz, Austria"	https://ClinicalTrials.gov/show/NCT04420676
1252	NCT04453475	Feasibility and Benefits of Digital Services During the COVID19 Pandemic	Not yet recruiting	No Results Available	"Psychosomatic Disorder|Parkinson|Psychological Distress|Psychological Stress|Psychological Disease|Psychological Disorder|Psychological Impairment|Psychological Disability|Psychological Adjustment|Psychological Adaptation|Communication|Health Care Seeking Behavior|Anxiety|Behavior, Health|Health Risk Behaviors|Healthy Lifestyle"	Behavioral: Training session adressing information and health literacy	Not Applicable	Interventional	"Jacobs University Bremen gGmbH, Bremen, Germany"	https://ClinicalTrials.gov/show/NCT04453475
1253	NCT04349371	Saved From COVID-19	Recruiting	No Results Available	COVID	Drug: Chloroquine|Drug: Placebo oral tablet	Phase 2	Interventional	"Columbia University Irving Medical Center/NYP, New York, New York, United States"	https://ClinicalTrials.gov/show/NCT04349371
1254	NCT04380909	ROCO - Self-help for People With Psychological Distress Due to the Covid-19 Situation	Recruiting	No Results Available	"Psychological Distress|Adjustment, Psychological|Coronavirus"	Behavioral: Internet-based self-help|Behavioral: Internet-based self-help after 3 weeks	Not Applicable	Interventional	"Universität Bern, Bern, Switzerland"	https://ClinicalTrials.gov/show/NCT04380909
1255	NCT04369378	Effectiveness of Using a Meditation App in Reducing Anxiety and Improving Well-being During the Covid-19 Pandemic	Not yet recruiting	No Results Available	Anxiety|Well-being	Behavioral: Meditation app usage	Not Applicable	Interventional		https://ClinicalTrials.gov/show/NCT04369378
1256	NCT04410536	Home Detox in Medication Overuse Headache (MOH) During Covid-19 Emergency	Not yet recruiting	No Results Available	"Migraine, Hemicrania"	Drug: Symptomatic drugs|Drug: Bridge therapy|Behavioral: Mindfulness program	Not Applicable	Interventional	"Fondazione IRCCS Istituto Neurologico C. Besta, Neuroalgology Unit, Milano, Italy"	https://ClinicalTrials.gov/show/NCT04410536
1257	NCT04422353	Video Dance Class and Unsupervised Physical Activity During Covid-19 Pandemic in People With Parkinson's Disease	Recruiting	No Results Available	Parkinson Disease|Parkinson Disease 10	Other: Video Dance classes|Other: Unsupervised physical activities	Not Applicable	Interventional	"Universidade Federal do Rio Grande do Sul, Porto Alegre, Rio Grande Do Sul, Brazil"	https://ClinicalTrials.gov/show/NCT04422353
1258	NCT04449627	Psychological Impact of Admission With Covid-19 During the SARS-CoV-2 Pandemic: Clinical Trial of a Digital Intervention to Improve Wellbeing	Not yet recruiting	No Results Available	Anxiety Disorders|Post Traumatic Stress Disorder|Depressive Disorder	Other: Feeling Good Digital App	Not Applicable	Interventional		https://ClinicalTrials.gov/show/NCT04449627
1259	NCT04347031	A Study of the Effectiveness of an Off Label Mefloquine Use for the Treatment of Patients With COVID19	"Active, not recruiting"	No Results Available	"Pneumonia, Viral|Respiratory Failure"	Drug: Mefloquine|Drug: Hydroxychloroquine|Combination Product: Mefloquine + azithromycin + / - tocilizumab|Combination Product: Hydroxychloroquine + azithromycin + / - tocilizumab	Phase 2|Phase 3	Interventional	"Burnasyan Federal Medical Biophysical Center FMBA of Russia, Moscow, Russian Federation"	https://ClinicalTrials.gov/show/NCT04347031
1260	NCT04455360	Early EMDR Following Covid-19 Critical Illness: A Feasibility Trial	Not yet recruiting	No Results Available	Post Traumatic Stress Disorder|Intensive Care Psychiatric Disorder|Anxiety Disorders|Depression|Critical Care|COVID	Other: Eye Movement Desensitisation and Reprocessing Recent traumatic Event Protocol	Not Applicable	Interventional		https://ClinicalTrials.gov/show/NCT04455360
1261	NCT04362358	Online Cognitive Behavioral Therapy (CBT) for Stress Disorders in Health Workers Involved in the Care of Patients During the Covid-19 Epidemic	Not yet recruiting	No Results Available	"Stress - Prevention of Sleep Disorders, PTSD and Depression"	Behavioral: Online cognitive behavioral therapy (CBT)|Behavioral: Online bibliotherapy programme	Not Applicable	Interventional		https://ClinicalTrials.gov/show/NCT04362358
1262	NCT04390152	Safety and Efficacy of Intravenous Wharton's Jelly Derived Mesenchymal Stem Cells in Acute Respiratory Distress Syndrome Due to COVID 19	Not yet recruiting	No Results Available	Acute Respiratory Distress Syndrome	"Drug: Wharton's jelly derived Mesenchymal stem cells.|Drug: Hydroxychloroquine, lopinavir/ritonavir or azithromycin and placebo (standard therapy)"	Phase 1|Phase 2	Interventional	"Clinical Somer, Rionegro, Antioquia, Colombia"	https://ClinicalTrials.gov/show/NCT04390152
1263	NCT04363528	Incidence of Deep Vein Thrombosis at Doppler Echo in Covid-19 Patients With SARS-Cov-2 Pneumopathy Hospitalized in ICU	Not yet recruiting	No Results Available	Deep Vein Thrombosis	Other: Doppler Echo	Not Applicable	Interventional	"Centre Hospitalier de Versailles, Le Chesnay, France"	https://ClinicalTrials.gov/show/NCT04363528
1264	NCT04348370	BCG Vaccine for Health Care Workers as Defense Against COVID 19	Recruiting	No Results Available	Coronavirus|Coronavirus Infection|Coronavirus as the Cause of Diseases Classified Elsewhere	Biological: BCG Vaccine|Biological: Placebo Vaccine	Phase 4	Interventional	"Cedars-Sinai Medical Center, Los Angeles, California, United States|Texas A&M Family Care Clinic, Bryan, Texas, United States|Baylor College of Medicine, Houston, Texas, United States|Baylor St. Luke's Medical Center, Houston, Texas, United States|Harris Health System - Ben Taub Hospital, Houston, Texas, United States|MD Anderson Cancer Center, Houston, Texas, United States"	https://ClinicalTrials.gov/show/NCT04348370
1265	NCT04350281	Double Therapy With IFN-beta 1b and Hydroxychloroquine	Recruiting	No Results Available	COVID	Drug: Interferon Beta-1B|Drug: Hydroxychloroquine	Phase 2	Interventional	"The University of Hong Kong, Queen Mary Hospital, Hong Kong, Hong Kong"	https://ClinicalTrials.gov/show/NCT04350281
1266	NCT04373824	Max Ivermectin- COVID 19 Study Versus Standard of Care Treatment for COVID 19 Cases. A Pilot Study	Recruiting	No Results Available	COVID	Drug: Ivermectin	Not Applicable	Interventional	"Max Super Speciality hospital, Saket (A unit of Devki Devi Foundation), New Delhi, Delhi, India"	https://ClinicalTrials.gov/show/NCT04373824
1267	NCT04343729	Methylprednisolone in the Treatment of Patients With Signs of Severe Acute Respiratory Syndrome in Covid-19	"Active, not recruiting"	No Results Available	SARS-CoV Infection|Severe Acute Respiratory Syndrome (SARS) Pneumonia	Drug: Methylprednisolone Sodium Succinate|Drug: Placebo solution	Phase 2	Interventional	"Hospital e Pronto Socorro Delphina Rinaldi Abdel Aziz, Manaus, Amazonas, Brazil"	https://ClinicalTrials.gov/show/NCT04343729
1268	NCT04341584	CORIMUNO-ANA: Trial Evaluating Efficacy Of Anakinra In Patients With Covid-19 Infection	Not yet recruiting	No Results Available	Corona Virus Infection	Drug: Anakinra	Phase 2	Interventional		https://ClinicalTrials.gov/show/NCT04341584
1269	NCT04340557	Do Angiotensin Receptor Blockers Mitigate Progression to Acute Respiratory Distress Syndrome With SARS-CoV-2 Infection	Recruiting	No Results Available	SARS-CoV Infection	Drug: Losartan	Phase 4	Interventional	"Sharp Grossmont Hospital, La Mesa, California, United States|Sharp Chula Vista Medical Center, San Diego, California, United States|Sharp Coronado Hospital, San Diego, California, United States|Sharp Memorial Hospital, San Diego, California, United States"	https://ClinicalTrials.gov/show/NCT04340557
1270	NCT04376034	Convalescent Plasma Collection and Treatment in Pediatrics and Adults	Recruiting	No Results Available	COVID19|Coronavirus Infection|Coronavirus|Virus Diseases|RNA Virus Infections	Biological: Convalescent Plasma 1 Unit|Biological: Convalescent Plasma 2 Units|Other: Standard of Care	Phase 3	Interventional	"WVU Medicine, Morgantown, West Virginia, United States"	https://ClinicalTrials.gov/show/NCT04376034
1271	NCT04269525	Umbilical Cord(UC)-Derived Mesenchymal Stem Cells(MSCs) Treatment for the 2019-novel Coronavirus(nCOV) Pneumonia	Recruiting	No Results Available	"Pneumonia, Viral|Pneumonia, Ventilator-Associated"	Biological: UC-MSCs	Phase 2	Interventional	"Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China"	https://ClinicalTrials.gov/show/NCT04269525
1272	NCT04423042	Tocilizumab in Coronavirus-19 Positive Patients	Not yet recruiting	No Results Available	Covid19|COVID-19|Severe Acute Respiratory Syndrome Coronavirus 2|Coronavirus|Inflammation	Biological: Tocilizumab	Phase 3	Interventional		https://ClinicalTrials.gov/show/NCT04423042
1273	NCT04325672	Convalescent Plasma to Limit Coronavirus Associated Complications	Withdrawn	No Results Available	Coronavirus	Biological: Convalescent Plasma	Phase 2	Interventional		https://ClinicalTrials.gov/show/NCT04325672
1274	NCT04261907	Evaluating and Comparing the Safety and Efficiency of ASC09/Ritonavir and Lopinavir/Ritonavir for Novel Coronavirus Infection	Not yet recruiting	No Results Available	2019-nCoV	Drug: ASC09/ritonavir group|Drug: lopinavir/ritonavir group	Not Applicable	Interventional		https://ClinicalTrials.gov/show/NCT04261907
1275	NCT04326075	Early CPAP in COVID Patients With Respiratory Failure.	Not yet recruiting	No Results Available	CPAP Ventilation|COVID-19|Emergency Departments	Device: CPAP treatment	Not Applicable	Interventional		https://ClinicalTrials.gov/show/NCT04326075
1276	NCT04454606	The New Silicone N99 Half-Piece Respirator	Completed	No Results Available	COVID|Personal Protective Equipment	Device: Fit test|Device: Filtration Test	Not Applicable	Interventional	"Bangkok Metroplitan Administration and Vajira Hospital, Bangkok, Thailand"	https://ClinicalTrials.gov/show/NCT04454606
1277	NCT04264533	Vitamin C Infusion for the Treatment of Severe 2019-nCoV Infected Pneumonia	Recruiting	No Results Available	"Vitamin C|Pneumonia, Viral|Pneumonia, Ventilator-Associated"	Drug: VC|Drug: Sterile Water for Injection	Phase 2	Interventional	"Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China"	https://ClinicalTrials.gov/show/NCT04264533
1278	NCT02765191	MR-Evaluation of Renal Function In Septic Patients	Recruiting	No Results Available	"Sepsis, Severe|Acute Kidney Injury|COVID-19"	Other: Plasma expansion with Ringer's Acetate	Not Applicable	Interventional	"Uppsala University Hospital, Uppsala, Sweden"	https://ClinicalTrials.gov/show/NCT02765191
1279	NCT04452318	Study Assessing the Efficacy and Safety of Anti-Spike SARS CoV-2 Monoclonal Antibodies for Prevention of SARS CoV-2 Infection Asymptomatic in Healthy Adults Who Are Household Contacts to an Individual With a Positive SARS-CoV-2 RT-PCR Assay	Not yet recruiting	No Results Available	Healthy Participants	Drug: REGN10933+REGN10987|Drug: Placebo	Phase 3	Interventional		https://ClinicalTrials.gov/show/NCT04452318
1280	NCT04338841	HOME-CoV: Hospitalization or Outpatient ManagEment of Patients With a SARS-CoV-2 Infection	Recruiting	No Results Available	Coronavirus Infection	Other: HOME-CoV rule implementation	Not Applicable	Interventional	"Clinique Universitaire Saint-Luc, Bruxelles, Belgium|CHU de Liège, Liege, Belgium|Ch Argenteuil, Argenteuil, France|CHU Brest, Brest, France|CH Cholet, Cholet, France|CHU Clermont Ferrand, Clermont Ferrand, France|Ch Colmar, Colmar, France|CH Alpes Lemant, Contamine-sur-Arve, France|CHU Dijon, Dijon, France|CH Le Mans, Le Mans, France|CH Libourne, Libourne, France|CH Limoges, Limoges, France|Ch Longjumeau, Longjumeau, France|Hospices Civils de Lyon (University Hospital of Lyon), Lyon, France|Chu Montpellier, Montpellier, France|Centre Hospitalier Universitaire de Nantes, Nantes, France|CH Niort, Niort, France|Hopital Paris Saint Joseph, Paris, France|Hopital Saint Antoine, Paris, France|Hôpital Bichat, Paris, France|Hôpital Lariboisière, Paris, France|CHU de Poitiers, Poitiers, France|CH Reims, Reims, France|Ch Remiremont, Remiremont, France|Chu Rennes, Rennes, France|CHU de Rouen, Rouen, France|CHU de St Etienne, Saint Etienne, France|CH de Saint-Brieuc, Saint-Brieuc, France|Ch Troyes, Troyes, France|CH VICHY, Vichy, France|CH Princesse Grace, Monaco, Monaco"	https://ClinicalTrials.gov/show/NCT04338841
1281	NCT04323527	Chloroquine Diphosphate for the Treatment of Severe Acute Respiratory Syndrome Secondary to SARS-CoV2	Recruiting	No Results Available	SARS-CoV Infection|Severe Acute Respiratory Syndrome (SARS) Pneumonia	Drug: Chloroquine diphosphate	Phase 2	Interventional	"Hospital e Pronto Socorro Delphina Rinaldi Abdel Aziz, Manaus, Amazonas, Brazil"	https://ClinicalTrials.gov/show/NCT04323527
1282	NCT04342728	Coronavirus 2019 (COVID-19)- Using Ascorbic Acid and Zinc Supplementation	Enrolling by invitation	No Results Available	COVID|Corona Virus Infection	Dietary Supplement: Ascorbic Acid|Dietary Supplement: Zinc Gluconate|Dietary Supplement: Ascorbic Acid and Zinc Gluconate|Other: Standard of Care	Not Applicable	Interventional	"Cleveland Clinic, Weston, Florida, United States|Cleveland Clinic, Cleveland, Ohio, United States"	https://ClinicalTrials.gov/show/NCT04342728
1283	NCT04435522	Maraviroc in SARS-CoV-2	Not yet recruiting	No Results Available	COVID	Drug: Maraviroc	Early Phase 1	Interventional	"Rhode Isand Hospital, Providence, Rhode Island, United States"	https://ClinicalTrials.gov/show/NCT04435522
1284	NCT04361838	The COVID-19 ICU PRAYER Study	Recruiting	No Results Available	Coronavirus Infection	Behavioral: prayer	Not Applicable	Interventional	"Research Medical Center, Kansas City, Missouri, United States"	https://ClinicalTrials.gov/show/NCT04361838
1285	NCT03331445	Inhaled Gaseous Nitric Oxide (gNO) Antimicrobial Treatment of Difficult Bacterial and Viral Lung (COVID-19) Infections	"Active, not recruiting"	No Results Available	Respiratory Tract Infections|Corona Virus Infection	Drug: Nitric Oxide 0.5 % / Nitrogen 99.5 % Gas for Inhalation	Phase 2	Interventional	"Diamond Centre, Vancouver, British Columbia, Canada"	https://ClinicalTrials.gov/show/NCT03331445
1286	NCT04322682	Colchicine Coronavirus SARS-CoV2 Trial (COLCORONA)	Recruiting	No Results Available	Corona Virus Infection	Drug: Colchicine|Drug: Placebo oral tablet	Phase 3	Interventional	"University of California, San Francisco - San Francisco General Hospital, San Francisco, California, United States|New York University School of Medecine, New York, New York, United States|Montreal Heart Institute, Montreal, Quebec, Canada|Hospital Universitario La Paz, IdiPaz, La Paz, Madrid, Spain"	https://ClinicalTrials.gov/show/NCT04322682
1287	NCT04281693	A New Screening Strategy for 2019 Novel Coronavirus Infection	Not yet recruiting	No Results Available	Novel Coronavirus Infection Pneumonia	Diagnostic Test: Standard screening strategy|Diagnostic Test: New screening strategy	Not Applicable	Interventional	"the Fifth Medical Center of Chinese PLA General Hospital, Beijing, Beijing, China"	https://ClinicalTrials.gov/show/NCT04281693
1288	NCT04377165	Innovative Tool to Limit Spread of SARS-CoV-2 in Residential Aged Care Facilities	Not yet recruiting	No Results Available	COVID|Influenza|Gastroenteritis	Behavioral: Gamification|Behavioral: Newsfeed function	Not Applicable	Interventional		https://ClinicalTrials.gov/show/NCT04377165
1289	NCT04429594	Study of the Incidence of SARS-CoV-2 Infection	Not yet recruiting	No Results Available	Coronavirus Infections	Other: blood sampling	Not Applicable	Interventional	"University Nice Hospital, Nice, France"	https://ClinicalTrials.gov/show/NCT04429594
1290	NCT04356833	Nebulised Rt-PA for ARDS Due to COVID-19	Recruiting	No Results Available	COVID	Drug: nebulised recombinant tissue-Plasminogen Activator (rt-PA)	Phase 2	Interventional	"The Royal Free Hospital, London, United Kingdom"	https://ClinicalTrials.gov/show/NCT04356833
1291	NCT04392219	"COVID-19 First In Human Study to Evaluate Safety, Tolerability, and Pharmacokinetics of EIDD-2801 in Healthy Volunteers"	Recruiting	No Results Available	Coronavirus	Drug: EIDD-2801|Drug: Placebo	Phase 1	Interventional	"Covance Daytona Beach Clinical Research Unit, Daytona Beach, Florida, United States|Covance Dallas Clinical Research Unit, Dallas, Texas, United States|Covance Madison Clinical Research Unit, Madison, Wisconsin, United States|Covance Leeds Clinical Research Unit, Leeds, United Kingdom"	https://ClinicalTrials.gov/show/NCT04392219
1292	NCT04385836	Trial of Alpha One Antitrypsin Inhalation in Treating Patient With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)	Recruiting	No Results Available	Coronavirus	Drug: alpha one antitrypsin inhalation	Early Phase 1	Interventional	"Ministry of Health, Mecca, Saudi Arabia"	https://ClinicalTrials.gov/show/NCT04385836
1293	NCT04275245	Clinical Study of Anti-CD147 Humanized Meplazumab for Injection to Treat With 2019-nCoV Pneumonia	Recruiting	No Results Available	2019-nCoVs Infection Pneumonia	Drug: Meplazumab for Injection	Phase 1|Phase 2	Interventional	"Tangdu Hospital, Xi'an, Shaanxi, China"	https://ClinicalTrials.gov/show/NCT04275245
1294	NCT04394403	Pilot Internet-based Self-Help Program for Managing Corona (COVID-19) Stress	Recruiting	No Results Available	"Stress|Stress, Psychological"	Behavioral: Internet-based guided self-help based on CBT principles	Not Applicable	Interventional	"Hebrew University of Jerusalem, Jerusalem, Israel"	https://ClinicalTrials.gov/show/NCT04394403
1295	NCT04355052	"Open Label Study to Compare Efficacy, Safety and Tolerability of Hydroxychloroquine Combined With Azithromycin Compared to Hydroxychloroquine Combined With Camostat Mesylate and to ""no Treatment"" in SARS CoV 2 Virus"	Recruiting	No Results Available	COVID - 19	Drug: hydroxychloroquine in combination with camostat mesylate|Drug: Hydroxychloroquine in combination of Azithromycin	Phase 3	Interventional	"Sheba Medical Center, Ramat Gan, Israel|Sheba Medical Center, Tel HaShomer, Israel"	https://ClinicalTrials.gov/show/NCT04355052
1296	NCT04341727	"Hydroxychloroquine,Hydroxychloroquine,Azithromycin in the Treatment of SARS CoV-2 Infection"	Suspended	No Results Available	Coronavirus Infection	Drug: Hydroxychloroquine Sulfate|Drug: Azithromycin|Drug: Chloroquine Sulfate	Phase 3	Interventional	"Washington University School of Medicine Infectious Disease Clinical Research Unit, Saint Louis, Missouri, United States|Washington University School of Medicine, Saint Louis, Missouri, United States"	https://ClinicalTrials.gov/show/NCT04341727
1297	NCT04382560	Coping Strategies and Responsiveness to a Brief Online Intervention During COVID-19 Pandemic	Recruiting	No Results Available	"Behavior, Social|Autonomic Imbalance"	Other: Deep Breathing training|Other: Compassion focused intervention	Not Applicable	Interventional	"Sapienza University of Rome, Rome, Italy"	https://ClinicalTrials.gov/show/NCT04382560
1298	NCT04420273	Targeted Melanoma Detection With Skin Self-Examination During COVID-19 Restricted Physician Access	Not yet recruiting	No Results Available	Melanoma	Behavioral: SSE educational intervention|Other: Home sample collection of concerning mole with physician supervision|Behavioral: Active control:Healthy Living	Not Applicable	Interventional	"Northwestern University Feinberg School of Medicine Department of Dermatology, Chicago, Illinois, United States"	https://ClinicalTrials.gov/show/NCT04420273
1299	NCT04373707	Weight-Adjusted vs Fixed Low Doses of Low Molecular Weight Heparin For Venous Thromboembolism Prevention in COVID-19	Recruiting	No Results Available	COVID|Thrombosis|Pulmonary Embolism|Deep Vein Thrombosis	Drug: Enoxaparin	Phase 4	Interventional	"Amiens Academic Hospital, Amiens, France|Besançon Academic Hospital, Besançon, France|Brest Academic Hospital, Brest, France|Civil Hospital, Colmar, France|Dijon Academic Hospital, Dijon, France|Marseille Academic Hospital, Marseille, France|Metz-Thionville Regional Hospital, Metz, France|Montpellier Academic Hospital, Montpellier, France|Emile Muller Hospital, Mulhouse, France|Nancy Academic Hospital, Nancy, France|George Pompidou European Hospital, Paris, France|St Etienne Academic Hospital, Saint-Étienne, France|Strasbourg Academic Hospital, Strasbourg, France|Toulouse Academic Hospital, Toulouse, France"	https://ClinicalTrials.gov/show/NCT04373707
1300	NCT04375774	Verification of Alternative Do-it-yourself Equipment Respirators for the COVID-19 Personal Protective Equipment (PPE)	Recruiting	No Results Available	COVID	Device: FFP2|Device: Facial mask|Device: MFS	Not Applicable	Interventional	"Cliniques Universitaires Saint-Luc, Brussels, Belgium"	https://ClinicalTrials.gov/show/NCT04375774
1301	NCT04368676	Breath Regulation and Yogic Exercise An Online Therapy for Calm and Happiness	Not yet recruiting	No Results Available	Job Stress|Workplace Stress|Compassion Fatigue|Psychological Trauma|Healthcare Workers|Healthcare Providers	Other: Sudarshan Kriya Yoga (SKY)|Other: Health Enhancement Program	Early Phase 1	Interventional	"London Health Sciences Centre, London, Ontario, Canada"	https://ClinicalTrials.gov/show/NCT04368676
1302	NCT04394039	Post-Pandemic Perception of Public Space in Singapore	Not yet recruiting	No Results Available	Stress|Anxiety	Other: Public space exposure	Not Applicable	Interventional	"Institute for Health Innovation & Technology (iHealthtech), Singapore, Singapore"	https://ClinicalTrials.gov/show/NCT04394039
1303	NCT04425616	SafeFit Trial: Virtual Clinics to Deliver Universal Interventions in People With Cancer	Recruiting	No Results Available	Cancer|COVID	Other: Exercise|Behavioral: Psychological and Behaviour Change Support|Other: Nutrition	Not Applicable	Interventional	"University Hospital Southampton NHS FT, Southampton, United Kingdom"	https://ClinicalTrials.gov/show/NCT04425616
1304	NCT03648372	"A Study to Evaluate the Safety, Tolerability and Pharmacokinetics (PK) of TAK-981 in Adult Participants With Advanced or Metastatic Solid Tumors or Relapsed/Refractory Hematologic Malignancies and in a Subset With Coronavirus Disease 2019 (COVID-19)"	Recruiting	No Results Available	Neoplasms|Lymphoma|Hematologic Neoplasms|Coronavirus Disease	Drug: TAK-981|Drug: Standard of care	Phase 1	Interventional	"University of California San Diego Moores Cancer Center, La Jolla, California, United States|Massachusetts General Hospital, Boston, Massachusetts, United States|Barbara Ann Karmanos Cancer Institute, Detroit, Michigan, United States|HealthPartners Cancer Care Center - Regions Hospital, Saint Paul, Minnesota, United States|University Hospitals Seidman Cancer Center, Cleveland, Ohio, United States|Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States|The University of Texas MD Anderson Cancer Center, Houston, Texas, United States|Froedtert and the Medical College of Wisconsin, Milwaukee, Wisconsin, United States"	https://ClinicalTrials.gov/show/NCT03648372
1305	NCT04378803	Mindfulness Training for Seniors	"Active, not recruiting"	No Results Available	Well Aging	Behavioral: Mindfulness training (MT) Connect	Not Applicable	Interventional	"University of Miami, Coral Gables, Florida, United States"	https://ClinicalTrials.gov/show/NCT04378803
1306	NCT04445428	OPV as Potential Protection Against COVID	Not yet recruiting	No Results Available	"Poliovirus Vaccine, Oral|COVID|Mortality|Morbidity|Non-Specific Effects of Vaccines"	Biological: oral polio vaccine + information|Behavioral: Information	Phase 4	Interventional	"Bandim Health Project, Bissau, Guinea-Bissau"	https://ClinicalTrials.gov/show/NCT04445428
1307	NCT04335851	Video-Based Exercises and Well-Being During Social Isolation	Completed	No Results Available	Social Isolation|Physical Inactivity|Well-Being	Other: Video based aerobic exercise	Not Applicable	Interventional	"Biruni University, Istanbul, Turkey|Istanbul University Cerrahpasa, Istanbul, Turkey"	https://ClinicalTrials.gov/show/NCT04335851
1308	NCT04399005	The Efficacy Comparing Daily and After-each-case Room Disinfection.	Completed	No Results Available	Daily Room Disinfection|After-each-case Room Disinfection	Other: after-each-case room disinfection|Other: daily room disinfection	Not Applicable	Interventional	"First Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China"	https://ClinicalTrials.gov/show/NCT04399005
1309	NCT04442958	Effectiveness of Convalescent Immune Plasma Therapy	Completed	No Results Available	Acute Respiratory Distress Syndrome	Other: Convalescent Immune Plasma	Not Applicable	Interventional	"Istanbul Bagcılar Training and Research Hospital, Istanbul, Turkey"	https://ClinicalTrials.gov/show/NCT04442958
1310	NCT04328467	Pre-exposure Prophylaxis for SARS-Coronavirus-2	"Active, not recruiting"	No Results Available	COVID-19|Corona Virus Infection|ARDS|Acute Respiratory Distress Syndrome	Drug: Hydroxychloroquine|Other: Placebo	Phase 3	Interventional	"Nationwide Enrollment via Internet, please email: covid19@umn.edu, Minneapolis, Minnesota, United States|University of Minnesota, Minneapolis, Minnesota, United States"	https://ClinicalTrials.gov/show/NCT04328467
1311	NCT04346927	Telerehabilitation for Patients Diagnosed With Coronavirus	Not yet recruiting	No Results Available	Telerehabilitation|Coronavirus	Other: Telerehabilitation|Other: exercise brochure	Not Applicable	Interventional		https://ClinicalTrials.gov/show/NCT04346927
1312	NCT04409496	Chat-based Support for Preveting Smoking Relapse	Recruiting	No Results Available	Smoking Cessation	Behavioral: Chat-based instant messaging support|Behavioral: SMS message support|Behavioral: Self-help booklet	Not Applicable	Interventional	"Tung Wah Group of Hospitals Integrated Centre on Smoking Cessation, Hong Kong, Hong Kong"	https://ClinicalTrials.gov/show/NCT04409496
1313	NCT04368299	Telemedicine for Follow-up of Systemic Lupus Erythematosus	Not yet recruiting	No Results Available	SLE	Other: Telemedicine|Other: Standard care	Not Applicable	Interventional		https://ClinicalTrials.gov/show/NCT04368299
1314	NCT04380961	A Study to Evaluate the Efficacy and Safety of Sirukumab in Confirmed Severe or Critical Confirmed Coronavirus Disease (COVID)-19	Recruiting	No Results Available	Severe or Critical Confirmed Coronavirus Disease (COVID)-19	Drug: Sirukumab|Drug: Placebo|Other: Standard of Care (SOC)	Phase 2	Interventional	"Loyola University Medical Center, Maywood, Illinois, United States|University of Illinois College of Medicine at Peoria, Peoria, Illinois, United States|Kentuckiana Pulmonary Associates, Louisville, Kentucky, United States|Louisiana State University Health Sciences Center, New Orleans, Louisiana, United States|Wayne State University/Detroit Medical Center, Detroit, Michigan, United States|Henry Ford Hospital, Detroit, Michigan, United States|Beaumont Health Systems, Royal Oak, Michigan, United States|Washington University School of Medicine, Saint Louis, Missouri, United States|Mercury Street Medical Group, PLLC, Butte, Montana, United States|Saint Michael's Medical Center - Infectious Disease, Newark, New Jersey, United States|SUNY Upstate Medical University, Syracuse, New York, United States|East Carolina University, Greenville, North Carolina, United States|Baylor Scott & White Research Institute, Dallas, Texas, United States"	https://ClinicalTrials.gov/show/NCT04380961
1315	NCT04369274	Repeated Measures Trial of Temporary Automated Manual Ventilation Versus Noninvasive Oxygenation or Conventional Vent	Not yet recruiting	No Results Available	Respiratory Failure	Device: Mechanical ventilation with the automated BVM compressor	Not Applicable	Interventional		https://ClinicalTrials.gov/show/NCT04369274
1316	NCT04418947	Project Resurgence Communication Trial	Not yet recruiting	No Results Available	Communication Research	Other: Communication type	Not Applicable	Interventional	"University of Pennsylvania, Philadelphia, Pennsylvania, United States"	https://ClinicalTrials.gov/show/NCT04418947
1317	NCT04413006	Self-compassion for Chronic Pain Virtual Group Treatment Program	Recruiting	No Results Available	Chronic Pain	Behavioral: Self-Compassion for Chronic Pain Virtual Group Treatment Program	Not Applicable	Interventional	"University of Manitoba, Winnipeg, Manitoba, Canada"	https://ClinicalTrials.gov/show/NCT04413006
1318	NCT04404192	PH94B in the Treatment of Adjustment Disorder With Anxiety	Not yet recruiting	No Results Available	Adjustment Disorder With Anxious Mood	Drug: PH94B	Phase 2	Interventional	"The Medical Research Network, New York, New York, United States"	https://ClinicalTrials.gov/show/NCT04404192
1319	NCT04372693	Unplanned Shifting to Online Distance Learning: Nursing Students' Perception and Achievement	Enrolling by invitation	No Results Available	Distance Learning-Online Learning|Traditional Classroom-Based Learning|Coronavirus Disease Social Distancing Measures|Nursing Students' Perception and Achievement	Other: impliminting Online Distance Learning	Not Applicable	Interventional	"Cairo University Hospital, Cairo, Egypt"	https://ClinicalTrials.gov/show/NCT04372693
1320	NCT04331808	CORIMUNO-19 - Tocilizumab Trial - TOCI (CORIMUNO-TOCI)	"Active, not recruiting"	No Results Available	Corona Virus Infection	Drug: Tocilizumab	Phase 2	Interventional	"APHP- Hopital Tenon, Paris, France|APHP - Beaujon, Paris, France|APHP - Bichat, Paris, France|APHP - Hopital Necker, Paris, France|APHP - Pitié Salpêtrière, Paris, France|APHP - Saint Louis, Paris, France|CHU Strasbourg, Strasbourg, France|Institut Gustave Roussy, Villejuif, France"	https://ClinicalTrials.gov/show/NCT04331808
1321	NCT04394455	Brief Cognitive Behavioral Therapy Versus Crisis Intervention Therapy Through Telepsychiatry on Psychiatric Symptoms	Enrolling by invitation	No Results Available	Anxiety|Depressive Symptoms|Post Traumatic Stress Symptoms|Perceived Stress	Behavioral: Brief cognitive behavioral therapy|Behavioral: Crisis intervention therapy	Not Applicable	Interventional	"Universidad Nacional Autónoma de Honduras, Tegucigalpa, Francisco Morazán, Honduras"	https://ClinicalTrials.gov/show/NCT04394455
1322	NCT04414618	A Study of Opaganib in Coronavirus Disease 2019 Pneumonia	Recruiting	No Results Available	Coronavirus Infections	Drug: Opaganib|Drug: Placebo	Phase 2	Interventional	"HonorHealth Research Institute, Scottsdale, Arizona, United States|Albany Medical Center, Albany, New York, United States|Oregon Health & Science University, Portland, Oregon, United States"	https://ClinicalTrials.gov/show/NCT04414618
1323	NCT04441632	Effect of Positive Attitudes on Behavior and Wellness	Recruiting	No Results Available	"Burnout|Stress, Emotional"	Behavioral: Positive feedback	Not Applicable	Interventional	"Cedars-Sinai Medical Center, Los Angeles, California, United States"	https://ClinicalTrials.gov/show/NCT04441632
1324	NCT04193878	ARrest RESpiraTory Failure From PNEUMONIA	Recruiting	No Results Available	Pneumonia|Hypoxemia|Acute Respiratory Failure|COVID-19	Drug: Inhaled budesonide and formoterol|Drug: Inhaled placebo	Phase 3	Interventional	"Mayo Clinic - Scottsdale, Scottsdale, Arizona, United States|University of Arizona, Tucson, Arizona, United States|Stanford University, Palo Alto, California, United States|University of Florida, Gainesville, Florida, United States|Mayo Clinic - Jacksonville, Jacksonville, Florida, United States|Johns Hopkins University, Baltimore, Maryland, United States|Mayo Clinic - Rochester, Rochester, Minnesota, United States|New York University - Langone Health, New York, New York, United States|Duke University, Durham, North Carolina, United States|Temple University, Philadelphia, Pennsylvania, United States"	https://ClinicalTrials.gov/show/NCT04193878
1325	NCT04413747	Yoga Pranayama Adjuvant to Treat Burden COVID -19	Not yet recruiting	No Results Available	Coronavirus Infection|Cytokine Storm|Mental Disorder	Behavioral: morning pranayama|Behavioral: pre_lunch pranayama|Behavioral: pre_dinner pranayama	Not Applicable	Interventional	"Ambulatorio Telemedicina Giardino St Lucia, Massa Lombarda, Ravenna, Italy"	https://ClinicalTrials.gov/show/NCT04413747
1326	NCT04333251	Study Testing Convalescent Plasma vs Best Supportive Care	Not yet recruiting	No Results Available	"Pneumonia, Interstitial"	Biological: high-titer anti-Sars-CoV-2 plasma|Other: oxygen therapy	Phase 1	Interventional		https://ClinicalTrials.gov/show/NCT04333251
1327	NCT04393415	Using PRP and Cord Blood in Treatment of Covid -19	Not yet recruiting	No Results Available	Virus	Combination Product: stem cells	Not Applicable	Interventional	"Aljazeera( Al Gazeera) hospital, Giza, Egypt"	https://ClinicalTrials.gov/show/NCT04393415
1328	NCT04393636	Digital Cardiac Counseling Trial: DCC Trial	Recruiting	No Results Available	Cardiovascular Diseases|Cardiovascular Risk Factor	Other: Digital cardiac Counseling	Not Applicable	Interventional	"Maastricht University Medical Center, Maastricht, Netherlands"	https://ClinicalTrials.gov/show/NCT04393636
1329	NCT04389372	"Effectiveness and Acceptability of MINDFULNESS by Smartphone, for Patients With Chronic Migraine and Medication Overuse"	Recruiting	No Results Available	Migraine Headache	Behavioral: Mindfulness	Not Applicable	Interventional	"UOC Neurologia 3, Milano, Italy"	https://ClinicalTrials.gov/show/NCT04389372
1330	NCT04428099	Healthy Lifestyle Promotion as Adjunctive Teletherapy for Treatment-resistant Major Depression	Recruiting	No Results Available	"Depressive Disorder, Treatment-Resistant"	Behavioral: Lifestyle change promotion program|Behavioral: Mindfullness based cognitive program|Behavioral: Written Information	Not Applicable	Interventional	"Universitat Illes Balears, Palma de Mallorca, Illes Balears, Spain"	https://ClinicalTrials.gov/show/NCT04428099
1331	NCT04396314	Effectiveness of Basic Body Awareness Therapy in Post-traumatic Stress Disorders: A Randomized Clinical Trial	Not yet recruiting	No Results Available	PostTraumatic Stress Disorder	Behavioral: Basic Body Awareness Therapy|Behavioral: Psychological treatment	Not Applicable	Interventional		https://ClinicalTrials.gov/show/NCT04396314
1332	NCT04380701	A Trial Investigating the Safety and Effects of Four BNT162 Vaccines Against COVID-2019 in Healthy Adults	Recruiting	No Results Available	"Infections, Respiratory|Virus Diseases|Infection Viral|Vaccine Adverse Reaction|RNA Virus Infections"	Biological: BNT162a1|Biological: BNT162b1|Biological: BNT162b2|Biological: BNT162c2	Phase 1|Phase 2	Interventional	"Contract Research Organization, Berlin, Germany"	https://ClinicalTrials.gov/show/NCT04380701
1333	NCT03852537	Steroid Dosing by bioMARker Guided Titration in Critically Ill Patients With Pneumonia	Recruiting	No Results Available	Pneumonia	Drug: Methylprednisolone|Other: Usual Care	Phase 2	Interventional	"Mayo Clinic in Rochester, Rochester, Minnesota, United States"	https://ClinicalTrials.gov/show/NCT03852537
1334	NCT04393077	Emotional Freedom Technique (EFT) Effect on Nurses	Recruiting	No Results Available	"Stress|Anxiety|Burnout, Caregiver"	Behavioral: Emotional Freedom Technique	Not Applicable	Interventional	"Medeniyet University, Istanbul, Turkey"	https://ClinicalTrials.gov/show/NCT04393077
1335	NCT04346940	The Effectiveness of Telerehabilitation-Based Exercises in Elderly People	Not yet recruiting	No Results Available	Telerehabilitation|Elderly People|Social Isolation	Other: Telerehabilitation|Other: Exercise brochure	Not Applicable	Interventional		https://ClinicalTrials.gov/show/NCT04346940
1336	NCT04367168	Colchicine Twice Daily During 10 Days as an Option for the Treatment of Symptoms Induced by Inflammation in Patients With Mild and Severe Coronavirus Disease	Recruiting	No Results Available	COVID	Drug: Colchicine|Drug: Placebo oral tablet	Phase 2	Interventional	"Instituto Nacional de Ciencias Medicas y Nutricion, Mexico City, Mexico"	https://ClinicalTrials.gov/show/NCT04367168
1337	NCT04316377	Norwegian Coronavirus Disease 2019 Study	"Active, not recruiting"	No Results Available	Corona Virus Infection	Drug: Hydroxychloroquine Sulfate	Phase 4	Interventional	"Akershus University Hospital, Lørenskog, Norway"	https://ClinicalTrials.gov/show/NCT04316377
1338	NCT04276688	"Lopinavir/ Ritonavir, Ribavirin and IFN-beta Combination for nCoV Treatment"	Completed	No Results Available	Novel Coronavirus Infection	Drug: Lopinavir/ritonavir|Drug: Ribavirin|Drug: Interferon Beta-1B	Phase 2	Interventional	"University of Hong Kong, Queen Mary Hospital, Hong Kong, Hong Kong"	https://ClinicalTrials.gov/show/NCT04276688
1339	NCT04363177	Global Mental Health of Urban Mothers	Not yet recruiting	No Results Available	Perinatal Depression|COVID19|Anxiety|PTSD|Pregnancy Related	Behavioral: Web-based psychosocial peer-to-peer support	Not Applicable	Interventional	"Shanghai Women's and Children's Health Center, Shanghai, Shanghai, China|Chinese University Hong Kong, Hong Kong, Hong Kong"	https://ClinicalTrials.gov/show/NCT04363177
1340	NCT03680274	Lessening Organ Dysfunction With VITamin C	Recruiting	No Results Available	Sepsis|Vitamin C|Intensive Care Unit|COVID-19|Pandemic|Coronavirus	Drug: Vitamin C|Other: Control	Phase 3	Interventional	"Research Center of the CHUS, Sherbrooke, Quebec, Canada"	https://ClinicalTrials.gov/show/NCT03680274
1341	NCT04387253	Study of Late Fetal Loss in Poitou-Charentes. GYNE-COVID	Recruiting	No Results Available	Identification of the Mother or Fetus Contamination by SARS Cov-2|Research the Presence of Viruses at Different Sites of the Mother and the Fetus or Father|The Survey Builds on a Network Work Already Organized Around the CPDPN of Poitou-Charentes|Analysis Laboratories of the Poitiers CHU	Diagnostic Test: Identification by PCR of the SARS-COV-2 virus in samples taken from the fetus	Not Applicable	Interventional	"CHU de Poitiers, Poitiers, France"	https://ClinicalTrials.gov/show/NCT04387253
1342	NCT04441047	Universal Anti-Viral Vaccine for Healthy Elderly Adults	Not yet recruiting	No Results Available	Virus Diseases	Drug: AlloStim	Phase 1|Phase 2	Interventional	"Medical Oncology and Hematology, Bronx, New York, United States"	https://ClinicalTrials.gov/show/NCT04441047
1343	NCT04346966	The Effectiveness of Video-Based Exercises in Young Adults	Not yet recruiting	No Results Available	Social Isolation|Exercise|Healthy	Other: Study Group	Not Applicable	Interventional		https://ClinicalTrials.gov/show/NCT04346966
1344	NCT04379986	Remote Blood Pressure Monitoring With the Wearable SENBIOSYS Photoplethysmographic Device	Not yet recruiting	No Results Available	Blood Pressure	Device: Sensbiosys	Not Applicable	Interventional	"University and hospital Fribourg, Fribourg, Switzerland"	https://ClinicalTrials.gov/show/NCT04379986
1345	NCT04308668	Post-exposure Prophylaxis / Preemptive Therapy for SARS-Coronavirus-2	Completed	No Results Available	Corona Virus Infection|Acute Respiratory Distress Syndrome|SARS-CoV Infection|Coronavirus|Coronavirus Infections	Drug: Hydroxychloroquine|Other: Placebo	Phase 3	Interventional	"Nationwide Enrollment via Internet, please email: covid19@umn.edu, Minneapolis, Minnesota, United States|University of Minnesota, Minneapolis, Minnesota, United States|University of Alberta, Edmonton, Alberta, Canada|University of Manitoba, Winnipeg, Manitoba, Canada|Research Institute of the McGill University Heath Centre, Montréal, Quebec, Canada"	https://ClinicalTrials.gov/show/NCT04308668
1346	NCT04351880	Meals MATTER: A Trial of Medically Tailored Meals 2 Weeks vs. 4 Weeks Post Hospital Discharge	Recruiting	No Results Available	Heart Failure|Copd|Liver Failure|Covid19|Diabetes Mellitus|Cancer|End Stage Renal Disease	Other: Medically Tailored Meals	Not Applicable	Interventional	"St Joseph's Hospital, Denver, Colorado, United States|Good Samaritan Medical Center, Lafayette, Colorado, United States"	https://ClinicalTrials.gov/show/NCT04351880
1347	NCT04329897	Acceptance and Commitment Therapy Delivered by Automated Software Messaging	Enrolling by invitation	No Results Available	Hip Osteoarthritis|Knee Osteoarthritis|Mental Stress|Coronavirus	Behavioral: Software Messaging	Not Applicable	Interventional	"University of Iowa Hospitals and Clinics, Iowa City, Iowa, United States"	https://ClinicalTrials.gov/show/NCT04329897
1348	NCT04414826	Preliminary Efficacy of a One-Session Mindfulness Telehealth Intervention for Loneliness	Recruiting	No Results Available	Loneliness	Behavioral: Mindfulness Alone (MO) Intervention|Behavioral: Mindfulness + Compassion Intervention (MC)	Not Applicable	Interventional	"Laboratory for the Study of Anxiety Disorders, University of Texas at Austin, Austin, Texas, United States"	https://ClinicalTrials.gov/show/NCT04414826
1349	NCT04444986	Bioequivalence Study of Favir 200 mg Film Tablet Kocak Under Fasting Conditions	Completed	No Results Available	Bioequivalence	Drug: FAVIR 200 MG FT|Drug: AVIGAN 200 mg FT	Phase 1	Interventional	"Novagenix Drug R&D Center, Akyurt, Ankara, Turkey|Farmagen Ar-Ge Biyot. Ltd. Sti., Gaziantep, Turkey"	https://ClinicalTrials.gov/show/NCT04444986
1350	NCT04363775	Comparison of VieScope vs. Macintosh Laryngoscope for Intubation in Level Cpersonal Protective Equipment Conditions	Completed	No Results Available	Tracheal Intubation|Infection|Projection	Device: The standard Macintosh laryngoscope|Device: The Vie Scope laryngoscope	Not Applicable	Interventional	"Lazarski Univeristy, Warsaw, Poland"	https://ClinicalTrials.gov/show/NCT04363775
1351	NCT04392115	The PREPARE for COVID Trial	Not yet recruiting	No Results Available	Comorbidities and Coexisting Conditions|Social Isolation	Behavioral: The PREPARE program	Not Applicable	Interventional		https://ClinicalTrials.gov/show/NCT04392115
1352	NCT04424212	ICBT for Mental Health Problems Related to the Coronavirus Pandemic	Recruiting	No Results Available	Depression and Quality of Life Related to the Coronavirus Pandemic	Behavioral: Intervention group CoronaCope	Not Applicable	Interventional	"Linköping University, Linköping, Östergötland, Sweden"	https://ClinicalTrials.gov/show/NCT04424212
1353	NCT04346979	Telerehabilitation-based Yoga and Mindfulness Home Program in Postmenopausal Women Having Social Isolation	Not yet recruiting	No Results Available	Telerehabilitation	Other: Telerehabilitation-Based|Other: Video-Based	Not Applicable	Interventional		https://ClinicalTrials.gov/show/NCT04346979
1354	NCT04406194	"Bioequivalence Study of Favipiravir 200 mg Film Tablet (ATABAY, Turkey) Under Fasting Conditions"	"Active, not recruiting"	No Results Available	Bioequivalence	Drug: Favipiravir 200 mg	Phase 1	Interventional	"Novagenix Drug R&D Center, Akyurt, Ankara, Turkey|Farmagen Ar-Ge Biyot. Ltd. Sti., Sahinbey, Gaziantep, Turkey"	https://ClinicalTrials.gov/show/NCT04406194
1355	NCT04400682	"Bioequivalence Study of Favipiravir 200 mg Film Tablet (Novelfarma, Turkey) Under Fasting Conditions"	"Active, not recruiting"	No Results Available	Bioequivalence	Drug: Test Drug 200 mg favipiravir|Drug: Reference Drug 200 mg favipiravir	Phase 1	Interventional	"Novagenix Drug R&D Center, Akyurt, Ankara, Turkey|Farmagen Ar-Ge Biyot. Ltd. Sti., Sahinbey, Gaziantep, Turkey"	https://ClinicalTrials.gov/show/NCT04400682
1356	NCT04407000	"Bioequivalence Study of Favipiravir 200 mg Film Tablet (World Medicine, Turkey) Under Fasting Conditions"	Not yet recruiting	No Results Available	Bioequivalence	Drug: Test: Favipiravir 200 mg (LOQULAR)|Drug: Reference: Favipiravir 200 mg (Avigan)	Phase 1	Interventional	"Novagenix Drug R&D Center, Akyurt, Ankara, Turkey|Farmagen Ar-Ge Biyot. Ltd. Sti., Sahinbey, Gaziantep, Turkey"	https://ClinicalTrials.gov/show/NCT04407000
1357	NCT04386876	"Bioequivalence Study of Lopinavir/Ritonavir 200/50 mg Film Tablet (World Medicine Ilac, Turkey) Under Fasting Conditions"	"Active, not recruiting"	No Results Available	Bioequivalence	Drug: Lopinavir 200Mg/Ritonavir 50Mg FT Test|Drug: Lopinavir 200Mg/Ritonavir 50Mg FT Reference	Phase 1	Interventional	"Novagenix Drug R&D Center, Akyurt, Ankara, Turkey|Farmagen Ar-Ge Biyot. Ltd. Sti., Sahinbey, Gaziantep, Turkey"	https://ClinicalTrials.gov/show/NCT04386876
1358	NCT04276987	A Pilot Clinical Study on Inhalation of Mesenchymal Stem Cells Exosomes Treating Severe Novel Coronavirus Pneumonia	Not yet recruiting	No Results Available	Coronavirus	Biological: MSCs-derived exosomes	Phase 1	Interventional		https://ClinicalTrials.gov/show/NCT04276987